data_6qjb_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6qjb _Structure_validation_residue.Date_analyzed 2019-06-28 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 5.9 t80 . . . . . 0 N--CA 1.504 2.265 0 N-CA-C 115.929 1.826 . . . . 0.0 115.929 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -120.04 152.46 37.49 Favored 'General case' 0 C--N 1.356 0.848 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 163.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.6 p -124.63 135.99 62.11 Favored 'Isoleucine or valine' 0 C--N 1.348 0.54 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 176.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.3 m -129.96 157.29 42.54 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.681 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 177.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 85.3 p -79.7 152.67 29.78 Favored 'General case' 0 N--CA 1.447 -0.585 0 O-C-N 121.246 -0.909 . . . . 0.0 112.57 173.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 16.6 t -110.22 9.6 23.81 Favored 'General case' 0 C--N 1.352 0.701 0 O-C-N 121.274 -0.891 . . . . 0.0 110.892 -174.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 56.51 42.95 26.64 Favored 'General case' 0 C--N 1.355 0.842 0 C-N-CA 126.762 2.025 . . . . 0.0 114.736 175.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 54.2 tptt -140.87 137.64 33.37 Favored 'General case' 0 C--N 1.351 0.657 0 O-C-N 120.668 -1.27 . . . . 0.0 107.801 177.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -91.03 130.11 36.97 Favored 'General case' 0 C--N 1.351 0.632 0 C-N-CA 125.642 1.577 . . . . 0.0 109.946 -177.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 10.6 p -111.43 156.13 22.11 Favored 'General case' 0 C--N 1.358 0.955 0 O-C-N 121.415 -0.803 . . . . 0.0 109.131 -178.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 21.4 p -127.04 152.72 46.88 Favored 'General case' 0 CA--C 1.496 -1.098 0 O-C-N 121.069 -1.019 . . . . 0.0 112.745 177.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 40.7 t -63.91 126.16 26.76 Favored 'General case' 0 C--N 1.359 0.995 0 CA-C-O 122.437 1.113 . . . . 0.0 110.249 177.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 92.63 -9.19 76.19 Favored Glycine 0 C--N 1.344 1.026 0 CA-C-N 114.975 -1.011 . . . . 0.0 113.05 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 15.1 mm-40 -121.54 -46.75 2.25 Favored 'General case' 0 C--N 1.352 0.677 0 CA-C-N 118.374 1.087 . . . . 0.0 111.902 179.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 51.41 47.51 24.68 Favored 'General case' 0 C--N 1.36 1.039 0 N-CA-C 116.343 1.979 . . . . 0.0 116.343 -177.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -67.5 118.03 10.26 Favored 'General case' 0 C--N 1.355 0.841 0 O-C-N 120.791 -1.193 . . . . 0.0 113.216 178.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 73.5 m -137.76 158.07 72.3 Favored Pre-proline 0 C--N 1.352 0.69 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 169.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.07 159.03 54.61 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.473 2.116 . . . . 0.0 110.428 164.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 58.6 mp0 -64.04 134.06 54.26 Favored 'General case' 0 C--N 1.352 0.717 0 CA-C-O 121.812 0.815 . . . . 0.0 112.467 -173.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 98.35 -15.06 61.75 Favored Glycine 0 C--N 1.355 1.601 0 C-N-CA 123.799 0.714 . . . . 0.0 112.934 -174.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 93.1 m -110.21 157.7 19.15 Favored 'General case' 0 C--N 1.349 0.549 0 C-N-CA 124.23 1.012 . . . . 0.0 110.248 176.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 28.4 p90 -142.14 164.31 30.51 Favored 'General case' 0 C--N 1.348 0.541 0 N-CA-C 105.674 -1.973 . . . . 0.0 105.674 -175.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 36.3 t -117.45 128.48 55.04 Favored 'General case' 0 CA--C 1.51 -0.578 0 O-C-N 121.039 -1.038 . . . . 0.0 108.915 -177.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -85.75 61.81 4.49 Favored Glycine 0 C--N 1.353 1.516 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 176.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.1 tt -69.81 139.55 53.2 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 125.159 1.384 . . . . 0.0 110.502 -175.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -80.89 72.37 7.88 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 125.423 1.489 . . . . 0.0 108.997 -163.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.75 14.71 81.19 Favored Glycine 0 C--N 1.352 1.456 0 O-C-N 120.689 -1.257 . . . . 0.0 113.292 178.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 56.35 41.24 29.29 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 127.35 2.26 . . . . 0.0 114.664 -170.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -68.47 -45.15 73.21 Favored 'General case' 0 C--N 1.356 0.887 0 N-CA-C 115.726 1.75 . . . . 0.0 115.726 174.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 17.5 pttp -155.15 -64.65 0.12 Allowed 'General case' 0 C--N 1.348 0.539 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -176.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.8 ptmt -157.21 161.2 39.26 Favored 'General case' 0 N--CA 1.439 -1.022 0 O-C-N 121.111 -0.993 . . . . 0.0 108.638 -172.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -159.28 -171.78 25.54 Favored Glycine 0 C--N 1.345 1.045 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 175.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 77.7 t60 -127.3 140.87 51.91 Favored 'General case' 0 C--N 1.35 0.603 0 O-C-N 121.301 -1.117 . . . . 0.0 108.309 -175.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 75.0 m -76.87 145.73 38.14 Favored 'General case' 0 C--N 1.356 0.879 0 O-C-N 120.83 -1.169 . . . . 0.0 113.626 -172.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -126.07 162.48 25.21 Favored 'General case' 0 C--N 1.358 0.976 0 C-N-CA 123.89 0.876 . . . . 0.0 108.815 -175.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -121.4 136.43 54.96 Favored 'General case' 0 C--N 1.351 0.632 0 C-N-CA 124.616 1.166 . . . . 0.0 108.514 166.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 84.8 mt -98.39 126.28 51.52 Favored 'Isoleucine or valine' 0 C--N 1.359 0.997 0 C-N-CA 124.851 1.261 . . . . 0.0 109.137 172.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.55 148.32 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 C-N-CA 125.321 1.448 . . . . 0.0 108.388 176.371 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.349 1.292 0 O-C-N 119.884 -1.76 . . . . 0.0 110.845 -176.804 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 14.0 t80 . . . . . 0 N--CA 1.504 2.249 0 N-CA-C 116.314 1.968 . . . . 0.0 116.314 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -123.05 155.62 36.52 Favored 'General case' 0 C--N 1.355 0.825 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 166.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.3 p -126.81 135.81 62.61 Favored 'Isoleucine or valine' 0 C--N 1.349 0.572 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 174.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 30.2 m -131.58 159.73 42.86 Favored 'Isoleucine or valine' 0 C--N 1.35 0.63 0 C-N-CA 124.709 1.204 . . . . 0.0 107.8 175.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 87.8 p -77.6 153.41 33.26 Favored 'General case' 0 C--N 1.351 0.646 0 CA-C-O 122.15 0.976 . . . . 0.0 112.58 174.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 8.8 t -104.73 3.59 31.53 Favored 'General case' 0 C--N 1.353 0.724 0 O-C-N 121.21 -0.931 . . . . 0.0 110.298 -176.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 72.4 m-80 58.26 41.38 23.49 Favored 'General case' 0 C--N 1.356 0.877 0 C-N-CA 127.456 2.303 . . . . 0.0 114.378 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 52.6 tptt -139.72 134.54 32.06 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 -177.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -89.01 133.61 34.27 Favored 'General case' 0 C--N 1.355 0.836 0 C-N-CA 125.002 1.321 . . . . 0.0 109.288 -179.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 26.1 p -131.99 152.58 51.04 Favored 'General case' 0 C--N 1.352 0.711 0 CA-C-O 122.049 0.928 . . . . 0.0 110.424 177.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.7 m -127.39 149.52 50.04 Favored 'General case' 0 C--N 1.349 0.569 0 N-CA-C 105.56 -2.015 . . . . 0.0 105.56 -167.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 36.6 t -62.71 133.43 54.8 Favored 'General case' 0 C--N 1.36 1.055 0 O-C-N 120.689 -1.257 . . . . 0.0 109.907 170.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 92.88 -15.08 63.58 Favored Glycine 0 C--N 1.349 1.286 0 C-N-CA 123.841 0.734 . . . . 0.0 112.443 -172.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -113.79 -53.56 2.67 Favored 'General case' 0 C--N 1.356 0.866 0 CA-C-N 118.652 1.226 . . . . 0.0 111.954 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 49.36 41.75 21.06 Favored 'General case' 0 C--N 1.364 1.204 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 -176.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 59.6 mm-40 -83.95 112.93 20.61 Favored 'General case' 0 C--N 1.353 0.752 0 O-C-N 120.436 -1.415 . . . . 0.0 111.581 -179.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 79.0 m -134.83 155.57 79.23 Favored Pre-proline 0 C--N 1.35 0.601 0 N-CA-C 106.169 -1.789 . . . . 0.0 106.169 171.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -70.54 160.1 50.59 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.589 2.192 . . . . 0.0 110.574 165.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -65.02 141.46 58.76 Favored 'General case' 0 C--N 1.353 0.757 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -175.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.8 -13.88 65.6 Favored Glycine 0 C--N 1.354 1.554 0 C-N-CA 123.774 0.702 . . . . 0.0 112.522 -172.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 71.2 m -115.32 154.94 28.23 Favored 'General case' 0 C--N 1.349 0.562 0 C-N-CA 124.487 1.115 . . . . 0.0 109.929 178.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -129.9 158.61 39.04 Favored 'General case' 0 C--N 1.352 0.686 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -178.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 52.2 t -88.66 126.53 35.35 Favored 'General case' 0 C--N 1.35 0.593 0 O-C-N 121.494 -0.754 . . . . 0.0 110.609 -174.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -82.55 67.88 3.64 Favored Glycine 0 C--N 1.356 1.665 0 O-C-N 121.107 -0.996 . . . . 0.0 113.79 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 56.7 mt -104.76 134.17 48.36 Favored 'General case' 0 CA--C 1.505 -0.759 0 C-N-CA 125.142 1.377 . . . . 0.0 110.429 170.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -70.0 -44.86 68.52 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 125.479 1.512 . . . . 0.0 111.035 -166.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -160.93 49.65 0.36 Allowed Glycine 0 C--N 1.346 1.123 0 N-CA-C 107.279 -2.328 . . . . 0.0 107.279 170.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 17.4 mp0 52.73 51.21 16.45 Favored 'General case' 0 C--N 1.356 0.862 0 C-N-CA 127.011 2.124 . . . . 0.0 114.605 -177.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 23.2 m120 -92.33 -53.69 4.12 Favored 'General case' 0 C--N 1.357 0.9 0 O-C-N 120.494 -1.379 . . . . 0.0 112.628 -166.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -131.46 -98.69 0.31 Allowed 'General case' 0 C--N 1.355 0.811 0 CA-C-O 122.394 1.092 . . . . 0.0 109.774 -174.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 15.0 ptmm? -138.25 156.93 47.2 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 106.012 -1.847 . . . . 0.0 106.012 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -148.53 -171.03 16.95 Favored Glycine 0 CA--C 1.493 -1.284 0 N-CA-C 108.405 -1.878 . . . . 0.0 108.405 -178.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 51.6 t60 -132.42 147.42 52.38 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 104.712 -2.329 . . . . 0.0 104.712 -176.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 71.9 m -78.46 139.38 38.71 Favored 'General case' 0 C--N 1.351 0.636 0 O-C-N 120.984 -1.072 . . . . 0.0 112.079 -174.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -125.72 156.91 38.63 Favored 'General case' 0 C--N 1.351 0.671 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 -176.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -112.46 135.54 53.04 Favored 'General case' 0 C--N 1.35 0.625 0 C-N-CA 124.043 0.937 . . . . 0.0 109.669 175.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 43.0 mm -91.8 122.06 42.88 Favored 'Isoleucine or valine' 0 C--N 1.361 1.091 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 172.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.64 137.54 57.05 Favored 'Isoleucine or valine' 0 C--N 1.351 0.663 0 CA-C-O 122.363 1.078 . . . . 0.0 110.46 169.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.327 0 N-CA-C 106.014 -2.834 . . . . 0.0 106.014 -176.072 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 14.0 t80 . . . . . 0 N--CA 1.503 2.218 0 N-CA-C 116.702 2.112 . . . . 0.0 116.702 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -111.74 151.83 28.49 Favored 'General case' 0 C--N 1.353 0.73 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 159.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.2 p -126.33 136.02 62.06 Favored 'Isoleucine or valine' 0 C--N 1.351 0.65 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 173.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.9 m -133.72 159.39 42.59 Favored 'Isoleucine or valine' 0 C--N 1.353 0.727 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 176.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 87.4 p -80.42 154.32 27.73 Favored 'General case' 0 C--N 1.349 0.547 0 CA-C-O 121.684 0.754 . . . . 0.0 112.934 171.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 78.2 m -105.38 5.0 31.4 Favored 'General case' 0 C--N 1.356 0.866 0 O-C-N 121.114 -0.991 . . . . 0.0 111.539 173.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 58.16 40.73 24.71 Favored 'General case' 0 C--N 1.355 0.821 0 C-N-CA 126.928 2.091 . . . . 0.0 114.977 178.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 37.2 mmtm -132.7 142.83 49.24 Favored 'General case' 0 C--N 1.351 0.632 0 C-N-CA 124.593 1.157 . . . . 0.0 110.416 176.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.5 t30 -88.09 133.29 34.02 Favored 'General case' 0 C--N 1.351 0.668 0 C-N-CA 126.374 1.87 . . . . 0.0 109.135 176.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 13.8 p -109.31 153.51 23.8 Favored 'General case' 0 C--N 1.356 0.887 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 171.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 59.7 m -128.9 145.71 51.14 Favored 'General case' 0 C--N 1.346 0.435 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 -173.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 47.4 t -59.2 138.53 57.55 Favored 'General case' 0 C--N 1.358 0.937 0 C-N-CA 123.829 0.852 . . . . 0.0 112.941 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.94 -53.88 4.4 Favored Glycine 0 C--N 1.358 1.774 0 C-N-CA 124.666 1.127 . . . . 0.0 112.377 -175.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -64.39 -45.74 86.35 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 128.685 2.794 . . . . 0.0 115.465 -178.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.4 m120 54.99 43.01 30.55 Favored 'General case' 0 C--N 1.355 0.814 0 C-N-CA 127.084 2.154 . . . . 0.0 115.654 168.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 55.2 mm-40 -75.76 117.89 18.0 Favored 'General case' 0 C--N 1.354 0.784 0 O-C-N 120.124 -1.61 . . . . 0.0 113.929 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 77.1 m -138.06 155.99 74.22 Favored Pre-proline 0 C--N 1.354 0.793 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 159.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.21 160.08 50.07 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 123.109 2.539 . . . . 0.0 111.25 166.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -62.94 131.14 47.69 Favored 'General case' 0 C--N 1.353 0.718 0 C-N-CA 123.539 0.735 . . . . 0.0 112.534 -176.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 100.27 -14.07 59.79 Favored Glycine 0 C--N 1.356 1.649 0 C-N-CA 123.827 0.727 . . . . 0.0 112.679 -174.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 75.0 m -112.69 156.67 22.38 Favored 'General case' 0 C--N 1.349 0.549 0 C-N-CA 124.055 0.942 . . . . 0.0 109.145 177.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -141.47 163.03 34.03 Favored 'General case' 0 C--N 1.348 0.509 0 N-CA-C 105.346 -2.094 . . . . 0.0 105.346 -178.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 46.3 t -124.25 125.9 45.18 Favored 'General case' 0 CA--C 1.508 -0.665 0 O-C-N 120.85 -1.156 . . . . 0.0 109.59 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -85.9 63.94 4.16 Favored Glycine 0 C--N 1.354 1.544 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 177.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -69.46 141.16 54.07 Favored 'General case' 0 C--N 1.349 0.573 0 C-N-CA 125.27 1.428 . . . . 0.0 110.292 -178.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -81.59 69.94 8.36 Favored 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 125.502 1.521 . . . . 0.0 109.288 -161.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.76 24.31 76.31 Favored Glycine 0 C--N 1.352 1.438 0 O-C-N 120.975 -1.078 . . . . 0.0 113.943 178.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 69.2 mm-40 58.32 34.29 23.91 Favored 'General case' 0 C--N 1.356 0.88 0 C-N-CA 126.2 1.8 . . . . 0.0 114.592 -175.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 57.4 m-80 -76.38 -46.92 25.17 Favored 'General case' 0 C--N 1.356 0.871 0 O-C-N 120.028 -1.67 . . . . 0.0 115.371 176.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 48.2 mmtm -137.7 -100.97 0.19 Allowed 'General case' 0 C--N 1.348 0.542 0 CA-C-O 122.103 0.954 . . . . 0.0 110.124 -173.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 10.3 ptpp? -143.58 161.65 37.94 Favored 'General case' 0 N--CA 1.436 -1.136 0 C-N-CA 125.311 1.444 . . . . 0.0 107.654 -173.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -154.91 -174.13 24.5 Favored Glycine 0 C--N 1.344 1.005 0 N-CA-C 108.748 -1.741 . . . . 0.0 108.748 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 52.6 t60 -126.7 142.97 51.38 Favored 'General case' 0 C--N 1.35 0.589 0 O-C-N 121.159 -1.201 . . . . 0.0 108.218 -173.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 75.9 m -80.15 139.98 36.57 Favored 'General case' 0 C--N 1.356 0.849 0 O-C-N 120.751 -1.218 . . . . 0.0 112.978 -173.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -128.0 162.15 27.48 Favored 'General case' 0 C--N 1.357 0.919 0 C-N-CA 124.0 0.92 . . . . 0.0 108.986 -173.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -116.35 137.91 51.77 Favored 'General case' 0 C--N 1.352 0.7 0 C-N-CA 124.596 1.158 . . . . 0.0 108.267 164.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 83.5 mt -95.56 126.42 48.08 Favored 'Isoleucine or valine' 0 C--N 1.358 0.972 0 C-N-CA 125.726 1.61 . . . . 0.0 107.54 167.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 4.7 mp -115.75 125.71 73.01 Favored 'Isoleucine or valine' 0 C--N 1.355 0.836 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 -177.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.353 1.503 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 173.434 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 13.3 t80 . . . . . 0 N--CA 1.503 2.205 0 N-CA-C 116.773 2.138 . . . . 0.0 116.773 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -120.53 150.6 40.6 Favored 'General case' 0 C--N 1.356 0.867 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 165.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.2 p -122.93 134.41 66.16 Favored 'Isoleucine or valine' 0 C--N 1.351 0.643 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 171.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 28.4 m -132.21 156.97 42.97 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.619 0 C-N-CA 124.983 1.313 . . . . 0.0 107.547 177.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 96.5 p -81.16 158.27 25.0 Favored 'General case' 0 C--N 1.353 0.735 0 CA-C-O 122.391 1.091 . . . . 0.0 112.342 175.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 79.0 m -98.77 10.53 41.01 Favored 'General case' 0 C--N 1.349 0.556 0 C-N-CA 125.007 1.323 . . . . 0.0 110.194 176.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 8.3 m120 62.69 21.55 12.8 Favored 'General case' 0 C--N 1.356 0.87 0 C-N-CA 128.788 2.835 . . . . 0.0 114.146 177.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt -118.8 143.12 47.12 Favored 'General case' 0 CA--C 1.511 -0.553 0 C-N-CA 125.038 1.335 . . . . 0.0 111.586 179.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -96.83 130.03 44.17 Favored 'General case' 0 C--N 1.351 0.666 0 C-N-CA 126.878 2.071 . . . . 0.0 109.992 178.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 14.2 p -103.17 155.69 18.24 Favored 'General case' 0 C--N 1.354 0.786 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 170.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 61.6 m -130.38 145.34 51.79 Favored 'General case' 0 C--N 1.353 0.749 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 -177.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 39.7 t -60.6 133.12 55.79 Favored 'General case' 0 C--N 1.356 0.855 0 O-C-N 119.531 -1.981 . . . . 0.0 112.003 177.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.71 -18.96 56.13 Favored Glycine 0 C--N 1.352 1.43 0 C-N-CA 125.024 1.297 . . . . 0.0 112.824 -172.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -148.8 102.21 3.26 Favored 'General case' 0 C--N 1.355 0.808 0 CA-C-O 123.847 1.784 . . . . 0.0 111.233 174.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 33.7 m120 -80.91 82.63 6.84 Favored 'General case' 0 C--N 1.353 0.747 0 O-C-N 120.058 -1.652 . . . . 0.0 110.833 -175.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -82.5 75.81 9.4 Favored 'General case' 0 C--N 1.353 0.734 0 C-N-CA 124.461 1.105 . . . . 0.0 112.581 -167.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 74.7 m -118.63 151.21 49.56 Favored Pre-proline 0 C--N 1.351 0.668 0 O-C-N 120.694 -1.254 . . . . 0.0 110.806 177.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -71.83 159.77 49.71 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.776 2.318 . . . . 0.0 110.603 163.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -63.77 134.82 55.99 Favored 'General case' 0 C--N 1.352 0.684 0 C-N-CA 123.503 0.721 . . . . 0.0 112.524 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 98.59 -10.51 62.84 Favored Glycine 0 C--N 1.356 1.639 0 C-N-CA 123.817 0.722 . . . . 0.0 113.542 -175.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 82.5 m -112.77 154.47 26.15 Favored 'General case' 0 C--N 1.348 0.52 0 CA-C-N 118.003 0.901 . . . . 0.0 108.891 178.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -129.03 160.36 32.99 Favored 'General case' 0 C--N 1.353 0.737 0 N-CA-C 104.691 -2.337 . . . . 0.0 104.691 177.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 41.9 t -114.21 128.59 56.44 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-N 120.586 1.539 . . . . 0.0 109.33 178.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -83.8 61.6 4.72 Favored Glycine 0 C--N 1.355 1.595 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -81.93 137.79 35.11 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 124.21 1.004 . . . . 0.0 109.142 -175.063 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -81.21 72.24 8.23 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 125.637 1.575 . . . . 0.0 109.044 -163.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.67 20.25 79.78 Favored Glycine 0 C--N 1.354 1.554 0 O-C-N 120.742 -1.224 . . . . 0.0 113.692 178.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 56.37 39.67 30.0 Favored 'General case' 0 C--N 1.352 0.717 0 C-N-CA 127.376 2.271 . . . . 0.0 114.091 -172.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 61.2 m-80 -80.47 -45.14 18.06 Favored 'General case' 0 C--N 1.351 0.671 0 N-CA-C 115.073 1.509 . . . . 0.0 115.073 173.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -131.0 -105.34 0.27 Allowed 'General case' 0 C--N 1.354 0.78 0 O-C-N 121.109 -0.995 . . . . 0.0 111.756 -169.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.03 164.57 31.68 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 105.38 -2.082 . . . . 0.0 105.38 -178.021 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -166.16 179.64 40.14 Favored Glycine 0 CA--C 1.493 -1.299 0 N-CA-C 108.25 -1.94 . . . . 0.0 108.25 178.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 12.3 m80 -105.83 150.94 25.12 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 115.689 1.737 . . . . 0.0 115.689 176.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 81.0 m -81.68 134.35 35.46 Favored 'General case' 0 C--N 1.353 0.733 0 C-N-CA 125.347 1.459 . . . . 0.0 110.047 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -127.68 158.97 36.14 Favored 'General case' 0 C--N 1.351 0.654 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 -172.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 20.7 pttm -125.22 154.87 40.96 Favored 'General case' 0 C--N 1.352 0.717 0 CA-C-O 121.987 0.898 . . . . 0.0 111.55 168.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 46.4 mm -103.62 121.15 54.68 Favored 'Isoleucine or valine' 0 C--N 1.353 0.725 0 C-N-CA 125.397 1.479 . . . . 0.0 107.671 -175.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.24 146.9 33.51 Favored 'Isoleucine or valine' 0 C--N 1.353 0.739 0 CA-C-O 121.908 0.861 . . . . 0.0 110.443 175.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.355 1.598 0 O-C-N 121.21 -0.931 . . . . 0.0 113.889 -179.88 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 11.3 t80 . . . . . 0 N--CA 1.504 2.25 0 N-CA-C 116.254 1.946 . . . . 0.0 116.254 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -123.19 147.91 46.35 Favored 'General case' 0 C--N 1.357 0.892 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 158.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 5.3 p -126.89 135.38 63.83 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.62 0 C-N-CA 124.474 1.109 . . . . 0.0 108.418 174.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 30.4 m -129.97 158.97 42.43 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.638 0 C-N-CA 124.715 1.206 . . . . 0.0 108.265 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 78.9 p -76.43 143.05 40.82 Favored 'General case' 0 N--CA 1.446 -0.647 0 O-C-N 121.186 -0.946 . . . . 0.0 112.741 174.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 15.5 t -91.98 -1.8 57.07 Favored 'General case' 0 C--N 1.354 0.768 0 O-C-N 121.256 -0.903 . . . . 0.0 110.916 178.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 54.5 t30 59.95 46.45 11.05 Favored 'General case' 0 C--N 1.356 0.869 0 C-N-CA 127.591 2.357 . . . . 0.0 113.55 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 55.6 tptt -140.98 138.26 33.62 Favored 'General case' 0 C--N 1.352 0.679 0 O-C-N 121.086 -1.009 . . . . 0.0 108.429 178.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -84.4 133.56 34.5 Favored 'General case' 0 C--N 1.355 0.816 0 C-N-CA 125.7 1.6 . . . . 0.0 111.217 176.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 26.0 p -132.48 157.37 44.81 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 122.122 0.963 . . . . 0.0 110.434 173.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 37.3 p -128.87 165.44 21.02 Favored 'General case' 0 CA--C 1.5 -0.978 0 C-N-CA 124.794 1.238 . . . . 0.0 111.362 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 47.3 t -58.94 135.1 57.48 Favored 'General case' 0 C--N 1.355 0.839 0 C-N-CA 125.956 1.702 . . . . 0.0 111.465 177.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 82.66 -61.08 4.8 Favored Glycine 0 C--N 1.352 1.456 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 -170.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 24.4 mm100 -62.15 -48.48 79.89 Favored 'General case' 0 C--N 1.351 0.643 0 N-CA-C 117.047 2.24 . . . . 0.0 117.047 -174.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 48.52 36.93 8.12 Favored 'General case' 0 C--N 1.359 1.006 0 N-CA-C 115.917 1.821 . . . . 0.0 115.917 175.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -81.53 117.79 22.22 Favored 'General case' 0 C--N 1.356 0.866 0 O-C-N 120.464 -1.397 . . . . 0.0 112.382 -173.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 82.1 m -137.14 158.03 73.35 Favored Pre-proline 0 N--CA 1.448 -0.548 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 176.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -70.15 159.96 51.28 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.626 2.217 . . . . 0.0 110.609 164.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -64.73 140.81 58.91 Favored 'General case' 0 C--N 1.353 0.73 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -174.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.22 -13.45 66.84 Favored Glycine 0 C--N 1.355 1.585 0 O-C-N 121.562 -0.711 . . . . 0.0 112.806 -173.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 72.8 m -115.41 155.09 28.05 Favored 'General case' 0 C--N 1.349 0.577 0 C-N-CA 124.458 1.103 . . . . 0.0 110.247 178.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -127.18 161.34 28.75 Favored 'General case' 0 C--N 1.348 0.527 0 C-N-CA 124.763 1.225 . . . . 0.0 109.472 178.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 53.2 t -86.83 125.46 33.99 Favored 'General case' 0 C--N 1.35 0.603 0 C-N-CA 123.939 0.895 . . . . 0.0 110.9 -177.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -91.08 84.82 1.28 Allowed Glycine 0 C--N 1.355 1.603 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 172.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -103.75 139.9 38.35 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 -179.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -80.29 68.11 6.35 Favored 'General case' 0 C--N 1.351 0.632 0 C-N-CA 125.162 1.385 . . . . 0.0 109.111 -175.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.16 21.51 77.12 Favored Glycine 0 C--N 1.356 1.646 0 O-C-N 120.699 -1.251 . . . . 0.0 113.695 179.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 56.91 35.37 26.26 Favored 'General case' 0 C--N 1.348 0.543 0 C-N-CA 127.365 2.266 . . . . 0.0 116.401 -173.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 61.3 m-80 -67.68 -44.8 76.94 Favored 'General case' 0 C--N 1.357 0.896 0 N-CA-C 115.065 1.506 . . . . 0.0 115.065 168.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.459 ' HG3' ' H ' ' A' ' 47' ' ' LYS . 20.1 pttp -149.33 -106.2 0.07 Allowed 'General case' 0 C--N 1.354 0.764 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 -173.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.459 ' H ' ' HG3' ' A' ' 46' ' ' LYS . 25.8 pttm -119.27 159.07 24.79 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 125.388 1.475 . . . . 0.0 110.109 -177.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -154.79 -166.76 15.62 Favored Glycine 0 C--N 1.352 1.417 0 N-CA-C 110.504 -1.039 . . . . 0.0 110.504 178.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 50.5 t60 -136.49 146.35 46.17 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 -172.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 79.2 m -79.92 140.88 36.52 Favored 'General case' 0 C--N 1.349 0.561 0 O-C-N 120.752 -1.218 . . . . 0.0 111.637 -177.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 17.3 m-30 -126.03 162.41 25.35 Favored 'General case' 0 C--N 1.355 0.823 0 O-C-N 121.048 -1.032 . . . . 0.0 108.821 -178.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -123.68 137.44 54.71 Favored 'General case' 0 C--N 1.352 0.689 0 C-N-CA 124.422 1.089 . . . . 0.0 108.448 168.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 94.3 mt -107.16 130.05 59.91 Favored 'Isoleucine or valine' 0 C--N 1.361 1.085 0 C-N-CA 124.242 1.017 . . . . 0.0 108.782 177.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -131.57 149.97 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 C-N-CA 125.796 1.639 . . . . 0.0 110.153 -177.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.35 1.355 0 N-CA-C 107.945 -2.062 . . . . 0.0 107.945 -177.846 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 7.5 t80 . . . . . 0 N--CA 1.5 2.075 0 N-CA-C 116.222 1.934 . . . . 0.0 116.222 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 49.0 m-20 -120.35 149.64 42.02 Favored 'General case' 0 C--N 1.354 0.782 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 161.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.9 p -125.21 135.15 64.95 Favored 'Isoleucine or valine' 0 C--N 1.35 0.593 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 174.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 28.9 m -132.01 155.88 41.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.574 0 C-N-CA 123.481 0.712 . . . . 0.0 109.122 179.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 79.2 p -79.91 147.87 31.49 Favored 'General case' 0 C--N 1.349 0.549 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 175.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 10.9 t -102.5 -4.13 25.82 Favored 'General case' 0 C--N 1.353 0.754 0 C-N-CA 123.732 0.813 . . . . 0.0 112.062 -175.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 56.6 t30 58.95 44.48 16.38 Favored 'General case' 0 C--N 1.357 0.91 0 C-N-CA 127.176 2.19 . . . . 0.0 113.656 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.5 tppt? -144.06 146.44 32.83 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 102.473 -3.158 . . . . 0.0 102.473 173.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.4 p-10 -120.05 167.96 11.67 Favored 'General case' 0 C--N 1.355 0.845 0 CA-C-N 120.976 1.716 . . . . 0.0 110.402 171.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 57.1 m -116.42 160.87 19.93 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 173.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 32.3 m -111.23 159.33 18.0 Favored 'General case' 0 C--N 1.345 0.409 0 N-CA-C 102.231 -3.248 . . . . 0.0 102.231 166.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.2 t -58.6 144.1 44.07 Favored 'General case' 0 C--N 1.352 0.716 0 CA-C-O 122.353 1.073 . . . . 0.0 112.922 178.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.58 -58.62 4.85 Favored Glycine 0 C--N 1.353 1.523 0 C-N-CA 124.125 0.869 . . . . 0.0 111.359 -171.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -63.55 -45.77 89.01 Favored 'General case' 0 C--N 1.348 0.535 0 N-CA-C 115.503 1.668 . . . . 0.0 115.503 -167.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 50.54 44.53 27.17 Favored 'General case' 0 C--N 1.36 1.039 0 N-CA-C 116.557 2.058 . . . . 0.0 116.557 175.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -91.93 114.77 27.4 Favored 'General case' 0 C--N 1.35 0.609 0 C-N-CA 124.396 1.079 . . . . 0.0 111.683 -176.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 98.2 m -132.6 157.4 78.41 Favored Pre-proline 0 C--N 1.351 0.671 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 171.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -69.72 160.27 50.34 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 122.775 2.317 . . . . 0.0 110.021 166.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -63.72 135.65 56.85 Favored 'General case' 0 C--N 1.353 0.75 0 N-CA-C 113.269 0.841 . . . . 0.0 113.269 -171.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.9 -12.62 65.7 Favored Glycine 0 C--N 1.355 1.587 0 C-N-CA 123.921 0.772 . . . . 0.0 113.212 -175.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 73.3 m -115.45 153.71 30.61 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-N 118.023 0.912 . . . . 0.0 110.489 -178.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -139.24 154.65 48.03 Favored 'General case' 0 C--N 1.355 0.831 0 O-C-N 121.099 -1.001 . . . . 0.0 110.015 -178.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 53.0 m -94.7 136.3 35.17 Favored 'General case' 0 C--N 1.353 0.752 0 CA-C-O 121.879 0.847 . . . . 0.0 111.053 168.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -91.88 90.05 1.47 Allowed Glycine 0 C--N 1.351 1.386 0 N-CA-C 107.332 -2.307 . . . . 0.0 107.332 167.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -106.1 125.52 51.1 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 -168.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -90.17 79.44 6.43 Favored 'General case' 0 C--N 1.352 0.678 0 O-C-N 120.987 -1.071 . . . . 0.0 109.68 -156.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 67.16 42.12 91.67 Favored Glycine 0 C--N 1.354 1.557 0 O-C-N 120.95 -1.094 . . . . 0.0 115.09 172.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 47.64 45.14 17.87 Favored 'General case' 0 C--N 1.354 0.766 0 C-N-CA 128.403 2.681 . . . . 0.0 116.843 -175.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 -94.62 -72.83 0.6 Allowed 'General case' 0 C--N 1.355 0.821 0 N-CA-C 114.72 1.378 . . . . 0.0 114.72 175.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -116.01 -96.41 0.46 Allowed 'General case' 0 C--N 1.357 0.919 0 O-C-N 120.536 -1.352 . . . . 0.0 113.083 -161.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -154.18 161.2 42.01 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 104.719 -2.326 . . . . 0.0 104.719 -171.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -154.25 156.48 26.87 Favored Glycine 0 CA--C 1.493 -1.329 0 N-CA-C 108.709 -1.756 . . . . 0.0 108.709 -177.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 73.6 t60 -101.45 144.84 29.74 Favored 'General case' 0 C--N 1.345 0.391 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 -175.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 72.3 m -78.98 133.22 36.87 Favored 'General case' 0 C--N 1.358 0.957 0 O-C-N 120.737 -1.227 . . . . 0.0 111.165 -178.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -123.61 159.91 28.23 Favored 'General case' 0 C--N 1.354 0.766 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 -175.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -118.98 135.09 54.79 Favored 'General case' 0 C--N 1.349 0.55 0 C-N-CA 124.228 1.011 . . . . 0.0 108.365 168.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 78.5 mt -101.28 125.71 55.22 Favored 'Isoleucine or valine' 0 C--N 1.358 0.944 0 C-N-CA 125.344 1.458 . . . . 0.0 109.038 173.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.5 162.4 39.88 Favored 'Isoleucine or valine' 0 C--N 1.351 0.644 0 C-N-CA 124.986 1.314 . . . . 0.0 110.678 179.153 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.355 1.593 0 O-C-N 121.074 -1.016 . . . . 0.0 111.667 -175.982 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 6.6 t80 . . . . . 0 N--CA 1.5 2.036 0 N-CA-C 115.0 1.481 . . . . 0.0 115.0 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -117.42 154.27 31.66 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 106.407 -1.701 . . . . 0.0 106.407 161.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.4 p -125.71 134.24 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 178.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.3 m -132.18 157.61 43.12 Favored 'Isoleucine or valine' 0 C--N 1.352 0.684 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 177.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 80.4 p -79.91 153.38 29.03 Favored 'General case' 0 C--N 1.349 0.548 0 O-C-N 120.704 -1.248 . . . . 0.0 113.97 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 21.0 t -121.96 25.25 9.22 Favored 'General case' 0 C--N 1.358 0.95 0 O-C-N 121.219 -0.926 . . . . 0.0 111.381 -171.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 45.57 39.18 4.57 Favored 'General case' 0 C--N 1.358 0.967 0 C-N-CA 128.184 2.594 . . . . 0.0 117.722 173.204 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 45.1 tptt -149.51 141.88 24.24 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 -174.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.8 p-10 -107.29 159.62 16.23 Favored 'General case' 0 C--N 1.355 0.837 0 CA-C-N 120.661 1.573 . . . . 0.0 111.075 170.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 84.5 m -106.61 156.15 18.9 Favored 'General case' 0 CA--C 1.509 -0.63 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 164.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 67.5 m -117.7 141.75 48.04 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 102.705 -3.072 . . . . 0.0 102.705 169.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 45.1 t -60.26 130.62 47.56 Favored 'General case' 0 C--N 1.357 0.893 0 O-C-N 120.815 -1.178 . . . . 0.0 111.242 178.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 89.32 -3.75 84.07 Favored Glycine 0 C--N 1.356 1.66 0 O-C-N 121.568 -0.707 . . . . 0.0 112.382 -176.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 11.4 mm-40 -112.55 -46.04 3.19 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 121.561 -0.964 . . . . 0.0 110.05 168.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 17.4 m120 53.47 43.61 31.07 Favored 'General case' 0 C--N 1.362 1.113 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 171.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -100.77 116.42 32.61 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 124.79 1.236 . . . . 0.0 111.877 -166.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 71.9 m -134.27 157.2 78.06 Favored Pre-proline 0 C--N 1.351 0.65 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 166.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.06 160.2 50.45 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.435 2.09 . . . . 0.0 110.962 166.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -62.64 134.67 56.67 Favored 'General case' 0 C--N 1.353 0.728 0 C-N-CA 123.91 0.884 . . . . 0.0 113.124 -173.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 98.8 -12.82 62.62 Favored Glycine 0 C--N 1.356 1.667 0 C-N-CA 124.185 0.897 . . . . 0.0 113.259 -173.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 71.2 m -116.29 154.56 29.96 Favored 'General case' 0 C--N 1.35 0.591 0 CA-C-N 118.019 0.909 . . . . 0.0 110.52 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -134.06 161.11 35.74 Favored 'General case' 0 C--N 1.355 0.811 0 N-CA-C 104.866 -2.272 . . . . 0.0 104.866 178.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 15.1 p -115.05 144.87 42.95 Favored 'General case' 0 CA--C 1.503 -0.849 0 CA-C-N 119.986 1.266 . . . . 0.0 112.455 172.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -90.97 62.91 2.89 Favored Glycine 0 C--N 1.352 1.421 0 CA-C-N 115.435 -0.802 . . . . 0.0 112.889 -172.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 62.6 mt -75.86 130.93 39.32 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 122.244 1.021 . . . . 0.0 111.895 167.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -66.92 -44.56 80.37 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 126.297 1.839 . . . . 0.0 111.62 -164.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -167.45 49.57 0.24 Allowed Glycine 0 CA--C 1.499 -0.934 0 N-CA-C 106.609 -2.597 . . . . 0.0 106.609 173.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 45.11 54.48 7.01 Favored 'General case' 0 C--N 1.359 0.986 0 C-N-CA 127.537 2.335 . . . . 0.0 115.774 -176.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -94.06 -50.55 5.25 Favored 'General case' 0 C--N 1.359 0.986 0 O-C-N 119.996 -1.69 . . . . 0.0 111.802 -174.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 63.4 mttm -131.15 -103.07 0.28 Allowed 'General case' 0 C--N 1.356 0.862 0 C-N-CA 123.803 0.841 . . . . 0.0 111.479 -171.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 57.5 pttt -142.7 152.09 42.02 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 126.246 1.818 . . . . 0.0 106.833 -176.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -157.1 158.33 28.78 Favored Glycine 0 C--N 1.351 1.365 0 N-CA-C 108.142 -1.983 . . . . 0.0 108.142 -178.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 67.8 t60 -95.67 147.24 23.81 Favored 'General case' 0 C--N 1.346 0.433 0 O-C-N 121.717 -0.873 . . . . 0.0 110.49 -169.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 72.0 m -79.81 137.83 37.07 Favored 'General case' 0 C--N 1.359 1.002 0 O-C-N 121.078 -1.014 . . . . 0.0 111.792 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -127.09 154.62 44.47 Favored 'General case' 0 C--N 1.349 0.587 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 -178.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -104.69 135.87 45.26 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 124.629 1.171 . . . . 0.0 108.077 172.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 91.1 mt -101.19 123.4 54.23 Favored 'Isoleucine or valine' 0 C--N 1.356 0.86 0 C-N-CA 123.725 0.81 . . . . 0.0 108.937 176.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.19 146.51 33.61 Favored 'Isoleucine or valine' 0 C--N 1.351 0.663 0 C-N-CA 124.287 1.035 . . . . 0.0 109.693 176.078 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.354 1.553 0 O-C-N 121.215 -0.928 . . . . 0.0 114.69 175.893 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 8.4 t80 . . . . . 0 N--CA 1.504 2.242 0 N-CA-C 116.528 2.048 . . . . 0.0 116.528 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -115.93 148.19 40.31 Favored 'General case' 0 C--N 1.354 0.789 0 C-N-CA 124.953 1.301 . . . . 0.0 107.721 161.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.7 p -123.09 133.26 69.6 Favored 'Isoleucine or valine' 0 C--N 1.351 0.648 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 171.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 24.0 m -133.39 154.12 38.44 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.683 0 C-N-CA 124.422 1.089 . . . . 0.0 108.235 178.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 96.2 p -79.67 155.72 27.91 Favored 'General case' 0 C--N 1.352 0.676 0 CA-C-O 121.856 0.836 . . . . 0.0 113.03 178.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 12.2 t -114.22 11.72 17.55 Favored 'General case' 0 C--N 1.351 0.648 0 C-N-CA 123.818 0.847 . . . . 0.0 110.519 -177.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 32.6 m120 59.24 28.9 18.35 Favored 'General case' 0 C--N 1.357 0.919 0 C-N-CA 128.108 2.563 . . . . 0.0 115.41 173.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 26.5 mmmt -134.74 160.07 39.33 Favored 'General case' 0 CA--C 1.513 -0.478 0 C-N-CA 127.057 2.143 . . . . 0.0 106.545 178.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -136.06 165.6 25.31 Favored 'General case' 0 C--N 1.351 0.664 0 O-C-N 121.088 -1.007 . . . . 0.0 109.493 173.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 30.7 m -120.9 147.87 44.83 Favored 'General case' 0 C--N 1.352 0.688 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 173.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 24.6 p -93.5 164.84 13.03 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 122.008 0.909 . . . . 0.0 110.365 153.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 46.9 t -61.32 130.84 48.13 Favored 'General case' 0 C--N 1.35 0.623 0 CA-C-O 122.125 0.964 . . . . 0.0 112.593 -178.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.35 -19.3 44.34 Favored Glycine 0 C--N 1.353 1.491 0 C-N-CA 124.94 1.257 . . . . 0.0 113.636 -178.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 21.8 mm100 -80.23 -47.94 13.86 Favored 'General case' 0 C--N 1.353 0.719 0 N-CA-C 114.775 1.398 . . . . 0.0 114.775 179.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 31.6 m120 50.08 41.19 23.15 Favored 'General case' 0 C--N 1.355 0.836 0 C-N-CA 126.17 1.788 . . . . 0.0 115.055 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -98.42 109.43 22.19 Favored 'General case' 0 C--N 1.355 0.839 0 O-C-N 121.033 -1.042 . . . . 0.0 111.38 -172.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 76.1 m -137.05 157.7 74.09 Favored Pre-proline 0 C--N 1.35 0.598 0 N-CA-C 105.728 -1.953 . . . . 0.0 105.728 167.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -69.41 159.71 52.6 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.756 2.304 . . . . 0.0 111.349 169.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -62.79 131.28 48.31 Favored 'General case' 0 C--N 1.354 0.765 0 C-N-CA 123.675 0.79 . . . . 0.0 112.229 -172.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 100.36 -13.7 59.82 Favored Glycine 0 C--N 1.356 1.643 0 C-N-CA 123.822 0.725 . . . . 0.0 112.575 -174.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 72.1 m -114.08 154.21 28.13 Favored 'General case' 0 C--N 1.349 0.574 0 C-N-CA 124.088 0.955 . . . . 0.0 109.949 177.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -136.3 156.67 48.32 Favored 'General case' 0 C--N 1.35 0.611 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 178.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 8.1 p -106.16 143.87 33.68 Favored 'General case' 0 CA--C 1.501 -0.905 0 CA-C-O 122.413 1.102 . . . . 0.0 111.157 171.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -84.09 74.93 2.44 Favored Glycine 0 C--N 1.352 1.432 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 178.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -92.22 121.53 33.83 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 -173.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -91.46 101.06 13.73 Favored 'General case' 0 C--N 1.352 0.678 0 O-C-N 120.674 -1.266 . . . . 0.0 108.969 -163.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 60.07 32.02 74.54 Favored Glycine 0 C--N 1.357 1.708 0 N-CA-C 115.629 1.012 . . . . 0.0 115.629 165.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 46.19 43.11 10.83 Favored 'General case' 0 C--N 1.354 0.8 0 C-N-CA 127.895 2.478 . . . . 0.0 116.148 -168.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 -89.6 -98.7 0.1 Allowed 'General case' 0 C--N 1.359 0.999 0 O-C-N 121.247 -0.908 . . . . 0.0 111.649 173.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -96.89 -89.16 0.28 Allowed 'General case' 0 C--N 1.355 0.809 0 O-C-N 120.646 -1.284 . . . . 0.0 113.636 -169.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -151.98 162.12 41.57 Favored 'General case' 0 N--CA 1.445 -0.707 0 O-C-N 121.142 -0.973 . . . . 0.0 108.956 -168.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -157.5 154.03 25.18 Favored Glycine 0 C--N 1.352 1.424 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 63.1 t60 -97.3 148.13 23.44 Favored 'General case' 0 C--N 1.349 0.569 0 O-C-N 121.601 -0.94 . . . . 0.0 109.166 -173.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 71.5 m -80.84 134.51 35.78 Favored 'General case' 0 C--N 1.359 1.02 0 O-C-N 120.956 -1.09 . . . . 0.0 111.516 -178.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -130.81 167.13 19.41 Favored 'General case' 0 C--N 1.351 0.633 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 -177.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 33.7 pttt -124.28 148.92 47.06 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 121.56 0.695 . . . . 0.0 110.553 156.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 82.3 mt -104.78 124.25 59.29 Favored 'Isoleucine or valine' 0 C--N 1.358 0.944 0 C-N-CA 125.811 1.645 . . . . 0.0 107.805 174.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.42 142.13 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 C-N-CA 124.989 1.316 . . . . 0.0 108.938 178.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.351 1.393 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -175.707 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 28.3 t80 . . . . . 0 N--CA 1.504 2.249 0 N-CA-C 116.988 2.218 . . . . 0.0 116.988 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -144.65 158.21 43.87 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 105.11 -2.181 . . . . 0.0 105.11 167.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.7 p -130.82 133.05 63.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 175.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.5 m -133.27 161.6 41.18 Favored 'Isoleucine or valine' 0 C--N 1.351 0.634 0 C-N-CA 124.326 1.05 . . . . 0.0 108.313 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 87.3 p -75.82 149.81 37.81 Favored 'General case' 0 C--N 1.352 0.679 0 O-C-N 120.745 -1.222 . . . . 0.0 113.249 176.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 34.5 t -114.11 -0.12 14.1 Favored 'General case' 0 C--N 1.356 0.885 0 O-C-N 121.236 -0.915 . . . . 0.0 111.337 -172.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 53.3 t30 58.51 45.67 16.07 Favored 'General case' 0 C--N 1.356 0.864 0 C-N-CA 127.146 2.179 . . . . 0.0 114.827 175.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 15.5 tppt? -141.7 144.43 34.06 Favored 'General case' 0 C--N 1.349 0.565 0 N-CA-C 105.27 -2.122 . . . . 0.0 105.27 173.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 30.0 t30 -114.07 136.26 53.11 Favored 'General case' 0 C--N 1.353 0.76 0 O-C-N 121.2 -0.937 . . . . 0.0 110.387 -176.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 85.9 m -102.31 151.72 21.91 Favored 'General case' 0 C--N 1.356 0.855 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 170.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 40.0 m -128.16 160.18 32.84 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 101.774 -3.417 . . . . 0.0 101.774 176.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.2 t -51.15 -40.23 58.1 Favored 'General case' 0 C--N 1.345 0.393 0 C-N-CA 126.138 1.775 . . . . 0.0 115.461 -169.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -78.95 -1.5 85.01 Favored Glycine 0 C--N 1.351 1.374 0 N-CA-C 116.226 1.25 . . . . 0.0 116.226 178.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -145.9 135.45 23.17 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-N 120.34 2.07 . . . . 0.0 112.628 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 34.7 m120 -98.55 101.09 12.42 Favored 'General case' 0 C--N 1.353 0.744 0 O-C-N 119.833 -1.792 . . . . 0.0 106.491 172.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -130.42 95.02 3.78 Favored 'General case' 0 N--CA 1.446 -0.649 0 O-C-N 121.811 -0.556 . . . . 0.0 109.905 -164.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 73.1 m -136.05 156.54 76.94 Favored Pre-proline 0 C--N 1.351 0.633 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 170.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.85 160.44 49.67 Favored 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 122.478 2.119 . . . . 0.0 110.611 162.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 64.6 mm-40 -64.76 137.98 58.11 Favored 'General case' 0 C--N 1.351 0.673 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -174.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.37 -10.67 67.24 Favored Glycine 0 C--N 1.356 1.643 0 C-N-CA 123.83 0.728 . . . . 0.0 112.879 -174.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 71.3 m -115.61 153.74 30.71 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.219 1.008 . . . . 0.0 110.18 179.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -132.65 157.82 43.84 Favored 'General case' 0 C--N 1.355 0.836 0 N-CA-C 105.216 -2.142 . . . . 0.0 105.216 175.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 12.7 p -110.21 144.31 39.06 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-N 119.545 1.066 . . . . 0.0 110.666 169.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -85.16 71.63 2.91 Favored Glycine 0 C--N 1.352 1.418 0 N-CA-C 110.031 -1.228 . . . . 0.0 110.031 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -93.18 121.31 34.41 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 -172.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -88.71 82.65 6.79 Favored 'General case' 0 C--N 1.351 0.644 0 O-C-N 120.753 -1.217 . . . . 0.0 110.011 -162.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 64.21 37.29 94.34 Favored Glycine 0 C--N 1.354 1.578 0 O-C-N 121.029 -1.045 . . . . 0.0 115.197 167.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 47.49 44.64 16.96 Favored 'General case' 0 C--N 1.352 0.717 0 C-N-CA 128.811 2.844 . . . . 0.0 115.847 -173.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 64.0 m-80 -90.66 -61.43 1.68 Allowed 'General case' 0 C--N 1.357 0.892 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 171.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -127.36 -103.77 0.33 Allowed 'General case' 0 C--N 1.356 0.887 0 O-C-N 120.964 -1.085 . . . . 0.0 112.851 -169.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -152.37 159.98 43.36 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -169.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -164.68 151.5 20.6 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 111.174 -0.771 . . . . 0.0 111.174 -176.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 79.1 t60 -96.96 143.64 27.63 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 121.812 -0.816 . . . . 0.0 109.763 -171.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 74.4 m -76.94 139.38 40.15 Favored 'General case' 0 C--N 1.356 0.853 0 O-C-N 121.008 -1.057 . . . . 0.0 112.139 -178.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -123.96 151.01 44.11 Favored 'General case' 0 C--N 1.351 0.642 0 N-CA-C 106.962 -1.495 . . . . 0.0 106.962 -179.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -100.3 134.11 43.72 Favored 'General case' 0 C--N 1.346 0.453 0 C-N-CA 124.224 1.009 . . . . 0.0 108.317 173.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 96.6 mt -101.41 124.78 55.36 Favored 'Isoleucine or valine' 0 C--N 1.356 0.885 0 CA-C-O 122.08 0.943 . . . . 0.0 109.323 171.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -128.04 148.53 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 C-N-CA 125.827 1.651 . . . . 0.0 108.592 175.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.492 -1.346 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 -179.619 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 5.4 t80 . . . . . 0 N--CA 1.503 2.178 0 N-CA-C 115.828 1.788 . . . . 0.0 115.828 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -118.38 148.31 42.65 Favored 'General case' 0 C--N 1.356 0.863 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 162.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.0 p -120.74 134.99 62.39 Favored 'Isoleucine or valine' 0 C--N 1.35 0.626 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 174.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.7 m -131.76 160.01 42.69 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.603 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 177.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 94.5 p -77.26 153.71 33.7 Favored 'General case' 0 C--N 1.352 0.685 0 O-C-N 120.95 -1.094 . . . . 0.0 111.614 171.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 11.2 t -94.76 -8.68 36.89 Favored 'General case' 0 C--N 1.352 0.682 0 O-C-N 121.099 -1.001 . . . . 0.0 109.721 178.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 62.1 t30 58.44 45.23 16.95 Favored 'General case' 0 C--N 1.355 0.83 0 C-N-CA 128.4 2.68 . . . . 0.0 112.666 -173.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 53.5 tptt -133.12 135.89 45.48 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 177.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -91.14 136.26 33.21 Favored 'General case' 0 C--N 1.352 0.712 0 C-N-CA 125.429 1.492 . . . . 0.0 108.788 -178.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 25.2 p -129.16 150.09 50.69 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-O 122.093 0.949 . . . . 0.0 110.771 176.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 90.5 m -125.3 148.27 48.77 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 104.551 -2.388 . . . . 0.0 104.551 -174.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 80.9 p -57.92 -42.52 84.95 Favored 'General case' 0 C--N 1.353 0.734 0 N-CA-C 117.529 2.418 . . . . 0.0 117.529 -159.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -78.71 -48.96 6.83 Favored Glycine 0 C--N 1.353 1.492 0 CA-C-N 119.408 1.004 . . . . 0.0 113.475 176.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.6 mp0 -67.27 -43.97 80.49 Favored 'General case' 0 C--N 1.35 0.589 0 C-N-CA 125.143 1.377 . . . . 0.0 113.458 -174.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 54.09 45.1 28.21 Favored 'General case' 0 C--N 1.355 0.826 0 C-N-CA 129.004 2.922 . . . . 0.0 115.136 169.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 53.7 mp0 -75.97 123.54 25.9 Favored 'General case' 0 C--N 1.36 1.057 0 O-C-N 119.68 -1.887 . . . . 0.0 113.518 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 73.3 m -135.94 154.99 78.08 Favored Pre-proline 0 C--N 1.35 0.593 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 159.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.65 161.34 45.58 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.727 2.285 . . . . 0.0 110.998 167.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -62.92 130.76 46.19 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 121.483 0.659 . . . . 0.0 112.469 -175.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 100.63 -14.23 59.21 Favored Glycine 0 C--N 1.355 1.608 0 C-N-CA 123.675 0.655 . . . . 0.0 112.62 -173.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 73.9 m -113.3 153.71 28.01 Favored 'General case' 0 C--N 1.349 0.579 0 C-N-CA 123.92 0.888 . . . . 0.0 109.892 176.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -134.85 155.56 50.45 Favored 'General case' 0 C--N 1.352 0.705 0 O-C-N 121.235 -0.915 . . . . 0.0 110.3 -177.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 47.3 t -91.67 125.59 36.46 Favored 'General case' 0 C--N 1.351 0.652 0 C-N-CA 124.619 1.168 . . . . 0.0 111.788 -169.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -84.77 60.37 4.82 Favored Glycine 0 C--N 1.352 1.459 0 O-C-N 121.375 -0.828 . . . . 0.0 113.435 174.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -117.87 122.14 42.57 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 174.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -119.8 144.94 47.04 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 -173.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 76.39 10.43 85.59 Favored Glycine 0 C--N 1.355 1.636 0 O-C-N 121.547 -0.721 . . . . 0.0 114.806 166.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 55.7 46.29 22.86 Favored 'General case' 0 C--N 1.35 0.612 0 C-N-CA 126.655 1.982 . . . . 0.0 114.375 -175.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 -87.98 -109.09 0.07 Allowed 'General case' 0 C--N 1.356 0.869 0 O-C-N 121.469 -0.769 . . . . 0.0 112.558 -179.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -105.4 -107.29 0.3 Allowed 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.498 -1.376 . . . . 0.0 114.568 -169.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -114.37 154.23 28.43 Favored 'General case' 0 N--CA 1.439 -0.978 0 C-N-CA 126.882 2.073 . . . . 0.0 108.095 179.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -133.37 178.66 18.06 Favored Glycine 0 CA--C 1.493 -1.295 0 N-CA-C 107.233 -2.347 . . . . 0.0 107.233 173.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 40.9 t60 -128.2 147.6 50.58 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 105.052 -2.203 . . . . 0.0 105.052 177.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 79.9 m -83.26 140.86 32.26 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.036 -1.04 . . . . 0.0 112.408 -173.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -121.59 161.92 21.56 Favored 'General case' 0 C--N 1.356 0.885 0 O-C-N 121.42 -0.8 . . . . 0.0 108.871 -178.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -120.18 135.14 55.07 Favored 'General case' 0 C--N 1.35 0.588 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 167.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 78.5 mt -101.25 126.46 55.04 Favored 'Isoleucine or valine' 0 C--N 1.357 0.934 0 C-N-CA 125.134 1.374 . . . . 0.0 108.41 171.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.76 156.85 42.75 Favored 'Isoleucine or valine' 0 C--N 1.35 0.614 0 C-N-CA 124.947 1.299 . . . . 0.0 109.423 177.007 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.355 1.638 0 O-C-N 121.023 -1.048 . . . . 0.0 113.115 -176.681 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 6.4 t80 . . . . . 0 N--CA 1.505 2.306 0 N-CA-C 116.097 1.888 . . . . 0.0 116.097 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 52.5 m-20 -116.58 152.36 34.32 Favored 'General case' 0 C--N 1.355 0.835 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 164.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.1 p -123.22 134.47 66.15 Favored 'Isoleucine or valine' 0 C--N 1.348 0.522 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 174.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.7 m -131.24 157.99 43.27 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.802 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 80.4 p -83.65 151.08 25.48 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 122.151 0.977 . . . . 0.0 113.471 176.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 83.2 m -96.01 -2.76 46.24 Favored 'General case' 0 C--N 1.356 0.859 0 C-N-CA 123.927 0.891 . . . . 0.0 110.472 173.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 59.5 t30 57.19 45.23 20.91 Favored 'General case' 0 C--N 1.35 0.592 0 C-N-CA 129.093 2.957 . . . . 0.0 114.241 178.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.6 mmmt -130.07 147.57 51.83 Favored 'General case' 0 CA--C 1.506 -0.719 0 C-N-CA 126.877 2.071 . . . . 0.0 105.972 170.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -85.47 174.76 9.27 Favored 'General case' 0 C--N 1.354 0.8 0 CA-C-N 118.751 0.705 . . . . 0.0 110.228 173.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 17.0 p -126.89 -178.9 4.57 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 105.416 -2.068 . . . . 0.0 105.416 162.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 31.1 m -134.03 142.31 47.55 Favored 'General case' 0 CA--C 1.504 -0.824 1 N-CA-C 99.917 -4.105 . . . . 0.0 99.917 165.398 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 35.2 t -59.05 -44.58 91.81 Favored 'General case' 0 C--N 1.351 0.667 0 CA-C-N 120.508 1.504 . . . . 0.0 115.031 -163.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.9 -45.09 65.2 Favored Glycine 0 C--N 1.354 1.559 0 O-C-N 121.231 -0.918 . . . . 0.0 115.294 176.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -70.07 -43.51 71.03 Favored 'General case' 0 C--N 1.351 0.666 0 C-N-CA 125.113 1.365 . . . . 0.0 112.838 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 55.22 46.59 23.45 Favored 'General case' 0 C--N 1.353 0.72 0 C-N-CA 130.507 3.523 . . . . 0.0 112.694 -178.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -62.9 124.45 21.1 Favored 'General case' 0 C--N 1.359 1.012 0 C-N-CA 125.574 1.55 . . . . 0.0 113.455 177.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 86.0 m -143.3 159.66 54.55 Favored Pre-proline 0 C--N 1.351 0.665 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 159.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -68.7 156.61 64.91 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 122.746 2.298 . . . . 0.0 110.783 162.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -63.65 131.63 48.59 Favored 'General case' 0 C--N 1.352 0.707 0 CA-C-O 121.607 0.718 . . . . 0.0 112.804 -173.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.19 -12.31 61.98 Favored Glycine 0 C--N 1.356 1.676 0 O-C-N 121.605 -0.684 . . . . 0.0 112.896 -175.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 79.2 m -111.93 156.46 22.06 Favored 'General case' 0 C--N 1.349 0.56 0 C-N-CA 124.039 0.936 . . . . 0.0 108.914 177.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -138.13 159.96 40.66 Favored 'General case' 0 C--N 1.35 0.599 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 -177.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 41.9 t -117.33 121.14 40.32 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -88.91 93.44 1.9 Allowed Glycine 0 C--N 1.352 1.446 0 N-CA-C 107.943 -2.063 . . . . 0.0 107.943 177.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -102.39 120.52 40.64 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 -167.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -89.65 115.11 26.79 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-O 123.18 1.466 . . . . 0.0 113.588 -177.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 69.64 14.19 69.5 Favored Glycine 0 C--N 1.356 1.685 0 N-CA-C 116.929 1.532 . . . . 0.0 116.929 159.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 60.22 27.73 17.26 Favored 'General case' 0 C--N 1.353 0.731 0 C-N-CA 126.672 1.989 . . . . 0.0 113.877 -176.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 65.4 m-80 -82.55 -46.79 12.91 Favored 'General case' 0 C--N 1.353 0.735 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 -172.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -139.24 -177.92 5.13 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-O 122.298 1.047 . . . . 0.0 108.261 -161.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.8 ptpp? -64.02 -37.71 88.42 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 126.9 2.08 . . . . 0.0 116.299 170.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.17 -162.38 53.0 Favored Glycine 0 C--N 1.355 1.591 0 O-C-N 119.494 -2.004 . . . . 0.0 112.678 -173.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 19.1 t60 -157.29 152.78 26.47 Favored 'General case' 0 C--N 1.356 0.876 0 N-CA-C 105.755 -1.942 . . . . 0.0 105.755 174.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 71.4 m -85.47 139.41 31.52 Favored 'General case' 0 C--N 1.357 0.896 0 O-C-N 120.581 -1.324 . . . . 0.0 113.469 -176.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -126.19 163.12 23.85 Favored 'General case' 0 C--N 1.357 0.926 0 C-N-CA 123.813 0.845 . . . . 0.0 109.447 -172.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 40.8 ttpt -121.23 136.97 54.88 Favored 'General case' 0 C--N 1.352 0.697 0 C-N-CA 125.336 1.454 . . . . 0.0 109.695 167.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 82.2 mt -94.03 124.4 46.48 Favored 'Isoleucine or valine' 0 C--N 1.361 1.078 0 C-N-CA 125.337 1.455 . . . . 0.0 109.687 172.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.72 140.02 49.14 Favored 'Isoleucine or valine' 0 C--N 1.351 0.643 0 C-N-CA 124.786 1.234 . . . . 0.0 109.977 173.194 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.491 -1.422 0 N-CA-C 108.713 -1.755 . . . . 0.0 108.713 178.479 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 9.4 t80 . . . . . 0 N--CA 1.503 2.186 0 N-CA-C 116.635 2.087 . . . . 0.0 116.635 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -123.12 148.36 45.77 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 161.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.1 p -119.53 132.0 70.55 Favored 'Isoleucine or valine' 0 C--N 1.351 0.662 0 N-CA-C 106.757 -1.572 . . . . 0.0 106.757 168.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.8 m -134.95 155.34 38.04 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.568 0 C-N-CA 124.795 1.238 . . . . 0.0 108.482 -177.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 89.6 p -79.73 157.48 27.14 Favored 'General case' 0 C--N 1.349 0.577 0 CA-C-O 122.25 1.024 . . . . 0.0 113.469 177.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 96.2 m -105.42 10.31 33.38 Favored 'General case' 0 C--N 1.352 0.703 0 C-N-CA 123.978 0.911 . . . . 0.0 111.971 177.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 53.7 t30 56.39 44.16 24.94 Favored 'General case' 0 C--N 1.355 0.825 0 C-N-CA 127.029 2.132 . . . . 0.0 113.166 -178.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 52.3 tptt -139.98 134.83 32.05 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.752 -1.217 . . . . 0.0 109.224 -177.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -87.09 121.18 29.19 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.184 1.793 . . . . 0.0 109.564 179.028 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 27.8 p -116.94 167.25 11.3 Favored 'General case' 0 C--N 1.35 0.618 0 C-N-CA 123.917 0.887 . . . . 0.0 108.741 173.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 73.7 m -129.51 146.11 51.38 Favored 'General case' 0 C--N 1.349 0.561 0 N-CA-C 104.063 -2.569 . . . . 0.0 104.063 170.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.4 t -57.75 -38.43 75.35 Favored 'General case' 0 C--N 1.355 0.807 0 C-N-CA 126.418 1.887 . . . . 0.0 113.727 -170.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -90.86 9.41 77.83 Favored Glycine 0 C--N 1.35 1.308 0 O-C-N 121.193 -0.942 . . . . 0.0 113.59 177.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 22.1 mm-40 -118.2 -43.33 2.74 Favored 'General case' 0 C--N 1.351 0.637 0 O-C-N 121.479 -1.012 . . . . 0.0 111.088 176.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 22.1 m120 56.17 38.04 29.45 Favored 'General case' 0 C--N 1.358 0.957 0 C-N-CA 127.38 2.272 . . . . 0.0 115.23 176.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -86.32 108.67 18.53 Favored 'General case' 0 C--N 1.351 0.654 0 O-C-N 120.683 -1.261 . . . . 0.0 110.785 -178.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 91.5 m -134.64 157.73 76.63 Favored Pre-proline 0 C--N 1.351 0.636 0 C-N-CA 125.033 1.333 . . . . 0.0 108.476 175.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -69.98 161.27 46.6 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.877 2.385 . . . . 0.0 111.206 168.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -64.28 134.83 55.47 Favored 'General case' 0 C--N 1.353 0.743 0 CA-C-O 121.646 0.736 . . . . 0.0 112.591 -174.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.53 -10.89 68.94 Favored Glycine 0 C--N 1.354 1.561 0 C-N-CA 123.473 0.558 . . . . 0.0 113.027 -174.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 85.6 m -114.8 154.6 28.28 Favored 'General case' 0 C--N 1.351 0.634 0 CA-C-N 118.034 0.917 . . . . 0.0 109.33 -179.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -131.35 160.4 35.14 Favored 'General case' 0 C--N 1.351 0.65 0 O-C-N 121.211 -0.93 . . . . 0.0 108.533 -179.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 43.2 t -89.45 119.76 30.18 Favored 'General case' 0 C--N 1.353 0.728 0 O-C-N 121.533 -0.73 . . . . 0.0 109.688 -175.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -90.21 63.8 3.04 Favored Glycine 0 C--N 1.353 1.494 0 O-C-N 121.168 -0.957 . . . . 0.0 114.003 -175.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -132.87 132.84 42.55 Favored 'General case' 0 C--N 1.352 0.712 0 CA-C-N 118.761 1.281 . . . . 0.0 108.414 177.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -115.8 133.4 56.07 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 -175.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.79 5.85 86.72 Favored Glycine 0 C--N 1.356 1.677 0 N-CA-C 115.92 1.128 . . . . 0.0 115.92 166.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 56.42 40.5 29.64 Favored 'General case' 0 C--N 1.349 0.557 0 C-N-CA 127.224 2.209 . . . . 0.0 113.731 -173.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 62.0 m-80 -67.78 -46.56 71.65 Favored 'General case' 0 C--N 1.355 0.824 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 172.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -139.4 -133.46 0.12 Allowed 'General case' 0 C--N 1.351 0.668 0 CA-C-O 121.718 0.771 . . . . 0.0 109.236 -177.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.5 pttm -103.46 -56.71 2.16 Favored 'General case' 0 C--N 1.351 0.648 0 C-N-CA 125.522 1.529 . . . . 0.0 113.444 -178.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 94.4 175.98 38.84 Favored Glycine 0 C--N 1.352 1.441 0 CA-C-O 122.843 1.246 . . . . 0.0 111.444 -171.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 51.6 t60 -149.0 152.95 37.19 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 102.692 -3.077 . . . . 0.0 102.692 177.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 79.1 m -81.85 135.19 35.45 Favored 'General case' 0 C--N 1.351 0.672 0 O-C-N 121.054 -1.029 . . . . 0.0 112.244 -174.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 13.1 m-30 -123.9 160.68 26.95 Favored 'General case' 0 C--N 1.357 0.896 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -178.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 20.2 pttm -121.36 150.98 40.66 Favored 'General case' 0 C--N 1.35 0.606 0 CA-C-O 121.689 0.757 . . . . 0.0 109.653 160.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 83.7 mt -114.36 130.54 68.48 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.788 0 C-N-CA 124.861 1.264 . . . . 0.0 109.976 176.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.61 140.41 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 C-N-CA 126.679 1.991 . . . . 0.0 109.053 178.379 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.35 1.35 0 N-CA-C 107.426 -2.269 . . . . 0.0 107.426 -172.029 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 11.8 t80 . . . . . 0 N--CA 1.504 2.259 0 N-CA-C 115.996 1.85 . . . . 0.0 115.996 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -116.87 154.12 31.33 Favored 'General case' 0 C--N 1.356 0.855 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 164.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.5 p -126.69 134.6 65.9 Favored 'Isoleucine or valine' 0 C--N 1.35 0.619 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 178.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 33.1 m -132.69 162.75 39.38 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 C-N-CA 124.585 1.154 . . . . 0.0 108.209 -179.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 78.5 p -72.9 145.06 47.11 Favored 'General case' 0 C--N 1.351 0.668 0 O-C-N 120.606 -1.309 . . . . 0.0 113.866 174.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 34.1 t -95.34 -10.12 31.0 Favored 'General case' 0 C--N 1.356 0.886 0 O-C-N 121.219 -0.926 . . . . 0.0 111.314 -179.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 54.0 t30 59.87 41.8 17.37 Favored 'General case' 0 C--N 1.355 0.835 0 C-N-CA 127.406 2.283 . . . . 0.0 112.874 -175.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 24.7 mmmt -130.83 144.21 51.29 Favored 'General case' 0 C--N 1.353 0.747 0 C-N-CA 124.571 1.148 . . . . 0.0 111.483 175.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 20.1 t30 -93.65 123.39 36.95 Favored 'General case' 0 C--N 1.354 0.796 0 CA-C-O 122.214 1.007 . . . . 0.0 110.231 -173.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 14.4 t -105.69 152.9 22.57 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 128.483 2.713 . . . . 0.0 107.638 176.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 42.1 m -131.09 160.07 35.74 Favored 'General case' 0 C--N 1.355 0.844 0 N-CA-C 104.729 -2.323 . . . . 0.0 104.729 172.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.5 t -62.35 -43.25 99.26 Favored 'General case' 0 C--N 1.353 0.737 0 O-C-N 120.083 -1.635 . . . . 0.0 112.966 174.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -63.76 -41.5 98.88 Favored Glycine 0 C--N 1.357 1.738 0 C-N-CA 124.397 0.998 . . . . 0.0 115.127 176.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 27.1 pt20 -132.53 117.01 17.45 Favored 'General case' 0 C--N 1.35 0.621 0 CA-C-O 122.698 1.237 . . . . 0.0 110.053 175.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 24.2 m120 -91.89 79.56 5.28 Favored 'General case' 0 C--N 1.353 0.742 0 O-C-N 120.514 -1.366 . . . . 0.0 108.644 -174.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -97.72 109.7 22.41 Favored 'General case' 0 C--N 1.35 0.612 0 O-C-N 120.906 -1.121 . . . . 0.0 110.885 -170.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 80.9 m -134.27 153.09 79.23 Favored Pre-proline 0 C--N 1.351 0.631 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 172.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -72.17 162.23 42.3 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 123.145 2.563 . . . . 0.0 111.036 168.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -64.92 135.15 55.36 Favored 'General case' 0 C--N 1.353 0.725 0 CA-C-O 121.647 0.736 . . . . 0.0 112.19 -178.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.76 -14.31 63.08 Favored Glycine 0 C--N 1.354 1.583 0 C-N-CA 123.779 0.704 . . . . 0.0 112.375 -171.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 76.7 m -113.76 155.24 25.99 Favored 'General case' 0 C--N 1.349 0.582 0 C-N-CA 124.236 1.014 . . . . 0.0 109.894 175.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -139.74 161.07 38.42 Favored 'General case' 0 C--N 1.352 0.714 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 -176.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 41.2 t -122.13 124.09 43.09 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 173.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -100.99 106.51 3.1 Favored Glycine 0 C--N 1.352 1.47 0 N-CA-C 107.092 -2.403 . . . . 0.0 107.092 170.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -101.13 120.1 39.72 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 -168.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -87.55 89.34 7.96 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-O 122.662 1.22 . . . . 0.0 113.122 -174.284 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 64.05 32.52 84.44 Favored Glycine 0 C--N 1.358 1.762 0 N-CA-C 117.226 1.65 . . . . 0.0 117.226 160.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.8 pm0 46.99 36.42 4.06 Favored 'General case' 0 C--N 1.354 0.79 0 C-N-CA 128.511 2.725 . . . . 0.0 115.172 -174.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 59.1 m-80 -77.92 -44.71 26.17 Favored 'General case' 0 CA--C 1.505 -0.78 0 C-N-CA 124.785 1.234 . . . . 0.0 112.372 174.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.5 pttm -155.61 174.54 15.12 Favored 'General case' 0 N--CA 1.425 -1.706 0 N-CA-C 106.009 -1.849 . . . . 0.0 106.009 -174.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -62.08 -36.5 81.86 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 129.747 3.219 . . . . 0.0 115.312 -173.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 83.47 -167.5 44.91 Favored Glycine 0 C--N 1.355 1.63 0 O-C-N 120.627 -1.296 . . . . 0.0 112.145 -175.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 69.1 t60 -156.9 151.3 25.33 Favored 'General case' 0 C--N 1.35 0.627 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 177.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 70.9 m -81.24 140.84 34.66 Favored 'General case' 0 C--N 1.356 0.86 0 CA-C-N 119.786 1.176 . . . . 0.0 112.723 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 8.6 m-30 -121.27 157.14 30.98 Favored 'General case' 0 C--N 1.353 0.74 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 -177.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 40.6 ttpt -110.42 137.43 48.14 Favored 'General case' 0 C--N 1.349 0.546 0 C-N-CA 124.17 0.988 . . . . 0.0 109.903 173.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 97.3 mt -97.12 123.55 49.52 Favored 'Isoleucine or valine' 0 C--N 1.361 1.066 0 C-N-CA 124.546 1.138 . . . . 0.0 109.874 176.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.78 138.23 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 C-N-CA 124.431 1.092 . . . . 0.0 108.798 173.285 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.35 1.332 0 N-CA-C 108.854 -1.698 . . . . 0.0 108.854 -175.973 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 10.7 t80 . . . . . 0 N--CA 1.504 2.237 0 N-CA-C 115.856 1.798 . . . . 0.0 115.856 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -117.37 153.88 32.27 Favored 'General case' 0 C--N 1.355 0.83 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 162.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.9 p -128.06 133.39 67.26 Favored 'Isoleucine or valine' 0 C--N 1.349 0.585 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 177.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.9 m -134.22 161.55 40.55 Favored 'Isoleucine or valine' 0 C--N 1.352 0.691 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 78.5 p -72.88 144.48 47.39 Favored 'General case' 0 C--N 1.351 0.648 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 177.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 29.1 t -99.05 -6.4 28.56 Favored 'General case' 0 C--N 1.356 0.884 0 C-N-CA 123.938 0.895 . . . . 0.0 111.749 -177.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 60.28 46.69 9.91 Favored 'General case' 0 C--N 1.355 0.83 0 C-N-CA 127.016 2.126 . . . . 0.0 112.549 -178.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -137.19 140.26 41.64 Favored 'General case' 0 C--N 1.352 0.676 0 O-C-N 120.55 -1.344 . . . . 0.0 107.748 175.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.9 t30 -87.29 126.01 34.57 Favored 'General case' 0 C--N 1.356 0.89 0 C-N-CA 124.423 1.089 . . . . 0.0 110.856 -174.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 16.9 t -106.15 144.37 32.95 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 126.973 2.109 . . . . 0.0 109.842 175.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 16.3 m -134.51 153.06 52.13 Favored 'General case' 0 C--N 1.352 0.68 0 N-CA-C 102.209 -3.256 . . . . 0.0 102.209 170.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 38.7 t -58.87 -44.67 91.13 Favored 'General case' 0 C--N 1.356 0.872 0 CA-C-N 120.685 1.584 . . . . 0.0 114.496 -171.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -81.3 -3.95 90.55 Favored Glycine 0 C--N 1.353 1.478 0 O-C-N 121.299 -0.876 . . . . 0.0 113.989 -177.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -113.98 -48.19 2.92 Favored 'General case' 0 C--N 1.35 0.607 0 CA-C-N 117.693 0.746 . . . . 0.0 110.331 -177.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 49.93 48.97 21.09 Favored 'General case' 0 C--N 1.358 0.958 0 C-N-CA 130.492 3.517 . . . . 0.0 112.261 176.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 52.3 mm-40 -96.5 115.39 27.35 Favored 'General case' 0 C--N 1.353 0.731 0 O-C-N 120.745 -1.222 . . . . 0.0 111.714 -167.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 81.7 m -134.28 154.27 79.86 Favored Pre-proline 0 C--N 1.35 0.612 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 174.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -71.27 161.04 47.05 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.68 2.254 . . . . 0.0 111.044 168.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -63.23 130.82 46.18 Favored 'General case' 0 C--N 1.352 0.714 0 C-N-CA 123.33 0.652 . . . . 0.0 111.598 -176.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 100.63 -13.92 59.32 Favored Glycine 0 C--N 1.354 1.58 0 C-N-CA 123.754 0.692 . . . . 0.0 112.469 -173.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 82.2 m -112.71 154.51 26.02 Favored 'General case' 0 C--N 1.349 0.573 0 C-N-CA 124.022 0.929 . . . . 0.0 110.134 175.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -137.28 159.89 40.63 Favored 'General case' 0 C--N 1.354 0.783 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 -175.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 40.6 t -111.6 119.05 37.4 Favored 'General case' 0 C--N 1.35 0.624 0 CA-C-O 121.81 0.814 . . . . 0.0 109.843 174.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -92.63 69.23 1.73 Allowed Glycine 0 C--N 1.35 1.339 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 173.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 60.1 tp -105.8 123.31 47.74 Favored 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 172.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -113.62 130.45 56.39 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 -173.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.2 5.04 70.26 Favored Glycine 0 C--N 1.355 1.627 0 N-CA-C 115.946 1.138 . . . . 0.0 115.946 162.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 55.9 47.13 20.71 Favored 'General case' 0 C--N 1.351 0.635 0 C-N-CA 126.357 1.863 . . . . 0.0 113.696 -170.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 -64.98 -49.29 70.86 Favored 'General case' 0 C--N 1.356 0.849 0 N-CA-C 115.098 1.518 . . . . 0.0 115.098 173.056 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -144.32 -120.81 0.08 Allowed 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 175.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 15.7 ptpt -115.27 -35.14 4.75 Favored 'General case' 0 N--CA 1.439 -1.013 0 C-N-CA 127.171 2.188 . . . . 0.0 114.238 -176.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 75.51 -162.48 53.3 Favored Glycine 0 C--N 1.355 1.638 0 O-C-N 119.993 -1.692 . . . . 0.0 110.464 -171.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 67.8 t60 -157.95 159.95 37.05 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 103.454 -2.795 . . . . 0.0 103.454 170.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 77.1 m -79.23 139.09 38.02 Favored 'General case' 0 C--N 1.352 0.717 0 CA-C-N 120.226 1.375 . . . . 0.0 112.44 175.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -124.42 155.92 38.03 Favored 'General case' 0 C--N 1.353 0.731 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 -175.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -108.23 137.39 46.29 Favored 'General case' 0 C--N 1.348 0.512 0 C-N-CA 124.645 1.178 . . . . 0.0 109.153 173.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 95.8 mt -97.14 122.73 48.98 Favored 'Isoleucine or valine' 0 C--N 1.361 1.076 0 C-N-CA 124.185 0.994 . . . . 0.0 109.288 173.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.25 158.21 43.24 Favored 'Isoleucine or valine' 0 C--N 1.35 0.611 0 C-N-CA 124.495 1.118 . . . . 0.0 109.512 177.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.355 1.622 0 O-C-N 121.218 -0.926 . . . . 0.0 113.667 -179.602 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 6.9 t80 . . . . . 0 N--CA 1.504 2.275 0 N-CA-C 116.23 1.937 . . . . 0.0 116.23 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -120.15 151.64 38.8 Favored 'General case' 0 C--N 1.354 0.79 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 161.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.6 p -123.5 136.29 60.52 Favored 'Isoleucine or valine' 0 C--N 1.35 0.589 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 178.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 28.9 m -130.5 156.46 42.5 Favored 'Isoleucine or valine' 0 C--N 1.35 0.594 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 175.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 87.2 p -79.62 150.38 31.03 Favored 'General case' 0 C--N 1.351 0.646 0 O-C-N 121.093 -1.004 . . . . 0.0 112.375 174.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 14.4 t -98.7 -10.7 22.82 Favored 'General case' 0 C--N 1.352 0.712 0 O-C-N 121.269 -0.894 . . . . 0.0 109.748 178.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 59.73 42.83 16.25 Favored 'General case' 0 C--N 1.355 0.836 0 C-N-CA 128.208 2.603 . . . . 0.0 114.459 178.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 55.9 tptt -122.16 135.71 54.82 Favored 'General case' 0 C--N 1.35 0.623 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 172.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -88.31 127.63 35.48 Favored 'General case' 0 C--N 1.355 0.811 0 C-N-CA 125.096 1.358 . . . . 0.0 109.765 -178.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 6.7 t -119.39 133.57 55.65 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 124.973 1.309 . . . . 0.0 111.249 -177.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 88.9 m -117.98 146.22 44.17 Favored 'General case' 0 C--N 1.351 0.666 0 N-CA-C 103.987 -2.597 . . . . 0.0 103.987 -178.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 84.8 p -59.22 -41.74 89.34 Favored 'General case' 0 C--N 1.35 0.618 0 N-CA-C 116.665 2.098 . . . . 0.0 116.665 -165.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.14 -36.81 93.72 Favored Glycine 0 C--N 1.351 1.362 0 C-N-CA 124.517 1.056 . . . . 0.0 114.268 172.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 23.9 mm100 -77.57 -47.69 18.82 Favored 'General case' 0 C--N 1.351 0.654 0 C-N-CA 123.804 0.842 . . . . 0.0 111.565 -177.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 52.23 39.95 28.0 Favored 'General case' 0 C--N 1.354 0.795 0 C-N-CA 128.628 2.771 . . . . 0.0 112.69 179.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -100.97 135.84 41.77 Favored 'General case' 0 C--N 1.356 0.879 0 O-C-N 120.571 -1.331 . . . . 0.0 113.353 -168.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 72.5 m -136.88 159.93 68.24 Favored Pre-proline 0 C--N 1.352 0.681 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 161.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -69.44 160.97 47.75 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.585 2.19 . . . . 0.0 110.556 162.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -64.59 136.95 57.54 Favored 'General case' 0 C--N 1.351 0.649 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -171.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.86 -12.3 65.87 Favored Glycine 0 C--N 1.355 1.621 0 C-N-CA 123.918 0.77 . . . . 0.0 112.832 -175.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 72.7 m -115.19 154.71 28.51 Favored 'General case' 0 C--N 1.348 0.507 0 C-N-CA 124.494 1.117 . . . . 0.0 109.533 179.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -133.36 154.79 50.43 Favored 'General case' 0 C--N 1.354 0.777 0 O-C-N 121.184 -0.948 . . . . 0.0 110.483 -177.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 43.8 t -104.85 119.26 38.59 Favored 'General case' 0 C--N 1.355 0.821 0 C-N-CA 124.479 1.112 . . . . 0.0 109.029 -177.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -90.48 69.99 2.22 Favored Glycine 0 C--N 1.351 1.417 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 175.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -107.79 123.73 48.99 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 178.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -117.17 138.06 51.92 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 -166.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.7 14.63 72.83 Favored Glycine 0 C--N 1.358 1.773 0 N-CA-C 115.99 1.156 . . . . 0.0 115.99 164.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 55.96 43.79 26.71 Favored 'General case' 0 C--N 1.349 0.556 0 C-N-CA 127.629 2.371 . . . . 0.0 113.213 -169.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 59.8 m-80 -70.13 168.16 16.22 Favored 'General case' 0 C--N 1.356 0.881 0 O-C-N 120.777 -1.202 . . . . 0.0 110.924 163.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -68.42 -48.27 65.07 Favored 'General case' 0 C--N 1.349 0.554 0 N-CA-C 116.005 1.854 . . . . 0.0 116.005 -163.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 79.9 mttt -136.36 150.1 48.67 Favored 'General case' 0 C--N 1.352 0.689 0 C-N-CA 123.492 0.717 . . . . 0.0 111.324 -176.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -136.66 168.58 24.15 Favored Glycine 0 C--N 1.348 1.195 0 N-CA-C 106.683 -2.567 . . . . 0.0 106.683 171.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 70.1 t60 -125.6 144.59 50.51 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 -176.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 74.7 m -80.43 137.63 36.52 Favored 'General case' 0 C--N 1.351 0.669 0 O-C-N 121.18 -0.95 . . . . 0.0 112.885 -176.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -126.22 162.65 24.94 Favored 'General case' 0 C--N 1.357 0.928 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -174.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -123.18 136.84 54.93 Favored 'General case' 0 C--N 1.35 0.626 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 166.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 81.1 mt -100.66 127.41 53.79 Favored 'Isoleucine or valine' 0 C--N 1.358 0.945 0 C-N-CA 125.741 1.616 . . . . 0.0 109.232 175.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.37 157.24 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 C-N-CA 124.967 1.307 . . . . 0.0 109.774 177.081 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.353 1.503 0 N-CA-C 108.922 -1.671 . . . . 0.0 108.922 -170.63 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 49.4 t80 . . . . . 0 N--CA 1.503 2.222 0 N-CA-C 117.675 2.472 . . . . 0.0 117.675 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -120.12 154.33 34.87 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 106.374 -1.713 . . . . 0.0 106.374 156.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.7 p -125.69 135.42 63.99 Favored 'Isoleucine or valine' 0 C--N 1.35 0.605 0 N-CA-C 106.271 -1.752 . . . . 0.0 106.271 170.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.0 m -134.0 161.46 40.85 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.912 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 89.5 p -77.15 151.99 35.07 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 121.835 0.826 . . . . 0.0 112.105 170.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 18.1 t -110.37 16.99 21.3 Favored 'General case' 0 C--N 1.352 0.706 0 C-N-CA 124.155 0.982 . . . . 0.0 110.261 -177.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 30.4 m120 57.98 36.5 26.2 Favored 'General case' 0 C--N 1.353 0.734 0 C-N-CA 127.34 2.256 . . . . 0.0 114.504 170.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 58.0 tptt -138.38 136.53 36.4 Favored 'General case' 0 C--N 1.354 0.79 0 O-C-N 121.27 -0.894 . . . . 0.0 110.32 -174.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -79.74 128.21 33.15 Favored 'General case' 0 C--N 1.356 0.884 0 C-N-CA 126.7 2.0 . . . . 0.0 112.337 178.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 12.0 t -118.01 131.6 56.46 Favored 'General case' 0 C--N 1.351 0.661 0 C-N-CA 126.584 1.954 . . . . 0.0 110.862 -179.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 12.6 m -119.89 151.93 38.14 Favored 'General case' 0 C--N 1.353 0.726 0 N-CA-C 105.279 -2.119 . . . . 0.0 105.279 -178.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 95.1 p -59.94 -37.02 78.34 Favored 'General case' 0 C--N 1.352 0.688 0 N-CA-C 115.513 1.672 . . . . 0.0 115.513 -168.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -93.02 0.12 68.91 Favored Glycine 0 C--N 1.353 1.493 0 O-C-N 121.846 -0.534 . . . . 0.0 113.811 177.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -110.97 -46.22 3.36 Favored 'General case' 0 C--N 1.35 0.629 0 CA-C-N 118.294 1.047 . . . . 0.0 111.1 179.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 31.2 m120 51.76 45.07 28.76 Favored 'General case' 0 C--N 1.359 0.979 0 C-N-CA 126.597 1.959 . . . . 0.0 114.142 -174.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -84.31 115.51 22.52 Favored 'General case' 0 C--N 1.353 0.727 0 O-C-N 121.338 -0.851 . . . . 0.0 112.503 -164.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 74.1 m -134.64 157.33 77.5 Favored Pre-proline 0 C--N 1.355 0.829 0 CA-C-O 118.478 -0.772 . . . . 0.0 109.065 172.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -70.43 159.35 53.22 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.63 2.22 . . . . 0.0 110.503 161.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -65.17 136.59 56.85 Favored 'General case' 0 C--N 1.352 0.694 0 CA-C-O 121.646 0.736 . . . . 0.0 112.63 -177.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.64 -13.57 63.92 Favored Glycine 0 C--N 1.354 1.543 0 C-N-CA 123.855 0.74 . . . . 0.0 113.112 -174.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 90.6 m -114.51 157.22 23.27 Favored 'General case' 0 C--N 1.349 0.55 0 C-N-CA 124.525 1.13 . . . . 0.0 109.947 176.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 24.8 p90 -137.57 161.17 37.15 Favored 'General case' 0 C--N 1.351 0.65 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 -172.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 43.3 t -118.35 127.36 53.62 Favored 'General case' 0 CA--C 1.507 -0.684 0 O-C-N 121.32 -0.863 . . . . 0.0 110.881 -179.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -97.19 78.63 0.67 Allowed Glycine 0 C--N 1.352 1.438 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 167.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -113.63 122.61 47.7 Favored 'General case' 0 C--N 1.352 0.679 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 168.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -119.76 146.67 45.45 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 -163.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.84 12.7 78.69 Favored Glycine 0 C--N 1.357 1.713 0 O-C-N 121.73 -0.606 . . . . 0.0 114.435 165.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 8.7 mp0 54.91 46.57 24.13 Favored 'General case' 0 C--N 1.351 0.638 0 C-N-CA 126.685 1.994 . . . . 0.0 113.539 -171.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -76.16 175.13 9.26 Favored 'General case' 0 C--N 1.357 0.892 0 C-N-CA 124.463 1.105 . . . . 0.0 110.409 166.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -64.74 -48.94 72.76 Favored 'General case' 0 C--N 1.348 0.519 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 -154.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 19.4 pttp -163.74 159.05 20.96 Favored 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 178.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -137.05 -165.06 10.31 Favored Glycine 0 C--N 1.344 0.996 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 176.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 37.3 t60 -143.79 149.18 36.67 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 105.76 -1.941 . . . . 0.0 105.76 -174.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 75.0 m -81.86 143.77 31.48 Favored 'General case' 0 C--N 1.352 0.697 0 O-C-N 121.021 -1.049 . . . . 0.0 113.096 -176.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -124.46 158.56 32.54 Favored 'General case' 0 C--N 1.356 0.877 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 -174.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -117.93 136.46 53.47 Favored 'General case' 0 C--N 1.35 0.596 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 166.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 80.5 mt -96.72 127.38 48.93 Favored 'Isoleucine or valine' 0 C--N 1.356 0.857 0 C-N-CA 125.307 1.443 . . . . 0.0 108.214 167.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 4.4 mp -116.05 124.32 72.24 Favored 'Isoleucine or valine' 0 C--N 1.354 0.793 0 N-CA-C 103.718 -2.697 . . . . 0.0 103.718 -177.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.25 0 O-C-N 120.756 -1.215 . . . . 0.0 110.487 -178.961 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 22.7 t80 . . . . . 0 N--CA 1.502 2.14 0 N-CA-C 116.966 2.21 . . . . 0.0 116.966 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -124.67 148.28 48.06 Favored 'General case' 0 C--N 1.353 0.747 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 159.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.9 p -124.12 134.05 67.64 Favored 'Isoleucine or valine' 0 C--N 1.349 0.557 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 173.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 28.0 m -131.25 154.05 39.99 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.744 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 175.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 80.4 p -79.26 151.83 30.92 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 177.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 19.9 t -123.97 33.18 5.36 Favored 'General case' 0 C--N 1.355 0.804 0 CA-C-O 121.761 0.791 . . . . 0.0 109.919 -172.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 44.75 37.88 2.51 Favored 'General case' 0 C--N 1.357 0.899 0 C-N-CA 129.016 2.926 . . . . 0.0 118.267 169.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -148.81 143.17 26.16 Favored 'General case' 0 C--N 1.348 0.536 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -175.449 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 33.8 t30 -115.45 135.87 53.66 Favored 'General case' 0 C--N 1.353 0.727 0 C-N-CA 124.27 1.028 . . . . 0.0 110.568 -175.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 83.6 m -101.5 152.1 21.17 Favored 'General case' 0 C--N 1.355 0.846 0 C-N-CA 124.151 0.98 . . . . 0.0 108.54 171.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 55.5 m -128.17 156.25 43.19 Favored 'General case' 0 CA--C 1.507 -0.682 0 N-CA-C 102.046 -3.316 . . . . 0.0 102.046 174.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 46.8 t -52.53 -39.24 61.15 Favored 'General case' 0 C--N 1.349 0.57 0 N-CA-C 115.68 1.733 . . . . 0.0 115.68 -162.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -77.28 -0.96 73.25 Favored Glycine 0 C--N 1.351 1.373 0 N-CA-C 116.475 1.35 . . . . 0.0 116.475 178.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -143.58 140.78 30.36 Favored 'General case' 0 C--N 1.356 0.858 0 CA-C-N 120.347 2.073 . . . . 0.0 112.009 179.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 34.5 m120 -102.15 103.52 14.06 Favored 'General case' 0 C--N 1.352 0.715 0 O-C-N 119.973 -1.705 . . . . 0.0 106.523 170.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -126.93 94.32 4.0 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 -168.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 72.9 m -136.77 156.88 75.82 Favored Pre-proline 0 C--N 1.351 0.662 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 172.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -70.51 160.42 49.55 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.52 2.147 . . . . 0.0 110.64 164.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -62.77 134.38 56.19 Favored 'General case' 0 C--N 1.354 0.779 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -174.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.25 -11.89 65.34 Favored Glycine 0 C--N 1.355 1.61 0 C-N-CA 124.194 0.902 . . . . 0.0 113.409 -175.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 73.8 m -114.15 153.77 28.96 Favored 'General case' 0 C--N 1.348 0.518 0 C-N-CA 124.145 0.978 . . . . 0.0 110.116 179.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 31.5 p90 -132.5 158.22 42.65 Favored 'General case' 0 C--N 1.352 0.684 0 N-CA-C 105.699 -1.963 . . . . 0.0 105.699 178.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 9.8 p -109.69 146.66 34.48 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-O 122.531 1.157 . . . . 0.0 112.923 173.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -82.74 69.29 3.39 Favored Glycine 0 C--N 1.353 1.498 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 176.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -91.81 122.46 34.37 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 -175.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -86.02 77.34 9.66 Favored 'General case' 0 C--N 1.352 0.701 0 O-C-N 120.709 -1.244 . . . . 0.0 110.829 -161.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 62.61 45.39 95.92 Favored Glycine 0 C--N 1.355 1.594 0 N-CA-C 115.448 0.939 . . . . 0.0 115.448 166.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 48.31 43.75 19.4 Favored 'General case' 0 C--N 1.354 0.779 0 C-N-CA 128.474 2.71 . . . . 0.0 115.984 -172.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 66.0 m-80 -97.48 -74.08 0.59 Allowed 'General case' 0 C--N 1.356 0.867 0 O-C-N 121.135 -0.978 . . . . 0.0 112.509 170.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -119.66 -101.55 0.42 Allowed 'General case' 0 C--N 1.357 0.932 0 O-C-N 120.917 -1.115 . . . . 0.0 113.649 -163.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.4 pptp? -145.76 161.01 40.9 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 -175.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -162.39 151.28 21.15 Favored Glycine 0 C--N 1.349 1.297 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 -179.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 72.4 t60 -99.19 146.82 25.76 Favored 'General case' 0 C--N 1.347 0.473 0 O-C-N 121.51 -0.994 . . . . 0.0 109.883 -170.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 76.4 m -76.85 136.55 38.9 Favored 'General case' 0 C--N 1.358 0.946 0 O-C-N 121.197 -0.939 . . . . 0.0 112.015 -179.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -130.63 161.5 31.44 Favored 'General case' 0 C--N 1.351 0.649 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 -177.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -114.28 132.81 56.03 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 164.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 96.3 mt -106.06 127.37 61.25 Favored 'Isoleucine or valine' 0 C--N 1.358 0.973 0 CA-C-O 122.632 1.206 . . . . 0.0 110.243 169.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.75 160.51 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 C-N-CA 126.879 2.071 . . . . 0.0 110.725 -176.733 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.354 1.532 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 -169.112 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 42.2 t80 . . . . . 0 N--CA 1.505 2.318 0 N-CA-C 116.815 2.154 . . . . 0.0 116.815 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -121.65 154.57 36.63 Favored 'General case' 0 C--N 1.354 0.796 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 159.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.9 p -128.71 132.91 67.29 Favored 'Isoleucine or valine' 0 C--N 1.349 0.582 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 174.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 33.0 m -134.55 161.56 40.28 Favored 'Isoleucine or valine' 0 C--N 1.349 0.564 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 -177.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 96.8 p -76.84 155.42 32.99 Favored 'General case' 0 C--N 1.354 0.771 0 O-C-N 120.665 -1.272 . . . . 0.0 112.986 178.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 33.9 t -120.38 28.6 7.92 Favored 'General case' 0 C--N 1.355 0.812 0 C-N-CA 123.881 0.873 . . . . 0.0 109.44 -177.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 45.83 36.55 2.9 Favored 'General case' 0 C--N 1.357 0.897 0 C-N-CA 128.58 2.752 . . . . 0.0 117.452 173.02 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 50.4 tptt -140.79 138.32 34.01 Favored 'General case' 0 C--N 1.352 0.687 0 O-C-N 120.664 -1.272 . . . . 0.0 109.208 -169.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -90.99 123.02 34.14 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.311 1.845 . . . . 0.0 108.559 -175.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 17.5 p -112.95 172.17 7.09 Favored 'General case' 0 C--N 1.357 0.918 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 175.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 27.5 m -130.43 146.18 51.95 Favored 'General case' 0 C--N 1.35 0.593 0 N-CA-C 102.279 -3.23 . . . . 0.0 102.279 167.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 90.6 p -59.97 -30.72 69.3 Favored 'General case' 0 C--N 1.35 0.592 0 N-CA-C 115.966 1.839 . . . . 0.0 115.966 -172.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -93.77 -1.21 65.87 Favored Glycine 0 C--N 1.354 1.53 0 CA-C-N 118.582 0.628 . . . . 0.0 114.138 175.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -108.62 -41.46 4.8 Favored 'General case' 0 C--N 1.352 0.685 0 CA-C-N 118.266 1.033 . . . . 0.0 111.145 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 25.3 m120 57.06 35.74 26.76 Favored 'General case' 0 C--N 1.358 0.939 0 C-N-CA 126.93 2.092 . . . . 0.0 115.028 174.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 60.9 mm-40 -87.09 114.95 24.14 Favored 'General case' 0 C--N 1.351 0.657 0 O-C-N 120.575 -1.328 . . . . 0.0 111.386 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 73.4 m -135.93 156.9 76.87 Favored Pre-proline 0 N--CA 1.447 -0.604 0 N-CA-C 105.601 -2.0 . . . . 0.0 105.601 168.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.55 161.84 44.59 Favored 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.783 2.322 . . . . 0.0 111.497 171.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -62.42 132.88 54.02 Favored 'General case' 0 C--N 1.354 0.778 0 CA-C-O 121.783 0.802 . . . . 0.0 113.006 -174.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.37 -11.66 68.64 Favored Glycine 0 C--N 1.355 1.606 0 C-N-CA 124.06 0.838 . . . . 0.0 112.91 -172.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 71.8 m -116.56 156.13 27.5 Favored 'General case' 0 C--N 1.349 0.565 0 C-N-CA 124.178 0.991 . . . . 0.0 110.394 179.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -145.21 165.87 27.09 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 104.999 -2.223 . . . . 0.0 104.999 -174.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 31.5 p -128.22 153.55 46.81 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-N 120.262 1.392 . . . . 0.0 108.724 165.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -121.79 76.92 0.34 Allowed Glycine 0 CA--C 1.492 -1.38 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 -174.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -106.18 124.79 50.14 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 105.944 -1.873 . . . . 0.0 105.944 177.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -113.92 140.57 48.27 Favored 'General case' 0 C--N 1.352 0.696 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 -175.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 76.78 8.7 86.53 Favored Glycine 0 C--N 1.355 1.634 0 N-CA-C 116.056 1.183 . . . . 0.0 116.056 164.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 57.83 35.89 25.88 Favored 'General case' 0 C--N 1.352 0.697 0 C-N-CA 126.865 2.066 . . . . 0.0 113.838 -175.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 60.8 m-80 -70.03 -43.77 70.61 Favored 'General case' 0 C--N 1.355 0.807 0 N-CA-C 114.228 1.195 . . . . 0.0 114.228 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm -144.13 -176.38 4.99 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.275 1.83 . . . . 0.0 106.465 -172.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -67.53 -45.59 75.29 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 115.878 1.806 . . . . 0.0 115.878 173.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.77 155.35 31.7 Favored Glycine 0 C--N 1.356 1.691 0 O-C-N 121.135 -0.978 . . . . 0.0 112.159 -168.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -137.81 143.81 41.2 Favored 'General case' 0 C--N 1.347 0.496 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 178.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 77.9 m -77.56 142.32 39.07 Favored 'General case' 0 C--N 1.353 0.747 0 CA-C-O 121.96 0.886 . . . . 0.0 113.126 -173.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -124.46 156.95 36.36 Favored 'General case' 0 C--N 1.35 0.606 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 -176.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 40.5 ttpt -112.7 136.03 52.76 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.649 1.18 . . . . 0.0 108.776 172.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 97.4 mt -98.49 125.32 51.87 Favored 'Isoleucine or valine' 0 C--N 1.359 0.994 0 C-N-CA 124.385 1.074 . . . . 0.0 108.987 175.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.92 156.26 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 C-N-CA 124.826 1.25 . . . . 0.0 109.536 178.116 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.353 1.501 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 -172.804 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 11.3 t80 . . . . . 0 N--CA 1.504 2.242 0 N-CA-C 116.3 1.963 . . . . 0.0 116.3 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -122.0 152.5 39.67 Favored 'General case' 0 C--N 1.355 0.821 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 162.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.3 p -127.1 135.94 62.14 Favored 'Isoleucine or valine' 0 C--N 1.349 0.585 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 176.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.4 m -131.21 158.0 43.27 Favored 'Isoleucine or valine' 0 C--N 1.351 0.647 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 177.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 87.7 p -81.88 157.37 24.39 Favored 'General case' 0 C--N 1.352 0.709 0 O-C-N 121.288 -0.882 . . . . 0.0 112.649 173.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 71.8 m -110.39 19.82 18.4 Favored 'General case' 0 C--N 1.355 0.847 0 O-C-N 121.413 -0.804 . . . . 0.0 111.791 177.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 47.34 39.56 9.14 Favored 'General case' 0 C--N 1.355 0.836 0 C-N-CA 127.432 2.293 . . . . 0.0 116.796 177.422 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 56.6 tptt -132.83 136.12 46.07 Favored 'General case' 0 C--N 1.352 0.677 0 O-C-N 121.127 -0.983 . . . . 0.0 109.006 -177.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -84.19 128.26 34.45 Favored 'General case' 0 C--N 1.354 0.786 0 C-N-CA 124.539 1.136 . . . . 0.0 110.742 -176.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 18.2 t -106.61 148.57 28.15 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 127.589 2.355 . . . . 0.0 108.93 178.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 23.3 m -133.0 154.73 50.24 Favored 'General case' 0 C--N 1.352 0.699 0 N-CA-C 102.488 -3.153 . . . . 0.0 102.488 168.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 79.4 p -58.93 -45.25 90.83 Favored 'General case' 0 C--N 1.349 0.549 0 N-CA-C 117.15 2.278 . . . . 0.0 117.15 -164.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -96.51 4.67 64.29 Favored Glycine 0 C--N 1.352 1.454 0 C-N-CA 123.605 0.622 . . . . 0.0 113.563 -176.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 11.1 mm-40 -115.96 -42.41 3.08 Favored 'General case' 0 C--N 1.346 0.433 0 O-C-N 121.82 -0.812 . . . . 0.0 109.803 178.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 56.3 45.95 22.02 Favored 'General case' 0 C--N 1.356 0.89 0 C-N-CA 128.575 2.75 . . . . 0.0 112.936 167.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -83.91 115.64 22.39 Favored 'General case' 0 C--N 1.352 0.701 0 O-C-N 121.043 -1.036 . . . . 0.0 112.742 -168.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 71.6 m -134.63 157.67 76.77 Favored Pre-proline 0 C--N 1.353 0.747 0 C-N-CA 124.785 1.234 . . . . 0.0 108.126 173.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.85 159.04 54.78 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.472 2.115 . . . . 0.0 110.618 164.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -65.09 135.17 55.23 Favored 'General case' 0 C--N 1.352 0.709 0 CA-C-O 121.599 0.714 . . . . 0.0 112.21 -176.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.59 -12.53 64.62 Favored Glycine 0 C--N 1.354 1.575 0 C-N-CA 123.593 0.616 . . . . 0.0 113.051 -173.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 72.2 m -113.13 155.45 24.94 Favored 'General case' 0 C--N 1.35 0.588 0 C-N-CA 124.242 1.017 . . . . 0.0 109.393 177.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -136.5 157.39 46.89 Favored 'General case' 0 C--N 1.351 0.634 0 O-C-N 121.278 -0.889 . . . . 0.0 108.729 -176.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 42.1 t -105.37 126.47 52.15 Favored 'General case' 0 CA--C 1.51 -0.57 0 O-C-N 121.205 -0.934 . . . . 0.0 111.027 -179.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.87 60.55 3.49 Favored Glycine 0 C--N 1.352 1.425 0 O-C-N 121.684 -0.635 . . . . 0.0 112.212 176.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -106.98 120.86 43.22 Favored 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 175.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -119.98 140.7 50.53 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 -176.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.18 5.42 76.4 Favored Glycine 0 C--N 1.355 1.603 0 N-CA-C 115.656 1.022 . . . . 0.0 115.656 161.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 56.75 42.9 26.07 Favored 'General case' 0 C--N 1.35 0.617 0 C-N-CA 126.639 1.976 . . . . 0.0 113.336 -171.669 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 54.0 m-80 -73.54 -49.37 26.84 Favored 'General case' 0 C--N 1.354 0.766 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 -178.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -140.65 -125.63 0.11 Allowed 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 177.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 16.6 pttp -107.79 -47.02 3.67 Favored 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 126.902 2.081 . . . . 0.0 114.146 -175.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 86.23 178.54 49.74 Favored Glycine 0 C--N 1.356 1.678 0 O-C-N 120.708 -1.245 . . . . 0.0 112.421 -173.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 72.7 t60 -154.12 155.24 35.04 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 105.877 -1.897 . . . . 0.0 105.877 178.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 76.4 m -86.86 135.57 33.28 Favored 'General case' 0 C--N 1.355 0.843 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -174.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -126.52 161.32 28.24 Favored 'General case' 0 C--N 1.358 0.946 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 -174.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -122.61 135.66 54.67 Favored 'General case' 0 C--N 1.352 0.69 0 C-N-CA 124.172 0.989 . . . . 0.0 110.098 165.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 83.3 mt -88.05 127.04 41.43 Favored 'Isoleucine or valine' 0 C--N 1.359 1.017 0 C-N-CA 125.963 1.705 . . . . 0.0 109.732 169.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.98 155.86 41.97 Favored 'Isoleucine or valine' 0 C--N 1.352 0.702 0 C-N-CA 123.949 0.899 . . . . 0.0 110.325 171.303 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.354 1.538 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -175.75 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 10.9 t80 . . . . . 0 N--CA 1.505 2.287 0 N-CA-C 116.349 1.981 . . . . 0.0 116.349 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -122.75 148.7 45.03 Favored 'General case' 0 C--N 1.357 0.895 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 163.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.1 p -123.7 133.14 70.06 Favored 'Isoleucine or valine' 0 C--N 1.35 0.595 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 173.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.2 m -133.22 153.78 38.08 Favored 'Isoleucine or valine' 0 C--N 1.354 0.786 0 O-C-N 121.35 -0.844 . . . . 0.0 108.975 177.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 88.2 p -80.48 150.61 29.62 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 -179.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 71.7 m -102.1 -4.5 25.82 Favored 'General case' 0 C--N 1.354 0.783 0 O-C-N 121.399 -0.813 . . . . 0.0 111.11 178.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 56.29 43.46 26.39 Favored 'General case' 0 C--N 1.357 0.918 0 C-N-CA 127.423 2.289 . . . . 0.0 115.734 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 23.4 mmmt -131.2 149.89 52.38 Favored 'General case' 0 N--CA 1.442 -0.825 0 C-N-CA 127.061 2.144 . . . . 0.0 106.08 165.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -92.52 174.52 7.23 Favored 'General case' 0 C--N 1.351 0.657 0 O-C-N 121.698 -0.626 . . . . 0.0 109.6 171.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 15.2 p -121.21 172.36 8.05 Favored 'General case' 0 C--N 1.353 0.745 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 159.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 63.1 m -135.5 144.75 46.53 Favored 'General case' 0 CA--C 1.504 -0.808 0 N-CA-C 100.975 -3.713 . . . . 0.0 100.975 168.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 37.0 t -57.76 -43.93 85.81 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-N 120.459 1.481 . . . . 0.0 114.315 -164.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.15 -44.84 58.91 Favored Glycine 0 C--N 1.355 1.592 0 O-C-N 121.023 -1.048 . . . . 0.0 115.0 175.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -69.04 -43.22 75.13 Favored 'General case' 0 C--N 1.349 0.558 0 C-N-CA 126.114 1.766 . . . . 0.0 113.579 -176.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 55.42 38.01 29.68 Favored 'General case' 0 C--N 1.354 0.804 0 C-N-CA 129.008 2.923 . . . . 0.0 113.82 176.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -68.42 127.43 32.94 Favored 'General case' 0 C--N 1.352 0.681 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 175.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 94.9 m -143.34 159.23 55.95 Favored Pre-proline 0 C--N 1.354 0.786 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 152.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -70.08 159.09 54.4 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.83 2.353 . . . . 0.0 110.551 162.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -65.61 136.74 56.73 Favored 'General case' 0 C--N 1.352 0.681 0 CA-C-O 121.58 0.705 . . . . 0.0 112.7 -175.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.1 -9.65 70.03 Favored Glycine 0 C--N 1.356 1.668 0 O-C-N 121.689 -0.632 . . . . 0.0 113.19 -175.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 84.2 m -114.92 155.94 25.94 Favored 'General case' 0 C--N 1.348 0.508 0 C-N-CA 124.502 1.121 . . . . 0.0 108.381 178.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -136.3 163.1 31.2 Favored 'General case' 0 C--N 1.352 0.699 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 178.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 45.2 t -119.43 124.05 45.58 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 105.931 -1.877 . . . . 0.0 105.931 178.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -83.29 78.77 1.98 Allowed Glycine 0 C--N 1.352 1.443 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 177.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -98.46 113.39 25.38 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 104.387 -2.449 . . . . 0.0 104.387 -176.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -77.03 -49.04 16.26 Favored 'General case' 0 C--N 1.357 0.929 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -148.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.94 76.97 0.16 Allowed Glycine 0 C--N 1.349 1.287 0 N-CA-C 108.69 -1.764 . . . . 0.0 108.69 175.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.8 pm0 45.59 59.38 3.65 Favored 'General case' 0 C--N 1.354 0.8 0 C-N-CA 128.519 2.727 . . . . 0.0 116.509 -178.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 34.7 m120 -103.33 -119.59 0.2 Allowed 'General case' 0 C--N 1.352 0.698 0 C-N-CA 123.953 0.901 . . . . 0.0 109.845 -171.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.72 -101.16 0.21 Allowed 'General case' 0 C--N 1.355 0.816 0 C-N-CA 124.159 0.984 . . . . 0.0 110.874 -172.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.0 pttm -130.33 -32.39 1.77 Allowed 'General case' 0 C--N 1.355 0.831 0 N-CA-C 116.306 1.965 . . . . 0.0 116.306 -163.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 62.05 -144.79 49.21 Favored Glycine 0 C--N 1.357 1.722 0 O-C-N 119.664 -1.897 . . . . 0.0 113.338 -174.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 43.4 t60 -160.51 160.41 31.91 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 101.808 -3.404 . . . . 0.0 101.808 163.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 72.5 m -89.36 134.16 34.19 Favored 'General case' 0 C--N 1.354 0.804 0 CA-C-N 120.89 1.677 . . . . 0.0 112.091 175.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -149.77 164.58 34.9 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.186 1.395 . . . . 0.0 112.099 -178.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -133.98 156.08 48.82 Favored 'General case' 0 C--N 1.354 0.784 0 CA-C-O 121.499 0.666 . . . . 0.0 111.516 -173.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 91.5 mt -108.77 124.98 65.74 Favored 'Isoleucine or valine' 0 C--N 1.355 0.843 0 C-N-CA 125.522 1.529 . . . . 0.0 108.84 -175.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.71 157.25 42.97 Favored 'Isoleucine or valine' 0 C--N 1.35 0.601 0 C-N-CA 124.224 1.01 . . . . 0.0 108.508 173.55 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.352 1.464 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 -178.689 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 5.9 t80 . . . . . 0 N--CA 1.504 2.265 0 N-CA-C 115.929 1.826 . . . . 0.0 115.929 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -120.04 152.46 37.49 Favored 'General case' 0 C--N 1.356 0.848 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 163.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.6 p -124.63 135.99 62.11 Favored 'Isoleucine or valine' 0 C--N 1.348 0.54 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 176.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.3 m -129.96 157.29 42.54 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.681 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 177.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 85.3 p -79.7 152.67 29.78 Favored 'General case' 0 N--CA 1.447 -0.585 0 O-C-N 121.246 -0.909 . . . . 0.0 112.57 173.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 16.6 t -110.22 9.6 23.81 Favored 'General case' 0 C--N 1.352 0.701 0 O-C-N 121.274 -0.891 . . . . 0.0 110.892 -174.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 56.51 42.95 26.64 Favored 'General case' 0 C--N 1.355 0.842 0 C-N-CA 126.762 2.025 . . . . 0.0 114.736 175.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 54.2 tptt -140.87 137.64 33.37 Favored 'General case' 0 C--N 1.351 0.657 0 O-C-N 120.668 -1.27 . . . . 0.0 107.801 177.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -91.03 130.11 36.97 Favored 'General case' 0 C--N 1.351 0.632 0 C-N-CA 125.642 1.577 . . . . 0.0 109.946 -177.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 10.6 p -111.43 156.13 22.11 Favored 'General case' 0 C--N 1.358 0.955 0 O-C-N 121.415 -0.803 . . . . 0.0 109.131 -178.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 21.4 p -127.04 152.72 46.88 Favored 'General case' 0 CA--C 1.496 -1.098 0 O-C-N 121.069 -1.019 . . . . 0.0 112.745 177.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 40.7 t -63.91 126.16 26.76 Favored 'General case' 0 C--N 1.359 0.995 0 CA-C-O 122.437 1.113 . . . . 0.0 110.249 177.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 92.63 -9.19 76.19 Favored Glycine 0 C--N 1.344 1.026 0 CA-C-N 114.975 -1.011 . . . . 0.0 113.05 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 15.1 mm-40 -121.54 -46.75 2.25 Favored 'General case' 0 C--N 1.352 0.677 0 CA-C-N 118.374 1.087 . . . . 0.0 111.902 179.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 51.41 47.51 24.68 Favored 'General case' 0 C--N 1.36 1.039 0 N-CA-C 116.343 1.979 . . . . 0.0 116.343 -177.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -67.5 118.03 10.26 Favored 'General case' 0 C--N 1.355 0.841 0 O-C-N 120.791 -1.193 . . . . 0.0 113.216 178.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 73.5 m -137.76 158.07 72.3 Favored Pre-proline 0 C--N 1.352 0.69 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 169.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.07 159.03 54.61 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.473 2.116 . . . . 0.0 110.428 164.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 58.6 mp0 -64.04 134.06 54.26 Favored 'General case' 0 C--N 1.352 0.717 0 CA-C-O 121.812 0.815 . . . . 0.0 112.467 -173.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 98.35 -15.06 61.75 Favored Glycine 0 C--N 1.355 1.601 0 C-N-CA 123.799 0.714 . . . . 0.0 112.934 -174.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 93.1 m -110.21 157.7 19.15 Favored 'General case' 0 C--N 1.349 0.549 0 C-N-CA 124.23 1.012 . . . . 0.0 110.248 176.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 28.4 p90 -142.14 164.31 30.51 Favored 'General case' 0 C--N 1.348 0.541 0 N-CA-C 105.674 -1.973 . . . . 0.0 105.674 -175.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 36.3 t -117.45 128.48 55.04 Favored 'General case' 0 CA--C 1.51 -0.578 0 O-C-N 121.039 -1.038 . . . . 0.0 108.915 -177.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -85.75 61.81 4.49 Favored Glycine 0 C--N 1.353 1.516 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 176.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.1 tt -69.81 139.55 53.2 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 125.159 1.384 . . . . 0.0 110.502 -175.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -80.89 72.37 7.88 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 125.423 1.489 . . . . 0.0 108.997 -163.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.75 14.71 81.19 Favored Glycine 0 C--N 1.352 1.456 0 O-C-N 120.689 -1.257 . . . . 0.0 113.292 178.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 56.35 41.24 29.29 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 127.35 2.26 . . . . 0.0 114.664 -170.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -68.47 -45.15 73.21 Favored 'General case' 0 C--N 1.356 0.887 0 N-CA-C 115.726 1.75 . . . . 0.0 115.726 174.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 17.5 pttp -155.15 -64.65 0.12 Allowed 'General case' 0 C--N 1.348 0.539 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -176.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.8 ptmt -157.21 161.2 39.26 Favored 'General case' 0 N--CA 1.439 -1.022 0 O-C-N 121.111 -0.993 . . . . 0.0 108.638 -172.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -159.28 -171.78 25.54 Favored Glycine 0 C--N 1.345 1.045 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 175.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 77.7 t60 -127.3 140.87 51.91 Favored 'General case' 0 C--N 1.35 0.603 0 O-C-N 121.301 -1.117 . . . . 0.0 108.309 -175.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 75.0 m -76.87 145.73 38.14 Favored 'General case' 0 C--N 1.356 0.879 0 O-C-N 120.83 -1.169 . . . . 0.0 113.626 -172.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -126.07 162.48 25.21 Favored 'General case' 0 C--N 1.358 0.976 0 C-N-CA 123.89 0.876 . . . . 0.0 108.815 -175.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -121.4 136.43 54.96 Favored 'General case' 0 C--N 1.351 0.632 0 C-N-CA 124.616 1.166 . . . . 0.0 108.514 166.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 84.8 mt -98.39 126.28 51.52 Favored 'Isoleucine or valine' 0 C--N 1.359 0.997 0 C-N-CA 124.851 1.261 . . . . 0.0 109.137 172.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.55 148.32 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 C-N-CA 125.321 1.448 . . . . 0.0 108.388 176.371 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 160.52 -154.02 24.99 Favored Glycine 0 C--N 1.349 1.292 0 O-C-N 119.884 -1.76 . . . . 0.0 110.845 -176.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 . . . . . 0 C--O 1.261 1.671 0 C-N-CA 124.499 1.12 . . . . 0.0 113.859 -175.431 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 14.0 t80 . . . . . 0 N--CA 1.504 2.249 0 N-CA-C 116.314 1.968 . . . . 0.0 116.314 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -123.05 155.62 36.52 Favored 'General case' 0 C--N 1.355 0.825 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 166.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.3 p -126.81 135.81 62.61 Favored 'Isoleucine or valine' 0 C--N 1.349 0.572 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 174.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 30.2 m -131.58 159.73 42.86 Favored 'Isoleucine or valine' 0 C--N 1.35 0.63 0 C-N-CA 124.709 1.204 . . . . 0.0 107.8 175.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 87.8 p -77.6 153.41 33.26 Favored 'General case' 0 C--N 1.351 0.646 0 CA-C-O 122.15 0.976 . . . . 0.0 112.58 174.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 8.8 t -104.73 3.59 31.53 Favored 'General case' 0 C--N 1.353 0.724 0 O-C-N 121.21 -0.931 . . . . 0.0 110.298 -176.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 72.4 m-80 58.26 41.38 23.49 Favored 'General case' 0 C--N 1.356 0.877 0 C-N-CA 127.456 2.303 . . . . 0.0 114.378 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 52.6 tptt -139.72 134.54 32.06 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 -177.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -89.01 133.61 34.27 Favored 'General case' 0 C--N 1.355 0.836 0 C-N-CA 125.002 1.321 . . . . 0.0 109.288 -179.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 26.1 p -131.99 152.58 51.04 Favored 'General case' 0 C--N 1.352 0.711 0 CA-C-O 122.049 0.928 . . . . 0.0 110.424 177.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.7 m -127.39 149.52 50.04 Favored 'General case' 0 C--N 1.349 0.569 0 N-CA-C 105.56 -2.015 . . . . 0.0 105.56 -167.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 36.6 t -62.71 133.43 54.8 Favored 'General case' 0 C--N 1.36 1.055 0 O-C-N 120.689 -1.257 . . . . 0.0 109.907 170.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 92.88 -15.08 63.58 Favored Glycine 0 C--N 1.349 1.286 0 C-N-CA 123.841 0.734 . . . . 0.0 112.443 -172.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -113.79 -53.56 2.67 Favored 'General case' 0 C--N 1.356 0.866 0 CA-C-N 118.652 1.226 . . . . 0.0 111.954 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 49.36 41.75 21.06 Favored 'General case' 0 C--N 1.364 1.204 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 -176.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 59.6 mm-40 -83.95 112.93 20.61 Favored 'General case' 0 C--N 1.353 0.752 0 O-C-N 120.436 -1.415 . . . . 0.0 111.581 -179.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 79.0 m -134.83 155.57 79.23 Favored Pre-proline 0 C--N 1.35 0.601 0 N-CA-C 106.169 -1.789 . . . . 0.0 106.169 171.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -70.54 160.1 50.59 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.589 2.192 . . . . 0.0 110.574 165.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -65.02 141.46 58.76 Favored 'General case' 0 C--N 1.353 0.757 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -175.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.8 -13.88 65.6 Favored Glycine 0 C--N 1.354 1.554 0 C-N-CA 123.774 0.702 . . . . 0.0 112.522 -172.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 71.2 m -115.32 154.94 28.23 Favored 'General case' 0 C--N 1.349 0.562 0 C-N-CA 124.487 1.115 . . . . 0.0 109.929 178.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -129.9 158.61 39.04 Favored 'General case' 0 C--N 1.352 0.686 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -178.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 52.2 t -88.66 126.53 35.35 Favored 'General case' 0 C--N 1.35 0.593 0 O-C-N 121.494 -0.754 . . . . 0.0 110.609 -174.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -82.55 67.88 3.64 Favored Glycine 0 C--N 1.356 1.665 0 O-C-N 121.107 -0.996 . . . . 0.0 113.79 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 56.7 mt -104.76 134.17 48.36 Favored 'General case' 0 CA--C 1.505 -0.759 0 C-N-CA 125.142 1.377 . . . . 0.0 110.429 170.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -70.0 -44.86 68.52 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 125.479 1.512 . . . . 0.0 111.035 -166.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -160.93 49.65 0.36 Allowed Glycine 0 C--N 1.346 1.123 0 N-CA-C 107.279 -2.328 . . . . 0.0 107.279 170.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 17.4 mp0 52.73 51.21 16.45 Favored 'General case' 0 C--N 1.356 0.862 0 C-N-CA 127.011 2.124 . . . . 0.0 114.605 -177.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 23.2 m120 -92.33 -53.69 4.12 Favored 'General case' 0 C--N 1.357 0.9 0 O-C-N 120.494 -1.379 . . . . 0.0 112.628 -166.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -131.46 -98.69 0.31 Allowed 'General case' 0 C--N 1.355 0.811 0 CA-C-O 122.394 1.092 . . . . 0.0 109.774 -174.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 15.0 ptmm? -138.25 156.93 47.2 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 106.012 -1.847 . . . . 0.0 106.012 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -148.53 -171.03 16.95 Favored Glycine 0 CA--C 1.493 -1.284 0 N-CA-C 108.405 -1.878 . . . . 0.0 108.405 -178.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 51.6 t60 -132.42 147.42 52.38 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 104.712 -2.329 . . . . 0.0 104.712 -176.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 71.9 m -78.46 139.38 38.71 Favored 'General case' 0 C--N 1.351 0.636 0 O-C-N 120.984 -1.072 . . . . 0.0 112.079 -174.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -125.72 156.91 38.63 Favored 'General case' 0 C--N 1.351 0.671 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 -176.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -112.46 135.54 53.04 Favored 'General case' 0 C--N 1.35 0.625 0 C-N-CA 124.043 0.937 . . . . 0.0 109.669 175.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 43.0 mm -91.8 122.06 42.88 Favored 'Isoleucine or valine' 0 C--N 1.361 1.091 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 172.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.64 137.54 57.05 Favored 'Isoleucine or valine' 0 C--N 1.351 0.663 0 CA-C-O 122.363 1.078 . . . . 0.0 110.46 169.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 166.45 -174.36 41.92 Favored Glycine 0 CA--C 1.493 -1.327 0 N-CA-C 106.014 -2.834 . . . . 0.0 106.014 -176.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 53.4 p30 . . . . . 0 C--O 1.259 1.584 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 178.932 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 14.0 t80 . . . . . 0 N--CA 1.503 2.218 0 N-CA-C 116.702 2.112 . . . . 0.0 116.702 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -111.74 151.83 28.49 Favored 'General case' 0 C--N 1.353 0.73 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 159.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.2 p -126.33 136.02 62.06 Favored 'Isoleucine or valine' 0 C--N 1.351 0.65 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 173.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.9 m -133.72 159.39 42.59 Favored 'Isoleucine or valine' 0 C--N 1.353 0.727 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 176.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 87.4 p -80.42 154.32 27.73 Favored 'General case' 0 C--N 1.349 0.547 0 CA-C-O 121.684 0.754 . . . . 0.0 112.934 171.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 78.2 m -105.38 5.0 31.4 Favored 'General case' 0 C--N 1.356 0.866 0 O-C-N 121.114 -0.991 . . . . 0.0 111.539 173.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 58.16 40.73 24.71 Favored 'General case' 0 C--N 1.355 0.821 0 C-N-CA 126.928 2.091 . . . . 0.0 114.977 178.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 37.2 mmtm -132.7 142.83 49.24 Favored 'General case' 0 C--N 1.351 0.632 0 C-N-CA 124.593 1.157 . . . . 0.0 110.416 176.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.5 t30 -88.09 133.29 34.02 Favored 'General case' 0 C--N 1.351 0.668 0 C-N-CA 126.374 1.87 . . . . 0.0 109.135 176.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 13.8 p -109.31 153.51 23.8 Favored 'General case' 0 C--N 1.356 0.887 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 171.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 59.7 m -128.9 145.71 51.14 Favored 'General case' 0 C--N 1.346 0.435 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 -173.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 47.4 t -59.2 138.53 57.55 Favored 'General case' 0 C--N 1.358 0.937 0 C-N-CA 123.829 0.852 . . . . 0.0 112.941 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.94 -53.88 4.4 Favored Glycine 0 C--N 1.358 1.774 0 C-N-CA 124.666 1.127 . . . . 0.0 112.377 -175.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -64.39 -45.74 86.35 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 128.685 2.794 . . . . 0.0 115.465 -178.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.4 m120 54.99 43.01 30.55 Favored 'General case' 0 C--N 1.355 0.814 0 C-N-CA 127.084 2.154 . . . . 0.0 115.654 168.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 55.2 mm-40 -75.76 117.89 18.0 Favored 'General case' 0 C--N 1.354 0.784 0 O-C-N 120.124 -1.61 . . . . 0.0 113.929 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 77.1 m -138.06 155.99 74.22 Favored Pre-proline 0 C--N 1.354 0.793 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 159.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.21 160.08 50.07 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 123.109 2.539 . . . . 0.0 111.25 166.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -62.94 131.14 47.69 Favored 'General case' 0 C--N 1.353 0.718 0 C-N-CA 123.539 0.735 . . . . 0.0 112.534 -176.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 100.27 -14.07 59.79 Favored Glycine 0 C--N 1.356 1.649 0 C-N-CA 123.827 0.727 . . . . 0.0 112.679 -174.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 75.0 m -112.69 156.67 22.38 Favored 'General case' 0 C--N 1.349 0.549 0 C-N-CA 124.055 0.942 . . . . 0.0 109.145 177.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -141.47 163.03 34.03 Favored 'General case' 0 C--N 1.348 0.509 0 N-CA-C 105.346 -2.094 . . . . 0.0 105.346 -178.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 46.3 t -124.25 125.9 45.18 Favored 'General case' 0 CA--C 1.508 -0.665 0 O-C-N 120.85 -1.156 . . . . 0.0 109.59 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -85.9 63.94 4.16 Favored Glycine 0 C--N 1.354 1.544 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 177.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -69.46 141.16 54.07 Favored 'General case' 0 C--N 1.349 0.573 0 C-N-CA 125.27 1.428 . . . . 0.0 110.292 -178.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -81.59 69.94 8.36 Favored 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 125.502 1.521 . . . . 0.0 109.288 -161.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.76 24.31 76.31 Favored Glycine 0 C--N 1.352 1.438 0 O-C-N 120.975 -1.078 . . . . 0.0 113.943 178.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 69.2 mm-40 58.32 34.29 23.91 Favored 'General case' 0 C--N 1.356 0.88 0 C-N-CA 126.2 1.8 . . . . 0.0 114.592 -175.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 57.4 m-80 -76.38 -46.92 25.17 Favored 'General case' 0 C--N 1.356 0.871 0 O-C-N 120.028 -1.67 . . . . 0.0 115.371 176.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 48.2 mmtm -137.7 -100.97 0.19 Allowed 'General case' 0 C--N 1.348 0.542 0 CA-C-O 122.103 0.954 . . . . 0.0 110.124 -173.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 10.3 ptpp? -143.58 161.65 37.94 Favored 'General case' 0 N--CA 1.436 -1.136 0 C-N-CA 125.311 1.444 . . . . 0.0 107.654 -173.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -154.91 -174.13 24.5 Favored Glycine 0 C--N 1.344 1.005 0 N-CA-C 108.748 -1.741 . . . . 0.0 108.748 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 52.6 t60 -126.7 142.97 51.38 Favored 'General case' 0 C--N 1.35 0.589 0 O-C-N 121.159 -1.201 . . . . 0.0 108.218 -173.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 75.9 m -80.15 139.98 36.57 Favored 'General case' 0 C--N 1.356 0.849 0 O-C-N 120.751 -1.218 . . . . 0.0 112.978 -173.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -128.0 162.15 27.48 Favored 'General case' 0 C--N 1.357 0.919 0 C-N-CA 124.0 0.92 . . . . 0.0 108.986 -173.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -116.35 137.91 51.77 Favored 'General case' 0 C--N 1.352 0.7 0 C-N-CA 124.596 1.158 . . . . 0.0 108.267 164.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 83.5 mt -95.56 126.42 48.08 Favored 'Isoleucine or valine' 0 C--N 1.358 0.972 0 C-N-CA 125.726 1.61 . . . . 0.0 107.54 167.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 4.7 mp -115.75 125.71 73.01 Favored 'Isoleucine or valine' 0 C--N 1.355 0.836 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 -177.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 142.16 -61.12 0.53 Allowed Glycine 0 C--N 1.353 1.503 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 173.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 24.9 p30 . . . . . 0 C--O 1.261 1.694 0 CA-C-O 117.014 -1.47 . . . . 0.0 114.225 177.729 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 13.3 t80 . . . . . 0 N--CA 1.503 2.205 0 N-CA-C 116.773 2.138 . . . . 0.0 116.773 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -120.53 150.6 40.6 Favored 'General case' 0 C--N 1.356 0.867 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 165.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.2 p -122.93 134.41 66.16 Favored 'Isoleucine or valine' 0 C--N 1.351 0.643 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 171.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 28.4 m -132.21 156.97 42.97 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.619 0 C-N-CA 124.983 1.313 . . . . 0.0 107.547 177.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 96.5 p -81.16 158.27 25.0 Favored 'General case' 0 C--N 1.353 0.735 0 CA-C-O 122.391 1.091 . . . . 0.0 112.342 175.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 79.0 m -98.77 10.53 41.01 Favored 'General case' 0 C--N 1.349 0.556 0 C-N-CA 125.007 1.323 . . . . 0.0 110.194 176.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 8.3 m120 62.69 21.55 12.8 Favored 'General case' 0 C--N 1.356 0.87 0 C-N-CA 128.788 2.835 . . . . 0.0 114.146 177.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt -118.8 143.12 47.12 Favored 'General case' 0 CA--C 1.511 -0.553 0 C-N-CA 125.038 1.335 . . . . 0.0 111.586 179.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -96.83 130.03 44.17 Favored 'General case' 0 C--N 1.351 0.666 0 C-N-CA 126.878 2.071 . . . . 0.0 109.992 178.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 14.2 p -103.17 155.69 18.24 Favored 'General case' 0 C--N 1.354 0.786 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 170.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 61.6 m -130.38 145.34 51.79 Favored 'General case' 0 C--N 1.353 0.749 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 -177.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 39.7 t -60.6 133.12 55.79 Favored 'General case' 0 C--N 1.356 0.855 0 O-C-N 119.531 -1.981 . . . . 0.0 112.003 177.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.71 -18.96 56.13 Favored Glycine 0 C--N 1.352 1.43 0 C-N-CA 125.024 1.297 . . . . 0.0 112.824 -172.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -148.8 102.21 3.26 Favored 'General case' 0 C--N 1.355 0.808 0 CA-C-O 123.847 1.784 . . . . 0.0 111.233 174.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 33.7 m120 -80.91 82.63 6.84 Favored 'General case' 0 C--N 1.353 0.747 0 O-C-N 120.058 -1.652 . . . . 0.0 110.833 -175.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -82.5 75.81 9.4 Favored 'General case' 0 C--N 1.353 0.734 0 C-N-CA 124.461 1.105 . . . . 0.0 112.581 -167.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 74.7 m -118.63 151.21 49.56 Favored Pre-proline 0 C--N 1.351 0.668 0 O-C-N 120.694 -1.254 . . . . 0.0 110.806 177.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -71.83 159.77 49.71 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.776 2.318 . . . . 0.0 110.603 163.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -63.77 134.82 55.99 Favored 'General case' 0 C--N 1.352 0.684 0 C-N-CA 123.503 0.721 . . . . 0.0 112.524 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 98.59 -10.51 62.84 Favored Glycine 0 C--N 1.356 1.639 0 C-N-CA 123.817 0.722 . . . . 0.0 113.542 -175.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 82.5 m -112.77 154.47 26.15 Favored 'General case' 0 C--N 1.348 0.52 0 CA-C-N 118.003 0.901 . . . . 0.0 108.891 178.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -129.03 160.36 32.99 Favored 'General case' 0 C--N 1.353 0.737 0 N-CA-C 104.691 -2.337 . . . . 0.0 104.691 177.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 41.9 t -114.21 128.59 56.44 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-N 120.586 1.539 . . . . 0.0 109.33 178.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -83.8 61.6 4.72 Favored Glycine 0 C--N 1.355 1.595 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -81.93 137.79 35.11 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 124.21 1.004 . . . . 0.0 109.142 -175.063 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -81.21 72.24 8.23 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 125.637 1.575 . . . . 0.0 109.044 -163.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.67 20.25 79.78 Favored Glycine 0 C--N 1.354 1.554 0 O-C-N 120.742 -1.224 . . . . 0.0 113.692 178.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 56.37 39.67 30.0 Favored 'General case' 0 C--N 1.352 0.717 0 C-N-CA 127.376 2.271 . . . . 0.0 114.091 -172.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 61.2 m-80 -80.47 -45.14 18.06 Favored 'General case' 0 C--N 1.351 0.671 0 N-CA-C 115.073 1.509 . . . . 0.0 115.073 173.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -131.0 -105.34 0.27 Allowed 'General case' 0 C--N 1.354 0.78 0 O-C-N 121.109 -0.995 . . . . 0.0 111.756 -169.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.03 164.57 31.68 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 105.38 -2.082 . . . . 0.0 105.38 -178.021 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -166.16 179.64 40.14 Favored Glycine 0 CA--C 1.493 -1.299 0 N-CA-C 108.25 -1.94 . . . . 0.0 108.25 178.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 12.3 m80 -105.83 150.94 25.12 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 115.689 1.737 . . . . 0.0 115.689 176.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 81.0 m -81.68 134.35 35.46 Favored 'General case' 0 C--N 1.353 0.733 0 C-N-CA 125.347 1.459 . . . . 0.0 110.047 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -127.68 158.97 36.14 Favored 'General case' 0 C--N 1.351 0.654 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 -172.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 20.7 pttm -125.22 154.87 40.96 Favored 'General case' 0 C--N 1.352 0.717 0 CA-C-O 121.987 0.898 . . . . 0.0 111.55 168.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 46.4 mm -103.62 121.15 54.68 Favored 'Isoleucine or valine' 0 C--N 1.353 0.725 0 C-N-CA 125.397 1.479 . . . . 0.0 107.671 -175.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.24 146.9 33.51 Favored 'Isoleucine or valine' 0 C--N 1.353 0.739 0 CA-C-O 121.908 0.861 . . . . 0.0 110.443 175.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 94.66 -7.57 71.02 Favored Glycine 0 C--N 1.355 1.598 0 O-C-N 121.21 -0.931 . . . . 0.0 113.889 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 . . . . . 0 CA--C 1.567 1.613 0 O-C-N 121.127 -1.22 . . . . 0.0 111.18 177.718 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 11.3 t80 . . . . . 0 N--CA 1.504 2.25 0 N-CA-C 116.254 1.946 . . . . 0.0 116.254 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -123.19 147.91 46.35 Favored 'General case' 0 C--N 1.357 0.892 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 158.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 5.3 p -126.89 135.38 63.83 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.62 0 C-N-CA 124.474 1.109 . . . . 0.0 108.418 174.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 30.4 m -129.97 158.97 42.43 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.638 0 C-N-CA 124.715 1.206 . . . . 0.0 108.265 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 78.9 p -76.43 143.05 40.82 Favored 'General case' 0 N--CA 1.446 -0.647 0 O-C-N 121.186 -0.946 . . . . 0.0 112.741 174.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 15.5 t -91.98 -1.8 57.07 Favored 'General case' 0 C--N 1.354 0.768 0 O-C-N 121.256 -0.903 . . . . 0.0 110.916 178.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 54.5 t30 59.95 46.45 11.05 Favored 'General case' 0 C--N 1.356 0.869 0 C-N-CA 127.591 2.357 . . . . 0.0 113.55 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 55.6 tptt -140.98 138.26 33.62 Favored 'General case' 0 C--N 1.352 0.679 0 O-C-N 121.086 -1.009 . . . . 0.0 108.429 178.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -84.4 133.56 34.5 Favored 'General case' 0 C--N 1.355 0.816 0 C-N-CA 125.7 1.6 . . . . 0.0 111.217 176.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 26.0 p -132.48 157.37 44.81 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 122.122 0.963 . . . . 0.0 110.434 173.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 37.3 p -128.87 165.44 21.02 Favored 'General case' 0 CA--C 1.5 -0.978 0 C-N-CA 124.794 1.238 . . . . 0.0 111.362 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 47.3 t -58.94 135.1 57.48 Favored 'General case' 0 C--N 1.355 0.839 0 C-N-CA 125.956 1.702 . . . . 0.0 111.465 177.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 82.66 -61.08 4.8 Favored Glycine 0 C--N 1.352 1.456 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 -170.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 24.4 mm100 -62.15 -48.48 79.89 Favored 'General case' 0 C--N 1.351 0.643 0 N-CA-C 117.047 2.24 . . . . 0.0 117.047 -174.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 48.52 36.93 8.12 Favored 'General case' 0 C--N 1.359 1.006 0 N-CA-C 115.917 1.821 . . . . 0.0 115.917 175.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -81.53 117.79 22.22 Favored 'General case' 0 C--N 1.356 0.866 0 O-C-N 120.464 -1.397 . . . . 0.0 112.382 -173.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 82.1 m -137.14 158.03 73.35 Favored Pre-proline 0 N--CA 1.448 -0.548 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 176.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -70.15 159.96 51.28 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.626 2.217 . . . . 0.0 110.609 164.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -64.73 140.81 58.91 Favored 'General case' 0 C--N 1.353 0.73 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -174.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.22 -13.45 66.84 Favored Glycine 0 C--N 1.355 1.585 0 O-C-N 121.562 -0.711 . . . . 0.0 112.806 -173.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 72.8 m -115.41 155.09 28.05 Favored 'General case' 0 C--N 1.349 0.577 0 C-N-CA 124.458 1.103 . . . . 0.0 110.247 178.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -127.18 161.34 28.75 Favored 'General case' 0 C--N 1.348 0.527 0 C-N-CA 124.763 1.225 . . . . 0.0 109.472 178.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 53.2 t -86.83 125.46 33.99 Favored 'General case' 0 C--N 1.35 0.603 0 C-N-CA 123.939 0.895 . . . . 0.0 110.9 -177.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -91.08 84.82 1.28 Allowed Glycine 0 C--N 1.355 1.603 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 172.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -103.75 139.9 38.35 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 -179.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -80.29 68.11 6.35 Favored 'General case' 0 C--N 1.351 0.632 0 C-N-CA 125.162 1.385 . . . . 0.0 109.111 -175.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.16 21.51 77.12 Favored Glycine 0 C--N 1.356 1.646 0 O-C-N 120.699 -1.251 . . . . 0.0 113.695 179.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 56.91 35.37 26.26 Favored 'General case' 0 C--N 1.348 0.543 0 C-N-CA 127.365 2.266 . . . . 0.0 116.401 -173.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 61.3 m-80 -67.68 -44.8 76.94 Favored 'General case' 0 C--N 1.357 0.896 0 N-CA-C 115.065 1.506 . . . . 0.0 115.065 168.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.459 ' HG3' ' H ' ' A' ' 47' ' ' LYS . 20.1 pttp -149.33 -106.2 0.07 Allowed 'General case' 0 C--N 1.354 0.764 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 -173.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.459 ' H ' ' HG3' ' A' ' 46' ' ' LYS . 25.8 pttm -119.27 159.07 24.79 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 125.388 1.475 . . . . 0.0 110.109 -177.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -154.79 -166.76 15.62 Favored Glycine 0 C--N 1.352 1.417 0 N-CA-C 110.504 -1.039 . . . . 0.0 110.504 178.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 50.5 t60 -136.49 146.35 46.17 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 -172.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 79.2 m -79.92 140.88 36.52 Favored 'General case' 0 C--N 1.349 0.561 0 O-C-N 120.752 -1.218 . . . . 0.0 111.637 -177.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 17.3 m-30 -126.03 162.41 25.35 Favored 'General case' 0 C--N 1.355 0.823 0 O-C-N 121.048 -1.032 . . . . 0.0 108.821 -178.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -123.68 137.44 54.71 Favored 'General case' 0 C--N 1.352 0.689 0 C-N-CA 124.422 1.089 . . . . 0.0 108.448 168.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 94.3 mt -107.16 130.05 59.91 Favored 'Isoleucine or valine' 0 C--N 1.361 1.085 0 C-N-CA 124.242 1.017 . . . . 0.0 108.782 177.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -131.57 149.97 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 C-N-CA 125.796 1.639 . . . . 0.0 110.153 -177.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 134.55 -155.4 21.91 Favored Glycine 0 C--N 1.35 1.355 0 N-CA-C 107.945 -2.062 . . . . 0.0 107.945 -177.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 59.5 t30 . . . . . 0 CA--C 1.569 1.711 0 CA-C-O 117.001 -1.476 . . . . 0.0 114.776 173.713 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 7.5 t80 . . . . . 0 N--CA 1.5 2.075 0 N-CA-C 116.222 1.934 . . . . 0.0 116.222 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 49.0 m-20 -120.35 149.64 42.02 Favored 'General case' 0 C--N 1.354 0.782 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 161.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.9 p -125.21 135.15 64.95 Favored 'Isoleucine or valine' 0 C--N 1.35 0.593 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 174.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 28.9 m -132.01 155.88 41.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.574 0 C-N-CA 123.481 0.712 . . . . 0.0 109.122 179.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 79.2 p -79.91 147.87 31.49 Favored 'General case' 0 C--N 1.349 0.549 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 175.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 10.9 t -102.5 -4.13 25.82 Favored 'General case' 0 C--N 1.353 0.754 0 C-N-CA 123.732 0.813 . . . . 0.0 112.062 -175.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 56.6 t30 58.95 44.48 16.38 Favored 'General case' 0 C--N 1.357 0.91 0 C-N-CA 127.176 2.19 . . . . 0.0 113.656 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.5 tppt? -144.06 146.44 32.83 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 102.473 -3.158 . . . . 0.0 102.473 173.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.4 p-10 -120.05 167.96 11.67 Favored 'General case' 0 C--N 1.355 0.845 0 CA-C-N 120.976 1.716 . . . . 0.0 110.402 171.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 57.1 m -116.42 160.87 19.93 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 173.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 32.3 m -111.23 159.33 18.0 Favored 'General case' 0 C--N 1.345 0.409 0 N-CA-C 102.231 -3.248 . . . . 0.0 102.231 166.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.2 t -58.6 144.1 44.07 Favored 'General case' 0 C--N 1.352 0.716 0 CA-C-O 122.353 1.073 . . . . 0.0 112.922 178.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.58 -58.62 4.85 Favored Glycine 0 C--N 1.353 1.523 0 C-N-CA 124.125 0.869 . . . . 0.0 111.359 -171.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -63.55 -45.77 89.01 Favored 'General case' 0 C--N 1.348 0.535 0 N-CA-C 115.503 1.668 . . . . 0.0 115.503 -167.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 50.54 44.53 27.17 Favored 'General case' 0 C--N 1.36 1.039 0 N-CA-C 116.557 2.058 . . . . 0.0 116.557 175.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -91.93 114.77 27.4 Favored 'General case' 0 C--N 1.35 0.609 0 C-N-CA 124.396 1.079 . . . . 0.0 111.683 -176.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 98.2 m -132.6 157.4 78.41 Favored Pre-proline 0 C--N 1.351 0.671 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 171.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -69.72 160.27 50.34 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 122.775 2.317 . . . . 0.0 110.021 166.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -63.72 135.65 56.85 Favored 'General case' 0 C--N 1.353 0.75 0 N-CA-C 113.269 0.841 . . . . 0.0 113.269 -171.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.9 -12.62 65.7 Favored Glycine 0 C--N 1.355 1.587 0 C-N-CA 123.921 0.772 . . . . 0.0 113.212 -175.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 73.3 m -115.45 153.71 30.61 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-N 118.023 0.912 . . . . 0.0 110.489 -178.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -139.24 154.65 48.03 Favored 'General case' 0 C--N 1.355 0.831 0 O-C-N 121.099 -1.001 . . . . 0.0 110.015 -178.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 53.0 m -94.7 136.3 35.17 Favored 'General case' 0 C--N 1.353 0.752 0 CA-C-O 121.879 0.847 . . . . 0.0 111.053 168.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -91.88 90.05 1.47 Allowed Glycine 0 C--N 1.351 1.386 0 N-CA-C 107.332 -2.307 . . . . 0.0 107.332 167.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -106.1 125.52 51.1 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 -168.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -90.17 79.44 6.43 Favored 'General case' 0 C--N 1.352 0.678 0 O-C-N 120.987 -1.071 . . . . 0.0 109.68 -156.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 67.16 42.12 91.67 Favored Glycine 0 C--N 1.354 1.557 0 O-C-N 120.95 -1.094 . . . . 0.0 115.09 172.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 47.64 45.14 17.87 Favored 'General case' 0 C--N 1.354 0.766 0 C-N-CA 128.403 2.681 . . . . 0.0 116.843 -175.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 -94.62 -72.83 0.6 Allowed 'General case' 0 C--N 1.355 0.821 0 N-CA-C 114.72 1.378 . . . . 0.0 114.72 175.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -116.01 -96.41 0.46 Allowed 'General case' 0 C--N 1.357 0.919 0 O-C-N 120.536 -1.352 . . . . 0.0 113.083 -161.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -154.18 161.2 42.01 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 104.719 -2.326 . . . . 0.0 104.719 -171.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -154.25 156.48 26.87 Favored Glycine 0 CA--C 1.493 -1.329 0 N-CA-C 108.709 -1.756 . . . . 0.0 108.709 -177.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 73.6 t60 -101.45 144.84 29.74 Favored 'General case' 0 C--N 1.345 0.391 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 -175.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 72.3 m -78.98 133.22 36.87 Favored 'General case' 0 C--N 1.358 0.957 0 O-C-N 120.737 -1.227 . . . . 0.0 111.165 -178.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -123.61 159.91 28.23 Favored 'General case' 0 C--N 1.354 0.766 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 -175.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -118.98 135.09 54.79 Favored 'General case' 0 C--N 1.349 0.55 0 C-N-CA 124.228 1.011 . . . . 0.0 108.365 168.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 78.5 mt -101.28 125.71 55.22 Favored 'Isoleucine or valine' 0 C--N 1.358 0.944 0 C-N-CA 125.344 1.458 . . . . 0.0 109.038 173.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.5 162.4 39.88 Favored 'Isoleucine or valine' 0 C--N 1.351 0.644 0 C-N-CA 124.986 1.314 . . . . 0.0 110.678 179.153 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 95.77 -59.47 1.5 Allowed Glycine 0 C--N 1.355 1.593 0 O-C-N 121.074 -1.016 . . . . 0.0 111.667 -175.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 . . . . . 0 C--O 1.259 1.573 0 O-C-N 121.331 -1.099 . . . . 0.0 113.21 178.797 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 6.6 t80 . . . . . 0 N--CA 1.5 2.036 0 N-CA-C 115.0 1.481 . . . . 0.0 115.0 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -117.42 154.27 31.66 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 106.407 -1.701 . . . . 0.0 106.407 161.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.4 p -125.71 134.24 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 178.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.3 m -132.18 157.61 43.12 Favored 'Isoleucine or valine' 0 C--N 1.352 0.684 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 177.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 80.4 p -79.91 153.38 29.03 Favored 'General case' 0 C--N 1.349 0.548 0 O-C-N 120.704 -1.248 . . . . 0.0 113.97 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 21.0 t -121.96 25.25 9.22 Favored 'General case' 0 C--N 1.358 0.95 0 O-C-N 121.219 -0.926 . . . . 0.0 111.381 -171.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 45.57 39.18 4.57 Favored 'General case' 0 C--N 1.358 0.967 0 C-N-CA 128.184 2.594 . . . . 0.0 117.722 173.204 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 45.1 tptt -149.51 141.88 24.24 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 -174.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.8 p-10 -107.29 159.62 16.23 Favored 'General case' 0 C--N 1.355 0.837 0 CA-C-N 120.661 1.573 . . . . 0.0 111.075 170.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 84.5 m -106.61 156.15 18.9 Favored 'General case' 0 CA--C 1.509 -0.63 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 164.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 67.5 m -117.7 141.75 48.04 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 102.705 -3.072 . . . . 0.0 102.705 169.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 45.1 t -60.26 130.62 47.56 Favored 'General case' 0 C--N 1.357 0.893 0 O-C-N 120.815 -1.178 . . . . 0.0 111.242 178.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 89.32 -3.75 84.07 Favored Glycine 0 C--N 1.356 1.66 0 O-C-N 121.568 -0.707 . . . . 0.0 112.382 -176.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 11.4 mm-40 -112.55 -46.04 3.19 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 121.561 -0.964 . . . . 0.0 110.05 168.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 17.4 m120 53.47 43.61 31.07 Favored 'General case' 0 C--N 1.362 1.113 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 171.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -100.77 116.42 32.61 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 124.79 1.236 . . . . 0.0 111.877 -166.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 71.9 m -134.27 157.2 78.06 Favored Pre-proline 0 C--N 1.351 0.65 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 166.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.06 160.2 50.45 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.435 2.09 . . . . 0.0 110.962 166.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -62.64 134.67 56.67 Favored 'General case' 0 C--N 1.353 0.728 0 C-N-CA 123.91 0.884 . . . . 0.0 113.124 -173.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 98.8 -12.82 62.62 Favored Glycine 0 C--N 1.356 1.667 0 C-N-CA 124.185 0.897 . . . . 0.0 113.259 -173.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 71.2 m -116.29 154.56 29.96 Favored 'General case' 0 C--N 1.35 0.591 0 CA-C-N 118.019 0.909 . . . . 0.0 110.52 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -134.06 161.11 35.74 Favored 'General case' 0 C--N 1.355 0.811 0 N-CA-C 104.866 -2.272 . . . . 0.0 104.866 178.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 15.1 p -115.05 144.87 42.95 Favored 'General case' 0 CA--C 1.503 -0.849 0 CA-C-N 119.986 1.266 . . . . 0.0 112.455 172.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -90.97 62.91 2.89 Favored Glycine 0 C--N 1.352 1.421 0 CA-C-N 115.435 -0.802 . . . . 0.0 112.889 -172.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 62.6 mt -75.86 130.93 39.32 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 122.244 1.021 . . . . 0.0 111.895 167.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -66.92 -44.56 80.37 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 126.297 1.839 . . . . 0.0 111.62 -164.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -167.45 49.57 0.24 Allowed Glycine 0 CA--C 1.499 -0.934 0 N-CA-C 106.609 -2.597 . . . . 0.0 106.609 173.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 45.11 54.48 7.01 Favored 'General case' 0 C--N 1.359 0.986 0 C-N-CA 127.537 2.335 . . . . 0.0 115.774 -176.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -94.06 -50.55 5.25 Favored 'General case' 0 C--N 1.359 0.986 0 O-C-N 119.996 -1.69 . . . . 0.0 111.802 -174.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 63.4 mttm -131.15 -103.07 0.28 Allowed 'General case' 0 C--N 1.356 0.862 0 C-N-CA 123.803 0.841 . . . . 0.0 111.479 -171.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 57.5 pttt -142.7 152.09 42.02 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 126.246 1.818 . . . . 0.0 106.833 -176.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -157.1 158.33 28.78 Favored Glycine 0 C--N 1.351 1.365 0 N-CA-C 108.142 -1.983 . . . . 0.0 108.142 -178.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 67.8 t60 -95.67 147.24 23.81 Favored 'General case' 0 C--N 1.346 0.433 0 O-C-N 121.717 -0.873 . . . . 0.0 110.49 -169.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 72.0 m -79.81 137.83 37.07 Favored 'General case' 0 C--N 1.359 1.002 0 O-C-N 121.078 -1.014 . . . . 0.0 111.792 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -127.09 154.62 44.47 Favored 'General case' 0 C--N 1.349 0.587 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 -178.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -104.69 135.87 45.26 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 124.629 1.171 . . . . 0.0 108.077 172.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 91.1 mt -101.19 123.4 54.23 Favored 'Isoleucine or valine' 0 C--N 1.356 0.86 0 C-N-CA 123.725 0.81 . . . . 0.0 108.937 176.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.19 146.51 33.61 Favored 'Isoleucine or valine' 0 C--N 1.351 0.663 0 C-N-CA 124.287 1.035 . . . . 0.0 109.693 176.078 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 93.24 -12.09 70.47 Favored Glycine 0 C--N 1.354 1.553 0 O-C-N 121.215 -0.928 . . . . 0.0 114.69 175.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 54.6 t30 . . . . . 0 C--O 1.259 1.564 0 O-C-N 121.082 -1.246 . . . . 0.0 111.574 -178.459 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 8.4 t80 . . . . . 0 N--CA 1.504 2.242 0 N-CA-C 116.528 2.048 . . . . 0.0 116.528 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -115.93 148.19 40.31 Favored 'General case' 0 C--N 1.354 0.789 0 C-N-CA 124.953 1.301 . . . . 0.0 107.721 161.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.7 p -123.09 133.26 69.6 Favored 'Isoleucine or valine' 0 C--N 1.351 0.648 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 171.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 24.0 m -133.39 154.12 38.44 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.683 0 C-N-CA 124.422 1.089 . . . . 0.0 108.235 178.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 96.2 p -79.67 155.72 27.91 Favored 'General case' 0 C--N 1.352 0.676 0 CA-C-O 121.856 0.836 . . . . 0.0 113.03 178.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 12.2 t -114.22 11.72 17.55 Favored 'General case' 0 C--N 1.351 0.648 0 C-N-CA 123.818 0.847 . . . . 0.0 110.519 -177.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 32.6 m120 59.24 28.9 18.35 Favored 'General case' 0 C--N 1.357 0.919 0 C-N-CA 128.108 2.563 . . . . 0.0 115.41 173.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 26.5 mmmt -134.74 160.07 39.33 Favored 'General case' 0 CA--C 1.513 -0.478 0 C-N-CA 127.057 2.143 . . . . 0.0 106.545 178.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -136.06 165.6 25.31 Favored 'General case' 0 C--N 1.351 0.664 0 O-C-N 121.088 -1.007 . . . . 0.0 109.493 173.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 30.7 m -120.9 147.87 44.83 Favored 'General case' 0 C--N 1.352 0.688 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 173.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 24.6 p -93.5 164.84 13.03 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 122.008 0.909 . . . . 0.0 110.365 153.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 46.9 t -61.32 130.84 48.13 Favored 'General case' 0 C--N 1.35 0.623 0 CA-C-O 122.125 0.964 . . . . 0.0 112.593 -178.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.35 -19.3 44.34 Favored Glycine 0 C--N 1.353 1.491 0 C-N-CA 124.94 1.257 . . . . 0.0 113.636 -178.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 21.8 mm100 -80.23 -47.94 13.86 Favored 'General case' 0 C--N 1.353 0.719 0 N-CA-C 114.775 1.398 . . . . 0.0 114.775 179.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 31.6 m120 50.08 41.19 23.15 Favored 'General case' 0 C--N 1.355 0.836 0 C-N-CA 126.17 1.788 . . . . 0.0 115.055 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -98.42 109.43 22.19 Favored 'General case' 0 C--N 1.355 0.839 0 O-C-N 121.033 -1.042 . . . . 0.0 111.38 -172.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 76.1 m -137.05 157.7 74.09 Favored Pre-proline 0 C--N 1.35 0.598 0 N-CA-C 105.728 -1.953 . . . . 0.0 105.728 167.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -69.41 159.71 52.6 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.756 2.304 . . . . 0.0 111.349 169.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -62.79 131.28 48.31 Favored 'General case' 0 C--N 1.354 0.765 0 C-N-CA 123.675 0.79 . . . . 0.0 112.229 -172.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 100.36 -13.7 59.82 Favored Glycine 0 C--N 1.356 1.643 0 C-N-CA 123.822 0.725 . . . . 0.0 112.575 -174.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 72.1 m -114.08 154.21 28.13 Favored 'General case' 0 C--N 1.349 0.574 0 C-N-CA 124.088 0.955 . . . . 0.0 109.949 177.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -136.3 156.67 48.32 Favored 'General case' 0 C--N 1.35 0.611 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 178.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 8.1 p -106.16 143.87 33.68 Favored 'General case' 0 CA--C 1.501 -0.905 0 CA-C-O 122.413 1.102 . . . . 0.0 111.157 171.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -84.09 74.93 2.44 Favored Glycine 0 C--N 1.352 1.432 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 178.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -92.22 121.53 33.83 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 -173.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -91.46 101.06 13.73 Favored 'General case' 0 C--N 1.352 0.678 0 O-C-N 120.674 -1.266 . . . . 0.0 108.969 -163.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 60.07 32.02 74.54 Favored Glycine 0 C--N 1.357 1.708 0 N-CA-C 115.629 1.012 . . . . 0.0 115.629 165.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 46.19 43.11 10.83 Favored 'General case' 0 C--N 1.354 0.8 0 C-N-CA 127.895 2.478 . . . . 0.0 116.148 -168.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 -89.6 -98.7 0.1 Allowed 'General case' 0 C--N 1.359 0.999 0 O-C-N 121.247 -0.908 . . . . 0.0 111.649 173.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -96.89 -89.16 0.28 Allowed 'General case' 0 C--N 1.355 0.809 0 O-C-N 120.646 -1.284 . . . . 0.0 113.636 -169.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -151.98 162.12 41.57 Favored 'General case' 0 N--CA 1.445 -0.707 0 O-C-N 121.142 -0.973 . . . . 0.0 108.956 -168.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -157.5 154.03 25.18 Favored Glycine 0 C--N 1.352 1.424 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 63.1 t60 -97.3 148.13 23.44 Favored 'General case' 0 C--N 1.349 0.569 0 O-C-N 121.601 -0.94 . . . . 0.0 109.166 -173.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 71.5 m -80.84 134.51 35.78 Favored 'General case' 0 C--N 1.359 1.02 0 O-C-N 120.956 -1.09 . . . . 0.0 111.516 -178.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -130.81 167.13 19.41 Favored 'General case' 0 C--N 1.351 0.633 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 -177.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 33.7 pttt -124.28 148.92 47.06 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 121.56 0.695 . . . . 0.0 110.553 156.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 82.3 mt -104.78 124.25 59.29 Favored 'Isoleucine or valine' 0 C--N 1.358 0.944 0 C-N-CA 125.811 1.645 . . . . 0.0 107.805 174.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.42 142.13 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 C-N-CA 124.989 1.316 . . . . 0.0 108.938 178.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 144.97 -148.27 19.93 Favored Glycine 0 C--N 1.351 1.393 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -175.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 15.5 p-10 . . . . . 0 C--O 1.259 1.565 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 179.631 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 28.3 t80 . . . . . 0 N--CA 1.504 2.249 0 N-CA-C 116.988 2.218 . . . . 0.0 116.988 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -144.65 158.21 43.87 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 105.11 -2.181 . . . . 0.0 105.11 167.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.7 p -130.82 133.05 63.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 175.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.5 m -133.27 161.6 41.18 Favored 'Isoleucine or valine' 0 C--N 1.351 0.634 0 C-N-CA 124.326 1.05 . . . . 0.0 108.313 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 87.3 p -75.82 149.81 37.81 Favored 'General case' 0 C--N 1.352 0.679 0 O-C-N 120.745 -1.222 . . . . 0.0 113.249 176.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 34.5 t -114.11 -0.12 14.1 Favored 'General case' 0 C--N 1.356 0.885 0 O-C-N 121.236 -0.915 . . . . 0.0 111.337 -172.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 53.3 t30 58.51 45.67 16.07 Favored 'General case' 0 C--N 1.356 0.864 0 C-N-CA 127.146 2.179 . . . . 0.0 114.827 175.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 15.5 tppt? -141.7 144.43 34.06 Favored 'General case' 0 C--N 1.349 0.565 0 N-CA-C 105.27 -2.122 . . . . 0.0 105.27 173.182 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 30.0 t30 -114.07 136.26 53.11 Favored 'General case' 0 C--N 1.353 0.76 0 O-C-N 121.2 -0.937 . . . . 0.0 110.387 -176.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 85.9 m -102.31 151.72 21.91 Favored 'General case' 0 C--N 1.356 0.855 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 170.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 40.0 m -128.16 160.18 32.84 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 101.774 -3.417 . . . . 0.0 101.774 176.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.2 t -51.15 -40.23 58.1 Favored 'General case' 0 C--N 1.345 0.393 0 C-N-CA 126.138 1.775 . . . . 0.0 115.461 -169.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -78.95 -1.5 85.01 Favored Glycine 0 C--N 1.351 1.374 0 N-CA-C 116.226 1.25 . . . . 0.0 116.226 178.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -145.9 135.45 23.17 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-N 120.34 2.07 . . . . 0.0 112.628 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 34.7 m120 -98.55 101.09 12.42 Favored 'General case' 0 C--N 1.353 0.744 0 O-C-N 119.833 -1.792 . . . . 0.0 106.491 172.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -130.42 95.02 3.78 Favored 'General case' 0 N--CA 1.446 -0.649 0 O-C-N 121.811 -0.556 . . . . 0.0 109.905 -164.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 73.1 m -136.05 156.54 76.94 Favored Pre-proline 0 C--N 1.351 0.633 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 170.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.85 160.44 49.67 Favored 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 122.478 2.119 . . . . 0.0 110.611 162.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 64.6 mm-40 -64.76 137.98 58.11 Favored 'General case' 0 C--N 1.351 0.673 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -174.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.37 -10.67 67.24 Favored Glycine 0 C--N 1.356 1.643 0 C-N-CA 123.83 0.728 . . . . 0.0 112.879 -174.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 71.3 m -115.61 153.74 30.71 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.219 1.008 . . . . 0.0 110.18 179.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -132.65 157.82 43.84 Favored 'General case' 0 C--N 1.355 0.836 0 N-CA-C 105.216 -2.142 . . . . 0.0 105.216 175.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 12.7 p -110.21 144.31 39.06 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-N 119.545 1.066 . . . . 0.0 110.666 169.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -85.16 71.63 2.91 Favored Glycine 0 C--N 1.352 1.418 0 N-CA-C 110.031 -1.228 . . . . 0.0 110.031 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -93.18 121.31 34.41 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 -172.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -88.71 82.65 6.79 Favored 'General case' 0 C--N 1.351 0.644 0 O-C-N 120.753 -1.217 . . . . 0.0 110.011 -162.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 64.21 37.29 94.34 Favored Glycine 0 C--N 1.354 1.578 0 O-C-N 121.029 -1.045 . . . . 0.0 115.197 167.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 47.49 44.64 16.96 Favored 'General case' 0 C--N 1.352 0.717 0 C-N-CA 128.811 2.844 . . . . 0.0 115.847 -173.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 64.0 m-80 -90.66 -61.43 1.68 Allowed 'General case' 0 C--N 1.357 0.892 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 171.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -127.36 -103.77 0.33 Allowed 'General case' 0 C--N 1.356 0.887 0 O-C-N 120.964 -1.085 . . . . 0.0 112.851 -169.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -152.37 159.98 43.36 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -169.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -164.68 151.5 20.6 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 111.174 -0.771 . . . . 0.0 111.174 -176.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 79.1 t60 -96.96 143.64 27.63 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 121.812 -0.816 . . . . 0.0 109.763 -171.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 74.4 m -76.94 139.38 40.15 Favored 'General case' 0 C--N 1.356 0.853 0 O-C-N 121.008 -1.057 . . . . 0.0 112.139 -178.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -123.96 151.01 44.11 Favored 'General case' 0 C--N 1.351 0.642 0 N-CA-C 106.962 -1.495 . . . . 0.0 106.962 -179.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -100.3 134.11 43.72 Favored 'General case' 0 C--N 1.346 0.453 0 C-N-CA 124.224 1.009 . . . . 0.0 108.317 173.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 96.6 mt -101.41 124.78 55.36 Favored 'Isoleucine or valine' 0 C--N 1.356 0.885 0 CA-C-O 122.08 0.943 . . . . 0.0 109.323 171.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -128.04 148.53 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 C-N-CA 125.827 1.651 . . . . 0.0 108.592 175.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 172.53 -167.3 40.18 Favored Glycine 0 CA--C 1.492 -1.346 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 47.4 p30 . . . . . 0 C--O 1.258 1.537 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 178.416 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 5.4 t80 . . . . . 0 N--CA 1.503 2.178 0 N-CA-C 115.828 1.788 . . . . 0.0 115.828 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -118.38 148.31 42.65 Favored 'General case' 0 C--N 1.356 0.863 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 162.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.0 p -120.74 134.99 62.39 Favored 'Isoleucine or valine' 0 C--N 1.35 0.626 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 174.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.7 m -131.76 160.01 42.69 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.603 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 177.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 94.5 p -77.26 153.71 33.7 Favored 'General case' 0 C--N 1.352 0.685 0 O-C-N 120.95 -1.094 . . . . 0.0 111.614 171.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 11.2 t -94.76 -8.68 36.89 Favored 'General case' 0 C--N 1.352 0.682 0 O-C-N 121.099 -1.001 . . . . 0.0 109.721 178.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 62.1 t30 58.44 45.23 16.95 Favored 'General case' 0 C--N 1.355 0.83 0 C-N-CA 128.4 2.68 . . . . 0.0 112.666 -173.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 53.5 tptt -133.12 135.89 45.48 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 177.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -91.14 136.26 33.21 Favored 'General case' 0 C--N 1.352 0.712 0 C-N-CA 125.429 1.492 . . . . 0.0 108.788 -178.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 25.2 p -129.16 150.09 50.69 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-O 122.093 0.949 . . . . 0.0 110.771 176.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 90.5 m -125.3 148.27 48.77 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 104.551 -2.388 . . . . 0.0 104.551 -174.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 80.9 p -57.92 -42.52 84.95 Favored 'General case' 0 C--N 1.353 0.734 0 N-CA-C 117.529 2.418 . . . . 0.0 117.529 -159.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -78.71 -48.96 6.83 Favored Glycine 0 C--N 1.353 1.492 0 CA-C-N 119.408 1.004 . . . . 0.0 113.475 176.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.6 mp0 -67.27 -43.97 80.49 Favored 'General case' 0 C--N 1.35 0.589 0 C-N-CA 125.143 1.377 . . . . 0.0 113.458 -174.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 54.09 45.1 28.21 Favored 'General case' 0 C--N 1.355 0.826 0 C-N-CA 129.004 2.922 . . . . 0.0 115.136 169.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 53.7 mp0 -75.97 123.54 25.9 Favored 'General case' 0 C--N 1.36 1.057 0 O-C-N 119.68 -1.887 . . . . 0.0 113.518 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 73.3 m -135.94 154.99 78.08 Favored Pre-proline 0 C--N 1.35 0.593 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 159.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.65 161.34 45.58 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.727 2.285 . . . . 0.0 110.998 167.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -62.92 130.76 46.19 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 121.483 0.659 . . . . 0.0 112.469 -175.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 100.63 -14.23 59.21 Favored Glycine 0 C--N 1.355 1.608 0 C-N-CA 123.675 0.655 . . . . 0.0 112.62 -173.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 73.9 m -113.3 153.71 28.01 Favored 'General case' 0 C--N 1.349 0.579 0 C-N-CA 123.92 0.888 . . . . 0.0 109.892 176.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -134.85 155.56 50.45 Favored 'General case' 0 C--N 1.352 0.705 0 O-C-N 121.235 -0.915 . . . . 0.0 110.3 -177.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 47.3 t -91.67 125.59 36.46 Favored 'General case' 0 C--N 1.351 0.652 0 C-N-CA 124.619 1.168 . . . . 0.0 111.788 -169.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -84.77 60.37 4.82 Favored Glycine 0 C--N 1.352 1.459 0 O-C-N 121.375 -0.828 . . . . 0.0 113.435 174.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -117.87 122.14 42.57 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 174.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -119.8 144.94 47.04 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 -173.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 76.39 10.43 85.59 Favored Glycine 0 C--N 1.355 1.636 0 O-C-N 121.547 -0.721 . . . . 0.0 114.806 166.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 55.7 46.29 22.86 Favored 'General case' 0 C--N 1.35 0.612 0 C-N-CA 126.655 1.982 . . . . 0.0 114.375 -175.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 -87.98 -109.09 0.07 Allowed 'General case' 0 C--N 1.356 0.869 0 O-C-N 121.469 -0.769 . . . . 0.0 112.558 -179.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -105.4 -107.29 0.3 Allowed 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.498 -1.376 . . . . 0.0 114.568 -169.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -114.37 154.23 28.43 Favored 'General case' 0 N--CA 1.439 -0.978 0 C-N-CA 126.882 2.073 . . . . 0.0 108.095 179.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -133.37 178.66 18.06 Favored Glycine 0 CA--C 1.493 -1.295 0 N-CA-C 107.233 -2.347 . . . . 0.0 107.233 173.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 40.9 t60 -128.2 147.6 50.58 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 105.052 -2.203 . . . . 0.0 105.052 177.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 79.9 m -83.26 140.86 32.26 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.036 -1.04 . . . . 0.0 112.408 -173.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -121.59 161.92 21.56 Favored 'General case' 0 C--N 1.356 0.885 0 O-C-N 121.42 -0.8 . . . . 0.0 108.871 -178.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -120.18 135.14 55.07 Favored 'General case' 0 C--N 1.35 0.588 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 167.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 78.5 mt -101.25 126.46 55.04 Favored 'Isoleucine or valine' 0 C--N 1.357 0.934 0 C-N-CA 125.134 1.374 . . . . 0.0 108.41 171.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.76 156.85 42.75 Favored 'Isoleucine or valine' 0 C--N 1.35 0.614 0 C-N-CA 124.947 1.299 . . . . 0.0 109.423 177.007 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 89.58 8.02 68.39 Favored Glycine 0 C--N 1.355 1.638 0 O-C-N 121.023 -1.048 . . . . 0.0 113.115 -176.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 17.2 p-10 . . . . . 0 C--O 1.259 1.566 0 N-CA-C 114.73 1.381 . . . . 0.0 114.73 179.203 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 6.4 t80 . . . . . 0 N--CA 1.505 2.306 0 N-CA-C 116.097 1.888 . . . . 0.0 116.097 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 52.5 m-20 -116.58 152.36 34.32 Favored 'General case' 0 C--N 1.355 0.835 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 164.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.1 p -123.22 134.47 66.15 Favored 'Isoleucine or valine' 0 C--N 1.348 0.522 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 174.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.7 m -131.24 157.99 43.27 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.802 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 80.4 p -83.65 151.08 25.48 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 122.151 0.977 . . . . 0.0 113.471 176.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 83.2 m -96.01 -2.76 46.24 Favored 'General case' 0 C--N 1.356 0.859 0 C-N-CA 123.927 0.891 . . . . 0.0 110.472 173.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 59.5 t30 57.19 45.23 20.91 Favored 'General case' 0 C--N 1.35 0.592 0 C-N-CA 129.093 2.957 . . . . 0.0 114.241 178.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.6 mmmt -130.07 147.57 51.83 Favored 'General case' 0 CA--C 1.506 -0.719 0 C-N-CA 126.877 2.071 . . . . 0.0 105.972 170.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -85.47 174.76 9.27 Favored 'General case' 0 C--N 1.354 0.8 0 CA-C-N 118.751 0.705 . . . . 0.0 110.228 173.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 17.0 p -126.89 -178.9 4.57 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 105.416 -2.068 . . . . 0.0 105.416 162.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 31.1 m -134.03 142.31 47.55 Favored 'General case' 0 CA--C 1.504 -0.824 1 N-CA-C 99.917 -4.105 . . . . 0.0 99.917 165.398 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 35.2 t -59.05 -44.58 91.81 Favored 'General case' 0 C--N 1.351 0.667 0 CA-C-N 120.508 1.504 . . . . 0.0 115.031 -163.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.9 -45.09 65.2 Favored Glycine 0 C--N 1.354 1.559 0 O-C-N 121.231 -0.918 . . . . 0.0 115.294 176.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -70.07 -43.51 71.03 Favored 'General case' 0 C--N 1.351 0.666 0 C-N-CA 125.113 1.365 . . . . 0.0 112.838 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 55.22 46.59 23.45 Favored 'General case' 0 C--N 1.353 0.72 0 C-N-CA 130.507 3.523 . . . . 0.0 112.694 -178.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -62.9 124.45 21.1 Favored 'General case' 0 C--N 1.359 1.012 0 C-N-CA 125.574 1.55 . . . . 0.0 113.455 177.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 86.0 m -143.3 159.66 54.55 Favored Pre-proline 0 C--N 1.351 0.665 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 159.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -68.7 156.61 64.91 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 122.746 2.298 . . . . 0.0 110.783 162.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -63.65 131.63 48.59 Favored 'General case' 0 C--N 1.352 0.707 0 CA-C-O 121.607 0.718 . . . . 0.0 112.804 -173.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.19 -12.31 61.98 Favored Glycine 0 C--N 1.356 1.676 0 O-C-N 121.605 -0.684 . . . . 0.0 112.896 -175.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 79.2 m -111.93 156.46 22.06 Favored 'General case' 0 C--N 1.349 0.56 0 C-N-CA 124.039 0.936 . . . . 0.0 108.914 177.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -138.13 159.96 40.66 Favored 'General case' 0 C--N 1.35 0.599 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 -177.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 41.9 t -117.33 121.14 40.32 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -88.91 93.44 1.9 Allowed Glycine 0 C--N 1.352 1.446 0 N-CA-C 107.943 -2.063 . . . . 0.0 107.943 177.061 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -102.39 120.52 40.64 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 -167.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -89.65 115.11 26.79 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-O 123.18 1.466 . . . . 0.0 113.588 -177.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 69.64 14.19 69.5 Favored Glycine 0 C--N 1.356 1.685 0 N-CA-C 116.929 1.532 . . . . 0.0 116.929 159.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 60.22 27.73 17.26 Favored 'General case' 0 C--N 1.353 0.731 0 C-N-CA 126.672 1.989 . . . . 0.0 113.877 -176.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 65.4 m-80 -82.55 -46.79 12.91 Favored 'General case' 0 C--N 1.353 0.735 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 -172.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -139.24 -177.92 5.13 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-O 122.298 1.047 . . . . 0.0 108.261 -161.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.8 ptpp? -64.02 -37.71 88.42 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 126.9 2.08 . . . . 0.0 116.299 170.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.17 -162.38 53.0 Favored Glycine 0 C--N 1.355 1.591 0 O-C-N 119.494 -2.004 . . . . 0.0 112.678 -173.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 19.1 t60 -157.29 152.78 26.47 Favored 'General case' 0 C--N 1.356 0.876 0 N-CA-C 105.755 -1.942 . . . . 0.0 105.755 174.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 71.4 m -85.47 139.41 31.52 Favored 'General case' 0 C--N 1.357 0.896 0 O-C-N 120.581 -1.324 . . . . 0.0 113.469 -176.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -126.19 163.12 23.85 Favored 'General case' 0 C--N 1.357 0.926 0 C-N-CA 123.813 0.845 . . . . 0.0 109.447 -172.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 40.8 ttpt -121.23 136.97 54.88 Favored 'General case' 0 C--N 1.352 0.697 0 C-N-CA 125.336 1.454 . . . . 0.0 109.695 167.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 82.2 mt -94.03 124.4 46.48 Favored 'Isoleucine or valine' 0 C--N 1.361 1.078 0 C-N-CA 125.337 1.455 . . . . 0.0 109.687 172.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.72 140.02 49.14 Favored 'Isoleucine or valine' 0 C--N 1.351 0.643 0 C-N-CA 124.786 1.234 . . . . 0.0 109.977 173.194 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 166.06 177.77 38.41 Favored Glycine 0 CA--C 1.491 -1.422 0 N-CA-C 108.713 -1.755 . . . . 0.0 108.713 178.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 . . . . . 0 C--O 1.26 1.657 0 CA-C-O 117.488 -1.244 . . . . 0.0 111.503 178.56 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 9.4 t80 . . . . . 0 N--CA 1.503 2.186 0 N-CA-C 116.635 2.087 . . . . 0.0 116.635 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -123.12 148.36 45.77 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 161.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.1 p -119.53 132.0 70.55 Favored 'Isoleucine or valine' 0 C--N 1.351 0.662 0 N-CA-C 106.757 -1.572 . . . . 0.0 106.757 168.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.8 m -134.95 155.34 38.04 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.568 0 C-N-CA 124.795 1.238 . . . . 0.0 108.482 -177.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 89.6 p -79.73 157.48 27.14 Favored 'General case' 0 C--N 1.349 0.577 0 CA-C-O 122.25 1.024 . . . . 0.0 113.469 177.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 96.2 m -105.42 10.31 33.38 Favored 'General case' 0 C--N 1.352 0.703 0 C-N-CA 123.978 0.911 . . . . 0.0 111.971 177.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 53.7 t30 56.39 44.16 24.94 Favored 'General case' 0 C--N 1.355 0.825 0 C-N-CA 127.029 2.132 . . . . 0.0 113.166 -178.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 52.3 tptt -139.98 134.83 32.05 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.752 -1.217 . . . . 0.0 109.224 -177.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -87.09 121.18 29.19 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.184 1.793 . . . . 0.0 109.564 179.028 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 27.8 p -116.94 167.25 11.3 Favored 'General case' 0 C--N 1.35 0.618 0 C-N-CA 123.917 0.887 . . . . 0.0 108.741 173.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 73.7 m -129.51 146.11 51.38 Favored 'General case' 0 C--N 1.349 0.561 0 N-CA-C 104.063 -2.569 . . . . 0.0 104.063 170.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.4 t -57.75 -38.43 75.35 Favored 'General case' 0 C--N 1.355 0.807 0 C-N-CA 126.418 1.887 . . . . 0.0 113.727 -170.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -90.86 9.41 77.83 Favored Glycine 0 C--N 1.35 1.308 0 O-C-N 121.193 -0.942 . . . . 0.0 113.59 177.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 22.1 mm-40 -118.2 -43.33 2.74 Favored 'General case' 0 C--N 1.351 0.637 0 O-C-N 121.479 -1.012 . . . . 0.0 111.088 176.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 22.1 m120 56.17 38.04 29.45 Favored 'General case' 0 C--N 1.358 0.957 0 C-N-CA 127.38 2.272 . . . . 0.0 115.23 176.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -86.32 108.67 18.53 Favored 'General case' 0 C--N 1.351 0.654 0 O-C-N 120.683 -1.261 . . . . 0.0 110.785 -178.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 91.5 m -134.64 157.73 76.63 Favored Pre-proline 0 C--N 1.351 0.636 0 C-N-CA 125.033 1.333 . . . . 0.0 108.476 175.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -69.98 161.27 46.6 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.877 2.385 . . . . 0.0 111.206 168.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -64.28 134.83 55.47 Favored 'General case' 0 C--N 1.353 0.743 0 CA-C-O 121.646 0.736 . . . . 0.0 112.591 -174.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.53 -10.89 68.94 Favored Glycine 0 C--N 1.354 1.561 0 C-N-CA 123.473 0.558 . . . . 0.0 113.027 -174.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 85.6 m -114.8 154.6 28.28 Favored 'General case' 0 C--N 1.351 0.634 0 CA-C-N 118.034 0.917 . . . . 0.0 109.33 -179.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -131.35 160.4 35.14 Favored 'General case' 0 C--N 1.351 0.65 0 O-C-N 121.211 -0.93 . . . . 0.0 108.533 -179.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 43.2 t -89.45 119.76 30.18 Favored 'General case' 0 C--N 1.353 0.728 0 O-C-N 121.533 -0.73 . . . . 0.0 109.688 -175.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -90.21 63.8 3.04 Favored Glycine 0 C--N 1.353 1.494 0 O-C-N 121.168 -0.957 . . . . 0.0 114.003 -175.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -132.87 132.84 42.55 Favored 'General case' 0 C--N 1.352 0.712 0 CA-C-N 118.761 1.281 . . . . 0.0 108.414 177.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -115.8 133.4 56.07 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 -175.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.79 5.85 86.72 Favored Glycine 0 C--N 1.356 1.677 0 N-CA-C 115.92 1.128 . . . . 0.0 115.92 166.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 56.42 40.5 29.64 Favored 'General case' 0 C--N 1.349 0.557 0 C-N-CA 127.224 2.209 . . . . 0.0 113.731 -173.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 62.0 m-80 -67.78 -46.56 71.65 Favored 'General case' 0 C--N 1.355 0.824 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 172.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -139.4 -133.46 0.12 Allowed 'General case' 0 C--N 1.351 0.668 0 CA-C-O 121.718 0.771 . . . . 0.0 109.236 -177.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.5 pttm -103.46 -56.71 2.16 Favored 'General case' 0 C--N 1.351 0.648 0 C-N-CA 125.522 1.529 . . . . 0.0 113.444 -178.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 94.4 175.98 38.84 Favored Glycine 0 C--N 1.352 1.441 0 CA-C-O 122.843 1.246 . . . . 0.0 111.444 -171.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 51.6 t60 -149.0 152.95 37.19 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 102.692 -3.077 . . . . 0.0 102.692 177.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 79.1 m -81.85 135.19 35.45 Favored 'General case' 0 C--N 1.351 0.672 0 O-C-N 121.054 -1.029 . . . . 0.0 112.244 -174.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 13.1 m-30 -123.9 160.68 26.95 Favored 'General case' 0 C--N 1.357 0.896 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -178.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 20.2 pttm -121.36 150.98 40.66 Favored 'General case' 0 C--N 1.35 0.606 0 CA-C-O 121.689 0.757 . . . . 0.0 109.653 160.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 83.7 mt -114.36 130.54 68.48 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.788 0 C-N-CA 124.861 1.264 . . . . 0.0 109.976 176.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.61 140.41 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 C-N-CA 126.679 1.991 . . . . 0.0 109.053 178.379 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 140.56 -140.48 10.56 Favored Glycine 0 C--N 1.35 1.35 0 N-CA-C 107.426 -2.269 . . . . 0.0 107.426 -172.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 . . . . . 0 C--O 1.26 1.633 0 CA-C-O 117.871 -1.062 . . . . 0.0 113.786 -179.546 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 11.8 t80 . . . . . 0 N--CA 1.504 2.259 0 N-CA-C 115.996 1.85 . . . . 0.0 115.996 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -116.87 154.12 31.33 Favored 'General case' 0 C--N 1.356 0.855 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 164.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.5 p -126.69 134.6 65.9 Favored 'Isoleucine or valine' 0 C--N 1.35 0.619 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 178.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 33.1 m -132.69 162.75 39.38 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 C-N-CA 124.585 1.154 . . . . 0.0 108.209 -179.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 78.5 p -72.9 145.06 47.11 Favored 'General case' 0 C--N 1.351 0.668 0 O-C-N 120.606 -1.309 . . . . 0.0 113.866 174.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 34.1 t -95.34 -10.12 31.0 Favored 'General case' 0 C--N 1.356 0.886 0 O-C-N 121.219 -0.926 . . . . 0.0 111.314 -179.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 54.0 t30 59.87 41.8 17.37 Favored 'General case' 0 C--N 1.355 0.835 0 C-N-CA 127.406 2.283 . . . . 0.0 112.874 -175.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 24.7 mmmt -130.83 144.21 51.29 Favored 'General case' 0 C--N 1.353 0.747 0 C-N-CA 124.571 1.148 . . . . 0.0 111.483 175.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 20.1 t30 -93.65 123.39 36.95 Favored 'General case' 0 C--N 1.354 0.796 0 CA-C-O 122.214 1.007 . . . . 0.0 110.231 -173.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 14.4 t -105.69 152.9 22.57 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 128.483 2.713 . . . . 0.0 107.638 176.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 42.1 m -131.09 160.07 35.74 Favored 'General case' 0 C--N 1.355 0.844 0 N-CA-C 104.729 -2.323 . . . . 0.0 104.729 172.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.5 t -62.35 -43.25 99.26 Favored 'General case' 0 C--N 1.353 0.737 0 O-C-N 120.083 -1.635 . . . . 0.0 112.966 174.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -63.76 -41.5 98.88 Favored Glycine 0 C--N 1.357 1.738 0 C-N-CA 124.397 0.998 . . . . 0.0 115.127 176.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 27.1 pt20 -132.53 117.01 17.45 Favored 'General case' 0 C--N 1.35 0.621 0 CA-C-O 122.698 1.237 . . . . 0.0 110.053 175.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 24.2 m120 -91.89 79.56 5.28 Favored 'General case' 0 C--N 1.353 0.742 0 O-C-N 120.514 -1.366 . . . . 0.0 108.644 -174.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -97.72 109.7 22.41 Favored 'General case' 0 C--N 1.35 0.612 0 O-C-N 120.906 -1.121 . . . . 0.0 110.885 -170.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 80.9 m -134.27 153.09 79.23 Favored Pre-proline 0 C--N 1.351 0.631 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 172.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -72.17 162.23 42.3 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 123.145 2.563 . . . . 0.0 111.036 168.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -64.92 135.15 55.36 Favored 'General case' 0 C--N 1.353 0.725 0 CA-C-O 121.647 0.736 . . . . 0.0 112.19 -178.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.76 -14.31 63.08 Favored Glycine 0 C--N 1.354 1.583 0 C-N-CA 123.779 0.704 . . . . 0.0 112.375 -171.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 76.7 m -113.76 155.24 25.99 Favored 'General case' 0 C--N 1.349 0.582 0 C-N-CA 124.236 1.014 . . . . 0.0 109.894 175.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -139.74 161.07 38.42 Favored 'General case' 0 C--N 1.352 0.714 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 -176.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 41.2 t -122.13 124.09 43.09 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 173.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -100.99 106.51 3.1 Favored Glycine 0 C--N 1.352 1.47 0 N-CA-C 107.092 -2.403 . . . . 0.0 107.092 170.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -101.13 120.1 39.72 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 -168.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -87.55 89.34 7.96 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-O 122.662 1.22 . . . . 0.0 113.122 -174.284 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 64.05 32.52 84.44 Favored Glycine 0 C--N 1.358 1.762 0 N-CA-C 117.226 1.65 . . . . 0.0 117.226 160.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.8 pm0 46.99 36.42 4.06 Favored 'General case' 0 C--N 1.354 0.79 0 C-N-CA 128.511 2.725 . . . . 0.0 115.172 -174.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 59.1 m-80 -77.92 -44.71 26.17 Favored 'General case' 0 CA--C 1.505 -0.78 0 C-N-CA 124.785 1.234 . . . . 0.0 112.372 174.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.5 pttm -155.61 174.54 15.12 Favored 'General case' 0 N--CA 1.425 -1.706 0 N-CA-C 106.009 -1.849 . . . . 0.0 106.009 -174.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -62.08 -36.5 81.86 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 129.747 3.219 . . . . 0.0 115.312 -173.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 83.47 -167.5 44.91 Favored Glycine 0 C--N 1.355 1.63 0 O-C-N 120.627 -1.296 . . . . 0.0 112.145 -175.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 69.1 t60 -156.9 151.3 25.33 Favored 'General case' 0 C--N 1.35 0.627 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 177.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 70.9 m -81.24 140.84 34.66 Favored 'General case' 0 C--N 1.356 0.86 0 CA-C-N 119.786 1.176 . . . . 0.0 112.723 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 8.6 m-30 -121.27 157.14 30.98 Favored 'General case' 0 C--N 1.353 0.74 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 -177.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 40.6 ttpt -110.42 137.43 48.14 Favored 'General case' 0 C--N 1.349 0.546 0 C-N-CA 124.17 0.988 . . . . 0.0 109.903 173.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 97.3 mt -97.12 123.55 49.52 Favored 'Isoleucine or valine' 0 C--N 1.361 1.066 0 C-N-CA 124.546 1.138 . . . . 0.0 109.874 176.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.78 138.23 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 C-N-CA 124.431 1.092 . . . . 0.0 108.798 173.285 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 148.95 -159.43 28.03 Favored Glycine 0 C--N 1.35 1.332 0 N-CA-C 108.854 -1.698 . . . . 0.0 108.854 -175.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 17.4 p-10 . . . . . 0 C--O 1.258 1.551 0 N-CA-C 114.823 1.416 . . . . 0.0 114.823 177.928 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 10.7 t80 . . . . . 0 N--CA 1.504 2.237 0 N-CA-C 115.856 1.798 . . . . 0.0 115.856 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -117.37 153.88 32.27 Favored 'General case' 0 C--N 1.355 0.83 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 162.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.9 p -128.06 133.39 67.26 Favored 'Isoleucine or valine' 0 C--N 1.349 0.585 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 177.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.9 m -134.22 161.55 40.55 Favored 'Isoleucine or valine' 0 C--N 1.352 0.691 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 78.5 p -72.88 144.48 47.39 Favored 'General case' 0 C--N 1.351 0.648 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 177.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 29.1 t -99.05 -6.4 28.56 Favored 'General case' 0 C--N 1.356 0.884 0 C-N-CA 123.938 0.895 . . . . 0.0 111.749 -177.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 60.28 46.69 9.91 Favored 'General case' 0 C--N 1.355 0.83 0 C-N-CA 127.016 2.126 . . . . 0.0 112.549 -178.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -137.19 140.26 41.64 Favored 'General case' 0 C--N 1.352 0.676 0 O-C-N 120.55 -1.344 . . . . 0.0 107.748 175.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.9 t30 -87.29 126.01 34.57 Favored 'General case' 0 C--N 1.356 0.89 0 C-N-CA 124.423 1.089 . . . . 0.0 110.856 -174.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 16.9 t -106.15 144.37 32.95 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 126.973 2.109 . . . . 0.0 109.842 175.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 16.3 m -134.51 153.06 52.13 Favored 'General case' 0 C--N 1.352 0.68 0 N-CA-C 102.209 -3.256 . . . . 0.0 102.209 170.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 38.7 t -58.87 -44.67 91.13 Favored 'General case' 0 C--N 1.356 0.872 0 CA-C-N 120.685 1.584 . . . . 0.0 114.496 -171.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -81.3 -3.95 90.55 Favored Glycine 0 C--N 1.353 1.478 0 O-C-N 121.299 -0.876 . . . . 0.0 113.989 -177.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -113.98 -48.19 2.92 Favored 'General case' 0 C--N 1.35 0.607 0 CA-C-N 117.693 0.746 . . . . 0.0 110.331 -177.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 49.93 48.97 21.09 Favored 'General case' 0 C--N 1.358 0.958 0 C-N-CA 130.492 3.517 . . . . 0.0 112.261 176.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 52.3 mm-40 -96.5 115.39 27.35 Favored 'General case' 0 C--N 1.353 0.731 0 O-C-N 120.745 -1.222 . . . . 0.0 111.714 -167.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 81.7 m -134.28 154.27 79.86 Favored Pre-proline 0 C--N 1.35 0.612 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 174.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -71.27 161.04 47.05 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.68 2.254 . . . . 0.0 111.044 168.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -63.23 130.82 46.18 Favored 'General case' 0 C--N 1.352 0.714 0 C-N-CA 123.33 0.652 . . . . 0.0 111.598 -176.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 100.63 -13.92 59.32 Favored Glycine 0 C--N 1.354 1.58 0 C-N-CA 123.754 0.692 . . . . 0.0 112.469 -173.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 82.2 m -112.71 154.51 26.02 Favored 'General case' 0 C--N 1.349 0.573 0 C-N-CA 124.022 0.929 . . . . 0.0 110.134 175.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -137.28 159.89 40.63 Favored 'General case' 0 C--N 1.354 0.783 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 -175.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 40.6 t -111.6 119.05 37.4 Favored 'General case' 0 C--N 1.35 0.624 0 CA-C-O 121.81 0.814 . . . . 0.0 109.843 174.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -92.63 69.23 1.73 Allowed Glycine 0 C--N 1.35 1.339 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 173.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 60.1 tp -105.8 123.31 47.74 Favored 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 172.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -113.62 130.45 56.39 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 -173.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.2 5.04 70.26 Favored Glycine 0 C--N 1.355 1.627 0 N-CA-C 115.946 1.138 . . . . 0.0 115.946 162.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 55.9 47.13 20.71 Favored 'General case' 0 C--N 1.351 0.635 0 C-N-CA 126.357 1.863 . . . . 0.0 113.696 -170.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 -64.98 -49.29 70.86 Favored 'General case' 0 C--N 1.356 0.849 0 N-CA-C 115.098 1.518 . . . . 0.0 115.098 173.056 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -144.32 -120.81 0.08 Allowed 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 175.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 15.7 ptpt -115.27 -35.14 4.75 Favored 'General case' 0 N--CA 1.439 -1.013 0 C-N-CA 127.171 2.188 . . . . 0.0 114.238 -176.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 75.51 -162.48 53.3 Favored Glycine 0 C--N 1.355 1.638 0 O-C-N 119.993 -1.692 . . . . 0.0 110.464 -171.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 67.8 t60 -157.95 159.95 37.05 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 103.454 -2.795 . . . . 0.0 103.454 170.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 77.1 m -79.23 139.09 38.02 Favored 'General case' 0 C--N 1.352 0.717 0 CA-C-N 120.226 1.375 . . . . 0.0 112.44 175.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -124.42 155.92 38.03 Favored 'General case' 0 C--N 1.353 0.731 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 -175.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -108.23 137.39 46.29 Favored 'General case' 0 C--N 1.348 0.512 0 C-N-CA 124.645 1.178 . . . . 0.0 109.153 173.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 95.8 mt -97.14 122.73 48.98 Favored 'Isoleucine or valine' 0 C--N 1.361 1.076 0 C-N-CA 124.185 0.994 . . . . 0.0 109.288 173.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.25 158.21 43.24 Favored 'Isoleucine or valine' 0 C--N 1.35 0.611 0 C-N-CA 124.495 1.118 . . . . 0.0 109.512 177.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 97.03 -12.66 65.5 Favored Glycine 0 C--N 1.355 1.622 0 O-C-N 121.218 -0.926 . . . . 0.0 113.667 -179.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 . . . . . 0 CA--C 1.569 1.69 0 O-C-N 121.101 -1.234 . . . . 0.0 111.918 176.128 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 6.9 t80 . . . . . 0 N--CA 1.504 2.275 0 N-CA-C 116.23 1.937 . . . . 0.0 116.23 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -120.15 151.64 38.8 Favored 'General case' 0 C--N 1.354 0.79 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 161.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.6 p -123.5 136.29 60.52 Favored 'Isoleucine or valine' 0 C--N 1.35 0.589 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 178.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 28.9 m -130.5 156.46 42.5 Favored 'Isoleucine or valine' 0 C--N 1.35 0.594 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 175.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 87.2 p -79.62 150.38 31.03 Favored 'General case' 0 C--N 1.351 0.646 0 O-C-N 121.093 -1.004 . . . . 0.0 112.375 174.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 14.4 t -98.7 -10.7 22.82 Favored 'General case' 0 C--N 1.352 0.712 0 O-C-N 121.269 -0.894 . . . . 0.0 109.748 178.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 59.73 42.83 16.25 Favored 'General case' 0 C--N 1.355 0.836 0 C-N-CA 128.208 2.603 . . . . 0.0 114.459 178.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 55.9 tptt -122.16 135.71 54.82 Favored 'General case' 0 C--N 1.35 0.623 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 172.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -88.31 127.63 35.48 Favored 'General case' 0 C--N 1.355 0.811 0 C-N-CA 125.096 1.358 . . . . 0.0 109.765 -178.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 6.7 t -119.39 133.57 55.65 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 124.973 1.309 . . . . 0.0 111.249 -177.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 88.9 m -117.98 146.22 44.17 Favored 'General case' 0 C--N 1.351 0.666 0 N-CA-C 103.987 -2.597 . . . . 0.0 103.987 -178.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 84.8 p -59.22 -41.74 89.34 Favored 'General case' 0 C--N 1.35 0.618 0 N-CA-C 116.665 2.098 . . . . 0.0 116.665 -165.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.14 -36.81 93.72 Favored Glycine 0 C--N 1.351 1.362 0 C-N-CA 124.517 1.056 . . . . 0.0 114.268 172.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 23.9 mm100 -77.57 -47.69 18.82 Favored 'General case' 0 C--N 1.351 0.654 0 C-N-CA 123.804 0.842 . . . . 0.0 111.565 -177.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 52.23 39.95 28.0 Favored 'General case' 0 C--N 1.354 0.795 0 C-N-CA 128.628 2.771 . . . . 0.0 112.69 179.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -100.97 135.84 41.77 Favored 'General case' 0 C--N 1.356 0.879 0 O-C-N 120.571 -1.331 . . . . 0.0 113.353 -168.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 72.5 m -136.88 159.93 68.24 Favored Pre-proline 0 C--N 1.352 0.681 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 161.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -69.44 160.97 47.75 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.585 2.19 . . . . 0.0 110.556 162.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -64.59 136.95 57.54 Favored 'General case' 0 C--N 1.351 0.649 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -171.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.86 -12.3 65.87 Favored Glycine 0 C--N 1.355 1.621 0 C-N-CA 123.918 0.77 . . . . 0.0 112.832 -175.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 72.7 m -115.19 154.71 28.51 Favored 'General case' 0 C--N 1.348 0.507 0 C-N-CA 124.494 1.117 . . . . 0.0 109.533 179.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -133.36 154.79 50.43 Favored 'General case' 0 C--N 1.354 0.777 0 O-C-N 121.184 -0.948 . . . . 0.0 110.483 -177.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 43.8 t -104.85 119.26 38.59 Favored 'General case' 0 C--N 1.355 0.821 0 C-N-CA 124.479 1.112 . . . . 0.0 109.029 -177.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -90.48 69.99 2.22 Favored Glycine 0 C--N 1.351 1.417 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 175.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -107.79 123.73 48.99 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 178.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -117.17 138.06 51.92 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 -166.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.7 14.63 72.83 Favored Glycine 0 C--N 1.358 1.773 0 N-CA-C 115.99 1.156 . . . . 0.0 115.99 164.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 55.96 43.79 26.71 Favored 'General case' 0 C--N 1.349 0.556 0 C-N-CA 127.629 2.371 . . . . 0.0 113.213 -169.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 59.8 m-80 -70.13 168.16 16.22 Favored 'General case' 0 C--N 1.356 0.881 0 O-C-N 120.777 -1.202 . . . . 0.0 110.924 163.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -68.42 -48.27 65.07 Favored 'General case' 0 C--N 1.349 0.554 0 N-CA-C 116.005 1.854 . . . . 0.0 116.005 -163.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 79.9 mttt -136.36 150.1 48.67 Favored 'General case' 0 C--N 1.352 0.689 0 C-N-CA 123.492 0.717 . . . . 0.0 111.324 -176.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -136.66 168.58 24.15 Favored Glycine 0 C--N 1.348 1.195 0 N-CA-C 106.683 -2.567 . . . . 0.0 106.683 171.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 70.1 t60 -125.6 144.59 50.51 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 -176.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 74.7 m -80.43 137.63 36.52 Favored 'General case' 0 C--N 1.351 0.669 0 O-C-N 121.18 -0.95 . . . . 0.0 112.885 -176.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -126.22 162.65 24.94 Favored 'General case' 0 C--N 1.357 0.928 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -174.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -123.18 136.84 54.93 Favored 'General case' 0 C--N 1.35 0.626 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 166.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 81.1 mt -100.66 127.41 53.79 Favored 'Isoleucine or valine' 0 C--N 1.358 0.945 0 C-N-CA 125.741 1.616 . . . . 0.0 109.232 175.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.37 157.24 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 C-N-CA 124.967 1.307 . . . . 0.0 109.774 177.081 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 98.71 -110.31 3.98 Favored Glycine 0 C--N 1.353 1.503 0 N-CA-C 108.922 -1.671 . . . . 0.0 108.922 -170.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 64.4 t30 . . . . . 0 CA--C 1.569 1.696 0 CA-C-O 117.057 -1.449 . . . . 0.0 114.678 174.759 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 49.4 t80 . . . . . 0 N--CA 1.503 2.222 0 N-CA-C 117.675 2.472 . . . . 0.0 117.675 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -120.12 154.33 34.87 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 106.374 -1.713 . . . . 0.0 106.374 156.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.7 p -125.69 135.42 63.99 Favored 'Isoleucine or valine' 0 C--N 1.35 0.605 0 N-CA-C 106.271 -1.752 . . . . 0.0 106.271 170.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.0 m -134.0 161.46 40.85 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.912 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 89.5 p -77.15 151.99 35.07 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 121.835 0.826 . . . . 0.0 112.105 170.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 18.1 t -110.37 16.99 21.3 Favored 'General case' 0 C--N 1.352 0.706 0 C-N-CA 124.155 0.982 . . . . 0.0 110.261 -177.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 30.4 m120 57.98 36.5 26.2 Favored 'General case' 0 C--N 1.353 0.734 0 C-N-CA 127.34 2.256 . . . . 0.0 114.504 170.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 58.0 tptt -138.38 136.53 36.4 Favored 'General case' 0 C--N 1.354 0.79 0 O-C-N 121.27 -0.894 . . . . 0.0 110.32 -174.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -79.74 128.21 33.15 Favored 'General case' 0 C--N 1.356 0.884 0 C-N-CA 126.7 2.0 . . . . 0.0 112.337 178.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 12.0 t -118.01 131.6 56.46 Favored 'General case' 0 C--N 1.351 0.661 0 C-N-CA 126.584 1.954 . . . . 0.0 110.862 -179.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 12.6 m -119.89 151.93 38.14 Favored 'General case' 0 C--N 1.353 0.726 0 N-CA-C 105.279 -2.119 . . . . 0.0 105.279 -178.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 95.1 p -59.94 -37.02 78.34 Favored 'General case' 0 C--N 1.352 0.688 0 N-CA-C 115.513 1.672 . . . . 0.0 115.513 -168.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -93.02 0.12 68.91 Favored Glycine 0 C--N 1.353 1.493 0 O-C-N 121.846 -0.534 . . . . 0.0 113.811 177.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -110.97 -46.22 3.36 Favored 'General case' 0 C--N 1.35 0.629 0 CA-C-N 118.294 1.047 . . . . 0.0 111.1 179.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 31.2 m120 51.76 45.07 28.76 Favored 'General case' 0 C--N 1.359 0.979 0 C-N-CA 126.597 1.959 . . . . 0.0 114.142 -174.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -84.31 115.51 22.52 Favored 'General case' 0 C--N 1.353 0.727 0 O-C-N 121.338 -0.851 . . . . 0.0 112.503 -164.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 74.1 m -134.64 157.33 77.5 Favored Pre-proline 0 C--N 1.355 0.829 0 CA-C-O 118.478 -0.772 . . . . 0.0 109.065 172.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -70.43 159.35 53.22 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.63 2.22 . . . . 0.0 110.503 161.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -65.17 136.59 56.85 Favored 'General case' 0 C--N 1.352 0.694 0 CA-C-O 121.646 0.736 . . . . 0.0 112.63 -177.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.64 -13.57 63.92 Favored Glycine 0 C--N 1.354 1.543 0 C-N-CA 123.855 0.74 . . . . 0.0 113.112 -174.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 90.6 m -114.51 157.22 23.27 Favored 'General case' 0 C--N 1.349 0.55 0 C-N-CA 124.525 1.13 . . . . 0.0 109.947 176.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 24.8 p90 -137.57 161.17 37.15 Favored 'General case' 0 C--N 1.351 0.65 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 -172.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 43.3 t -118.35 127.36 53.62 Favored 'General case' 0 CA--C 1.507 -0.684 0 O-C-N 121.32 -0.863 . . . . 0.0 110.881 -179.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -97.19 78.63 0.67 Allowed Glycine 0 C--N 1.352 1.438 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 167.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -113.63 122.61 47.7 Favored 'General case' 0 C--N 1.352 0.679 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 168.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -119.76 146.67 45.45 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 -163.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.84 12.7 78.69 Favored Glycine 0 C--N 1.357 1.713 0 O-C-N 121.73 -0.606 . . . . 0.0 114.435 165.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 8.7 mp0 54.91 46.57 24.13 Favored 'General case' 0 C--N 1.351 0.638 0 C-N-CA 126.685 1.994 . . . . 0.0 113.539 -171.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -76.16 175.13 9.26 Favored 'General case' 0 C--N 1.357 0.892 0 C-N-CA 124.463 1.105 . . . . 0.0 110.409 166.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -64.74 -48.94 72.76 Favored 'General case' 0 C--N 1.348 0.519 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 -154.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 19.4 pttp -163.74 159.05 20.96 Favored 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 178.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -137.05 -165.06 10.31 Favored Glycine 0 C--N 1.344 0.996 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 176.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 37.3 t60 -143.79 149.18 36.67 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 105.76 -1.941 . . . . 0.0 105.76 -174.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 75.0 m -81.86 143.77 31.48 Favored 'General case' 0 C--N 1.352 0.697 0 O-C-N 121.021 -1.049 . . . . 0.0 113.096 -176.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -124.46 158.56 32.54 Favored 'General case' 0 C--N 1.356 0.877 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 -174.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -117.93 136.46 53.47 Favored 'General case' 0 C--N 1.35 0.596 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 166.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 80.5 mt -96.72 127.38 48.93 Favored 'Isoleucine or valine' 0 C--N 1.356 0.857 0 C-N-CA 125.307 1.443 . . . . 0.0 108.214 167.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 4.4 mp -116.05 124.32 72.24 Favored 'Isoleucine or valine' 0 C--N 1.354 0.793 0 N-CA-C 103.718 -2.697 . . . . 0.0 103.718 -177.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -179.69 -173.35 44.69 Favored Glycine 0 CA--C 1.494 -1.25 0 O-C-N 120.756 -1.215 . . . . 0.0 110.487 -178.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 23.5 p30 . . . . . 0 C--O 1.261 1.699 0 CA-C-O 116.726 -1.607 . . . . 0.0 114.774 -179.001 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 22.7 t80 . . . . . 0 N--CA 1.502 2.14 0 N-CA-C 116.966 2.21 . . . . 0.0 116.966 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -124.67 148.28 48.06 Favored 'General case' 0 C--N 1.353 0.747 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 159.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.9 p -124.12 134.05 67.64 Favored 'Isoleucine or valine' 0 C--N 1.349 0.557 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 173.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 28.0 m -131.25 154.05 39.99 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.744 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 175.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 80.4 p -79.26 151.83 30.92 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 177.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 19.9 t -123.97 33.18 5.36 Favored 'General case' 0 C--N 1.355 0.804 0 CA-C-O 121.761 0.791 . . . . 0.0 109.919 -172.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 44.75 37.88 2.51 Favored 'General case' 0 C--N 1.357 0.899 0 C-N-CA 129.016 2.926 . . . . 0.0 118.267 169.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -148.81 143.17 26.16 Favored 'General case' 0 C--N 1.348 0.536 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -175.449 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 33.8 t30 -115.45 135.87 53.66 Favored 'General case' 0 C--N 1.353 0.727 0 C-N-CA 124.27 1.028 . . . . 0.0 110.568 -175.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 83.6 m -101.5 152.1 21.17 Favored 'General case' 0 C--N 1.355 0.846 0 C-N-CA 124.151 0.98 . . . . 0.0 108.54 171.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 55.5 m -128.17 156.25 43.19 Favored 'General case' 0 CA--C 1.507 -0.682 0 N-CA-C 102.046 -3.316 . . . . 0.0 102.046 174.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 46.8 t -52.53 -39.24 61.15 Favored 'General case' 0 C--N 1.349 0.57 0 N-CA-C 115.68 1.733 . . . . 0.0 115.68 -162.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -77.28 -0.96 73.25 Favored Glycine 0 C--N 1.351 1.373 0 N-CA-C 116.475 1.35 . . . . 0.0 116.475 178.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -143.58 140.78 30.36 Favored 'General case' 0 C--N 1.356 0.858 0 CA-C-N 120.347 2.073 . . . . 0.0 112.009 179.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 34.5 m120 -102.15 103.52 14.06 Favored 'General case' 0 C--N 1.352 0.715 0 O-C-N 119.973 -1.705 . . . . 0.0 106.523 170.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -126.93 94.32 4.0 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 -168.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 72.9 m -136.77 156.88 75.82 Favored Pre-proline 0 C--N 1.351 0.662 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 172.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -70.51 160.42 49.55 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.52 2.147 . . . . 0.0 110.64 164.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -62.77 134.38 56.19 Favored 'General case' 0 C--N 1.354 0.779 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -174.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.25 -11.89 65.34 Favored Glycine 0 C--N 1.355 1.61 0 C-N-CA 124.194 0.902 . . . . 0.0 113.409 -175.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 73.8 m -114.15 153.77 28.96 Favored 'General case' 0 C--N 1.348 0.518 0 C-N-CA 124.145 0.978 . . . . 0.0 110.116 179.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 31.5 p90 -132.5 158.22 42.65 Favored 'General case' 0 C--N 1.352 0.684 0 N-CA-C 105.699 -1.963 . . . . 0.0 105.699 178.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 9.8 p -109.69 146.66 34.48 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-O 122.531 1.157 . . . . 0.0 112.923 173.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -82.74 69.29 3.39 Favored Glycine 0 C--N 1.353 1.498 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 176.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -91.81 122.46 34.37 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 -175.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -86.02 77.34 9.66 Favored 'General case' 0 C--N 1.352 0.701 0 O-C-N 120.709 -1.244 . . . . 0.0 110.829 -161.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 62.61 45.39 95.92 Favored Glycine 0 C--N 1.355 1.594 0 N-CA-C 115.448 0.939 . . . . 0.0 115.448 166.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 48.31 43.75 19.4 Favored 'General case' 0 C--N 1.354 0.779 0 C-N-CA 128.474 2.71 . . . . 0.0 115.984 -172.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 66.0 m-80 -97.48 -74.08 0.59 Allowed 'General case' 0 C--N 1.356 0.867 0 O-C-N 121.135 -0.978 . . . . 0.0 112.509 170.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -119.66 -101.55 0.42 Allowed 'General case' 0 C--N 1.357 0.932 0 O-C-N 120.917 -1.115 . . . . 0.0 113.649 -163.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.4 pptp? -145.76 161.01 40.9 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 -175.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -162.39 151.28 21.15 Favored Glycine 0 C--N 1.349 1.297 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 -179.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 72.4 t60 -99.19 146.82 25.76 Favored 'General case' 0 C--N 1.347 0.473 0 O-C-N 121.51 -0.994 . . . . 0.0 109.883 -170.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 76.4 m -76.85 136.55 38.9 Favored 'General case' 0 C--N 1.358 0.946 0 O-C-N 121.197 -0.939 . . . . 0.0 112.015 -179.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -130.63 161.5 31.44 Favored 'General case' 0 C--N 1.351 0.649 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 -177.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -114.28 132.81 56.03 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 164.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 96.3 mt -106.06 127.37 61.25 Favored 'Isoleucine or valine' 0 C--N 1.358 0.973 0 CA-C-O 122.632 1.206 . . . . 0.0 110.243 169.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.75 160.51 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 C-N-CA 126.879 2.071 . . . . 0.0 110.725 -176.733 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 95.19 -73.17 0.95 Allowed Glycine 0 C--N 1.354 1.532 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 -169.112 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 . . . . . 0 C--O 1.26 1.64 0 N-CA-C 115.426 1.639 . . . . 0.0 115.426 176.309 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 42.2 t80 . . . . . 0 N--CA 1.505 2.318 0 N-CA-C 116.815 2.154 . . . . 0.0 116.815 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -121.65 154.57 36.63 Favored 'General case' 0 C--N 1.354 0.796 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 159.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.9 p -128.71 132.91 67.29 Favored 'Isoleucine or valine' 0 C--N 1.349 0.582 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 174.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 33.0 m -134.55 161.56 40.28 Favored 'Isoleucine or valine' 0 C--N 1.349 0.564 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 -177.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 96.8 p -76.84 155.42 32.99 Favored 'General case' 0 C--N 1.354 0.771 0 O-C-N 120.665 -1.272 . . . . 0.0 112.986 178.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 33.9 t -120.38 28.6 7.92 Favored 'General case' 0 C--N 1.355 0.812 0 C-N-CA 123.881 0.873 . . . . 0.0 109.44 -177.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 45.83 36.55 2.9 Favored 'General case' 0 C--N 1.357 0.897 0 C-N-CA 128.58 2.752 . . . . 0.0 117.452 173.02 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 50.4 tptt -140.79 138.32 34.01 Favored 'General case' 0 C--N 1.352 0.687 0 O-C-N 120.664 -1.272 . . . . 0.0 109.208 -169.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -90.99 123.02 34.14 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.311 1.845 . . . . 0.0 108.559 -175.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 17.5 p -112.95 172.17 7.09 Favored 'General case' 0 C--N 1.357 0.918 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 175.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 27.5 m -130.43 146.18 51.95 Favored 'General case' 0 C--N 1.35 0.593 0 N-CA-C 102.279 -3.23 . . . . 0.0 102.279 167.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 90.6 p -59.97 -30.72 69.3 Favored 'General case' 0 C--N 1.35 0.592 0 N-CA-C 115.966 1.839 . . . . 0.0 115.966 -172.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -93.77 -1.21 65.87 Favored Glycine 0 C--N 1.354 1.53 0 CA-C-N 118.582 0.628 . . . . 0.0 114.138 175.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -108.62 -41.46 4.8 Favored 'General case' 0 C--N 1.352 0.685 0 CA-C-N 118.266 1.033 . . . . 0.0 111.145 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 25.3 m120 57.06 35.74 26.76 Favored 'General case' 0 C--N 1.358 0.939 0 C-N-CA 126.93 2.092 . . . . 0.0 115.028 174.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 60.9 mm-40 -87.09 114.95 24.14 Favored 'General case' 0 C--N 1.351 0.657 0 O-C-N 120.575 -1.328 . . . . 0.0 111.386 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 73.4 m -135.93 156.9 76.87 Favored Pre-proline 0 N--CA 1.447 -0.604 0 N-CA-C 105.601 -2.0 . . . . 0.0 105.601 168.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.55 161.84 44.59 Favored 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.783 2.322 . . . . 0.0 111.497 171.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -62.42 132.88 54.02 Favored 'General case' 0 C--N 1.354 0.778 0 CA-C-O 121.783 0.802 . . . . 0.0 113.006 -174.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.37 -11.66 68.64 Favored Glycine 0 C--N 1.355 1.606 0 C-N-CA 124.06 0.838 . . . . 0.0 112.91 -172.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 71.8 m -116.56 156.13 27.5 Favored 'General case' 0 C--N 1.349 0.565 0 C-N-CA 124.178 0.991 . . . . 0.0 110.394 179.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -145.21 165.87 27.09 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 104.999 -2.223 . . . . 0.0 104.999 -174.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 31.5 p -128.22 153.55 46.81 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-N 120.262 1.392 . . . . 0.0 108.724 165.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -121.79 76.92 0.34 Allowed Glycine 0 CA--C 1.492 -1.38 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 -174.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -106.18 124.79 50.14 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 105.944 -1.873 . . . . 0.0 105.944 177.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -113.92 140.57 48.27 Favored 'General case' 0 C--N 1.352 0.696 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 -175.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 76.78 8.7 86.53 Favored Glycine 0 C--N 1.355 1.634 0 N-CA-C 116.056 1.183 . . . . 0.0 116.056 164.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 57.83 35.89 25.88 Favored 'General case' 0 C--N 1.352 0.697 0 C-N-CA 126.865 2.066 . . . . 0.0 113.838 -175.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 60.8 m-80 -70.03 -43.77 70.61 Favored 'General case' 0 C--N 1.355 0.807 0 N-CA-C 114.228 1.195 . . . . 0.0 114.228 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm -144.13 -176.38 4.99 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.275 1.83 . . . . 0.0 106.465 -172.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -67.53 -45.59 75.29 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 115.878 1.806 . . . . 0.0 115.878 173.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.77 155.35 31.7 Favored Glycine 0 C--N 1.356 1.691 0 O-C-N 121.135 -0.978 . . . . 0.0 112.159 -168.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -137.81 143.81 41.2 Favored 'General case' 0 C--N 1.347 0.496 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 178.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 77.9 m -77.56 142.32 39.07 Favored 'General case' 0 C--N 1.353 0.747 0 CA-C-O 121.96 0.886 . . . . 0.0 113.126 -173.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -124.46 156.95 36.36 Favored 'General case' 0 C--N 1.35 0.606 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 -176.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 40.5 ttpt -112.7 136.03 52.76 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.649 1.18 . . . . 0.0 108.776 172.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 97.4 mt -98.49 125.32 51.87 Favored 'Isoleucine or valine' 0 C--N 1.359 0.994 0 C-N-CA 124.385 1.074 . . . . 0.0 108.987 175.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.92 156.26 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 C-N-CA 124.826 1.25 . . . . 0.0 109.536 178.116 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 102.25 -112.64 4.37 Favored Glycine 0 C--N 1.353 1.501 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 -172.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 . . . . . 0 C--O 1.258 1.543 0 O-C-N 121.373 -1.075 . . . . 0.0 113.523 -179.279 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 11.3 t80 . . . . . 0 N--CA 1.504 2.242 0 N-CA-C 116.3 1.963 . . . . 0.0 116.3 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -122.0 152.5 39.67 Favored 'General case' 0 C--N 1.355 0.821 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 162.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.3 p -127.1 135.94 62.14 Favored 'Isoleucine or valine' 0 C--N 1.349 0.585 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 176.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.4 m -131.21 158.0 43.27 Favored 'Isoleucine or valine' 0 C--N 1.351 0.647 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 177.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 87.7 p -81.88 157.37 24.39 Favored 'General case' 0 C--N 1.352 0.709 0 O-C-N 121.288 -0.882 . . . . 0.0 112.649 173.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 71.8 m -110.39 19.82 18.4 Favored 'General case' 0 C--N 1.355 0.847 0 O-C-N 121.413 -0.804 . . . . 0.0 111.791 177.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 47.34 39.56 9.14 Favored 'General case' 0 C--N 1.355 0.836 0 C-N-CA 127.432 2.293 . . . . 0.0 116.796 177.422 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 56.6 tptt -132.83 136.12 46.07 Favored 'General case' 0 C--N 1.352 0.677 0 O-C-N 121.127 -0.983 . . . . 0.0 109.006 -177.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -84.19 128.26 34.45 Favored 'General case' 0 C--N 1.354 0.786 0 C-N-CA 124.539 1.136 . . . . 0.0 110.742 -176.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 18.2 t -106.61 148.57 28.15 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 127.589 2.355 . . . . 0.0 108.93 178.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 23.3 m -133.0 154.73 50.24 Favored 'General case' 0 C--N 1.352 0.699 0 N-CA-C 102.488 -3.153 . . . . 0.0 102.488 168.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 79.4 p -58.93 -45.25 90.83 Favored 'General case' 0 C--N 1.349 0.549 0 N-CA-C 117.15 2.278 . . . . 0.0 117.15 -164.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -96.51 4.67 64.29 Favored Glycine 0 C--N 1.352 1.454 0 C-N-CA 123.605 0.622 . . . . 0.0 113.563 -176.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 11.1 mm-40 -115.96 -42.41 3.08 Favored 'General case' 0 C--N 1.346 0.433 0 O-C-N 121.82 -0.812 . . . . 0.0 109.803 178.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 56.3 45.95 22.02 Favored 'General case' 0 C--N 1.356 0.89 0 C-N-CA 128.575 2.75 . . . . 0.0 112.936 167.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -83.91 115.64 22.39 Favored 'General case' 0 C--N 1.352 0.701 0 O-C-N 121.043 -1.036 . . . . 0.0 112.742 -168.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 71.6 m -134.63 157.67 76.77 Favored Pre-proline 0 C--N 1.353 0.747 0 C-N-CA 124.785 1.234 . . . . 0.0 108.126 173.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.85 159.04 54.78 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.472 2.115 . . . . 0.0 110.618 164.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -65.09 135.17 55.23 Favored 'General case' 0 C--N 1.352 0.709 0 CA-C-O 121.599 0.714 . . . . 0.0 112.21 -176.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.59 -12.53 64.62 Favored Glycine 0 C--N 1.354 1.575 0 C-N-CA 123.593 0.616 . . . . 0.0 113.051 -173.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 72.2 m -113.13 155.45 24.94 Favored 'General case' 0 C--N 1.35 0.588 0 C-N-CA 124.242 1.017 . . . . 0.0 109.393 177.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -136.5 157.39 46.89 Favored 'General case' 0 C--N 1.351 0.634 0 O-C-N 121.278 -0.889 . . . . 0.0 108.729 -176.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 42.1 t -105.37 126.47 52.15 Favored 'General case' 0 CA--C 1.51 -0.57 0 O-C-N 121.205 -0.934 . . . . 0.0 111.027 -179.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.87 60.55 3.49 Favored Glycine 0 C--N 1.352 1.425 0 O-C-N 121.684 -0.635 . . . . 0.0 112.212 176.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -106.98 120.86 43.22 Favored 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 175.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -119.98 140.7 50.53 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 -176.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.18 5.42 76.4 Favored Glycine 0 C--N 1.355 1.603 0 N-CA-C 115.656 1.022 . . . . 0.0 115.656 161.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 56.75 42.9 26.07 Favored 'General case' 0 C--N 1.35 0.617 0 C-N-CA 126.639 1.976 . . . . 0.0 113.336 -171.669 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 54.0 m-80 -73.54 -49.37 26.84 Favored 'General case' 0 C--N 1.354 0.766 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 -178.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -140.65 -125.63 0.11 Allowed 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 177.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 16.6 pttp -107.79 -47.02 3.67 Favored 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 126.902 2.081 . . . . 0.0 114.146 -175.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 86.23 178.54 49.74 Favored Glycine 0 C--N 1.356 1.678 0 O-C-N 120.708 -1.245 . . . . 0.0 112.421 -173.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 72.7 t60 -154.12 155.24 35.04 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 105.877 -1.897 . . . . 0.0 105.877 178.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 76.4 m -86.86 135.57 33.28 Favored 'General case' 0 C--N 1.355 0.843 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -174.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -126.52 161.32 28.24 Favored 'General case' 0 C--N 1.358 0.946 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 -174.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -122.61 135.66 54.67 Favored 'General case' 0 C--N 1.352 0.69 0 C-N-CA 124.172 0.989 . . . . 0.0 110.098 165.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 83.3 mt -88.05 127.04 41.43 Favored 'Isoleucine or valine' 0 C--N 1.359 1.017 0 C-N-CA 125.963 1.705 . . . . 0.0 109.732 169.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.98 155.86 41.97 Favored 'Isoleucine or valine' 0 C--N 1.352 0.702 0 C-N-CA 123.949 0.899 . . . . 0.0 110.325 171.303 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 107.65 -149.64 16.75 Favored Glycine 0 C--N 1.354 1.538 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -175.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 . . . . . 0 C--O 1.26 1.629 0 N-CA-C 114.807 1.41 . . . . 0.0 114.807 177.943 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 10.9 t80 . . . . . 0 N--CA 1.505 2.287 0 N-CA-C 116.349 1.981 . . . . 0.0 116.349 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -122.75 148.7 45.03 Favored 'General case' 0 C--N 1.357 0.895 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 163.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.1 p -123.7 133.14 70.06 Favored 'Isoleucine or valine' 0 C--N 1.35 0.595 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 173.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.2 m -133.22 153.78 38.08 Favored 'Isoleucine or valine' 0 C--N 1.354 0.786 0 O-C-N 121.35 -0.844 . . . . 0.0 108.975 177.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 88.2 p -80.48 150.61 29.62 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 -179.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 71.7 m -102.1 -4.5 25.82 Favored 'General case' 0 C--N 1.354 0.783 0 O-C-N 121.399 -0.813 . . . . 0.0 111.11 178.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 56.29 43.46 26.39 Favored 'General case' 0 C--N 1.357 0.918 0 C-N-CA 127.423 2.289 . . . . 0.0 115.734 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 23.4 mmmt -131.2 149.89 52.38 Favored 'General case' 0 N--CA 1.442 -0.825 0 C-N-CA 127.061 2.144 . . . . 0.0 106.08 165.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -92.52 174.52 7.23 Favored 'General case' 0 C--N 1.351 0.657 0 O-C-N 121.698 -0.626 . . . . 0.0 109.6 171.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 15.2 p -121.21 172.36 8.05 Favored 'General case' 0 C--N 1.353 0.745 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 159.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 63.1 m -135.5 144.75 46.53 Favored 'General case' 0 CA--C 1.504 -0.808 0 N-CA-C 100.975 -3.713 . . . . 0.0 100.975 168.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 37.0 t -57.76 -43.93 85.81 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-N 120.459 1.481 . . . . 0.0 114.315 -164.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.15 -44.84 58.91 Favored Glycine 0 C--N 1.355 1.592 0 O-C-N 121.023 -1.048 . . . . 0.0 115.0 175.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -69.04 -43.22 75.13 Favored 'General case' 0 C--N 1.349 0.558 0 C-N-CA 126.114 1.766 . . . . 0.0 113.579 -176.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 55.42 38.01 29.68 Favored 'General case' 0 C--N 1.354 0.804 0 C-N-CA 129.008 2.923 . . . . 0.0 113.82 176.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -68.42 127.43 32.94 Favored 'General case' 0 C--N 1.352 0.681 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 175.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 94.9 m -143.34 159.23 55.95 Favored Pre-proline 0 C--N 1.354 0.786 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 152.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -70.08 159.09 54.4 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.83 2.353 . . . . 0.0 110.551 162.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -65.61 136.74 56.73 Favored 'General case' 0 C--N 1.352 0.681 0 CA-C-O 121.58 0.705 . . . . 0.0 112.7 -175.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.1 -9.65 70.03 Favored Glycine 0 C--N 1.356 1.668 0 O-C-N 121.689 -0.632 . . . . 0.0 113.19 -175.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 84.2 m -114.92 155.94 25.94 Favored 'General case' 0 C--N 1.348 0.508 0 C-N-CA 124.502 1.121 . . . . 0.0 108.381 178.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -136.3 163.1 31.2 Favored 'General case' 0 C--N 1.352 0.699 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 178.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 45.2 t -119.43 124.05 45.58 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 105.931 -1.877 . . . . 0.0 105.931 178.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -83.29 78.77 1.98 Allowed Glycine 0 C--N 1.352 1.443 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 177.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -98.46 113.39 25.38 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 104.387 -2.449 . . . . 0.0 104.387 -176.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -77.03 -49.04 16.26 Favored 'General case' 0 C--N 1.357 0.929 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -148.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.94 76.97 0.16 Allowed Glycine 0 C--N 1.349 1.287 0 N-CA-C 108.69 -1.764 . . . . 0.0 108.69 175.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.8 pm0 45.59 59.38 3.65 Favored 'General case' 0 C--N 1.354 0.8 0 C-N-CA 128.519 2.727 . . . . 0.0 116.509 -178.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 34.7 m120 -103.33 -119.59 0.2 Allowed 'General case' 0 C--N 1.352 0.698 0 C-N-CA 123.953 0.901 . . . . 0.0 109.845 -171.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.72 -101.16 0.21 Allowed 'General case' 0 C--N 1.355 0.816 0 C-N-CA 124.159 0.984 . . . . 0.0 110.874 -172.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.0 pttm -130.33 -32.39 1.77 Allowed 'General case' 0 C--N 1.355 0.831 0 N-CA-C 116.306 1.965 . . . . 0.0 116.306 -163.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 62.05 -144.79 49.21 Favored Glycine 0 C--N 1.357 1.722 0 O-C-N 119.664 -1.897 . . . . 0.0 113.338 -174.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 43.4 t60 -160.51 160.41 31.91 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 101.808 -3.404 . . . . 0.0 101.808 163.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 72.5 m -89.36 134.16 34.19 Favored 'General case' 0 C--N 1.354 0.804 0 CA-C-N 120.89 1.677 . . . . 0.0 112.091 175.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -149.77 164.58 34.9 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.186 1.395 . . . . 0.0 112.099 -178.131 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -133.98 156.08 48.82 Favored 'General case' 0 C--N 1.354 0.784 0 CA-C-O 121.499 0.666 . . . . 0.0 111.516 -173.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 91.5 mt -108.77 124.98 65.74 Favored 'Isoleucine or valine' 0 C--N 1.355 0.843 0 C-N-CA 125.522 1.529 . . . . 0.0 108.84 -175.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.71 157.25 42.97 Favored 'Isoleucine or valine' 0 C--N 1.35 0.601 0 C-N-CA 124.224 1.01 . . . . 0.0 108.508 173.55 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 137.93 -147.28 19.13 Favored Glycine 0 C--N 1.352 1.464 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 -178.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 64.3 t30 . . . . . 0 CA--C 1.566 1.591 0 C-N-CA 124.192 0.997 . . . . 0.0 113.411 179.858 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 5.9 t80 . . . . . 0 N--CA 1.504 2.265 0 N-CA-C 115.929 1.826 . . . . 0.0 115.929 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -120.04 152.46 37.49 Favored 'General case' 0 C--N 1.356 0.848 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 163.519 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.6 p -124.63 135.99 62.11 Favored 'Isoleucine or valine' 0 C--N 1.348 0.54 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 176.168 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.3 m -129.96 157.29 42.54 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.681 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 177.042 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 85.3 p -79.7 152.67 29.78 Favored 'General case' 0 N--CA 1.447 -0.585 0 O-C-N 121.246 -0.909 . . . . 0.0 112.57 173.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 16.6 t -110.22 9.6 23.81 Favored 'General case' 0 C--N 1.352 0.701 0 O-C-N 121.274 -0.891 . . . . 0.0 110.892 -174.28 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 56.51 42.95 26.64 Favored 'General case' 0 C--N 1.355 0.842 0 C-N-CA 126.762 2.025 . . . . 0.0 114.736 175.13 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 54.2 tptt -140.87 137.64 33.37 Favored 'General case' 0 C--N 1.351 0.657 0 O-C-N 120.668 -1.27 . . . . 0.0 107.801 177.542 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -91.03 130.11 36.97 Favored 'General case' 0 C--N 1.351 0.632 0 C-N-CA 125.642 1.577 . . . . 0.0 109.946 -177.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 10.6 p -111.43 156.13 22.11 Favored 'General case' 0 C--N 1.358 0.955 0 O-C-N 121.415 -0.803 . . . . 0.0 109.131 -178.62 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 21.4 p -127.04 152.72 46.88 Favored 'General case' 0 CA--C 1.496 -1.098 0 O-C-N 121.069 -1.019 . . . . 0.0 112.745 177.134 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 40.7 t -63.91 126.16 26.76 Favored 'General case' 0 C--N 1.359 0.995 0 CA-C-O 122.437 1.113 . . . . 0.0 110.249 177.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 92.63 -9.19 76.19 Favored Glycine 0 C--N 1.344 1.026 0 CA-C-N 114.975 -1.011 . . . . 0.0 113.05 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 15.1 mm-40 -121.54 -46.75 2.25 Favored 'General case' 0 C--N 1.352 0.677 0 CA-C-N 118.374 1.087 . . . . 0.0 111.902 179.46 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 51.41 47.51 24.68 Favored 'General case' 0 C--N 1.36 1.039 0 N-CA-C 116.343 1.979 . . . . 0.0 116.343 -177.017 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -67.5 118.03 10.26 Favored 'General case' 0 C--N 1.355 0.841 0 O-C-N 120.791 -1.193 . . . . 0.0 113.216 178.263 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 73.5 m -137.76 158.07 72.3 Favored Pre-proline 0 C--N 1.352 0.69 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 169.051 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.07 159.03 54.61 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.473 2.116 . . . . 0.0 110.428 164.136 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 58.6 mp0 -64.04 134.06 54.26 Favored 'General case' 0 C--N 1.352 0.717 0 CA-C-O 121.812 0.815 . . . . 0.0 112.467 -173.534 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 98.35 -15.06 61.75 Favored Glycine 0 C--N 1.355 1.601 0 C-N-CA 123.799 0.714 . . . . 0.0 112.934 -174.481 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 93.1 m -110.21 157.7 19.15 Favored 'General case' 0 C--N 1.349 0.549 0 C-N-CA 124.23 1.012 . . . . 0.0 110.248 176.001 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 28.4 p90 -142.14 164.31 30.51 Favored 'General case' 0 C--N 1.348 0.541 0 N-CA-C 105.674 -1.973 . . . . 0.0 105.674 -175.684 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 36.3 t -117.45 128.48 55.04 Favored 'General case' 0 CA--C 1.51 -0.578 0 O-C-N 121.039 -1.038 . . . . 0.0 108.915 -177.267 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -85.75 61.81 4.49 Favored Glycine 0 C--N 1.353 1.516 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 176.039 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.6 HD23 ' H ' ' A' ' 42' ' ' LEU . 1.1 tt -69.81 139.55 53.2 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 125.159 1.384 . . . . 0.0 110.502 -175.76 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.6 ' H ' HD23 ' A' ' 41' ' ' LEU . 1.5 mm? -80.89 72.37 7.88 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 125.423 1.489 . . . . 0.0 108.997 -163.574 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.75 14.71 81.19 Favored Glycine 0 C--N 1.352 1.456 0 O-C-N 120.689 -1.257 . . . . 0.0 113.292 178.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.497 ' HA ' HD22 ' A' ' 41' ' ' LEU . 34.6 mt-30 56.35 41.24 29.29 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 127.35 2.26 . . . . 0.0 114.664 -170.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -68.47 -45.15 73.21 Favored 'General case' 0 C--N 1.356 0.887 0 N-CA-C 115.726 1.75 . . . . 0.0 115.726 174.589 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 17.5 pttp -155.15 -64.65 0.12 Allowed 'General case' 0 C--N 1.348 0.539 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -176.184 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.8 ptmt -157.21 161.2 39.26 Favored 'General case' 0 N--CA 1.439 -1.022 0 O-C-N 121.111 -0.993 . . . . 0.0 108.638 -172.548 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -159.28 -171.78 25.54 Favored Glycine 0 C--N 1.345 1.045 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 175.408 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 77.7 t60 -127.3 140.87 51.91 Favored 'General case' 0 C--N 1.35 0.603 0 O-C-N 121.301 -1.117 . . . . 0.0 108.309 -175.436 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 75.0 m -76.87 145.73 38.14 Favored 'General case' 0 C--N 1.356 0.879 0 O-C-N 120.83 -1.169 . . . . 0.0 113.626 -172.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -126.07 162.48 25.21 Favored 'General case' 0 C--N 1.358 0.976 0 C-N-CA 123.89 0.876 . . . . 0.0 108.815 -175.169 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -121.4 136.43 54.96 Favored 'General case' 0 C--N 1.351 0.632 0 C-N-CA 124.616 1.166 . . . . 0.0 108.514 166.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 84.8 mt -98.39 126.28 51.52 Favored 'Isoleucine or valine' 0 C--N 1.359 0.997 0 C-N-CA 124.851 1.261 . . . . 0.0 109.137 172.533 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.55 148.32 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 C-N-CA 125.321 1.448 . . . . 0.0 108.388 176.371 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.349 1.292 0 O-C-N 119.884 -1.76 . . . . 0.0 110.845 -176.804 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 14.0 t80 . . . . . 0 N--CA 1.504 2.249 0 N-CA-C 116.314 1.968 . . . . 0.0 116.314 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -123.05 155.62 36.52 Favored 'General case' 0 C--N 1.355 0.825 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 166.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.3 p -126.81 135.81 62.61 Favored 'Isoleucine or valine' 0 C--N 1.349 0.572 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 174.155 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 30.2 m -131.58 159.73 42.86 Favored 'Isoleucine or valine' 0 C--N 1.35 0.63 0 C-N-CA 124.709 1.204 . . . . 0.0 107.8 175.287 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 87.8 p -77.6 153.41 33.26 Favored 'General case' 0 C--N 1.351 0.646 0 CA-C-O 122.15 0.976 . . . . 0.0 112.58 174.539 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 8.8 t -104.73 3.59 31.53 Favored 'General case' 0 C--N 1.353 0.724 0 O-C-N 121.21 -0.931 . . . . 0.0 110.298 -176.395 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 72.4 m-80 58.26 41.38 23.49 Favored 'General case' 0 C--N 1.356 0.877 0 C-N-CA 127.456 2.303 . . . . 0.0 114.378 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 52.6 tptt -139.72 134.54 32.06 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 -177.026 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -89.01 133.61 34.27 Favored 'General case' 0 C--N 1.355 0.836 0 C-N-CA 125.002 1.321 . . . . 0.0 109.288 -179.12 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 26.1 p -131.99 152.58 51.04 Favored 'General case' 0 C--N 1.352 0.711 0 CA-C-O 122.049 0.928 . . . . 0.0 110.424 177.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.7 m -127.39 149.52 50.04 Favored 'General case' 0 C--N 1.349 0.569 0 N-CA-C 105.56 -2.015 . . . . 0.0 105.56 -167.338 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 36.6 t -62.71 133.43 54.8 Favored 'General case' 0 C--N 1.36 1.055 0 O-C-N 120.689 -1.257 . . . . 0.0 109.907 170.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 92.88 -15.08 63.58 Favored Glycine 0 C--N 1.349 1.286 0 C-N-CA 123.841 0.734 . . . . 0.0 112.443 -172.092 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -113.79 -53.56 2.67 Favored 'General case' 0 C--N 1.356 0.866 0 CA-C-N 118.652 1.226 . . . . 0.0 111.954 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 49.36 41.75 21.06 Favored 'General case' 0 C--N 1.364 1.204 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 -176.43 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 59.6 mm-40 -83.95 112.93 20.61 Favored 'General case' 0 C--N 1.353 0.752 0 O-C-N 120.436 -1.415 . . . . 0.0 111.581 -179.071 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 79.0 m -134.83 155.57 79.23 Favored Pre-proline 0 C--N 1.35 0.601 0 N-CA-C 106.169 -1.789 . . . . 0.0 106.169 171.37 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -70.54 160.1 50.59 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.589 2.192 . . . . 0.0 110.574 165.281 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -65.02 141.46 58.76 Favored 'General case' 0 C--N 1.353 0.757 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -175.125 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.8 -13.88 65.6 Favored Glycine 0 C--N 1.354 1.554 0 C-N-CA 123.774 0.702 . . . . 0.0 112.522 -172.517 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 71.2 m -115.32 154.94 28.23 Favored 'General case' 0 C--N 1.349 0.562 0 C-N-CA 124.487 1.115 . . . . 0.0 109.929 178.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -129.9 158.61 39.04 Favored 'General case' 0 C--N 1.352 0.686 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -178.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 52.2 t -88.66 126.53 35.35 Favored 'General case' 0 C--N 1.35 0.593 0 O-C-N 121.494 -0.754 . . . . 0.0 110.609 -174.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -82.55 67.88 3.64 Favored Glycine 0 C--N 1.356 1.665 0 O-C-N 121.107 -0.996 . . . . 0.0 113.79 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 56.7 mt -104.76 134.17 48.36 Favored 'General case' 0 CA--C 1.505 -0.759 0 C-N-CA 125.142 1.377 . . . . 0.0 110.429 170.617 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.526 HD22 ' H ' ' A' ' 42' ' ' LEU . 1.5 mm? -70.0 -44.86 68.52 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 125.479 1.512 . . . . 0.0 111.035 -166.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -160.93 49.65 0.36 Allowed Glycine 0 C--N 1.346 1.123 0 N-CA-C 107.279 -2.328 . . . . 0.0 107.279 170.208 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 17.4 mp0 52.73 51.21 16.45 Favored 'General case' 0 C--N 1.356 0.862 0 C-N-CA 127.011 2.124 . . . . 0.0 114.605 -177.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 23.2 m120 -92.33 -53.69 4.12 Favored 'General case' 0 C--N 1.357 0.9 0 O-C-N 120.494 -1.379 . . . . 0.0 112.628 -166.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -131.46 -98.69 0.31 Allowed 'General case' 0 C--N 1.355 0.811 0 CA-C-O 122.394 1.092 . . . . 0.0 109.774 -174.251 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 15.0 ptmm? -138.25 156.93 47.2 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 106.012 -1.847 . . . . 0.0 106.012 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -148.53 -171.03 16.95 Favored Glycine 0 CA--C 1.493 -1.284 0 N-CA-C 108.405 -1.878 . . . . 0.0 108.405 -178.61 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 51.6 t60 -132.42 147.42 52.38 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 104.712 -2.329 . . . . 0.0 104.712 -176.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 71.9 m -78.46 139.38 38.71 Favored 'General case' 0 C--N 1.351 0.636 0 O-C-N 120.984 -1.072 . . . . 0.0 112.079 -174.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -125.72 156.91 38.63 Favored 'General case' 0 C--N 1.351 0.671 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 -176.188 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -112.46 135.54 53.04 Favored 'General case' 0 C--N 1.35 0.625 0 C-N-CA 124.043 0.937 . . . . 0.0 109.669 175.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 43.0 mm -91.8 122.06 42.88 Favored 'Isoleucine or valine' 0 C--N 1.361 1.091 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 172.096 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.64 137.54 57.05 Favored 'Isoleucine or valine' 0 C--N 1.351 0.663 0 CA-C-O 122.363 1.078 . . . . 0.0 110.46 169.662 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.327 0 N-CA-C 106.014 -2.834 . . . . 0.0 106.014 -176.072 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 14.0 t80 . . . . . 0 N--CA 1.503 2.218 0 N-CA-C 116.702 2.112 . . . . 0.0 116.702 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -111.74 151.83 28.49 Favored 'General case' 0 C--N 1.353 0.73 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 159.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.2 p -126.33 136.02 62.06 Favored 'Isoleucine or valine' 0 C--N 1.351 0.65 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 173.329 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.585 HG22 HD11 ' A' ' 54' ' ' ILE . 35.9 m -133.72 159.39 42.59 Favored 'Isoleucine or valine' 0 C--N 1.353 0.727 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 176.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 87.4 p -80.42 154.32 27.73 Favored 'General case' 0 C--N 1.349 0.547 0 CA-C-O 121.684 0.754 . . . . 0.0 112.934 171.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 78.2 m -105.38 5.0 31.4 Favored 'General case' 0 C--N 1.356 0.866 0 O-C-N 121.114 -0.991 . . . . 0.0 111.539 173.409 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 58.16 40.73 24.71 Favored 'General case' 0 C--N 1.355 0.821 0 C-N-CA 126.928 2.091 . . . . 0.0 114.977 178.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 37.2 mmtm -132.7 142.83 49.24 Favored 'General case' 0 C--N 1.351 0.632 0 C-N-CA 124.593 1.157 . . . . 0.0 110.416 176.016 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.5 t30 -88.09 133.29 34.02 Favored 'General case' 0 C--N 1.351 0.668 0 C-N-CA 126.374 1.87 . . . . 0.0 109.135 176.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 13.8 p -109.31 153.51 23.8 Favored 'General case' 0 C--N 1.356 0.887 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 171.024 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 59.7 m -128.9 145.71 51.14 Favored 'General case' 0 C--N 1.346 0.435 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 -173.018 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 47.4 t -59.2 138.53 57.55 Favored 'General case' 0 C--N 1.358 0.937 0 C-N-CA 123.829 0.852 . . . . 0.0 112.941 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.94 -53.88 4.4 Favored Glycine 0 C--N 1.358 1.774 0 C-N-CA 124.666 1.127 . . . . 0.0 112.377 -175.217 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -64.39 -45.74 86.35 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 128.685 2.794 . . . . 0.0 115.465 -178.079 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.4 m120 54.99 43.01 30.55 Favored 'General case' 0 C--N 1.355 0.814 0 C-N-CA 127.084 2.154 . . . . 0.0 115.654 168.182 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 55.2 mm-40 -75.76 117.89 18.0 Favored 'General case' 0 C--N 1.354 0.784 0 O-C-N 120.124 -1.61 . . . . 0.0 113.929 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 77.1 m -138.06 155.99 74.22 Favored Pre-proline 0 C--N 1.354 0.793 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 159.379 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.21 160.08 50.07 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 123.109 2.539 . . . . 0.0 111.25 166.239 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -62.94 131.14 47.69 Favored 'General case' 0 C--N 1.353 0.718 0 C-N-CA 123.539 0.735 . . . . 0.0 112.534 -176.792 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 100.27 -14.07 59.79 Favored Glycine 0 C--N 1.356 1.649 0 C-N-CA 123.827 0.727 . . . . 0.0 112.679 -174.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 75.0 m -112.69 156.67 22.38 Favored 'General case' 0 C--N 1.349 0.549 0 C-N-CA 124.055 0.942 . . . . 0.0 109.145 177.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -141.47 163.03 34.03 Favored 'General case' 0 C--N 1.348 0.509 0 N-CA-C 105.346 -2.094 . . . . 0.0 105.346 -178.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 46.3 t -124.25 125.9 45.18 Favored 'General case' 0 CA--C 1.508 -0.665 0 O-C-N 120.85 -1.156 . . . . 0.0 109.59 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -85.9 63.94 4.16 Favored Glycine 0 C--N 1.354 1.544 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 177.092 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.612 HD23 ' H ' ' A' ' 42' ' ' LEU . 1.0 OUTLIER -69.46 141.16 54.07 Favored 'General case' 0 C--N 1.349 0.573 0 C-N-CA 125.27 1.428 . . . . 0.0 110.292 -178.94 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.612 ' H ' HD23 ' A' ' 41' ' ' LEU . 1.4 mm? -81.59 69.94 8.36 Favored 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 125.502 1.521 . . . . 0.0 109.288 -161.282 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.76 24.31 76.31 Favored Glycine 0 C--N 1.352 1.438 0 O-C-N 120.975 -1.078 . . . . 0.0 113.943 178.368 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 69.2 mm-40 58.32 34.29 23.91 Favored 'General case' 0 C--N 1.356 0.88 0 C-N-CA 126.2 1.8 . . . . 0.0 114.592 -175.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 57.4 m-80 -76.38 -46.92 25.17 Favored 'General case' 0 C--N 1.356 0.871 0 O-C-N 120.028 -1.67 . . . . 0.0 115.371 176.593 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 48.2 mmtm -137.7 -100.97 0.19 Allowed 'General case' 0 C--N 1.348 0.542 0 CA-C-O 122.103 0.954 . . . . 0.0 110.124 -173.152 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 10.3 ptpp? -143.58 161.65 37.94 Favored 'General case' 0 N--CA 1.436 -1.136 0 C-N-CA 125.311 1.444 . . . . 0.0 107.654 -173.273 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -154.91 -174.13 24.5 Favored Glycine 0 C--N 1.344 1.005 0 N-CA-C 108.748 -1.741 . . . . 0.0 108.748 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 52.6 t60 -126.7 142.97 51.38 Favored 'General case' 0 C--N 1.35 0.589 0 O-C-N 121.159 -1.201 . . . . 0.0 108.218 -173.261 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 75.9 m -80.15 139.98 36.57 Favored 'General case' 0 C--N 1.356 0.849 0 O-C-N 120.751 -1.218 . . . . 0.0 112.978 -173.114 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -128.0 162.15 27.48 Favored 'General case' 0 C--N 1.357 0.919 0 C-N-CA 124.0 0.92 . . . . 0.0 108.986 -173.236 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -116.35 137.91 51.77 Favored 'General case' 0 C--N 1.352 0.7 0 C-N-CA 124.596 1.158 . . . . 0.0 108.267 164.694 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 83.5 mt -95.56 126.42 48.08 Favored 'Isoleucine or valine' 0 C--N 1.358 0.972 0 C-N-CA 125.726 1.61 . . . . 0.0 107.54 167.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.585 HD11 HG22 ' A' ' 20' ' ' VAL . 4.7 mp -115.75 125.71 73.01 Favored 'Isoleucine or valine' 0 C--N 1.355 0.836 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 -177.178 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.353 1.503 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 173.434 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 13.3 t80 . . . . . 0 N--CA 1.503 2.205 0 N-CA-C 116.773 2.138 . . . . 0.0 116.773 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -120.53 150.6 40.6 Favored 'General case' 0 C--N 1.356 0.867 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 165.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.2 p -122.93 134.41 66.16 Favored 'Isoleucine or valine' 0 C--N 1.351 0.643 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 171.373 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 28.4 m -132.21 156.97 42.97 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.619 0 C-N-CA 124.983 1.313 . . . . 0.0 107.547 177.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 96.5 p -81.16 158.27 25.0 Favored 'General case' 0 C--N 1.353 0.735 0 CA-C-O 122.391 1.091 . . . . 0.0 112.342 175.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 79.0 m -98.77 10.53 41.01 Favored 'General case' 0 C--N 1.349 0.556 0 C-N-CA 125.007 1.323 . . . . 0.0 110.194 176.399 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 8.3 m120 62.69 21.55 12.8 Favored 'General case' 0 C--N 1.356 0.87 0 C-N-CA 128.788 2.835 . . . . 0.0 114.146 177.256 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt -118.8 143.12 47.12 Favored 'General case' 0 CA--C 1.511 -0.553 0 C-N-CA 125.038 1.335 . . . . 0.0 111.586 179.321 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -96.83 130.03 44.17 Favored 'General case' 0 C--N 1.351 0.666 0 C-N-CA 126.878 2.071 . . . . 0.0 109.992 178.196 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 14.2 p -103.17 155.69 18.24 Favored 'General case' 0 C--N 1.354 0.786 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 170.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 61.6 m -130.38 145.34 51.79 Favored 'General case' 0 C--N 1.353 0.749 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 -177.344 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 39.7 t -60.6 133.12 55.79 Favored 'General case' 0 C--N 1.356 0.855 0 O-C-N 119.531 -1.981 . . . . 0.0 112.003 177.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.71 -18.96 56.13 Favored Glycine 0 C--N 1.352 1.43 0 C-N-CA 125.024 1.297 . . . . 0.0 112.824 -172.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -148.8 102.21 3.26 Favored 'General case' 0 C--N 1.355 0.808 0 CA-C-O 123.847 1.784 . . . . 0.0 111.233 174.692 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 33.7 m120 -80.91 82.63 6.84 Favored 'General case' 0 C--N 1.353 0.747 0 O-C-N 120.058 -1.652 . . . . 0.0 110.833 -175.431 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -82.5 75.81 9.4 Favored 'General case' 0 C--N 1.353 0.734 0 C-N-CA 124.461 1.105 . . . . 0.0 112.581 -167.554 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 74.7 m -118.63 151.21 49.56 Favored Pre-proline 0 C--N 1.351 0.668 0 O-C-N 120.694 -1.254 . . . . 0.0 110.806 177.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -71.83 159.77 49.71 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.776 2.318 . . . . 0.0 110.603 163.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -63.77 134.82 55.99 Favored 'General case' 0 C--N 1.352 0.684 0 C-N-CA 123.503 0.721 . . . . 0.0 112.524 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 98.59 -10.51 62.84 Favored Glycine 0 C--N 1.356 1.639 0 C-N-CA 123.817 0.722 . . . . 0.0 113.542 -175.373 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 82.5 m -112.77 154.47 26.15 Favored 'General case' 0 C--N 1.348 0.52 0 CA-C-N 118.003 0.901 . . . . 0.0 108.891 178.441 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -129.03 160.36 32.99 Favored 'General case' 0 C--N 1.353 0.737 0 N-CA-C 104.691 -2.337 . . . . 0.0 104.691 177.084 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 41.9 t -114.21 128.59 56.44 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-N 120.586 1.539 . . . . 0.0 109.33 178.027 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -83.8 61.6 4.72 Favored Glycine 0 C--N 1.355 1.595 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.528 HD23 ' H ' ' A' ' 42' ' ' LEU . 0.8 OUTLIER -81.93 137.79 35.11 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 124.21 1.004 . . . . 0.0 109.142 -175.063 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.528 ' H ' HD23 ' A' ' 41' ' ' LEU . 1.3 mm? -81.21 72.24 8.23 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 125.637 1.575 . . . . 0.0 109.044 -163.564 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.67 20.25 79.78 Favored Glycine 0 C--N 1.354 1.554 0 O-C-N 120.742 -1.224 . . . . 0.0 113.692 178.303 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 56.37 39.67 30.0 Favored 'General case' 0 C--N 1.352 0.717 0 C-N-CA 127.376 2.271 . . . . 0.0 114.091 -172.642 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 61.2 m-80 -80.47 -45.14 18.06 Favored 'General case' 0 C--N 1.351 0.671 0 N-CA-C 115.073 1.509 . . . . 0.0 115.073 173.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -131.0 -105.34 0.27 Allowed 'General case' 0 C--N 1.354 0.78 0 O-C-N 121.109 -0.995 . . . . 0.0 111.756 -169.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.03 164.57 31.68 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 105.38 -2.082 . . . . 0.0 105.38 -178.021 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -166.16 179.64 40.14 Favored Glycine 0 CA--C 1.493 -1.299 0 N-CA-C 108.25 -1.94 . . . . 0.0 108.25 178.452 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 12.3 m80 -105.83 150.94 25.12 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 115.689 1.737 . . . . 0.0 115.689 176.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 81.0 m -81.68 134.35 35.46 Favored 'General case' 0 C--N 1.353 0.733 0 C-N-CA 125.347 1.459 . . . . 0.0 110.047 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -127.68 158.97 36.14 Favored 'General case' 0 C--N 1.351 0.654 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 -172.524 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 20.7 pttm -125.22 154.87 40.96 Favored 'General case' 0 C--N 1.352 0.717 0 CA-C-O 121.987 0.898 . . . . 0.0 111.55 168.01 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 46.4 mm -103.62 121.15 54.68 Favored 'Isoleucine or valine' 0 C--N 1.353 0.725 0 C-N-CA 125.397 1.479 . . . . 0.0 107.671 -175.169 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.24 146.9 33.51 Favored 'Isoleucine or valine' 0 C--N 1.353 0.739 0 CA-C-O 121.908 0.861 . . . . 0.0 110.443 175.754 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.355 1.598 0 O-C-N 121.21 -0.931 . . . . 0.0 113.889 -179.88 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 11.3 t80 . . . . . 0 N--CA 1.504 2.25 0 N-CA-C 116.254 1.946 . . . . 0.0 116.254 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -123.19 147.91 46.35 Favored 'General case' 0 C--N 1.357 0.892 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 158.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 5.3 p -126.89 135.38 63.83 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.62 0 C-N-CA 124.474 1.109 . . . . 0.0 108.418 174.061 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 30.4 m -129.97 158.97 42.43 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.638 0 C-N-CA 124.715 1.206 . . . . 0.0 108.265 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 78.9 p -76.43 143.05 40.82 Favored 'General case' 0 N--CA 1.446 -0.647 0 O-C-N 121.186 -0.946 . . . . 0.0 112.741 174.706 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 15.5 t -91.98 -1.8 57.07 Favored 'General case' 0 C--N 1.354 0.768 0 O-C-N 121.256 -0.903 . . . . 0.0 110.916 178.296 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 54.5 t30 59.95 46.45 11.05 Favored 'General case' 0 C--N 1.356 0.869 0 C-N-CA 127.591 2.357 . . . . 0.0 113.55 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 55.6 tptt -140.98 138.26 33.62 Favored 'General case' 0 C--N 1.352 0.679 0 O-C-N 121.086 -1.009 . . . . 0.0 108.429 178.284 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -84.4 133.56 34.5 Favored 'General case' 0 C--N 1.355 0.816 0 C-N-CA 125.7 1.6 . . . . 0.0 111.217 176.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 26.0 p -132.48 157.37 44.81 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 122.122 0.963 . . . . 0.0 110.434 173.511 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 37.3 p -128.87 165.44 21.02 Favored 'General case' 0 CA--C 1.5 -0.978 0 C-N-CA 124.794 1.238 . . . . 0.0 111.362 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 47.3 t -58.94 135.1 57.48 Favored 'General case' 0 C--N 1.355 0.839 0 C-N-CA 125.956 1.702 . . . . 0.0 111.465 177.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 82.66 -61.08 4.8 Favored Glycine 0 C--N 1.352 1.456 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 -170.48 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 24.4 mm100 -62.15 -48.48 79.89 Favored 'General case' 0 C--N 1.351 0.643 0 N-CA-C 117.047 2.24 . . . . 0.0 117.047 -174.377 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 48.52 36.93 8.12 Favored 'General case' 0 C--N 1.359 1.006 0 N-CA-C 115.917 1.821 . . . . 0.0 115.917 175.358 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -81.53 117.79 22.22 Favored 'General case' 0 C--N 1.356 0.866 0 O-C-N 120.464 -1.397 . . . . 0.0 112.382 -173.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 82.1 m -137.14 158.03 73.35 Favored Pre-proline 0 N--CA 1.448 -0.548 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 176.614 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -70.15 159.96 51.28 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.626 2.217 . . . . 0.0 110.609 164.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -64.73 140.81 58.91 Favored 'General case' 0 C--N 1.353 0.73 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -174.442 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.22 -13.45 66.84 Favored Glycine 0 C--N 1.355 1.585 0 O-C-N 121.562 -0.711 . . . . 0.0 112.806 -173.196 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 72.8 m -115.41 155.09 28.05 Favored 'General case' 0 C--N 1.349 0.577 0 C-N-CA 124.458 1.103 . . . . 0.0 110.247 178.248 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -127.18 161.34 28.75 Favored 'General case' 0 C--N 1.348 0.527 0 C-N-CA 124.763 1.225 . . . . 0.0 109.472 178.225 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 53.2 t -86.83 125.46 33.99 Favored 'General case' 0 C--N 1.35 0.603 0 C-N-CA 123.939 0.895 . . . . 0.0 110.9 -177.396 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -91.08 84.82 1.28 Allowed Glycine 0 C--N 1.355 1.603 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 172.144 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -103.75 139.9 38.35 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 -179.241 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -80.29 68.11 6.35 Favored 'General case' 0 C--N 1.351 0.632 0 C-N-CA 125.162 1.385 . . . . 0.0 109.111 -175.031 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.16 21.51 77.12 Favored Glycine 0 C--N 1.356 1.646 0 O-C-N 120.699 -1.251 . . . . 0.0 113.695 179.224 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 56.91 35.37 26.26 Favored 'General case' 0 C--N 1.348 0.543 0 C-N-CA 127.365 2.266 . . . . 0.0 116.401 -173.446 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 61.3 m-80 -67.68 -44.8 76.94 Favored 'General case' 0 C--N 1.357 0.896 0 N-CA-C 115.065 1.506 . . . . 0.0 115.065 168.012 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.516 ' HG3' ' H ' ' A' ' 47' ' ' LYS . 20.1 pttp -149.33 -106.2 0.07 Allowed 'General case' 0 C--N 1.354 0.764 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 -173.451 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.516 ' H ' ' HG3' ' A' ' 46' ' ' LYS . 25.8 pttm -119.27 159.07 24.79 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 125.388 1.475 . . . . 0.0 110.109 -177.518 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -154.79 -166.76 15.62 Favored Glycine 0 C--N 1.352 1.417 0 N-CA-C 110.504 -1.039 . . . . 0.0 110.504 178.123 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 50.5 t60 -136.49 146.35 46.17 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 -172.147 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 79.2 m -79.92 140.88 36.52 Favored 'General case' 0 C--N 1.349 0.561 0 O-C-N 120.752 -1.218 . . . . 0.0 111.637 -177.438 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 17.3 m-30 -126.03 162.41 25.35 Favored 'General case' 0 C--N 1.355 0.823 0 O-C-N 121.048 -1.032 . . . . 0.0 108.821 -178.297 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -123.68 137.44 54.71 Favored 'General case' 0 C--N 1.352 0.689 0 C-N-CA 124.422 1.089 . . . . 0.0 108.448 168.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 94.3 mt -107.16 130.05 59.91 Favored 'Isoleucine or valine' 0 C--N 1.361 1.085 0 C-N-CA 124.242 1.017 . . . . 0.0 108.782 177.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -131.57 149.97 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 C-N-CA 125.796 1.639 . . . . 0.0 110.153 -177.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.35 1.355 0 N-CA-C 107.945 -2.062 . . . . 0.0 107.945 -177.846 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 7.5 t80 . . . . . 0 N--CA 1.5 2.075 0 N-CA-C 116.222 1.934 . . . . 0.0 116.222 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 49.0 m-20 -120.35 149.64 42.02 Favored 'General case' 0 C--N 1.354 0.782 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 161.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.9 p -125.21 135.15 64.95 Favored 'Isoleucine or valine' 0 C--N 1.35 0.593 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 174.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 28.9 m -132.01 155.88 41.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.574 0 C-N-CA 123.481 0.712 . . . . 0.0 109.122 179.239 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 79.2 p -79.91 147.87 31.49 Favored 'General case' 0 C--N 1.349 0.549 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 175.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 10.9 t -102.5 -4.13 25.82 Favored 'General case' 0 C--N 1.353 0.754 0 C-N-CA 123.732 0.813 . . . . 0.0 112.062 -175.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 56.6 t30 58.95 44.48 16.38 Favored 'General case' 0 C--N 1.357 0.91 0 C-N-CA 127.176 2.19 . . . . 0.0 113.656 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.5 tppt? -144.06 146.44 32.83 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 102.473 -3.158 . . . . 0.0 102.473 173.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.4 p-10 -120.05 167.96 11.67 Favored 'General case' 0 C--N 1.355 0.845 0 CA-C-N 120.976 1.716 . . . . 0.0 110.402 171.436 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 57.1 m -116.42 160.87 19.93 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 173.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 32.3 m -111.23 159.33 18.0 Favored 'General case' 0 C--N 1.345 0.409 0 N-CA-C 102.231 -3.248 . . . . 0.0 102.231 166.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.2 t -58.6 144.1 44.07 Favored 'General case' 0 C--N 1.352 0.716 0 CA-C-O 122.353 1.073 . . . . 0.0 112.922 178.144 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.58 -58.62 4.85 Favored Glycine 0 C--N 1.353 1.523 0 C-N-CA 124.125 0.869 . . . . 0.0 111.359 -171.706 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -63.55 -45.77 89.01 Favored 'General case' 0 C--N 1.348 0.535 0 N-CA-C 115.503 1.668 . . . . 0.0 115.503 -167.009 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 50.54 44.53 27.17 Favored 'General case' 0 C--N 1.36 1.039 0 N-CA-C 116.557 2.058 . . . . 0.0 116.557 175.168 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -91.93 114.77 27.4 Favored 'General case' 0 C--N 1.35 0.609 0 C-N-CA 124.396 1.079 . . . . 0.0 111.683 -176.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 98.2 m -132.6 157.4 78.41 Favored Pre-proline 0 C--N 1.351 0.671 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 171.021 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -69.72 160.27 50.34 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 122.775 2.317 . . . . 0.0 110.021 166.535 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -63.72 135.65 56.85 Favored 'General case' 0 C--N 1.353 0.75 0 N-CA-C 113.269 0.841 . . . . 0.0 113.269 -171.12 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.9 -12.62 65.7 Favored Glycine 0 C--N 1.355 1.587 0 C-N-CA 123.921 0.772 . . . . 0.0 113.212 -175.598 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 73.3 m -115.45 153.71 30.61 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-N 118.023 0.912 . . . . 0.0 110.489 -178.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -139.24 154.65 48.03 Favored 'General case' 0 C--N 1.355 0.831 0 O-C-N 121.099 -1.001 . . . . 0.0 110.015 -178.465 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 53.0 m -94.7 136.3 35.17 Favored 'General case' 0 C--N 1.353 0.752 0 CA-C-O 121.879 0.847 . . . . 0.0 111.053 168.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -91.88 90.05 1.47 Allowed Glycine 0 C--N 1.351 1.386 0 N-CA-C 107.332 -2.307 . . . . 0.0 107.332 167.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -106.1 125.52 51.1 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 -168.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -90.17 79.44 6.43 Favored 'General case' 0 C--N 1.352 0.678 0 O-C-N 120.987 -1.071 . . . . 0.0 109.68 -156.555 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 67.16 42.12 91.67 Favored Glycine 0 C--N 1.354 1.557 0 O-C-N 120.95 -1.094 . . . . 0.0 115.09 172.031 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 47.64 45.14 17.87 Favored 'General case' 0 C--N 1.354 0.766 0 C-N-CA 128.403 2.681 . . . . 0.0 116.843 -175.142 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 -94.62 -72.83 0.6 Allowed 'General case' 0 C--N 1.355 0.821 0 N-CA-C 114.72 1.378 . . . . 0.0 114.72 175.109 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -116.01 -96.41 0.46 Allowed 'General case' 0 C--N 1.357 0.919 0 O-C-N 120.536 -1.352 . . . . 0.0 113.083 -161.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -154.18 161.2 42.01 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 104.719 -2.326 . . . . 0.0 104.719 -171.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -154.25 156.48 26.87 Favored Glycine 0 CA--C 1.493 -1.329 0 N-CA-C 108.709 -1.756 . . . . 0.0 108.709 -177.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 73.6 t60 -101.45 144.84 29.74 Favored 'General case' 0 C--N 1.345 0.391 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 -175.549 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 72.3 m -78.98 133.22 36.87 Favored 'General case' 0 C--N 1.358 0.957 0 O-C-N 120.737 -1.227 . . . . 0.0 111.165 -178.145 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -123.61 159.91 28.23 Favored 'General case' 0 C--N 1.354 0.766 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 -175.305 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -118.98 135.09 54.79 Favored 'General case' 0 C--N 1.349 0.55 0 C-N-CA 124.228 1.011 . . . . 0.0 108.365 168.045 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 78.5 mt -101.28 125.71 55.22 Favored 'Isoleucine or valine' 0 C--N 1.358 0.944 0 C-N-CA 125.344 1.458 . . . . 0.0 109.038 173.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.5 162.4 39.88 Favored 'Isoleucine or valine' 0 C--N 1.351 0.644 0 C-N-CA 124.986 1.314 . . . . 0.0 110.678 179.153 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.355 1.593 0 O-C-N 121.074 -1.016 . . . . 0.0 111.667 -175.982 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 6.6 t80 . . . . . 0 N--CA 1.5 2.036 0 N-CA-C 115.0 1.481 . . . . 0.0 115.0 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -117.42 154.27 31.66 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 106.407 -1.701 . . . . 0.0 106.407 161.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.4 p -125.71 134.24 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 178.21 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.3 m -132.18 157.61 43.12 Favored 'Isoleucine or valine' 0 C--N 1.352 0.684 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 177.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 80.4 p -79.91 153.38 29.03 Favored 'General case' 0 C--N 1.349 0.548 0 O-C-N 120.704 -1.248 . . . . 0.0 113.97 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 21.0 t -121.96 25.25 9.22 Favored 'General case' 0 C--N 1.358 0.95 0 O-C-N 121.219 -0.926 . . . . 0.0 111.381 -171.133 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 45.57 39.18 4.57 Favored 'General case' 0 C--N 1.358 0.967 0 C-N-CA 128.184 2.594 . . . . 0.0 117.722 173.204 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 45.1 tptt -149.51 141.88 24.24 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 -174.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.8 p-10 -107.29 159.62 16.23 Favored 'General case' 0 C--N 1.355 0.837 0 CA-C-N 120.661 1.573 . . . . 0.0 111.075 170.244 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 84.5 m -106.61 156.15 18.9 Favored 'General case' 0 CA--C 1.509 -0.63 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 164.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 67.5 m -117.7 141.75 48.04 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 102.705 -3.072 . . . . 0.0 102.705 169.204 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 45.1 t -60.26 130.62 47.56 Favored 'General case' 0 C--N 1.357 0.893 0 O-C-N 120.815 -1.178 . . . . 0.0 111.242 178.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 89.32 -3.75 84.07 Favored Glycine 0 C--N 1.356 1.66 0 O-C-N 121.568 -0.707 . . . . 0.0 112.382 -176.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 11.4 mm-40 -112.55 -46.04 3.19 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 121.561 -0.964 . . . . 0.0 110.05 168.024 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 17.4 m120 53.47 43.61 31.07 Favored 'General case' 0 C--N 1.362 1.113 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 171.225 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -100.77 116.42 32.61 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 124.79 1.236 . . . . 0.0 111.877 -166.299 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 71.9 m -134.27 157.2 78.06 Favored Pre-proline 0 C--N 1.351 0.65 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 166.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.06 160.2 50.45 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.435 2.09 . . . . 0.0 110.962 166.151 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -62.64 134.67 56.67 Favored 'General case' 0 C--N 1.353 0.728 0 C-N-CA 123.91 0.884 . . . . 0.0 113.124 -173.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 98.8 -12.82 62.62 Favored Glycine 0 C--N 1.356 1.667 0 C-N-CA 124.185 0.897 . . . . 0.0 113.259 -173.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 71.2 m -116.29 154.56 29.96 Favored 'General case' 0 C--N 1.35 0.591 0 CA-C-N 118.019 0.909 . . . . 0.0 110.52 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -134.06 161.11 35.74 Favored 'General case' 0 C--N 1.355 0.811 0 N-CA-C 104.866 -2.272 . . . . 0.0 104.866 178.423 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 15.1 p -115.05 144.87 42.95 Favored 'General case' 0 CA--C 1.503 -0.849 0 CA-C-N 119.986 1.266 . . . . 0.0 112.455 172.186 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -90.97 62.91 2.89 Favored Glycine 0 C--N 1.352 1.421 0 CA-C-N 115.435 -0.802 . . . . 0.0 112.889 -172.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 62.6 mt -75.86 130.93 39.32 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 122.244 1.021 . . . . 0.0 111.895 167.485 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.537 HD22 ' H ' ' A' ' 42' ' ' LEU . 1.8 mm? -66.92 -44.56 80.37 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 126.297 1.839 . . . . 0.0 111.62 -164.116 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -167.45 49.57 0.24 Allowed Glycine 0 CA--C 1.499 -0.934 0 N-CA-C 106.609 -2.597 . . . . 0.0 106.609 173.378 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.6 pm0 45.11 54.48 7.01 Favored 'General case' 0 C--N 1.359 0.986 0 C-N-CA 127.537 2.335 . . . . 0.0 115.774 -176.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -94.06 -50.55 5.25 Favored 'General case' 0 C--N 1.359 0.986 0 O-C-N 119.996 -1.69 . . . . 0.0 111.802 -174.455 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 63.4 mttm -131.15 -103.07 0.28 Allowed 'General case' 0 C--N 1.356 0.862 0 C-N-CA 123.803 0.841 . . . . 0.0 111.479 -171.065 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 57.5 pttt -142.7 152.09 42.02 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 126.246 1.818 . . . . 0.0 106.833 -176.279 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -157.1 158.33 28.78 Favored Glycine 0 C--N 1.351 1.365 0 N-CA-C 108.142 -1.983 . . . . 0.0 108.142 -178.218 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 67.8 t60 -95.67 147.24 23.81 Favored 'General case' 0 C--N 1.346 0.433 0 O-C-N 121.717 -0.873 . . . . 0.0 110.49 -169.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 72.0 m -79.81 137.83 37.07 Favored 'General case' 0 C--N 1.359 1.002 0 O-C-N 121.078 -1.014 . . . . 0.0 111.792 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -127.09 154.62 44.47 Favored 'General case' 0 C--N 1.349 0.587 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 -178.496 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -104.69 135.87 45.26 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 124.629 1.171 . . . . 0.0 108.077 172.51 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 91.1 mt -101.19 123.4 54.23 Favored 'Isoleucine or valine' 0 C--N 1.356 0.86 0 C-N-CA 123.725 0.81 . . . . 0.0 108.937 176.612 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.19 146.51 33.61 Favored 'Isoleucine or valine' 0 C--N 1.351 0.663 0 C-N-CA 124.287 1.035 . . . . 0.0 109.693 176.078 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.354 1.553 0 O-C-N 121.215 -0.928 . . . . 0.0 114.69 175.893 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 8.4 t80 . . . . . 0 N--CA 1.504 2.242 0 N-CA-C 116.528 2.048 . . . . 0.0 116.528 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -115.93 148.19 40.31 Favored 'General case' 0 C--N 1.354 0.789 0 C-N-CA 124.953 1.301 . . . . 0.0 107.721 161.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.7 p -123.09 133.26 69.6 Favored 'Isoleucine or valine' 0 C--N 1.351 0.648 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 171.071 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 24.0 m -133.39 154.12 38.44 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.683 0 C-N-CA 124.422 1.089 . . . . 0.0 108.235 178.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 96.2 p -79.67 155.72 27.91 Favored 'General case' 0 C--N 1.352 0.676 0 CA-C-O 121.856 0.836 . . . . 0.0 113.03 178.084 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 12.2 t -114.22 11.72 17.55 Favored 'General case' 0 C--N 1.351 0.648 0 C-N-CA 123.818 0.847 . . . . 0.0 110.519 -177.194 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 32.6 m120 59.24 28.9 18.35 Favored 'General case' 0 C--N 1.357 0.919 0 C-N-CA 128.108 2.563 . . . . 0.0 115.41 173.02 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 26.5 mmmt -134.74 160.07 39.33 Favored 'General case' 0 CA--C 1.513 -0.478 0 C-N-CA 127.057 2.143 . . . . 0.0 106.545 178.218 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -136.06 165.6 25.31 Favored 'General case' 0 C--N 1.351 0.664 0 O-C-N 121.088 -1.007 . . . . 0.0 109.493 173.237 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 30.7 m -120.9 147.87 44.83 Favored 'General case' 0 C--N 1.352 0.688 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 173.212 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 24.6 p -93.5 164.84 13.03 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 122.008 0.909 . . . . 0.0 110.365 153.34 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 46.9 t -61.32 130.84 48.13 Favored 'General case' 0 C--N 1.35 0.623 0 CA-C-O 122.125 0.964 . . . . 0.0 112.593 -178.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.35 -19.3 44.34 Favored Glycine 0 C--N 1.353 1.491 0 C-N-CA 124.94 1.257 . . . . 0.0 113.636 -178.034 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 21.8 mm100 -80.23 -47.94 13.86 Favored 'General case' 0 C--N 1.353 0.719 0 N-CA-C 114.775 1.398 . . . . 0.0 114.775 179.317 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 31.6 m120 50.08 41.19 23.15 Favored 'General case' 0 C--N 1.355 0.836 0 C-N-CA 126.17 1.788 . . . . 0.0 115.055 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -98.42 109.43 22.19 Favored 'General case' 0 C--N 1.355 0.839 0 O-C-N 121.033 -1.042 . . . . 0.0 111.38 -172.303 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 76.1 m -137.05 157.7 74.09 Favored Pre-proline 0 C--N 1.35 0.598 0 N-CA-C 105.728 -1.953 . . . . 0.0 105.728 167.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -69.41 159.71 52.6 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.756 2.304 . . . . 0.0 111.349 169.081 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -62.79 131.28 48.31 Favored 'General case' 0 C--N 1.354 0.765 0 C-N-CA 123.675 0.79 . . . . 0.0 112.229 -172.375 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 100.36 -13.7 59.82 Favored Glycine 0 C--N 1.356 1.643 0 C-N-CA 123.822 0.725 . . . . 0.0 112.575 -174.366 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 72.1 m -114.08 154.21 28.13 Favored 'General case' 0 C--N 1.349 0.574 0 C-N-CA 124.088 0.955 . . . . 0.0 109.949 177.176 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -136.3 156.67 48.32 Favored 'General case' 0 C--N 1.35 0.611 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 178.411 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 8.1 p -106.16 143.87 33.68 Favored 'General case' 0 CA--C 1.501 -0.905 0 CA-C-O 122.413 1.102 . . . . 0.0 111.157 171.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -84.09 74.93 2.44 Favored Glycine 0 C--N 1.352 1.432 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 178.575 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -92.22 121.53 33.83 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 -173.164 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -91.46 101.06 13.73 Favored 'General case' 0 C--N 1.352 0.678 0 O-C-N 120.674 -1.266 . . . . 0.0 108.969 -163.448 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 60.07 32.02 74.54 Favored Glycine 0 C--N 1.357 1.708 0 N-CA-C 115.629 1.012 . . . . 0.0 115.629 165.538 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 46.19 43.11 10.83 Favored 'General case' 0 C--N 1.354 0.8 0 C-N-CA 127.895 2.478 . . . . 0.0 116.148 -168.351 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 -89.6 -98.7 0.1 Allowed 'General case' 0 C--N 1.359 0.999 0 O-C-N 121.247 -0.908 . . . . 0.0 111.649 173.196 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -96.89 -89.16 0.28 Allowed 'General case' 0 C--N 1.355 0.809 0 O-C-N 120.646 -1.284 . . . . 0.0 113.636 -169.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -151.98 162.12 41.57 Favored 'General case' 0 N--CA 1.445 -0.707 0 O-C-N 121.142 -0.973 . . . . 0.0 108.956 -168.074 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -157.5 154.03 25.18 Favored Glycine 0 C--N 1.352 1.424 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 63.1 t60 -97.3 148.13 23.44 Favored 'General case' 0 C--N 1.349 0.569 0 O-C-N 121.601 -0.94 . . . . 0.0 109.166 -173.668 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 71.5 m -80.84 134.51 35.78 Favored 'General case' 0 C--N 1.359 1.02 0 O-C-N 120.956 -1.09 . . . . 0.0 111.516 -178.536 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -130.81 167.13 19.41 Favored 'General case' 0 C--N 1.351 0.633 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 -177.096 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 33.7 pttt -124.28 148.92 47.06 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 121.56 0.695 . . . . 0.0 110.553 156.456 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 82.3 mt -104.78 124.25 59.29 Favored 'Isoleucine or valine' 0 C--N 1.358 0.944 0 C-N-CA 125.811 1.645 . . . . 0.0 107.805 174.323 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.42 142.13 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 C-N-CA 124.989 1.316 . . . . 0.0 108.938 178.529 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.351 1.393 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -175.707 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 28.3 t80 . . . . . 0 N--CA 1.504 2.249 0 N-CA-C 116.988 2.218 . . . . 0.0 116.988 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -144.65 158.21 43.87 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 105.11 -2.181 . . . . 0.0 105.11 167.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.7 p -130.82 133.05 63.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 175.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.5 m -133.27 161.6 41.18 Favored 'Isoleucine or valine' 0 C--N 1.351 0.634 0 C-N-CA 124.326 1.05 . . . . 0.0 108.313 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 87.3 p -75.82 149.81 37.81 Favored 'General case' 0 C--N 1.352 0.679 0 O-C-N 120.745 -1.222 . . . . 0.0 113.249 176.621 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 34.5 t -114.11 -0.12 14.1 Favored 'General case' 0 C--N 1.356 0.885 0 O-C-N 121.236 -0.915 . . . . 0.0 111.337 -172.217 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 53.3 t30 58.51 45.67 16.07 Favored 'General case' 0 C--N 1.356 0.864 0 C-N-CA 127.146 2.179 . . . . 0.0 114.827 175.294 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 15.5 tppt? -141.7 144.43 34.06 Favored 'General case' 0 C--N 1.349 0.565 0 N-CA-C 105.27 -2.122 . . . . 0.0 105.27 173.182 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 30.0 t30 -114.07 136.26 53.11 Favored 'General case' 0 C--N 1.353 0.76 0 O-C-N 121.2 -0.937 . . . . 0.0 110.387 -176.235 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 85.9 m -102.31 151.72 21.91 Favored 'General case' 0 C--N 1.356 0.855 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 170.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 40.0 m -128.16 160.18 32.84 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 101.774 -3.417 . . . . 0.0 101.774 176.096 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.2 t -51.15 -40.23 58.1 Favored 'General case' 0 C--N 1.345 0.393 0 C-N-CA 126.138 1.775 . . . . 0.0 115.461 -169.4 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -78.95 -1.5 85.01 Favored Glycine 0 C--N 1.351 1.374 0 N-CA-C 116.226 1.25 . . . . 0.0 116.226 178.535 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -145.9 135.45 23.17 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-N 120.34 2.07 . . . . 0.0 112.628 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 34.7 m120 -98.55 101.09 12.42 Favored 'General case' 0 C--N 1.353 0.744 0 O-C-N 119.833 -1.792 . . . . 0.0 106.491 172.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -130.42 95.02 3.78 Favored 'General case' 0 N--CA 1.446 -0.649 0 O-C-N 121.811 -0.556 . . . . 0.0 109.905 -164.62 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 73.1 m -136.05 156.54 76.94 Favored Pre-proline 0 C--N 1.351 0.633 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 170.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.85 160.44 49.67 Favored 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 122.478 2.119 . . . . 0.0 110.611 162.458 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 64.6 mm-40 -64.76 137.98 58.11 Favored 'General case' 0 C--N 1.351 0.673 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -174.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.37 -10.67 67.24 Favored Glycine 0 C--N 1.356 1.643 0 C-N-CA 123.83 0.728 . . . . 0.0 112.879 -174.327 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 71.3 m -115.61 153.74 30.71 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.219 1.008 . . . . 0.0 110.18 179.149 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -132.65 157.82 43.84 Favored 'General case' 0 C--N 1.355 0.836 0 N-CA-C 105.216 -2.142 . . . . 0.0 105.216 175.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 12.7 p -110.21 144.31 39.06 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-N 119.545 1.066 . . . . 0.0 110.666 169.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -85.16 71.63 2.91 Favored Glycine 0 C--N 1.352 1.418 0 N-CA-C 110.031 -1.228 . . . . 0.0 110.031 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -93.18 121.31 34.41 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 -172.199 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -88.71 82.65 6.79 Favored 'General case' 0 C--N 1.351 0.644 0 O-C-N 120.753 -1.217 . . . . 0.0 110.011 -162.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 64.21 37.29 94.34 Favored Glycine 0 C--N 1.354 1.578 0 O-C-N 121.029 -1.045 . . . . 0.0 115.197 167.511 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 47.49 44.64 16.96 Favored 'General case' 0 C--N 1.352 0.717 0 C-N-CA 128.811 2.844 . . . . 0.0 115.847 -173.119 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 64.0 m-80 -90.66 -61.43 1.68 Allowed 'General case' 0 C--N 1.357 0.892 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 171.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -127.36 -103.77 0.33 Allowed 'General case' 0 C--N 1.356 0.887 0 O-C-N 120.964 -1.085 . . . . 0.0 112.851 -169.123 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -152.37 159.98 43.36 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -169.241 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -164.68 151.5 20.6 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 111.174 -0.771 . . . . 0.0 111.174 -176.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 79.1 t60 -96.96 143.64 27.63 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 121.812 -0.816 . . . . 0.0 109.763 -171.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 74.4 m -76.94 139.38 40.15 Favored 'General case' 0 C--N 1.356 0.853 0 O-C-N 121.008 -1.057 . . . . 0.0 112.139 -178.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -123.96 151.01 44.11 Favored 'General case' 0 C--N 1.351 0.642 0 N-CA-C 106.962 -1.495 . . . . 0.0 106.962 -179.309 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -100.3 134.11 43.72 Favored 'General case' 0 C--N 1.346 0.453 0 C-N-CA 124.224 1.009 . . . . 0.0 108.317 173.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 96.6 mt -101.41 124.78 55.36 Favored 'Isoleucine or valine' 0 C--N 1.356 0.885 0 CA-C-O 122.08 0.943 . . . . 0.0 109.323 171.518 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -128.04 148.53 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 C-N-CA 125.827 1.651 . . . . 0.0 108.592 175.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.492 -1.346 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 -179.619 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 5.4 t80 . . . . . 0 N--CA 1.503 2.178 0 N-CA-C 115.828 1.788 . . . . 0.0 115.828 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -118.38 148.31 42.65 Favored 'General case' 0 C--N 1.356 0.863 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 162.378 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.0 p -120.74 134.99 62.39 Favored 'Isoleucine or valine' 0 C--N 1.35 0.626 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 174.057 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.7 m -131.76 160.01 42.69 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.603 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 177.135 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 94.5 p -77.26 153.71 33.7 Favored 'General case' 0 C--N 1.352 0.685 0 O-C-N 120.95 -1.094 . . . . 0.0 111.614 171.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 11.2 t -94.76 -8.68 36.89 Favored 'General case' 0 C--N 1.352 0.682 0 O-C-N 121.099 -1.001 . . . . 0.0 109.721 178.294 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 62.1 t30 58.44 45.23 16.95 Favored 'General case' 0 C--N 1.355 0.83 0 C-N-CA 128.4 2.68 . . . . 0.0 112.666 -173.274 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 53.5 tptt -133.12 135.89 45.48 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 177.169 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -91.14 136.26 33.21 Favored 'General case' 0 C--N 1.352 0.712 0 C-N-CA 125.429 1.492 . . . . 0.0 108.788 -178.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 25.2 p -129.16 150.09 50.69 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-O 122.093 0.949 . . . . 0.0 110.771 176.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 90.5 m -125.3 148.27 48.77 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 104.551 -2.388 . . . . 0.0 104.551 -174.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 80.9 p -57.92 -42.52 84.95 Favored 'General case' 0 C--N 1.353 0.734 0 N-CA-C 117.529 2.418 . . . . 0.0 117.529 -159.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -78.71 -48.96 6.83 Favored Glycine 0 C--N 1.353 1.492 0 CA-C-N 119.408 1.004 . . . . 0.0 113.475 176.168 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.6 mp0 -67.27 -43.97 80.49 Favored 'General case' 0 C--N 1.35 0.589 0 C-N-CA 125.143 1.377 . . . . 0.0 113.458 -174.685 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 54.09 45.1 28.21 Favored 'General case' 0 C--N 1.355 0.826 0 C-N-CA 129.004 2.922 . . . . 0.0 115.136 169.051 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 53.7 mp0 -75.97 123.54 25.9 Favored 'General case' 0 C--N 1.36 1.057 0 O-C-N 119.68 -1.887 . . . . 0.0 113.518 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 73.3 m -135.94 154.99 78.08 Favored Pre-proline 0 C--N 1.35 0.593 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 159.078 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.65 161.34 45.58 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.727 2.285 . . . . 0.0 110.998 167.196 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -62.92 130.76 46.19 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 121.483 0.659 . . . . 0.0 112.469 -175.73 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 100.63 -14.23 59.21 Favored Glycine 0 C--N 1.355 1.608 0 C-N-CA 123.675 0.655 . . . . 0.0 112.62 -173.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 73.9 m -113.3 153.71 28.01 Favored 'General case' 0 C--N 1.349 0.579 0 C-N-CA 123.92 0.888 . . . . 0.0 109.892 176.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -134.85 155.56 50.45 Favored 'General case' 0 C--N 1.352 0.705 0 O-C-N 121.235 -0.915 . . . . 0.0 110.3 -177.23 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 47.3 t -91.67 125.59 36.46 Favored 'General case' 0 C--N 1.351 0.652 0 C-N-CA 124.619 1.168 . . . . 0.0 111.788 -169.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -84.77 60.37 4.82 Favored Glycine 0 C--N 1.352 1.459 0 O-C-N 121.375 -0.828 . . . . 0.0 113.435 174.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -117.87 122.14 42.57 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 174.377 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -119.8 144.94 47.04 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 -173.507 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 76.39 10.43 85.59 Favored Glycine 0 C--N 1.355 1.636 0 O-C-N 121.547 -0.721 . . . . 0.0 114.806 166.508 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 55.7 46.29 22.86 Favored 'General case' 0 C--N 1.35 0.612 0 C-N-CA 126.655 1.982 . . . . 0.0 114.375 -175.105 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 -87.98 -109.09 0.07 Allowed 'General case' 0 C--N 1.356 0.869 0 O-C-N 121.469 -0.769 . . . . 0.0 112.558 -179.357 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -105.4 -107.29 0.3 Allowed 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.498 -1.376 . . . . 0.0 114.568 -169.375 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -114.37 154.23 28.43 Favored 'General case' 0 N--CA 1.439 -0.978 0 C-N-CA 126.882 2.073 . . . . 0.0 108.095 179.051 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -133.37 178.66 18.06 Favored Glycine 0 CA--C 1.493 -1.295 0 N-CA-C 107.233 -2.347 . . . . 0.0 107.233 173.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 40.9 t60 -128.2 147.6 50.58 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 105.052 -2.203 . . . . 0.0 105.052 177.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 79.9 m -83.26 140.86 32.26 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.036 -1.04 . . . . 0.0 112.408 -173.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -121.59 161.92 21.56 Favored 'General case' 0 C--N 1.356 0.885 0 O-C-N 121.42 -0.8 . . . . 0.0 108.871 -178.124 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -120.18 135.14 55.07 Favored 'General case' 0 C--N 1.35 0.588 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 167.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 78.5 mt -101.25 126.46 55.04 Favored 'Isoleucine or valine' 0 C--N 1.357 0.934 0 C-N-CA 125.134 1.374 . . . . 0.0 108.41 171.392 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.76 156.85 42.75 Favored 'Isoleucine or valine' 0 C--N 1.35 0.614 0 C-N-CA 124.947 1.299 . . . . 0.0 109.423 177.007 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.355 1.638 0 O-C-N 121.023 -1.048 . . . . 0.0 113.115 -176.681 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 6.4 t80 . . . . . 0 N--CA 1.505 2.306 0 N-CA-C 116.097 1.888 . . . . 0.0 116.097 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 52.5 m-20 -116.58 152.36 34.32 Favored 'General case' 0 C--N 1.355 0.835 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 164.602 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.1 p -123.22 134.47 66.15 Favored 'Isoleucine or valine' 0 C--N 1.348 0.522 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 174.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.7 m -131.24 157.99 43.27 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.802 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.3 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 80.4 p -83.65 151.08 25.48 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 122.151 0.977 . . . . 0.0 113.471 176.723 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 83.2 m -96.01 -2.76 46.24 Favored 'General case' 0 C--N 1.356 0.859 0 C-N-CA 123.927 0.891 . . . . 0.0 110.472 173.478 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 59.5 t30 57.19 45.23 20.91 Favored 'General case' 0 C--N 1.35 0.592 0 C-N-CA 129.093 2.957 . . . . 0.0 114.241 178.141 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.6 mmmt -130.07 147.57 51.83 Favored 'General case' 0 CA--C 1.506 -0.719 0 C-N-CA 126.877 2.071 . . . . 0.0 105.972 170.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -85.47 174.76 9.27 Favored 'General case' 0 C--N 1.354 0.8 0 CA-C-N 118.751 0.705 . . . . 0.0 110.228 173.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 17.0 p -126.89 -178.9 4.57 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 105.416 -2.068 . . . . 0.0 105.416 162.021 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 31.1 m -134.03 142.31 47.55 Favored 'General case' 0 CA--C 1.504 -0.824 1 N-CA-C 99.917 -4.105 . . . . 0.0 99.917 165.398 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 35.2 t -59.05 -44.58 91.81 Favored 'General case' 0 C--N 1.351 0.667 0 CA-C-N 120.508 1.504 . . . . 0.0 115.031 -163.702 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.9 -45.09 65.2 Favored Glycine 0 C--N 1.354 1.559 0 O-C-N 121.231 -0.918 . . . . 0.0 115.294 176.72 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -70.07 -43.51 71.03 Favored 'General case' 0 C--N 1.351 0.666 0 C-N-CA 125.113 1.365 . . . . 0.0 112.838 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 55.22 46.59 23.45 Favored 'General case' 0 C--N 1.353 0.72 0 C-N-CA 130.507 3.523 . . . . 0.0 112.694 -178.638 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -62.9 124.45 21.1 Favored 'General case' 0 C--N 1.359 1.012 0 C-N-CA 125.574 1.55 . . . . 0.0 113.455 177.143 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 86.0 m -143.3 159.66 54.55 Favored Pre-proline 0 C--N 1.351 0.665 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 159.739 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -68.7 156.61 64.91 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 122.746 2.298 . . . . 0.0 110.783 162.244 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -63.65 131.63 48.59 Favored 'General case' 0 C--N 1.352 0.707 0 CA-C-O 121.607 0.718 . . . . 0.0 112.804 -173.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.19 -12.31 61.98 Favored Glycine 0 C--N 1.356 1.676 0 O-C-N 121.605 -0.684 . . . . 0.0 112.896 -175.498 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 79.2 m -111.93 156.46 22.06 Favored 'General case' 0 C--N 1.349 0.56 0 C-N-CA 124.039 0.936 . . . . 0.0 108.914 177.191 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -138.13 159.96 40.66 Favored 'General case' 0 C--N 1.35 0.599 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 -177.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 41.9 t -117.33 121.14 40.32 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -88.91 93.44 1.9 Allowed Glycine 0 C--N 1.352 1.446 0 N-CA-C 107.943 -2.063 . . . . 0.0 107.943 177.061 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.418 HD21 ' O ' ' A' ' 46' ' ' LYS . 2.2 tm? -102.39 120.52 40.64 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 -167.176 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.483 HD22 ' H ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -89.65 115.11 26.79 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-O 123.18 1.466 . . . . 0.0 113.588 -177.84 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 69.64 14.19 69.5 Favored Glycine 0 C--N 1.356 1.685 0 N-CA-C 116.929 1.532 . . . . 0.0 116.929 159.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 60.22 27.73 17.26 Favored 'General case' 0 C--N 1.353 0.731 0 C-N-CA 126.672 1.989 . . . . 0.0 113.877 -176.04 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 65.4 m-80 -82.55 -46.79 12.91 Favored 'General case' 0 C--N 1.353 0.735 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 -172.772 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.418 ' O ' HD21 ' A' ' 41' ' ' LEU . 56.4 mtmt -139.24 -177.92 5.13 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-O 122.298 1.047 . . . . 0.0 108.261 -161.826 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.8 ptpp? -64.02 -37.71 88.42 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 126.9 2.08 . . . . 0.0 116.299 170.812 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.17 -162.38 53.0 Favored Glycine 0 C--N 1.355 1.591 0 O-C-N 119.494 -2.004 . . . . 0.0 112.678 -173.669 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 19.1 t60 -157.29 152.78 26.47 Favored 'General case' 0 C--N 1.356 0.876 0 N-CA-C 105.755 -1.942 . . . . 0.0 105.755 174.094 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 71.4 m -85.47 139.41 31.52 Favored 'General case' 0 C--N 1.357 0.896 0 O-C-N 120.581 -1.324 . . . . 0.0 113.469 -176.37 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -126.19 163.12 23.85 Favored 'General case' 0 C--N 1.357 0.926 0 C-N-CA 123.813 0.845 . . . . 0.0 109.447 -172.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 40.8 ttpt -121.23 136.97 54.88 Favored 'General case' 0 C--N 1.352 0.697 0 C-N-CA 125.336 1.454 . . . . 0.0 109.695 167.761 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 82.2 mt -94.03 124.4 46.48 Favored 'Isoleucine or valine' 0 C--N 1.361 1.078 0 C-N-CA 125.337 1.455 . . . . 0.0 109.687 172.416 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.72 140.02 49.14 Favored 'Isoleucine or valine' 0 C--N 1.351 0.643 0 C-N-CA 124.786 1.234 . . . . 0.0 109.977 173.194 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.491 -1.422 0 N-CA-C 108.713 -1.755 . . . . 0.0 108.713 178.479 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 9.4 t80 . . . . . 0 N--CA 1.503 2.186 0 N-CA-C 116.635 2.087 . . . . 0.0 116.635 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -123.12 148.36 45.77 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 161.59 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.1 p -119.53 132.0 70.55 Favored 'Isoleucine or valine' 0 C--N 1.351 0.662 0 N-CA-C 106.757 -1.572 . . . . 0.0 106.757 168.679 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.8 m -134.95 155.34 38.04 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.568 0 C-N-CA 124.795 1.238 . . . . 0.0 108.482 -177.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 89.6 p -79.73 157.48 27.14 Favored 'General case' 0 C--N 1.349 0.577 0 CA-C-O 122.25 1.024 . . . . 0.0 113.469 177.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 96.2 m -105.42 10.31 33.38 Favored 'General case' 0 C--N 1.352 0.703 0 C-N-CA 123.978 0.911 . . . . 0.0 111.971 177.023 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 53.7 t30 56.39 44.16 24.94 Favored 'General case' 0 C--N 1.355 0.825 0 C-N-CA 127.029 2.132 . . . . 0.0 113.166 -178.662 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 52.3 tptt -139.98 134.83 32.05 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.752 -1.217 . . . . 0.0 109.224 -177.087 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 60.8 t-20 -87.09 121.18 29.19 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.184 1.793 . . . . 0.0 109.564 179.028 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 27.8 p -116.94 167.25 11.3 Favored 'General case' 0 C--N 1.35 0.618 0 C-N-CA 123.917 0.887 . . . . 0.0 108.741 173.525 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 73.7 m -129.51 146.11 51.38 Favored 'General case' 0 C--N 1.349 0.561 0 N-CA-C 104.063 -2.569 . . . . 0.0 104.063 170.208 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.502 ' HB2' HD12 ' A' ' 41' ' ' LEU . 33.4 t -57.75 -38.43 75.35 Favored 'General case' 0 C--N 1.355 0.807 0 C-N-CA 126.418 1.887 . . . . 0.0 113.727 -170.192 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -90.86 9.41 77.83 Favored Glycine 0 C--N 1.35 1.308 0 O-C-N 121.193 -0.942 . . . . 0.0 113.59 177.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 22.1 mm-40 -118.2 -43.33 2.74 Favored 'General case' 0 C--N 1.351 0.637 0 O-C-N 121.479 -1.012 . . . . 0.0 111.088 176.653 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 22.1 m120 56.17 38.04 29.45 Favored 'General case' 0 C--N 1.358 0.957 0 C-N-CA 127.38 2.272 . . . . 0.0 115.23 176.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -86.32 108.67 18.53 Favored 'General case' 0 C--N 1.351 0.654 0 O-C-N 120.683 -1.261 . . . . 0.0 110.785 -178.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 91.5 m -134.64 157.73 76.63 Favored Pre-proline 0 C--N 1.351 0.636 0 C-N-CA 125.033 1.333 . . . . 0.0 108.476 175.253 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -69.98 161.27 46.6 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.877 2.385 . . . . 0.0 111.206 168.816 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -64.28 134.83 55.47 Favored 'General case' 0 C--N 1.353 0.743 0 CA-C-O 121.646 0.736 . . . . 0.0 112.591 -174.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.53 -10.89 68.94 Favored Glycine 0 C--N 1.354 1.561 0 C-N-CA 123.473 0.558 . . . . 0.0 113.027 -174.427 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 85.6 m -114.8 154.6 28.28 Favored 'General case' 0 C--N 1.351 0.634 0 CA-C-N 118.034 0.917 . . . . 0.0 109.33 -179.548 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -131.35 160.4 35.14 Favored 'General case' 0 C--N 1.351 0.65 0 O-C-N 121.211 -0.93 . . . . 0.0 108.533 -179.307 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 43.2 t -89.45 119.76 30.18 Favored 'General case' 0 C--N 1.353 0.728 0 O-C-N 121.533 -0.73 . . . . 0.0 109.688 -175.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -90.21 63.8 3.04 Favored Glycine 0 C--N 1.353 1.494 0 O-C-N 121.168 -0.957 . . . . 0.0 114.003 -175.584 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.502 HD12 ' HB2' ' A' ' 28' ' ' SER . 2.4 tm? -132.87 132.84 42.55 Favored 'General case' 0 C--N 1.352 0.712 0 CA-C-N 118.761 1.281 . . . . 0.0 108.414 177.371 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.43 ' N ' HD13 ' A' ' 41' ' ' LEU . 1.8 mm? -115.8 133.4 56.07 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 -175.103 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.79 5.85 86.72 Favored Glycine 0 C--N 1.356 1.677 0 N-CA-C 115.92 1.128 . . . . 0.0 115.92 166.393 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 56.42 40.5 29.64 Favored 'General case' 0 C--N 1.349 0.557 0 C-N-CA 127.224 2.209 . . . . 0.0 113.731 -173.262 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 62.0 m-80 -67.78 -46.56 71.65 Favored 'General case' 0 C--N 1.355 0.824 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 172.752 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -139.4 -133.46 0.12 Allowed 'General case' 0 C--N 1.351 0.668 0 CA-C-O 121.718 0.771 . . . . 0.0 109.236 -177.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.5 pttm -103.46 -56.71 2.16 Favored 'General case' 0 C--N 1.351 0.648 0 C-N-CA 125.522 1.529 . . . . 0.0 113.444 -178.721 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 94.4 175.98 38.84 Favored Glycine 0 C--N 1.352 1.441 0 CA-C-O 122.843 1.246 . . . . 0.0 111.444 -171.833 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 51.6 t60 -149.0 152.95 37.19 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 102.692 -3.077 . . . . 0.0 102.692 177.451 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 79.1 m -81.85 135.19 35.45 Favored 'General case' 0 C--N 1.351 0.672 0 O-C-N 121.054 -1.029 . . . . 0.0 112.244 -174.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 13.1 m-30 -123.9 160.68 26.95 Favored 'General case' 0 C--N 1.357 0.896 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -178.001 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 20.2 pttm -121.36 150.98 40.66 Favored 'General case' 0 C--N 1.35 0.606 0 CA-C-O 121.689 0.757 . . . . 0.0 109.653 160.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 83.7 mt -114.36 130.54 68.48 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.788 0 C-N-CA 124.861 1.264 . . . . 0.0 109.976 176.327 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.61 140.41 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 C-N-CA 126.679 1.991 . . . . 0.0 109.053 178.379 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.35 1.35 0 N-CA-C 107.426 -2.269 . . . . 0.0 107.426 -172.029 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 11.8 t80 . . . . . 0 N--CA 1.504 2.259 0 N-CA-C 115.996 1.85 . . . . 0.0 115.996 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -116.87 154.12 31.33 Favored 'General case' 0 C--N 1.356 0.855 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 164.425 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.5 p -126.69 134.6 65.9 Favored 'Isoleucine or valine' 0 C--N 1.35 0.619 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 178.07 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 33.1 m -132.69 162.75 39.38 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 C-N-CA 124.585 1.154 . . . . 0.0 108.209 -179.613 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 78.5 p -72.9 145.06 47.11 Favored 'General case' 0 C--N 1.351 0.668 0 O-C-N 120.606 -1.309 . . . . 0.0 113.866 174.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 34.1 t -95.34 -10.12 31.0 Favored 'General case' 0 C--N 1.356 0.886 0 O-C-N 121.219 -0.926 . . . . 0.0 111.314 -179.506 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 54.0 t30 59.87 41.8 17.37 Favored 'General case' 0 C--N 1.355 0.835 0 C-N-CA 127.406 2.283 . . . . 0.0 112.874 -175.23 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 24.7 mmmt -130.83 144.21 51.29 Favored 'General case' 0 C--N 1.353 0.747 0 C-N-CA 124.571 1.148 . . . . 0.0 111.483 175.198 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 20.1 t30 -93.65 123.39 36.95 Favored 'General case' 0 C--N 1.354 0.796 0 CA-C-O 122.214 1.007 . . . . 0.0 110.231 -173.445 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 14.4 t -105.69 152.9 22.57 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 128.483 2.713 . . . . 0.0 107.638 176.298 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 42.1 m -131.09 160.07 35.74 Favored 'General case' 0 C--N 1.355 0.844 0 N-CA-C 104.729 -2.323 . . . . 0.0 104.729 172.24 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.5 t -62.35 -43.25 99.26 Favored 'General case' 0 C--N 1.353 0.737 0 O-C-N 120.083 -1.635 . . . . 0.0 112.966 174.814 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -63.76 -41.5 98.88 Favored Glycine 0 C--N 1.357 1.738 0 C-N-CA 124.397 0.998 . . . . 0.0 115.127 176.765 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 27.1 pt20 -132.53 117.01 17.45 Favored 'General case' 0 C--N 1.35 0.621 0 CA-C-O 122.698 1.237 . . . . 0.0 110.053 175.147 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 24.2 m120 -91.89 79.56 5.28 Favored 'General case' 0 C--N 1.353 0.742 0 O-C-N 120.514 -1.366 . . . . 0.0 108.644 -174.653 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -97.72 109.7 22.41 Favored 'General case' 0 C--N 1.35 0.612 0 O-C-N 120.906 -1.121 . . . . 0.0 110.885 -170.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 80.9 m -134.27 153.09 79.23 Favored Pre-proline 0 C--N 1.351 0.631 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 172.028 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -72.17 162.23 42.3 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 123.145 2.563 . . . . 0.0 111.036 168.718 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -64.92 135.15 55.36 Favored 'General case' 0 C--N 1.353 0.725 0 CA-C-O 121.647 0.736 . . . . 0.0 112.19 -178.521 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.76 -14.31 63.08 Favored Glycine 0 C--N 1.354 1.583 0 C-N-CA 123.779 0.704 . . . . 0.0 112.375 -171.589 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 76.7 m -113.76 155.24 25.99 Favored 'General case' 0 C--N 1.349 0.582 0 C-N-CA 124.236 1.014 . . . . 0.0 109.894 175.517 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -139.74 161.07 38.42 Favored 'General case' 0 C--N 1.352 0.714 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 -176.351 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 41.2 t -122.13 124.09 43.09 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 173.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -100.99 106.51 3.1 Favored Glycine 0 C--N 1.352 1.47 0 N-CA-C 107.092 -2.403 . . . . 0.0 107.092 170.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -101.13 120.1 39.72 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 -168.533 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -87.55 89.34 7.96 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-O 122.662 1.22 . . . . 0.0 113.122 -174.284 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 64.05 32.52 84.44 Favored Glycine 0 C--N 1.358 1.762 0 N-CA-C 117.226 1.65 . . . . 0.0 117.226 160.129 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.8 pm0 46.99 36.42 4.06 Favored 'General case' 0 C--N 1.354 0.79 0 C-N-CA 128.511 2.725 . . . . 0.0 115.172 -174.518 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 59.1 m-80 -77.92 -44.71 26.17 Favored 'General case' 0 CA--C 1.505 -0.78 0 C-N-CA 124.785 1.234 . . . . 0.0 112.372 174.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.5 pttm -155.61 174.54 15.12 Favored 'General case' 0 N--CA 1.425 -1.706 0 N-CA-C 106.009 -1.849 . . . . 0.0 106.009 -174.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -62.08 -36.5 81.86 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 129.747 3.219 . . . . 0.0 115.312 -173.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 83.47 -167.5 44.91 Favored Glycine 0 C--N 1.355 1.63 0 O-C-N 120.627 -1.296 . . . . 0.0 112.145 -175.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 69.1 t60 -156.9 151.3 25.33 Favored 'General case' 0 C--N 1.35 0.627 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 177.515 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 70.9 m -81.24 140.84 34.66 Favored 'General case' 0 C--N 1.356 0.86 0 CA-C-N 119.786 1.176 . . . . 0.0 112.723 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 8.6 m-30 -121.27 157.14 30.98 Favored 'General case' 0 C--N 1.353 0.74 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 -177.429 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 40.6 ttpt -110.42 137.43 48.14 Favored 'General case' 0 C--N 1.349 0.546 0 C-N-CA 124.17 0.988 . . . . 0.0 109.903 173.277 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 97.3 mt -97.12 123.55 49.52 Favored 'Isoleucine or valine' 0 C--N 1.361 1.066 0 C-N-CA 124.546 1.138 . . . . 0.0 109.874 176.657 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.78 138.23 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 C-N-CA 124.431 1.092 . . . . 0.0 108.798 173.285 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.35 1.332 0 N-CA-C 108.854 -1.698 . . . . 0.0 108.854 -175.973 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 10.7 t80 . . . . . 0 N--CA 1.504 2.237 0 N-CA-C 115.856 1.798 . . . . 0.0 115.856 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -117.37 153.88 32.27 Favored 'General case' 0 C--N 1.355 0.83 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 162.226 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.9 p -128.06 133.39 67.26 Favored 'Isoleucine or valine' 0 C--N 1.349 0.585 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 177.175 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.9 m -134.22 161.55 40.55 Favored 'Isoleucine or valine' 0 C--N 1.352 0.691 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 78.5 p -72.88 144.48 47.39 Favored 'General case' 0 C--N 1.351 0.648 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 177.153 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 29.1 t -99.05 -6.4 28.56 Favored 'General case' 0 C--N 1.356 0.884 0 C-N-CA 123.938 0.895 . . . . 0.0 111.749 -177.782 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 60.28 46.69 9.91 Favored 'General case' 0 C--N 1.355 0.83 0 C-N-CA 127.016 2.126 . . . . 0.0 112.549 -178.792 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -137.19 140.26 41.64 Favored 'General case' 0 C--N 1.352 0.676 0 O-C-N 120.55 -1.344 . . . . 0.0 107.748 175.079 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.9 t30 -87.29 126.01 34.57 Favored 'General case' 0 C--N 1.356 0.89 0 C-N-CA 124.423 1.089 . . . . 0.0 110.856 -174.676 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 16.9 t -106.15 144.37 32.95 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 126.973 2.109 . . . . 0.0 109.842 175.481 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 16.3 m -134.51 153.06 52.13 Favored 'General case' 0 C--N 1.352 0.68 0 N-CA-C 102.209 -3.256 . . . . 0.0 102.209 170.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 38.7 t -58.87 -44.67 91.13 Favored 'General case' 0 C--N 1.356 0.872 0 CA-C-N 120.685 1.584 . . . . 0.0 114.496 -171.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -81.3 -3.95 90.55 Favored Glycine 0 C--N 1.353 1.478 0 O-C-N 121.299 -0.876 . . . . 0.0 113.989 -177.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -113.98 -48.19 2.92 Favored 'General case' 0 C--N 1.35 0.607 0 CA-C-N 117.693 0.746 . . . . 0.0 110.331 -177.495 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 49.93 48.97 21.09 Favored 'General case' 0 C--N 1.358 0.958 0 C-N-CA 130.492 3.517 . . . . 0.0 112.261 176.497 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 52.3 mm-40 -96.5 115.39 27.35 Favored 'General case' 0 C--N 1.353 0.731 0 O-C-N 120.745 -1.222 . . . . 0.0 111.714 -167.45 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 81.7 m -134.28 154.27 79.86 Favored Pre-proline 0 C--N 1.35 0.612 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 174.007 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -71.27 161.04 47.05 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.68 2.254 . . . . 0.0 111.044 168.711 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -63.23 130.82 46.18 Favored 'General case' 0 C--N 1.352 0.714 0 C-N-CA 123.33 0.652 . . . . 0.0 111.598 -176.825 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 100.63 -13.92 59.32 Favored Glycine 0 C--N 1.354 1.58 0 C-N-CA 123.754 0.692 . . . . 0.0 112.469 -173.041 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 82.2 m -112.71 154.51 26.02 Favored 'General case' 0 C--N 1.349 0.573 0 C-N-CA 124.022 0.929 . . . . 0.0 110.134 175.414 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -137.28 159.89 40.63 Favored 'General case' 0 C--N 1.354 0.783 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 -175.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 40.6 t -111.6 119.05 37.4 Favored 'General case' 0 C--N 1.35 0.624 0 CA-C-O 121.81 0.814 . . . . 0.0 109.843 174.704 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -92.63 69.23 1.73 Allowed Glycine 0 C--N 1.35 1.339 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 173.072 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 60.1 tp -105.8 123.31 47.74 Favored 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 172.807 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -113.62 130.45 56.39 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 -173.416 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.2 5.04 70.26 Favored Glycine 0 C--N 1.355 1.627 0 N-CA-C 115.946 1.138 . . . . 0.0 115.946 162.395 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 55.9 47.13 20.71 Favored 'General case' 0 C--N 1.351 0.635 0 C-N-CA 126.357 1.863 . . . . 0.0 113.696 -170.372 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 -64.98 -49.29 70.86 Favored 'General case' 0 C--N 1.356 0.849 0 N-CA-C 115.098 1.518 . . . . 0.0 115.098 173.056 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -144.32 -120.81 0.08 Allowed 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 175.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 15.7 ptpt -115.27 -35.14 4.75 Favored 'General case' 0 N--CA 1.439 -1.013 0 C-N-CA 127.171 2.188 . . . . 0.0 114.238 -176.559 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 75.51 -162.48 53.3 Favored Glycine 0 C--N 1.355 1.638 0 O-C-N 119.993 -1.692 . . . . 0.0 110.464 -171.074 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 67.8 t60 -157.95 159.95 37.05 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 103.454 -2.795 . . . . 0.0 103.454 170.193 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 77.1 m -79.23 139.09 38.02 Favored 'General case' 0 C--N 1.352 0.717 0 CA-C-N 120.226 1.375 . . . . 0.0 112.44 175.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -124.42 155.92 38.03 Favored 'General case' 0 C--N 1.353 0.731 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 -175.125 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -108.23 137.39 46.29 Favored 'General case' 0 C--N 1.348 0.512 0 C-N-CA 124.645 1.178 . . . . 0.0 109.153 173.408 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 95.8 mt -97.14 122.73 48.98 Favored 'Isoleucine or valine' 0 C--N 1.361 1.076 0 C-N-CA 124.185 0.994 . . . . 0.0 109.288 173.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.25 158.21 43.24 Favored 'Isoleucine or valine' 0 C--N 1.35 0.611 0 C-N-CA 124.495 1.118 . . . . 0.0 109.512 177.774 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.355 1.622 0 O-C-N 121.218 -0.926 . . . . 0.0 113.667 -179.602 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 6.9 t80 . . . . . 0 N--CA 1.504 2.275 0 N-CA-C 116.23 1.937 . . . . 0.0 116.23 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -120.15 151.64 38.8 Favored 'General case' 0 C--N 1.354 0.79 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 161.07 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.6 p -123.5 136.29 60.52 Favored 'Isoleucine or valine' 0 C--N 1.35 0.589 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 178.094 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 28.9 m -130.5 156.46 42.5 Favored 'Isoleucine or valine' 0 C--N 1.35 0.594 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 175.248 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 87.2 p -79.62 150.38 31.03 Favored 'General case' 0 C--N 1.351 0.646 0 O-C-N 121.093 -1.004 . . . . 0.0 112.375 174.814 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 14.4 t -98.7 -10.7 22.82 Favored 'General case' 0 C--N 1.352 0.712 0 O-C-N 121.269 -0.894 . . . . 0.0 109.748 178.737 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 59.73 42.83 16.25 Favored 'General case' 0 C--N 1.355 0.836 0 C-N-CA 128.208 2.603 . . . . 0.0 114.459 178.642 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 55.9 tptt -122.16 135.71 54.82 Favored 'General case' 0 C--N 1.35 0.623 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 172.07 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -88.31 127.63 35.48 Favored 'General case' 0 C--N 1.355 0.811 0 C-N-CA 125.096 1.358 . . . . 0.0 109.765 -178.725 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 6.7 t -119.39 133.57 55.65 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 124.973 1.309 . . . . 0.0 111.249 -177.502 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 88.9 m -117.98 146.22 44.17 Favored 'General case' 0 C--N 1.351 0.666 0 N-CA-C 103.987 -2.597 . . . . 0.0 103.987 -178.816 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 84.8 p -59.22 -41.74 89.34 Favored 'General case' 0 C--N 1.35 0.618 0 N-CA-C 116.665 2.098 . . . . 0.0 116.665 -165.071 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.14 -36.81 93.72 Favored Glycine 0 C--N 1.351 1.362 0 C-N-CA 124.517 1.056 . . . . 0.0 114.268 172.776 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 23.9 mm100 -77.57 -47.69 18.82 Favored 'General case' 0 C--N 1.351 0.654 0 C-N-CA 123.804 0.842 . . . . 0.0 111.565 -177.084 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 52.23 39.95 28.0 Favored 'General case' 0 C--N 1.354 0.795 0 C-N-CA 128.628 2.771 . . . . 0.0 112.69 179.201 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -100.97 135.84 41.77 Favored 'General case' 0 C--N 1.356 0.879 0 O-C-N 120.571 -1.331 . . . . 0.0 113.353 -168.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 72.5 m -136.88 159.93 68.24 Favored Pre-proline 0 C--N 1.352 0.681 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 161.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -69.44 160.97 47.75 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.585 2.19 . . . . 0.0 110.556 162.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -64.59 136.95 57.54 Favored 'General case' 0 C--N 1.351 0.649 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -171.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.86 -12.3 65.87 Favored Glycine 0 C--N 1.355 1.621 0 C-N-CA 123.918 0.77 . . . . 0.0 112.832 -175.086 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 72.7 m -115.19 154.71 28.51 Favored 'General case' 0 C--N 1.348 0.507 0 C-N-CA 124.494 1.117 . . . . 0.0 109.533 179.182 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -133.36 154.79 50.43 Favored 'General case' 0 C--N 1.354 0.777 0 O-C-N 121.184 -0.948 . . . . 0.0 110.483 -177.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 43.8 t -104.85 119.26 38.59 Favored 'General case' 0 C--N 1.355 0.821 0 C-N-CA 124.479 1.112 . . . . 0.0 109.029 -177.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -90.48 69.99 2.22 Favored Glycine 0 C--N 1.351 1.417 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 175.809 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -107.79 123.73 48.99 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 178.3 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -117.17 138.06 51.92 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 -166.147 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.7 14.63 72.83 Favored Glycine 0 C--N 1.358 1.773 0 N-CA-C 115.99 1.156 . . . . 0.0 115.99 164.086 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 55.96 43.79 26.71 Favored 'General case' 0 C--N 1.349 0.556 0 C-N-CA 127.629 2.371 . . . . 0.0 113.213 -169.007 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 59.8 m-80 -70.13 168.16 16.22 Favored 'General case' 0 C--N 1.356 0.881 0 O-C-N 120.777 -1.202 . . . . 0.0 110.924 163.84 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -68.42 -48.27 65.07 Favored 'General case' 0 C--N 1.349 0.554 0 N-CA-C 116.005 1.854 . . . . 0.0 116.005 -163.529 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 79.9 mttt -136.36 150.1 48.67 Favored 'General case' 0 C--N 1.352 0.689 0 C-N-CA 123.492 0.717 . . . . 0.0 111.324 -176.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -136.66 168.58 24.15 Favored Glycine 0 C--N 1.348 1.195 0 N-CA-C 106.683 -2.567 . . . . 0.0 106.683 171.429 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 70.1 t60 -125.6 144.59 50.51 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 -176.729 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 74.7 m -80.43 137.63 36.52 Favored 'General case' 0 C--N 1.351 0.669 0 O-C-N 121.18 -0.95 . . . . 0.0 112.885 -176.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -126.22 162.65 24.94 Favored 'General case' 0 C--N 1.357 0.928 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -174.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -123.18 136.84 54.93 Favored 'General case' 0 C--N 1.35 0.626 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 166.71 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 81.1 mt -100.66 127.41 53.79 Favored 'Isoleucine or valine' 0 C--N 1.358 0.945 0 C-N-CA 125.741 1.616 . . . . 0.0 109.232 175.366 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.37 157.24 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 C-N-CA 124.967 1.307 . . . . 0.0 109.774 177.081 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.353 1.503 0 N-CA-C 108.922 -1.671 . . . . 0.0 108.922 -170.63 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 49.4 t80 . . . . . 0 N--CA 1.503 2.222 0 N-CA-C 117.675 2.472 . . . . 0.0 117.675 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -120.12 154.33 34.87 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 106.374 -1.713 . . . . 0.0 106.374 156.765 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.7 p -125.69 135.42 63.99 Favored 'Isoleucine or valine' 0 C--N 1.35 0.605 0 N-CA-C 106.271 -1.752 . . . . 0.0 106.271 170.189 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.687 HG22 HD11 ' A' ' 54' ' ' ILE . 27.0 m -134.0 161.46 40.85 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.912 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -179.777 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 89.5 p -77.15 151.99 35.07 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 121.835 0.826 . . . . 0.0 112.105 170.702 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 18.1 t -110.37 16.99 21.3 Favored 'General case' 0 C--N 1.352 0.706 0 C-N-CA 124.155 0.982 . . . . 0.0 110.261 -177.472 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 30.4 m120 57.98 36.5 26.2 Favored 'General case' 0 C--N 1.353 0.734 0 C-N-CA 127.34 2.256 . . . . 0.0 114.504 170.344 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 58.0 tptt -138.38 136.53 36.4 Favored 'General case' 0 C--N 1.354 0.79 0 O-C-N 121.27 -0.894 . . . . 0.0 110.32 -174.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -79.74 128.21 33.15 Favored 'General case' 0 C--N 1.356 0.884 0 C-N-CA 126.7 2.0 . . . . 0.0 112.337 178.177 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 12.0 t -118.01 131.6 56.46 Favored 'General case' 0 C--N 1.351 0.661 0 C-N-CA 126.584 1.954 . . . . 0.0 110.862 -179.512 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 12.6 m -119.89 151.93 38.14 Favored 'General case' 0 C--N 1.353 0.726 0 N-CA-C 105.279 -2.119 . . . . 0.0 105.279 -178.31 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 95.1 p -59.94 -37.02 78.34 Favored 'General case' 0 C--N 1.352 0.688 0 N-CA-C 115.513 1.672 . . . . 0.0 115.513 -168.192 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -93.02 0.12 68.91 Favored Glycine 0 C--N 1.353 1.493 0 O-C-N 121.846 -0.534 . . . . 0.0 113.811 177.168 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -110.97 -46.22 3.36 Favored 'General case' 0 C--N 1.35 0.629 0 CA-C-N 118.294 1.047 . . . . 0.0 111.1 179.262 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 31.2 m120 51.76 45.07 28.76 Favored 'General case' 0 C--N 1.359 0.979 0 C-N-CA 126.597 1.959 . . . . 0.0 114.142 -174.09 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -84.31 115.51 22.52 Favored 'General case' 0 C--N 1.353 0.727 0 O-C-N 121.338 -0.851 . . . . 0.0 112.503 -164.042 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 74.1 m -134.64 157.33 77.5 Favored Pre-proline 0 C--N 1.355 0.829 0 CA-C-O 118.478 -0.772 . . . . 0.0 109.065 172.626 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -70.43 159.35 53.22 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.63 2.22 . . . . 0.0 110.503 161.63 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -65.17 136.59 56.85 Favored 'General case' 0 C--N 1.352 0.694 0 CA-C-O 121.646 0.736 . . . . 0.0 112.63 -177.197 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.64 -13.57 63.92 Favored Glycine 0 C--N 1.354 1.543 0 C-N-CA 123.855 0.74 . . . . 0.0 113.112 -174.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 90.6 m -114.51 157.22 23.27 Favored 'General case' 0 C--N 1.349 0.55 0 C-N-CA 124.525 1.13 . . . . 0.0 109.947 176.707 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 24.8 p90 -137.57 161.17 37.15 Favored 'General case' 0 C--N 1.351 0.65 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 -172.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 43.3 t -118.35 127.36 53.62 Favored 'General case' 0 CA--C 1.507 -0.684 0 O-C-N 121.32 -0.863 . . . . 0.0 110.881 -179.507 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -97.19 78.63 0.67 Allowed Glycine 0 C--N 1.352 1.438 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 167.813 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -113.63 122.61 47.7 Favored 'General case' 0 C--N 1.352 0.679 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 168.579 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -119.76 146.67 45.45 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 -163.762 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.84 12.7 78.69 Favored Glycine 0 C--N 1.357 1.713 0 O-C-N 121.73 -0.606 . . . . 0.0 114.435 165.681 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 8.7 mp0 54.91 46.57 24.13 Favored 'General case' 0 C--N 1.351 0.638 0 C-N-CA 126.685 1.994 . . . . 0.0 113.539 -171.083 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -76.16 175.13 9.26 Favored 'General case' 0 C--N 1.357 0.892 0 C-N-CA 124.463 1.105 . . . . 0.0 110.409 166.771 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -64.74 -48.94 72.76 Favored 'General case' 0 C--N 1.348 0.519 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 -154.844 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 19.4 pttp -163.74 159.05 20.96 Favored 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 178.39 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -137.05 -165.06 10.31 Favored Glycine 0 C--N 1.344 0.996 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 176.694 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 37.3 t60 -143.79 149.18 36.67 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 105.76 -1.941 . . . . 0.0 105.76 -174.27 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 75.0 m -81.86 143.77 31.48 Favored 'General case' 0 C--N 1.352 0.697 0 O-C-N 121.021 -1.049 . . . . 0.0 113.096 -176.841 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -124.46 158.56 32.54 Favored 'General case' 0 C--N 1.356 0.877 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 -174.839 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -117.93 136.46 53.47 Favored 'General case' 0 C--N 1.35 0.596 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 166.749 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 80.5 mt -96.72 127.38 48.93 Favored 'Isoleucine or valine' 0 C--N 1.356 0.857 0 C-N-CA 125.307 1.443 . . . . 0.0 108.214 167.126 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.687 HD11 HG22 ' A' ' 20' ' ' VAL . 4.4 mp -116.05 124.32 72.24 Favored 'Isoleucine or valine' 0 C--N 1.354 0.793 0 N-CA-C 103.718 -2.697 . . . . 0.0 103.718 -177.316 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.25 0 O-C-N 120.756 -1.215 . . . . 0.0 110.487 -178.961 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 22.7 t80 . . . . . 0 N--CA 1.502 2.14 0 N-CA-C 116.966 2.21 . . . . 0.0 116.966 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -124.67 148.28 48.06 Favored 'General case' 0 C--N 1.353 0.747 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 159.442 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.9 p -124.12 134.05 67.64 Favored 'Isoleucine or valine' 0 C--N 1.349 0.557 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 173.008 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 28.0 m -131.25 154.05 39.99 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.744 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 175.578 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 80.4 p -79.26 151.83 30.92 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 177.725 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 19.9 t -123.97 33.18 5.36 Favored 'General case' 0 C--N 1.355 0.804 0 CA-C-O 121.761 0.791 . . . . 0.0 109.919 -172.379 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 44.75 37.88 2.51 Favored 'General case' 0 C--N 1.357 0.899 0 C-N-CA 129.016 2.926 . . . . 0.0 118.267 169.78 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -148.81 143.17 26.16 Favored 'General case' 0 C--N 1.348 0.536 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -175.449 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 33.8 t30 -115.45 135.87 53.66 Favored 'General case' 0 C--N 1.353 0.727 0 C-N-CA 124.27 1.028 . . . . 0.0 110.568 -175.206 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 83.6 m -101.5 152.1 21.17 Favored 'General case' 0 C--N 1.355 0.846 0 C-N-CA 124.151 0.98 . . . . 0.0 108.54 171.252 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 55.5 m -128.17 156.25 43.19 Favored 'General case' 0 CA--C 1.507 -0.682 0 N-CA-C 102.046 -3.316 . . . . 0.0 102.046 174.585 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 46.8 t -52.53 -39.24 61.15 Favored 'General case' 0 C--N 1.349 0.57 0 N-CA-C 115.68 1.733 . . . . 0.0 115.68 -162.19 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -77.28 -0.96 73.25 Favored Glycine 0 C--N 1.351 1.373 0 N-CA-C 116.475 1.35 . . . . 0.0 116.475 178.012 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -143.58 140.78 30.36 Favored 'General case' 0 C--N 1.356 0.858 0 CA-C-N 120.347 2.073 . . . . 0.0 112.009 179.02 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 34.5 m120 -102.15 103.52 14.06 Favored 'General case' 0 C--N 1.352 0.715 0 O-C-N 119.973 -1.705 . . . . 0.0 106.523 170.188 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -126.93 94.32 4.0 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 -168.105 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 72.9 m -136.77 156.88 75.82 Favored Pre-proline 0 C--N 1.351 0.662 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 172.272 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -70.51 160.42 49.55 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.52 2.147 . . . . 0.0 110.64 164.252 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -62.77 134.38 56.19 Favored 'General case' 0 C--N 1.354 0.779 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -174.732 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.25 -11.89 65.34 Favored Glycine 0 C--N 1.355 1.61 0 C-N-CA 124.194 0.902 . . . . 0.0 113.409 -175.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 73.8 m -114.15 153.77 28.96 Favored 'General case' 0 C--N 1.348 0.518 0 C-N-CA 124.145 0.978 . . . . 0.0 110.116 179.019 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 31.5 p90 -132.5 158.22 42.65 Favored 'General case' 0 C--N 1.352 0.684 0 N-CA-C 105.699 -1.963 . . . . 0.0 105.699 178.812 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 9.8 p -109.69 146.66 34.48 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-O 122.531 1.157 . . . . 0.0 112.923 173.525 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -82.74 69.29 3.39 Favored Glycine 0 C--N 1.353 1.498 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 176.31 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -91.81 122.46 34.37 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 -175.785 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -86.02 77.34 9.66 Favored 'General case' 0 C--N 1.352 0.701 0 O-C-N 120.709 -1.244 . . . . 0.0 110.829 -161.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 62.61 45.39 95.92 Favored Glycine 0 C--N 1.355 1.594 0 N-CA-C 115.448 0.939 . . . . 0.0 115.448 166.714 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 48.31 43.75 19.4 Favored 'General case' 0 C--N 1.354 0.779 0 C-N-CA 128.474 2.71 . . . . 0.0 115.984 -172.614 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 66.0 m-80 -97.48 -74.08 0.59 Allowed 'General case' 0 C--N 1.356 0.867 0 O-C-N 121.135 -0.978 . . . . 0.0 112.509 170.594 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -119.66 -101.55 0.42 Allowed 'General case' 0 C--N 1.357 0.932 0 O-C-N 120.917 -1.115 . . . . 0.0 113.649 -163.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.4 pptp? -145.76 161.01 40.9 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 -175.7 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -162.39 151.28 21.15 Favored Glycine 0 C--N 1.349 1.297 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 -179.096 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 72.4 t60 -99.19 146.82 25.76 Favored 'General case' 0 C--N 1.347 0.473 0 O-C-N 121.51 -0.994 . . . . 0.0 109.883 -170.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 76.4 m -76.85 136.55 38.9 Favored 'General case' 0 C--N 1.358 0.946 0 O-C-N 121.197 -0.939 . . . . 0.0 112.015 -179.227 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -130.63 161.5 31.44 Favored 'General case' 0 C--N 1.351 0.649 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 -177.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -114.28 132.81 56.03 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 164.32 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 96.3 mt -106.06 127.37 61.25 Favored 'Isoleucine or valine' 0 C--N 1.358 0.973 0 CA-C-O 122.632 1.206 . . . . 0.0 110.243 169.782 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.75 160.51 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 C-N-CA 126.879 2.071 . . . . 0.0 110.725 -176.733 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.354 1.532 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 -169.112 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 42.2 t80 . . . . . 0 N--CA 1.505 2.318 0 N-CA-C 116.815 2.154 . . . . 0.0 116.815 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -121.65 154.57 36.63 Favored 'General case' 0 C--N 1.354 0.796 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 159.052 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.9 p -128.71 132.91 67.29 Favored 'Isoleucine or valine' 0 C--N 1.349 0.582 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 174.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 33.0 m -134.55 161.56 40.28 Favored 'Isoleucine or valine' 0 C--N 1.349 0.564 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 -177.409 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 96.8 p -76.84 155.42 32.99 Favored 'General case' 0 C--N 1.354 0.771 0 O-C-N 120.665 -1.272 . . . . 0.0 112.986 178.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 33.9 t -120.38 28.6 7.92 Favored 'General case' 0 C--N 1.355 0.812 0 C-N-CA 123.881 0.873 . . . . 0.0 109.44 -177.238 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 45.83 36.55 2.9 Favored 'General case' 0 C--N 1.357 0.897 0 C-N-CA 128.58 2.752 . . . . 0.0 117.452 173.02 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 50.4 tptt -140.79 138.32 34.01 Favored 'General case' 0 C--N 1.352 0.687 0 O-C-N 120.664 -1.272 . . . . 0.0 109.208 -169.801 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -90.99 123.02 34.14 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.311 1.845 . . . . 0.0 108.559 -175.528 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 17.5 p -112.95 172.17 7.09 Favored 'General case' 0 C--N 1.357 0.918 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 175.49 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 27.5 m -130.43 146.18 51.95 Favored 'General case' 0 C--N 1.35 0.593 0 N-CA-C 102.279 -3.23 . . . . 0.0 102.279 167.843 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.565 ' HB3' HD12 ' A' ' 41' ' ' LEU . 90.6 p -59.97 -30.72 69.3 Favored 'General case' 0 C--N 1.35 0.592 0 N-CA-C 115.966 1.839 . . . . 0.0 115.966 -172.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -93.77 -1.21 65.87 Favored Glycine 0 C--N 1.354 1.53 0 CA-C-N 118.582 0.628 . . . . 0.0 114.138 175.43 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -108.62 -41.46 4.8 Favored 'General case' 0 C--N 1.352 0.685 0 CA-C-N 118.266 1.033 . . . . 0.0 111.145 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 25.3 m120 57.06 35.74 26.76 Favored 'General case' 0 C--N 1.358 0.939 0 C-N-CA 126.93 2.092 . . . . 0.0 115.028 174.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 60.9 mm-40 -87.09 114.95 24.14 Favored 'General case' 0 C--N 1.351 0.657 0 O-C-N 120.575 -1.328 . . . . 0.0 111.386 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 73.4 m -135.93 156.9 76.87 Favored Pre-proline 0 N--CA 1.447 -0.604 0 N-CA-C 105.601 -2.0 . . . . 0.0 105.601 168.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.55 161.84 44.59 Favored 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.783 2.322 . . . . 0.0 111.497 171.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -62.42 132.88 54.02 Favored 'General case' 0 C--N 1.354 0.778 0 CA-C-O 121.783 0.802 . . . . 0.0 113.006 -174.387 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.37 -11.66 68.64 Favored Glycine 0 C--N 1.355 1.606 0 C-N-CA 124.06 0.838 . . . . 0.0 112.91 -172.144 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 71.8 m -116.56 156.13 27.5 Favored 'General case' 0 C--N 1.349 0.565 0 C-N-CA 124.178 0.991 . . . . 0.0 110.394 179.09 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -145.21 165.87 27.09 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 104.999 -2.223 . . . . 0.0 104.999 -174.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 31.5 p -128.22 153.55 46.81 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-N 120.262 1.392 . . . . 0.0 108.724 165.356 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -121.79 76.92 0.34 Allowed Glycine 0 CA--C 1.492 -1.38 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 -174.208 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.565 HD12 ' HB3' ' A' ' 28' ' ' SER . 3.4 tm? -106.18 124.79 50.14 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 105.944 -1.873 . . . . 0.0 105.944 177.729 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -113.92 140.57 48.27 Favored 'General case' 0 C--N 1.352 0.696 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 -175.829 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 76.78 8.7 86.53 Favored Glycine 0 C--N 1.355 1.634 0 N-CA-C 116.056 1.183 . . . . 0.0 116.056 164.072 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 57.83 35.89 25.88 Favored 'General case' 0 C--N 1.352 0.697 0 C-N-CA 126.865 2.066 . . . . 0.0 113.838 -175.603 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 60.8 m-80 -70.03 -43.77 70.61 Favored 'General case' 0 C--N 1.355 0.807 0 N-CA-C 114.228 1.195 . . . . 0.0 114.228 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm -144.13 -176.38 4.99 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.275 1.83 . . . . 0.0 106.465 -172.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -67.53 -45.59 75.29 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 115.878 1.806 . . . . 0.0 115.878 173.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.77 155.35 31.7 Favored Glycine 0 C--N 1.356 1.691 0 O-C-N 121.135 -0.978 . . . . 0.0 112.159 -168.297 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -137.81 143.81 41.2 Favored 'General case' 0 C--N 1.347 0.496 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 178.2 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 77.9 m -77.56 142.32 39.07 Favored 'General case' 0 C--N 1.353 0.747 0 CA-C-O 121.96 0.886 . . . . 0.0 113.126 -173.719 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -124.46 156.95 36.36 Favored 'General case' 0 C--N 1.35 0.606 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 -176.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 40.5 ttpt -112.7 136.03 52.76 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.649 1.18 . . . . 0.0 108.776 172.241 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 97.4 mt -98.49 125.32 51.87 Favored 'Isoleucine or valine' 0 C--N 1.359 0.994 0 C-N-CA 124.385 1.074 . . . . 0.0 108.987 175.685 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.92 156.26 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 C-N-CA 124.826 1.25 . . . . 0.0 109.536 178.116 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.353 1.501 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 -172.804 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 11.3 t80 . . . . . 0 N--CA 1.504 2.242 0 N-CA-C 116.3 1.963 . . . . 0.0 116.3 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -122.0 152.5 39.67 Favored 'General case' 0 C--N 1.355 0.821 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 162.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.3 p -127.1 135.94 62.14 Favored 'Isoleucine or valine' 0 C--N 1.349 0.585 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 176.601 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.4 m -131.21 158.0 43.27 Favored 'Isoleucine or valine' 0 C--N 1.351 0.647 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 177.811 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 87.7 p -81.88 157.37 24.39 Favored 'General case' 0 C--N 1.352 0.709 0 O-C-N 121.288 -0.882 . . . . 0.0 112.649 173.861 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 71.8 m -110.39 19.82 18.4 Favored 'General case' 0 C--N 1.355 0.847 0 O-C-N 121.413 -0.804 . . . . 0.0 111.791 177.429 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 47.34 39.56 9.14 Favored 'General case' 0 C--N 1.355 0.836 0 C-N-CA 127.432 2.293 . . . . 0.0 116.796 177.422 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 56.6 tptt -132.83 136.12 46.07 Favored 'General case' 0 C--N 1.352 0.677 0 O-C-N 121.127 -0.983 . . . . 0.0 109.006 -177.127 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -84.19 128.26 34.45 Favored 'General case' 0 C--N 1.354 0.786 0 C-N-CA 124.539 1.136 . . . . 0.0 110.742 -176.324 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 18.2 t -106.61 148.57 28.15 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 127.589 2.355 . . . . 0.0 108.93 178.319 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 23.3 m -133.0 154.73 50.24 Favored 'General case' 0 C--N 1.352 0.699 0 N-CA-C 102.488 -3.153 . . . . 0.0 102.488 168.256 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 79.4 p -58.93 -45.25 90.83 Favored 'General case' 0 C--N 1.349 0.549 0 N-CA-C 117.15 2.278 . . . . 0.0 117.15 -164.584 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -96.51 4.67 64.29 Favored Glycine 0 C--N 1.352 1.454 0 C-N-CA 123.605 0.622 . . . . 0.0 113.563 -176.887 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 11.1 mm-40 -115.96 -42.41 3.08 Favored 'General case' 0 C--N 1.346 0.433 0 O-C-N 121.82 -0.812 . . . . 0.0 109.803 178.459 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 56.3 45.95 22.02 Favored 'General case' 0 C--N 1.356 0.89 0 C-N-CA 128.575 2.75 . . . . 0.0 112.936 167.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -83.91 115.64 22.39 Favored 'General case' 0 C--N 1.352 0.701 0 O-C-N 121.043 -1.036 . . . . 0.0 112.742 -168.505 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 71.6 m -134.63 157.67 76.77 Favored Pre-proline 0 C--N 1.353 0.747 0 C-N-CA 124.785 1.234 . . . . 0.0 108.126 173.676 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.85 159.04 54.78 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.472 2.115 . . . . 0.0 110.618 164.372 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -65.09 135.17 55.23 Favored 'General case' 0 C--N 1.352 0.709 0 CA-C-O 121.599 0.714 . . . . 0.0 112.21 -176.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.59 -12.53 64.62 Favored Glycine 0 C--N 1.354 1.575 0 C-N-CA 123.593 0.616 . . . . 0.0 113.051 -173.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 72.2 m -113.13 155.45 24.94 Favored 'General case' 0 C--N 1.35 0.588 0 C-N-CA 124.242 1.017 . . . . 0.0 109.393 177.331 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -136.5 157.39 46.89 Favored 'General case' 0 C--N 1.351 0.634 0 O-C-N 121.278 -0.889 . . . . 0.0 108.729 -176.375 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 42.1 t -105.37 126.47 52.15 Favored 'General case' 0 CA--C 1.51 -0.57 0 O-C-N 121.205 -0.934 . . . . 0.0 111.027 -179.426 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.87 60.55 3.49 Favored Glycine 0 C--N 1.352 1.425 0 O-C-N 121.684 -0.635 . . . . 0.0 112.212 176.111 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -106.98 120.86 43.22 Favored 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 175.072 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -119.98 140.7 50.53 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 -176.009 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.18 5.42 76.4 Favored Glycine 0 C--N 1.355 1.603 0 N-CA-C 115.656 1.022 . . . . 0.0 115.656 161.866 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 56.75 42.9 26.07 Favored 'General case' 0 C--N 1.35 0.617 0 C-N-CA 126.639 1.976 . . . . 0.0 113.336 -171.669 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 54.0 m-80 -73.54 -49.37 26.84 Favored 'General case' 0 C--N 1.354 0.766 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 -178.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -140.65 -125.63 0.11 Allowed 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 177.676 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 16.6 pttp -107.79 -47.02 3.67 Favored 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 126.902 2.081 . . . . 0.0 114.146 -175.66 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 86.23 178.54 49.74 Favored Glycine 0 C--N 1.356 1.678 0 O-C-N 120.708 -1.245 . . . . 0.0 112.421 -173.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 72.7 t60 -154.12 155.24 35.04 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 105.877 -1.897 . . . . 0.0 105.877 178.272 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 76.4 m -86.86 135.57 33.28 Favored 'General case' 0 C--N 1.355 0.843 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -174.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -126.52 161.32 28.24 Favored 'General case' 0 C--N 1.358 0.946 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 -174.232 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -122.61 135.66 54.67 Favored 'General case' 0 C--N 1.352 0.69 0 C-N-CA 124.172 0.989 . . . . 0.0 110.098 165.674 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 83.3 mt -88.05 127.04 41.43 Favored 'Isoleucine or valine' 0 C--N 1.359 1.017 0 C-N-CA 125.963 1.705 . . . . 0.0 109.732 169.468 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.98 155.86 41.97 Favored 'Isoleucine or valine' 0 C--N 1.352 0.702 0 C-N-CA 123.949 0.899 . . . . 0.0 110.325 171.303 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.354 1.538 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -175.75 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 10.9 t80 . . . . . 0 N--CA 1.505 2.287 0 N-CA-C 116.349 1.981 . . . . 0.0 116.349 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -122.75 148.7 45.03 Favored 'General case' 0 C--N 1.357 0.895 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 163.104 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.1 p -123.7 133.14 70.06 Favored 'Isoleucine or valine' 0 C--N 1.35 0.595 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 173.641 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.2 m -133.22 153.78 38.08 Favored 'Isoleucine or valine' 0 C--N 1.354 0.786 0 O-C-N 121.35 -0.844 . . . . 0.0 108.975 177.8 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 88.2 p -80.48 150.61 29.62 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 -179.151 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 71.7 m -102.1 -4.5 25.82 Favored 'General case' 0 C--N 1.354 0.783 0 O-C-N 121.399 -0.813 . . . . 0.0 111.11 178.817 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 56.29 43.46 26.39 Favored 'General case' 0 C--N 1.357 0.918 0 C-N-CA 127.423 2.289 . . . . 0.0 115.734 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 23.4 mmmt -131.2 149.89 52.38 Favored 'General case' 0 N--CA 1.442 -0.825 0 C-N-CA 127.061 2.144 . . . . 0.0 106.08 165.252 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -92.52 174.52 7.23 Favored 'General case' 0 C--N 1.351 0.657 0 O-C-N 121.698 -0.626 . . . . 0.0 109.6 171.28 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 15.2 p -121.21 172.36 8.05 Favored 'General case' 0 C--N 1.353 0.745 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 159.409 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 63.1 m -135.5 144.75 46.53 Favored 'General case' 0 CA--C 1.504 -0.808 0 N-CA-C 100.975 -3.713 . . . . 0.0 100.975 168.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 37.0 t -57.76 -43.93 85.81 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-N 120.459 1.481 . . . . 0.0 114.315 -164.649 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.15 -44.84 58.91 Favored Glycine 0 C--N 1.355 1.592 0 O-C-N 121.023 -1.048 . . . . 0.0 115.0 175.806 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -69.04 -43.22 75.13 Favored 'General case' 0 C--N 1.349 0.558 0 C-N-CA 126.114 1.766 . . . . 0.0 113.579 -176.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 55.42 38.01 29.68 Favored 'General case' 0 C--N 1.354 0.804 0 C-N-CA 129.008 2.923 . . . . 0.0 113.82 176.529 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -68.42 127.43 32.94 Favored 'General case' 0 C--N 1.352 0.681 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 175.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 94.9 m -143.34 159.23 55.95 Favored Pre-proline 0 C--N 1.354 0.786 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 152.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -70.08 159.09 54.4 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.83 2.353 . . . . 0.0 110.551 162.437 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -65.61 136.74 56.73 Favored 'General case' 0 C--N 1.352 0.681 0 CA-C-O 121.58 0.705 . . . . 0.0 112.7 -175.6 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.1 -9.65 70.03 Favored Glycine 0 C--N 1.356 1.668 0 O-C-N 121.689 -0.632 . . . . 0.0 113.19 -175.716 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 84.2 m -114.92 155.94 25.94 Favored 'General case' 0 C--N 1.348 0.508 0 C-N-CA 124.502 1.121 . . . . 0.0 108.381 178.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -136.3 163.1 31.2 Favored 'General case' 0 C--N 1.352 0.699 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 178.515 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 45.2 t -119.43 124.05 45.58 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 105.931 -1.877 . . . . 0.0 105.931 178.219 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -83.29 78.77 1.98 Allowed Glycine 0 C--N 1.352 1.443 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 177.752 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -98.46 113.39 25.38 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 104.387 -2.449 . . . . 0.0 104.387 -176.213 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.45 HD22 ' H ' ' A' ' 42' ' ' LEU . 2.1 mm? -77.03 -49.04 16.26 Favored 'General case' 0 C--N 1.357 0.929 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -148.216 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.94 76.97 0.16 Allowed Glycine 0 C--N 1.349 1.287 0 N-CA-C 108.69 -1.764 . . . . 0.0 108.69 175.001 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.8 pm0 45.59 59.38 3.65 Favored 'General case' 0 C--N 1.354 0.8 0 C-N-CA 128.519 2.727 . . . . 0.0 116.509 -178.106 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 34.7 m120 -103.33 -119.59 0.2 Allowed 'General case' 0 C--N 1.352 0.698 0 C-N-CA 123.953 0.901 . . . . 0.0 109.845 -171.292 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.72 -101.16 0.21 Allowed 'General case' 0 C--N 1.355 0.816 0 C-N-CA 124.159 0.984 . . . . 0.0 110.874 -172.734 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.0 pttm -130.33 -32.39 1.77 Allowed 'General case' 0 C--N 1.355 0.831 0 N-CA-C 116.306 1.965 . . . . 0.0 116.306 -163.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 62.05 -144.79 49.21 Favored Glycine 0 C--N 1.357 1.722 0 O-C-N 119.664 -1.897 . . . . 0.0 113.338 -174.474 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 43.4 t60 -160.51 160.41 31.91 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 101.808 -3.404 . . . . 0.0 101.808 163.548 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 72.5 m -89.36 134.16 34.19 Favored 'General case' 0 C--N 1.354 0.804 0 CA-C-N 120.89 1.677 . . . . 0.0 112.091 175.543 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -149.77 164.58 34.9 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.186 1.395 . . . . 0.0 112.099 -178.131 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -133.98 156.08 48.82 Favored 'General case' 0 C--N 1.354 0.784 0 CA-C-O 121.499 0.666 . . . . 0.0 111.516 -173.789 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 91.5 mt -108.77 124.98 65.74 Favored 'Isoleucine or valine' 0 C--N 1.355 0.843 0 C-N-CA 125.522 1.529 . . . . 0.0 108.84 -175.522 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.71 157.25 42.97 Favored 'Isoleucine or valine' 0 C--N 1.35 0.601 0 C-N-CA 124.224 1.01 . . . . 0.0 108.508 173.55 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.352 1.464 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 -178.689 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 5.9 t80 . . . . . 0 N--CA 1.504 2.265 0 N-CA-C 115.929 1.826 . . . . 0.0 115.929 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -120.04 152.46 37.49 Favored 'General case' 0 C--N 1.356 0.848 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 163.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.6 p -124.63 135.99 62.11 Favored 'Isoleucine or valine' 0 C--N 1.348 0.54 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 176.168 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.3 m -129.96 157.29 42.54 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.681 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 177.042 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 85.3 p -79.7 152.67 29.78 Favored 'General case' 0 N--CA 1.447 -0.585 0 O-C-N 121.246 -0.909 . . . . 0.0 112.57 173.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 16.6 t -110.22 9.6 23.81 Favored 'General case' 0 C--N 1.352 0.701 0 O-C-N 121.274 -0.891 . . . . 0.0 110.892 -174.28 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 56.51 42.95 26.64 Favored 'General case' 0 C--N 1.355 0.842 0 C-N-CA 126.762 2.025 . . . . 0.0 114.736 175.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 54.2 tptt -140.87 137.64 33.37 Favored 'General case' 0 C--N 1.351 0.657 0 O-C-N 120.668 -1.27 . . . . 0.0 107.801 177.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -91.03 130.11 36.97 Favored 'General case' 0 C--N 1.351 0.632 0 C-N-CA 125.642 1.577 . . . . 0.0 109.946 -177.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 10.6 p -111.43 156.13 22.11 Favored 'General case' 0 C--N 1.358 0.955 0 O-C-N 121.415 -0.803 . . . . 0.0 109.131 -178.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 21.4 p -127.04 152.72 46.88 Favored 'General case' 0 CA--C 1.496 -1.098 0 O-C-N 121.069 -1.019 . . . . 0.0 112.745 177.134 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 40.7 t -63.91 126.16 26.76 Favored 'General case' 0 C--N 1.359 0.995 0 CA-C-O 122.437 1.113 . . . . 0.0 110.249 177.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 92.63 -9.19 76.19 Favored Glycine 0 C--N 1.344 1.026 0 CA-C-N 114.975 -1.011 . . . . 0.0 113.05 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 15.1 mm-40 -121.54 -46.75 2.25 Favored 'General case' 0 C--N 1.352 0.677 0 CA-C-N 118.374 1.087 . . . . 0.0 111.902 179.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 51.41 47.51 24.68 Favored 'General case' 0 C--N 1.36 1.039 0 N-CA-C 116.343 1.979 . . . . 0.0 116.343 -177.017 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -67.5 118.03 10.26 Favored 'General case' 0 C--N 1.355 0.841 0 O-C-N 120.791 -1.193 . . . . 0.0 113.216 178.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 73.5 m -137.76 158.07 72.3 Favored Pre-proline 0 C--N 1.352 0.69 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 169.051 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.07 159.03 54.61 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.473 2.116 . . . . 0.0 110.428 164.136 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 58.6 mp0 -64.04 134.06 54.26 Favored 'General case' 0 C--N 1.352 0.717 0 CA-C-O 121.812 0.815 . . . . 0.0 112.467 -173.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 98.35 -15.06 61.75 Favored Glycine 0 C--N 1.355 1.601 0 C-N-CA 123.799 0.714 . . . . 0.0 112.934 -174.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 93.1 m -110.21 157.7 19.15 Favored 'General case' 0 C--N 1.349 0.549 0 C-N-CA 124.23 1.012 . . . . 0.0 110.248 176.001 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 28.4 p90 -142.14 164.31 30.51 Favored 'General case' 0 C--N 1.348 0.541 0 N-CA-C 105.674 -1.973 . . . . 0.0 105.674 -175.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 36.3 t -117.45 128.48 55.04 Favored 'General case' 0 CA--C 1.51 -0.578 0 O-C-N 121.039 -1.038 . . . . 0.0 108.915 -177.267 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -85.75 61.81 4.49 Favored Glycine 0 C--N 1.353 1.516 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 176.039 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.6 HD23 ' H ' ' A' ' 42' ' ' LEU . 1.1 tt -69.81 139.55 53.2 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 125.159 1.384 . . . . 0.0 110.502 -175.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.6 ' H ' HD23 ' A' ' 41' ' ' LEU . 1.5 mm? -80.89 72.37 7.88 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 125.423 1.489 . . . . 0.0 108.997 -163.574 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.75 14.71 81.19 Favored Glycine 0 C--N 1.352 1.456 0 O-C-N 120.689 -1.257 . . . . 0.0 113.292 178.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.497 ' HA ' HD22 ' A' ' 41' ' ' LEU . 34.6 mt-30 56.35 41.24 29.29 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 127.35 2.26 . . . . 0.0 114.664 -170.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -68.47 -45.15 73.21 Favored 'General case' 0 C--N 1.356 0.887 0 N-CA-C 115.726 1.75 . . . . 0.0 115.726 174.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 17.5 pttp -155.15 -64.65 0.12 Allowed 'General case' 0 C--N 1.348 0.539 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -176.184 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.8 ptmt -157.21 161.2 39.26 Favored 'General case' 0 N--CA 1.439 -1.022 0 O-C-N 121.111 -0.993 . . . . 0.0 108.638 -172.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -159.28 -171.78 25.54 Favored Glycine 0 C--N 1.345 1.045 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 175.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 77.7 t60 -127.3 140.87 51.91 Favored 'General case' 0 C--N 1.35 0.603 0 O-C-N 121.301 -1.117 . . . . 0.0 108.309 -175.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 75.0 m -76.87 145.73 38.14 Favored 'General case' 0 C--N 1.356 0.879 0 O-C-N 120.83 -1.169 . . . . 0.0 113.626 -172.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -126.07 162.48 25.21 Favored 'General case' 0 C--N 1.358 0.976 0 C-N-CA 123.89 0.876 . . . . 0.0 108.815 -175.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -121.4 136.43 54.96 Favored 'General case' 0 C--N 1.351 0.632 0 C-N-CA 124.616 1.166 . . . . 0.0 108.514 166.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 84.8 mt -98.39 126.28 51.52 Favored 'Isoleucine or valine' 0 C--N 1.359 0.997 0 C-N-CA 124.851 1.261 . . . . 0.0 109.137 172.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.55 148.32 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 C-N-CA 125.321 1.448 . . . . 0.0 108.388 176.371 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 160.52 -154.02 24.99 Favored Glycine 0 C--N 1.349 1.292 0 O-C-N 119.884 -1.76 . . . . 0.0 110.845 -176.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 . . . . . 0 C--O 1.261 1.671 0 C-N-CA 124.499 1.12 . . . . 0.0 113.859 -175.431 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 14.0 t80 . . . . . 0 N--CA 1.504 2.249 0 N-CA-C 116.314 1.968 . . . . 0.0 116.314 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -123.05 155.62 36.52 Favored 'General case' 0 C--N 1.355 0.825 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 166.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.3 p -126.81 135.81 62.61 Favored 'Isoleucine or valine' 0 C--N 1.349 0.572 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 174.155 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 30.2 m -131.58 159.73 42.86 Favored 'Isoleucine or valine' 0 C--N 1.35 0.63 0 C-N-CA 124.709 1.204 . . . . 0.0 107.8 175.287 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 87.8 p -77.6 153.41 33.26 Favored 'General case' 0 C--N 1.351 0.646 0 CA-C-O 122.15 0.976 . . . . 0.0 112.58 174.539 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 8.8 t -104.73 3.59 31.53 Favored 'General case' 0 C--N 1.353 0.724 0 O-C-N 121.21 -0.931 . . . . 0.0 110.298 -176.395 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 72.4 m-80 58.26 41.38 23.49 Favored 'General case' 0 C--N 1.356 0.877 0 C-N-CA 127.456 2.303 . . . . 0.0 114.378 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 52.6 tptt -139.72 134.54 32.06 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 -177.026 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -89.01 133.61 34.27 Favored 'General case' 0 C--N 1.355 0.836 0 C-N-CA 125.002 1.321 . . . . 0.0 109.288 -179.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 26.1 p -131.99 152.58 51.04 Favored 'General case' 0 C--N 1.352 0.711 0 CA-C-O 122.049 0.928 . . . . 0.0 110.424 177.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.7 m -127.39 149.52 50.04 Favored 'General case' 0 C--N 1.349 0.569 0 N-CA-C 105.56 -2.015 . . . . 0.0 105.56 -167.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 36.6 t -62.71 133.43 54.8 Favored 'General case' 0 C--N 1.36 1.055 0 O-C-N 120.689 -1.257 . . . . 0.0 109.907 170.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 92.88 -15.08 63.58 Favored Glycine 0 C--N 1.349 1.286 0 C-N-CA 123.841 0.734 . . . . 0.0 112.443 -172.092 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -113.79 -53.56 2.67 Favored 'General case' 0 C--N 1.356 0.866 0 CA-C-N 118.652 1.226 . . . . 0.0 111.954 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 49.36 41.75 21.06 Favored 'General case' 0 C--N 1.364 1.204 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 -176.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 59.6 mm-40 -83.95 112.93 20.61 Favored 'General case' 0 C--N 1.353 0.752 0 O-C-N 120.436 -1.415 . . . . 0.0 111.581 -179.071 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 79.0 m -134.83 155.57 79.23 Favored Pre-proline 0 C--N 1.35 0.601 0 N-CA-C 106.169 -1.789 . . . . 0.0 106.169 171.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -70.54 160.1 50.59 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.589 2.192 . . . . 0.0 110.574 165.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -65.02 141.46 58.76 Favored 'General case' 0 C--N 1.353 0.757 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -175.125 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.8 -13.88 65.6 Favored Glycine 0 C--N 1.354 1.554 0 C-N-CA 123.774 0.702 . . . . 0.0 112.522 -172.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 71.2 m -115.32 154.94 28.23 Favored 'General case' 0 C--N 1.349 0.562 0 C-N-CA 124.487 1.115 . . . . 0.0 109.929 178.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -129.9 158.61 39.04 Favored 'General case' 0 C--N 1.352 0.686 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -178.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 52.2 t -88.66 126.53 35.35 Favored 'General case' 0 C--N 1.35 0.593 0 O-C-N 121.494 -0.754 . . . . 0.0 110.609 -174.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -82.55 67.88 3.64 Favored Glycine 0 C--N 1.356 1.665 0 O-C-N 121.107 -0.996 . . . . 0.0 113.79 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 56.7 mt -104.76 134.17 48.36 Favored 'General case' 0 CA--C 1.505 -0.759 0 C-N-CA 125.142 1.377 . . . . 0.0 110.429 170.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.526 HD22 ' H ' ' A' ' 42' ' ' LEU . 1.5 mm? -70.0 -44.86 68.52 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 125.479 1.512 . . . . 0.0 111.035 -166.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -160.93 49.65 0.36 Allowed Glycine 0 C--N 1.346 1.123 0 N-CA-C 107.279 -2.328 . . . . 0.0 107.279 170.208 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 17.4 mp0 52.73 51.21 16.45 Favored 'General case' 0 C--N 1.356 0.862 0 C-N-CA 127.011 2.124 . . . . 0.0 114.605 -177.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 23.2 m120 -92.33 -53.69 4.12 Favored 'General case' 0 C--N 1.357 0.9 0 O-C-N 120.494 -1.379 . . . . 0.0 112.628 -166.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -131.46 -98.69 0.31 Allowed 'General case' 0 C--N 1.355 0.811 0 CA-C-O 122.394 1.092 . . . . 0.0 109.774 -174.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 15.0 ptmm? -138.25 156.93 47.2 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 106.012 -1.847 . . . . 0.0 106.012 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -148.53 -171.03 16.95 Favored Glycine 0 CA--C 1.493 -1.284 0 N-CA-C 108.405 -1.878 . . . . 0.0 108.405 -178.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 51.6 t60 -132.42 147.42 52.38 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 104.712 -2.329 . . . . 0.0 104.712 -176.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 71.9 m -78.46 139.38 38.71 Favored 'General case' 0 C--N 1.351 0.636 0 O-C-N 120.984 -1.072 . . . . 0.0 112.079 -174.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -125.72 156.91 38.63 Favored 'General case' 0 C--N 1.351 0.671 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 -176.188 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -112.46 135.54 53.04 Favored 'General case' 0 C--N 1.35 0.625 0 C-N-CA 124.043 0.937 . . . . 0.0 109.669 175.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 43.0 mm -91.8 122.06 42.88 Favored 'Isoleucine or valine' 0 C--N 1.361 1.091 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 172.096 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.64 137.54 57.05 Favored 'Isoleucine or valine' 0 C--N 1.351 0.663 0 CA-C-O 122.363 1.078 . . . . 0.0 110.46 169.662 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 166.45 -174.36 41.92 Favored Glycine 0 CA--C 1.493 -1.327 0 N-CA-C 106.014 -2.834 . . . . 0.0 106.014 -176.072 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 53.4 p30 . . . . . 0 C--O 1.259 1.584 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 178.932 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 14.0 t80 . . . . . 0 N--CA 1.503 2.218 0 N-CA-C 116.702 2.112 . . . . 0.0 116.702 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -111.74 151.83 28.49 Favored 'General case' 0 C--N 1.353 0.73 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 159.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.2 p -126.33 136.02 62.06 Favored 'Isoleucine or valine' 0 C--N 1.351 0.65 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 173.329 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.585 HG22 HD11 ' A' ' 54' ' ' ILE . 35.9 m -133.72 159.39 42.59 Favored 'Isoleucine or valine' 0 C--N 1.353 0.727 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 176.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 87.4 p -80.42 154.32 27.73 Favored 'General case' 0 C--N 1.349 0.547 0 CA-C-O 121.684 0.754 . . . . 0.0 112.934 171.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 78.2 m -105.38 5.0 31.4 Favored 'General case' 0 C--N 1.356 0.866 0 O-C-N 121.114 -0.991 . . . . 0.0 111.539 173.409 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 58.16 40.73 24.71 Favored 'General case' 0 C--N 1.355 0.821 0 C-N-CA 126.928 2.091 . . . . 0.0 114.977 178.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 37.2 mmtm -132.7 142.83 49.24 Favored 'General case' 0 C--N 1.351 0.632 0 C-N-CA 124.593 1.157 . . . . 0.0 110.416 176.016 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.5 t30 -88.09 133.29 34.02 Favored 'General case' 0 C--N 1.351 0.668 0 C-N-CA 126.374 1.87 . . . . 0.0 109.135 176.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 13.8 p -109.31 153.51 23.8 Favored 'General case' 0 C--N 1.356 0.887 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 171.024 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 59.7 m -128.9 145.71 51.14 Favored 'General case' 0 C--N 1.346 0.435 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 -173.018 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 47.4 t -59.2 138.53 57.55 Favored 'General case' 0 C--N 1.358 0.937 0 C-N-CA 123.829 0.852 . . . . 0.0 112.941 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.94 -53.88 4.4 Favored Glycine 0 C--N 1.358 1.774 0 C-N-CA 124.666 1.127 . . . . 0.0 112.377 -175.217 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -64.39 -45.74 86.35 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 128.685 2.794 . . . . 0.0 115.465 -178.079 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.4 m120 54.99 43.01 30.55 Favored 'General case' 0 C--N 1.355 0.814 0 C-N-CA 127.084 2.154 . . . . 0.0 115.654 168.182 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 55.2 mm-40 -75.76 117.89 18.0 Favored 'General case' 0 C--N 1.354 0.784 0 O-C-N 120.124 -1.61 . . . . 0.0 113.929 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 77.1 m -138.06 155.99 74.22 Favored Pre-proline 0 C--N 1.354 0.793 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 159.379 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.21 160.08 50.07 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 123.109 2.539 . . . . 0.0 111.25 166.239 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -62.94 131.14 47.69 Favored 'General case' 0 C--N 1.353 0.718 0 C-N-CA 123.539 0.735 . . . . 0.0 112.534 -176.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 100.27 -14.07 59.79 Favored Glycine 0 C--N 1.356 1.649 0 C-N-CA 123.827 0.727 . . . . 0.0 112.679 -174.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 75.0 m -112.69 156.67 22.38 Favored 'General case' 0 C--N 1.349 0.549 0 C-N-CA 124.055 0.942 . . . . 0.0 109.145 177.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -141.47 163.03 34.03 Favored 'General case' 0 C--N 1.348 0.509 0 N-CA-C 105.346 -2.094 . . . . 0.0 105.346 -178.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 46.3 t -124.25 125.9 45.18 Favored 'General case' 0 CA--C 1.508 -0.665 0 O-C-N 120.85 -1.156 . . . . 0.0 109.59 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -85.9 63.94 4.16 Favored Glycine 0 C--N 1.354 1.544 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 177.092 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.612 HD23 ' H ' ' A' ' 42' ' ' LEU . 1.0 OUTLIER -69.46 141.16 54.07 Favored 'General case' 0 C--N 1.349 0.573 0 C-N-CA 125.27 1.428 . . . . 0.0 110.292 -178.94 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.612 ' H ' HD23 ' A' ' 41' ' ' LEU . 1.4 mm? -81.59 69.94 8.36 Favored 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 125.502 1.521 . . . . 0.0 109.288 -161.282 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.76 24.31 76.31 Favored Glycine 0 C--N 1.352 1.438 0 O-C-N 120.975 -1.078 . . . . 0.0 113.943 178.368 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 69.2 mm-40 58.32 34.29 23.91 Favored 'General case' 0 C--N 1.356 0.88 0 C-N-CA 126.2 1.8 . . . . 0.0 114.592 -175.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 57.4 m-80 -76.38 -46.92 25.17 Favored 'General case' 0 C--N 1.356 0.871 0 O-C-N 120.028 -1.67 . . . . 0.0 115.371 176.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 48.2 mmtm -137.7 -100.97 0.19 Allowed 'General case' 0 C--N 1.348 0.542 0 CA-C-O 122.103 0.954 . . . . 0.0 110.124 -173.152 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 10.3 ptpp? -143.58 161.65 37.94 Favored 'General case' 0 N--CA 1.436 -1.136 0 C-N-CA 125.311 1.444 . . . . 0.0 107.654 -173.273 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -154.91 -174.13 24.5 Favored Glycine 0 C--N 1.344 1.005 0 N-CA-C 108.748 -1.741 . . . . 0.0 108.748 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 52.6 t60 -126.7 142.97 51.38 Favored 'General case' 0 C--N 1.35 0.589 0 O-C-N 121.159 -1.201 . . . . 0.0 108.218 -173.261 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 75.9 m -80.15 139.98 36.57 Favored 'General case' 0 C--N 1.356 0.849 0 O-C-N 120.751 -1.218 . . . . 0.0 112.978 -173.114 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -128.0 162.15 27.48 Favored 'General case' 0 C--N 1.357 0.919 0 C-N-CA 124.0 0.92 . . . . 0.0 108.986 -173.236 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -116.35 137.91 51.77 Favored 'General case' 0 C--N 1.352 0.7 0 C-N-CA 124.596 1.158 . . . . 0.0 108.267 164.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 83.5 mt -95.56 126.42 48.08 Favored 'Isoleucine or valine' 0 C--N 1.358 0.972 0 C-N-CA 125.726 1.61 . . . . 0.0 107.54 167.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.585 HD11 HG22 ' A' ' 20' ' ' VAL . 4.7 mp -115.75 125.71 73.01 Favored 'Isoleucine or valine' 0 C--N 1.355 0.836 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 -177.178 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 142.16 -61.12 0.53 Allowed Glycine 0 C--N 1.353 1.503 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 173.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 24.9 p30 . . . . . 0 C--O 1.261 1.694 0 CA-C-O 117.014 -1.47 . . . . 0.0 114.225 177.729 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 13.3 t80 . . . . . 0 N--CA 1.503 2.205 0 N-CA-C 116.773 2.138 . . . . 0.0 116.773 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -120.53 150.6 40.6 Favored 'General case' 0 C--N 1.356 0.867 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 165.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.2 p -122.93 134.41 66.16 Favored 'Isoleucine or valine' 0 C--N 1.351 0.643 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 171.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 28.4 m -132.21 156.97 42.97 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.619 0 C-N-CA 124.983 1.313 . . . . 0.0 107.547 177.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 96.5 p -81.16 158.27 25.0 Favored 'General case' 0 C--N 1.353 0.735 0 CA-C-O 122.391 1.091 . . . . 0.0 112.342 175.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 79.0 m -98.77 10.53 41.01 Favored 'General case' 0 C--N 1.349 0.556 0 C-N-CA 125.007 1.323 . . . . 0.0 110.194 176.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 8.3 m120 62.69 21.55 12.8 Favored 'General case' 0 C--N 1.356 0.87 0 C-N-CA 128.788 2.835 . . . . 0.0 114.146 177.256 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt -118.8 143.12 47.12 Favored 'General case' 0 CA--C 1.511 -0.553 0 C-N-CA 125.038 1.335 . . . . 0.0 111.586 179.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -96.83 130.03 44.17 Favored 'General case' 0 C--N 1.351 0.666 0 C-N-CA 126.878 2.071 . . . . 0.0 109.992 178.196 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 14.2 p -103.17 155.69 18.24 Favored 'General case' 0 C--N 1.354 0.786 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 170.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 61.6 m -130.38 145.34 51.79 Favored 'General case' 0 C--N 1.353 0.749 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 -177.344 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 39.7 t -60.6 133.12 55.79 Favored 'General case' 0 C--N 1.356 0.855 0 O-C-N 119.531 -1.981 . . . . 0.0 112.003 177.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.71 -18.96 56.13 Favored Glycine 0 C--N 1.352 1.43 0 C-N-CA 125.024 1.297 . . . . 0.0 112.824 -172.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -148.8 102.21 3.26 Favored 'General case' 0 C--N 1.355 0.808 0 CA-C-O 123.847 1.784 . . . . 0.0 111.233 174.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 33.7 m120 -80.91 82.63 6.84 Favored 'General case' 0 C--N 1.353 0.747 0 O-C-N 120.058 -1.652 . . . . 0.0 110.833 -175.431 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -82.5 75.81 9.4 Favored 'General case' 0 C--N 1.353 0.734 0 C-N-CA 124.461 1.105 . . . . 0.0 112.581 -167.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 74.7 m -118.63 151.21 49.56 Favored Pre-proline 0 C--N 1.351 0.668 0 O-C-N 120.694 -1.254 . . . . 0.0 110.806 177.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -71.83 159.77 49.71 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.776 2.318 . . . . 0.0 110.603 163.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -63.77 134.82 55.99 Favored 'General case' 0 C--N 1.352 0.684 0 C-N-CA 123.503 0.721 . . . . 0.0 112.524 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 98.59 -10.51 62.84 Favored Glycine 0 C--N 1.356 1.639 0 C-N-CA 123.817 0.722 . . . . 0.0 113.542 -175.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 82.5 m -112.77 154.47 26.15 Favored 'General case' 0 C--N 1.348 0.52 0 CA-C-N 118.003 0.901 . . . . 0.0 108.891 178.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -129.03 160.36 32.99 Favored 'General case' 0 C--N 1.353 0.737 0 N-CA-C 104.691 -2.337 . . . . 0.0 104.691 177.084 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 41.9 t -114.21 128.59 56.44 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-N 120.586 1.539 . . . . 0.0 109.33 178.027 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -83.8 61.6 4.72 Favored Glycine 0 C--N 1.355 1.595 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.528 HD23 ' H ' ' A' ' 42' ' ' LEU . 0.8 OUTLIER -81.93 137.79 35.11 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 124.21 1.004 . . . . 0.0 109.142 -175.063 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.528 ' H ' HD23 ' A' ' 41' ' ' LEU . 1.3 mm? -81.21 72.24 8.23 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 125.637 1.575 . . . . 0.0 109.044 -163.564 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.67 20.25 79.78 Favored Glycine 0 C--N 1.354 1.554 0 O-C-N 120.742 -1.224 . . . . 0.0 113.692 178.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 56.37 39.67 30.0 Favored 'General case' 0 C--N 1.352 0.717 0 C-N-CA 127.376 2.271 . . . . 0.0 114.091 -172.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 61.2 m-80 -80.47 -45.14 18.06 Favored 'General case' 0 C--N 1.351 0.671 0 N-CA-C 115.073 1.509 . . . . 0.0 115.073 173.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -131.0 -105.34 0.27 Allowed 'General case' 0 C--N 1.354 0.78 0 O-C-N 121.109 -0.995 . . . . 0.0 111.756 -169.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.03 164.57 31.68 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 105.38 -2.082 . . . . 0.0 105.38 -178.021 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -166.16 179.64 40.14 Favored Glycine 0 CA--C 1.493 -1.299 0 N-CA-C 108.25 -1.94 . . . . 0.0 108.25 178.452 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 12.3 m80 -105.83 150.94 25.12 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 115.689 1.737 . . . . 0.0 115.689 176.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 81.0 m -81.68 134.35 35.46 Favored 'General case' 0 C--N 1.353 0.733 0 C-N-CA 125.347 1.459 . . . . 0.0 110.047 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -127.68 158.97 36.14 Favored 'General case' 0 C--N 1.351 0.654 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 -172.524 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 20.7 pttm -125.22 154.87 40.96 Favored 'General case' 0 C--N 1.352 0.717 0 CA-C-O 121.987 0.898 . . . . 0.0 111.55 168.01 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 46.4 mm -103.62 121.15 54.68 Favored 'Isoleucine or valine' 0 C--N 1.353 0.725 0 C-N-CA 125.397 1.479 . . . . 0.0 107.671 -175.169 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.24 146.9 33.51 Favored 'Isoleucine or valine' 0 C--N 1.353 0.739 0 CA-C-O 121.908 0.861 . . . . 0.0 110.443 175.754 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 94.66 -7.57 71.02 Favored Glycine 0 C--N 1.355 1.598 0 O-C-N 121.21 -0.931 . . . . 0.0 113.889 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 . . . . . 0 CA--C 1.567 1.613 0 O-C-N 121.127 -1.22 . . . . 0.0 111.18 177.718 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 11.3 t80 . . . . . 0 N--CA 1.504 2.25 0 N-CA-C 116.254 1.946 . . . . 0.0 116.254 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -123.19 147.91 46.35 Favored 'General case' 0 C--N 1.357 0.892 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 158.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 5.3 p -126.89 135.38 63.83 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.62 0 C-N-CA 124.474 1.109 . . . . 0.0 108.418 174.061 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 30.4 m -129.97 158.97 42.43 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.638 0 C-N-CA 124.715 1.206 . . . . 0.0 108.265 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 78.9 p -76.43 143.05 40.82 Favored 'General case' 0 N--CA 1.446 -0.647 0 O-C-N 121.186 -0.946 . . . . 0.0 112.741 174.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 15.5 t -91.98 -1.8 57.07 Favored 'General case' 0 C--N 1.354 0.768 0 O-C-N 121.256 -0.903 . . . . 0.0 110.916 178.296 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 54.5 t30 59.95 46.45 11.05 Favored 'General case' 0 C--N 1.356 0.869 0 C-N-CA 127.591 2.357 . . . . 0.0 113.55 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 55.6 tptt -140.98 138.26 33.62 Favored 'General case' 0 C--N 1.352 0.679 0 O-C-N 121.086 -1.009 . . . . 0.0 108.429 178.284 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -84.4 133.56 34.5 Favored 'General case' 0 C--N 1.355 0.816 0 C-N-CA 125.7 1.6 . . . . 0.0 111.217 176.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 26.0 p -132.48 157.37 44.81 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 122.122 0.963 . . . . 0.0 110.434 173.511 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 37.3 p -128.87 165.44 21.02 Favored 'General case' 0 CA--C 1.5 -0.978 0 C-N-CA 124.794 1.238 . . . . 0.0 111.362 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 47.3 t -58.94 135.1 57.48 Favored 'General case' 0 C--N 1.355 0.839 0 C-N-CA 125.956 1.702 . . . . 0.0 111.465 177.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 82.66 -61.08 4.8 Favored Glycine 0 C--N 1.352 1.456 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 -170.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 24.4 mm100 -62.15 -48.48 79.89 Favored 'General case' 0 C--N 1.351 0.643 0 N-CA-C 117.047 2.24 . . . . 0.0 117.047 -174.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 48.52 36.93 8.12 Favored 'General case' 0 C--N 1.359 1.006 0 N-CA-C 115.917 1.821 . . . . 0.0 115.917 175.358 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -81.53 117.79 22.22 Favored 'General case' 0 C--N 1.356 0.866 0 O-C-N 120.464 -1.397 . . . . 0.0 112.382 -173.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 82.1 m -137.14 158.03 73.35 Favored Pre-proline 0 N--CA 1.448 -0.548 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 176.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -70.15 159.96 51.28 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.626 2.217 . . . . 0.0 110.609 164.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -64.73 140.81 58.91 Favored 'General case' 0 C--N 1.353 0.73 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -174.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.22 -13.45 66.84 Favored Glycine 0 C--N 1.355 1.585 0 O-C-N 121.562 -0.711 . . . . 0.0 112.806 -173.196 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 72.8 m -115.41 155.09 28.05 Favored 'General case' 0 C--N 1.349 0.577 0 C-N-CA 124.458 1.103 . . . . 0.0 110.247 178.248 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -127.18 161.34 28.75 Favored 'General case' 0 C--N 1.348 0.527 0 C-N-CA 124.763 1.225 . . . . 0.0 109.472 178.225 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 53.2 t -86.83 125.46 33.99 Favored 'General case' 0 C--N 1.35 0.603 0 C-N-CA 123.939 0.895 . . . . 0.0 110.9 -177.396 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -91.08 84.82 1.28 Allowed Glycine 0 C--N 1.355 1.603 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 172.144 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -103.75 139.9 38.35 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 -179.241 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -80.29 68.11 6.35 Favored 'General case' 0 C--N 1.351 0.632 0 C-N-CA 125.162 1.385 . . . . 0.0 109.111 -175.031 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.16 21.51 77.12 Favored Glycine 0 C--N 1.356 1.646 0 O-C-N 120.699 -1.251 . . . . 0.0 113.695 179.224 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 56.91 35.37 26.26 Favored 'General case' 0 C--N 1.348 0.543 0 C-N-CA 127.365 2.266 . . . . 0.0 116.401 -173.446 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 61.3 m-80 -67.68 -44.8 76.94 Favored 'General case' 0 C--N 1.357 0.896 0 N-CA-C 115.065 1.506 . . . . 0.0 115.065 168.012 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.516 ' HG3' ' H ' ' A' ' 47' ' ' LYS . 20.1 pttp -149.33 -106.2 0.07 Allowed 'General case' 0 C--N 1.354 0.764 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 -173.451 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.516 ' H ' ' HG3' ' A' ' 46' ' ' LYS . 25.8 pttm -119.27 159.07 24.79 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 125.388 1.475 . . . . 0.0 110.109 -177.518 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -154.79 -166.76 15.62 Favored Glycine 0 C--N 1.352 1.417 0 N-CA-C 110.504 -1.039 . . . . 0.0 110.504 178.123 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 50.5 t60 -136.49 146.35 46.17 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 -172.147 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 79.2 m -79.92 140.88 36.52 Favored 'General case' 0 C--N 1.349 0.561 0 O-C-N 120.752 -1.218 . . . . 0.0 111.637 -177.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 17.3 m-30 -126.03 162.41 25.35 Favored 'General case' 0 C--N 1.355 0.823 0 O-C-N 121.048 -1.032 . . . . 0.0 108.821 -178.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -123.68 137.44 54.71 Favored 'General case' 0 C--N 1.352 0.689 0 C-N-CA 124.422 1.089 . . . . 0.0 108.448 168.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 94.3 mt -107.16 130.05 59.91 Favored 'Isoleucine or valine' 0 C--N 1.361 1.085 0 C-N-CA 124.242 1.017 . . . . 0.0 108.782 177.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -131.57 149.97 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 C-N-CA 125.796 1.639 . . . . 0.0 110.153 -177.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 134.55 -155.4 21.91 Favored Glycine 0 C--N 1.35 1.355 0 N-CA-C 107.945 -2.062 . . . . 0.0 107.945 -177.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 59.5 t30 . . . . . 0 CA--C 1.569 1.711 0 CA-C-O 117.001 -1.476 . . . . 0.0 114.776 173.713 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 7.5 t80 . . . . . 0 N--CA 1.5 2.075 0 N-CA-C 116.222 1.934 . . . . 0.0 116.222 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 49.0 m-20 -120.35 149.64 42.02 Favored 'General case' 0 C--N 1.354 0.782 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 161.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.9 p -125.21 135.15 64.95 Favored 'Isoleucine or valine' 0 C--N 1.35 0.593 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 174.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 28.9 m -132.01 155.88 41.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.574 0 C-N-CA 123.481 0.712 . . . . 0.0 109.122 179.239 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 79.2 p -79.91 147.87 31.49 Favored 'General case' 0 C--N 1.349 0.549 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 175.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 10.9 t -102.5 -4.13 25.82 Favored 'General case' 0 C--N 1.353 0.754 0 C-N-CA 123.732 0.813 . . . . 0.0 112.062 -175.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 56.6 t30 58.95 44.48 16.38 Favored 'General case' 0 C--N 1.357 0.91 0 C-N-CA 127.176 2.19 . . . . 0.0 113.656 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.5 tppt? -144.06 146.44 32.83 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 102.473 -3.158 . . . . 0.0 102.473 173.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.4 p-10 -120.05 167.96 11.67 Favored 'General case' 0 C--N 1.355 0.845 0 CA-C-N 120.976 1.716 . . . . 0.0 110.402 171.436 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 57.1 m -116.42 160.87 19.93 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 173.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 32.3 m -111.23 159.33 18.0 Favored 'General case' 0 C--N 1.345 0.409 0 N-CA-C 102.231 -3.248 . . . . 0.0 102.231 166.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.2 t -58.6 144.1 44.07 Favored 'General case' 0 C--N 1.352 0.716 0 CA-C-O 122.353 1.073 . . . . 0.0 112.922 178.144 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.58 -58.62 4.85 Favored Glycine 0 C--N 1.353 1.523 0 C-N-CA 124.125 0.869 . . . . 0.0 111.359 -171.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -63.55 -45.77 89.01 Favored 'General case' 0 C--N 1.348 0.535 0 N-CA-C 115.503 1.668 . . . . 0.0 115.503 -167.009 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 50.54 44.53 27.17 Favored 'General case' 0 C--N 1.36 1.039 0 N-CA-C 116.557 2.058 . . . . 0.0 116.557 175.168 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -91.93 114.77 27.4 Favored 'General case' 0 C--N 1.35 0.609 0 C-N-CA 124.396 1.079 . . . . 0.0 111.683 -176.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 98.2 m -132.6 157.4 78.41 Favored Pre-proline 0 C--N 1.351 0.671 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 171.021 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -69.72 160.27 50.34 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 122.775 2.317 . . . . 0.0 110.021 166.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -63.72 135.65 56.85 Favored 'General case' 0 C--N 1.353 0.75 0 N-CA-C 113.269 0.841 . . . . 0.0 113.269 -171.12 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.9 -12.62 65.7 Favored Glycine 0 C--N 1.355 1.587 0 C-N-CA 123.921 0.772 . . . . 0.0 113.212 -175.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 73.3 m -115.45 153.71 30.61 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-N 118.023 0.912 . . . . 0.0 110.489 -178.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -139.24 154.65 48.03 Favored 'General case' 0 C--N 1.355 0.831 0 O-C-N 121.099 -1.001 . . . . 0.0 110.015 -178.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 53.0 m -94.7 136.3 35.17 Favored 'General case' 0 C--N 1.353 0.752 0 CA-C-O 121.879 0.847 . . . . 0.0 111.053 168.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -91.88 90.05 1.47 Allowed Glycine 0 C--N 1.351 1.386 0 N-CA-C 107.332 -2.307 . . . . 0.0 107.332 167.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -106.1 125.52 51.1 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 -168.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -90.17 79.44 6.43 Favored 'General case' 0 C--N 1.352 0.678 0 O-C-N 120.987 -1.071 . . . . 0.0 109.68 -156.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 67.16 42.12 91.67 Favored Glycine 0 C--N 1.354 1.557 0 O-C-N 120.95 -1.094 . . . . 0.0 115.09 172.031 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 47.64 45.14 17.87 Favored 'General case' 0 C--N 1.354 0.766 0 C-N-CA 128.403 2.681 . . . . 0.0 116.843 -175.142 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 -94.62 -72.83 0.6 Allowed 'General case' 0 C--N 1.355 0.821 0 N-CA-C 114.72 1.378 . . . . 0.0 114.72 175.109 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -116.01 -96.41 0.46 Allowed 'General case' 0 C--N 1.357 0.919 0 O-C-N 120.536 -1.352 . . . . 0.0 113.083 -161.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -154.18 161.2 42.01 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 104.719 -2.326 . . . . 0.0 104.719 -171.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -154.25 156.48 26.87 Favored Glycine 0 CA--C 1.493 -1.329 0 N-CA-C 108.709 -1.756 . . . . 0.0 108.709 -177.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 73.6 t60 -101.45 144.84 29.74 Favored 'General case' 0 C--N 1.345 0.391 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 -175.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 72.3 m -78.98 133.22 36.87 Favored 'General case' 0 C--N 1.358 0.957 0 O-C-N 120.737 -1.227 . . . . 0.0 111.165 -178.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -123.61 159.91 28.23 Favored 'General case' 0 C--N 1.354 0.766 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 -175.305 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -118.98 135.09 54.79 Favored 'General case' 0 C--N 1.349 0.55 0 C-N-CA 124.228 1.011 . . . . 0.0 108.365 168.045 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 78.5 mt -101.28 125.71 55.22 Favored 'Isoleucine or valine' 0 C--N 1.358 0.944 0 C-N-CA 125.344 1.458 . . . . 0.0 109.038 173.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.5 162.4 39.88 Favored 'Isoleucine or valine' 0 C--N 1.351 0.644 0 C-N-CA 124.986 1.314 . . . . 0.0 110.678 179.153 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 95.77 -59.47 1.5 Allowed Glycine 0 C--N 1.355 1.593 0 O-C-N 121.074 -1.016 . . . . 0.0 111.667 -175.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 . . . . . 0 C--O 1.259 1.573 0 O-C-N 121.331 -1.099 . . . . 0.0 113.21 178.797 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 6.6 t80 . . . . . 0 N--CA 1.5 2.036 0 N-CA-C 115.0 1.481 . . . . 0.0 115.0 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -117.42 154.27 31.66 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 106.407 -1.701 . . . . 0.0 106.407 161.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.4 p -125.71 134.24 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 178.21 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.3 m -132.18 157.61 43.12 Favored 'Isoleucine or valine' 0 C--N 1.352 0.684 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 177.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 80.4 p -79.91 153.38 29.03 Favored 'General case' 0 C--N 1.349 0.548 0 O-C-N 120.704 -1.248 . . . . 0.0 113.97 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 21.0 t -121.96 25.25 9.22 Favored 'General case' 0 C--N 1.358 0.95 0 O-C-N 121.219 -0.926 . . . . 0.0 111.381 -171.133 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 45.57 39.18 4.57 Favored 'General case' 0 C--N 1.358 0.967 0 C-N-CA 128.184 2.594 . . . . 0.0 117.722 173.204 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 45.1 tptt -149.51 141.88 24.24 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 -174.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.8 p-10 -107.29 159.62 16.23 Favored 'General case' 0 C--N 1.355 0.837 0 CA-C-N 120.661 1.573 . . . . 0.0 111.075 170.244 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 84.5 m -106.61 156.15 18.9 Favored 'General case' 0 CA--C 1.509 -0.63 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 164.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 67.5 m -117.7 141.75 48.04 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 102.705 -3.072 . . . . 0.0 102.705 169.204 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 45.1 t -60.26 130.62 47.56 Favored 'General case' 0 C--N 1.357 0.893 0 O-C-N 120.815 -1.178 . . . . 0.0 111.242 178.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 89.32 -3.75 84.07 Favored Glycine 0 C--N 1.356 1.66 0 O-C-N 121.568 -0.707 . . . . 0.0 112.382 -176.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 11.4 mm-40 -112.55 -46.04 3.19 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 121.561 -0.964 . . . . 0.0 110.05 168.024 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 17.4 m120 53.47 43.61 31.07 Favored 'General case' 0 C--N 1.362 1.113 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 171.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -100.77 116.42 32.61 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 124.79 1.236 . . . . 0.0 111.877 -166.299 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 71.9 m -134.27 157.2 78.06 Favored Pre-proline 0 C--N 1.351 0.65 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 166.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.06 160.2 50.45 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.435 2.09 . . . . 0.0 110.962 166.151 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -62.64 134.67 56.67 Favored 'General case' 0 C--N 1.353 0.728 0 C-N-CA 123.91 0.884 . . . . 0.0 113.124 -173.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 98.8 -12.82 62.62 Favored Glycine 0 C--N 1.356 1.667 0 C-N-CA 124.185 0.897 . . . . 0.0 113.259 -173.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 71.2 m -116.29 154.56 29.96 Favored 'General case' 0 C--N 1.35 0.591 0 CA-C-N 118.019 0.909 . . . . 0.0 110.52 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -134.06 161.11 35.74 Favored 'General case' 0 C--N 1.355 0.811 0 N-CA-C 104.866 -2.272 . . . . 0.0 104.866 178.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 15.1 p -115.05 144.87 42.95 Favored 'General case' 0 CA--C 1.503 -0.849 0 CA-C-N 119.986 1.266 . . . . 0.0 112.455 172.186 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -90.97 62.91 2.89 Favored Glycine 0 C--N 1.352 1.421 0 CA-C-N 115.435 -0.802 . . . . 0.0 112.889 -172.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 62.6 mt -75.86 130.93 39.32 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 122.244 1.021 . . . . 0.0 111.895 167.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.537 HD22 ' H ' ' A' ' 42' ' ' LEU . 1.8 mm? -66.92 -44.56 80.37 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 126.297 1.839 . . . . 0.0 111.62 -164.116 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -167.45 49.57 0.24 Allowed Glycine 0 CA--C 1.499 -0.934 0 N-CA-C 106.609 -2.597 . . . . 0.0 106.609 173.378 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.6 pm0 45.11 54.48 7.01 Favored 'General case' 0 C--N 1.359 0.986 0 C-N-CA 127.537 2.335 . . . . 0.0 115.774 -176.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -94.06 -50.55 5.25 Favored 'General case' 0 C--N 1.359 0.986 0 O-C-N 119.996 -1.69 . . . . 0.0 111.802 -174.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 63.4 mttm -131.15 -103.07 0.28 Allowed 'General case' 0 C--N 1.356 0.862 0 C-N-CA 123.803 0.841 . . . . 0.0 111.479 -171.065 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 57.5 pttt -142.7 152.09 42.02 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 126.246 1.818 . . . . 0.0 106.833 -176.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -157.1 158.33 28.78 Favored Glycine 0 C--N 1.351 1.365 0 N-CA-C 108.142 -1.983 . . . . 0.0 108.142 -178.218 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 67.8 t60 -95.67 147.24 23.81 Favored 'General case' 0 C--N 1.346 0.433 0 O-C-N 121.717 -0.873 . . . . 0.0 110.49 -169.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 72.0 m -79.81 137.83 37.07 Favored 'General case' 0 C--N 1.359 1.002 0 O-C-N 121.078 -1.014 . . . . 0.0 111.792 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -127.09 154.62 44.47 Favored 'General case' 0 C--N 1.349 0.587 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 -178.496 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -104.69 135.87 45.26 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 124.629 1.171 . . . . 0.0 108.077 172.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 91.1 mt -101.19 123.4 54.23 Favored 'Isoleucine or valine' 0 C--N 1.356 0.86 0 C-N-CA 123.725 0.81 . . . . 0.0 108.937 176.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.19 146.51 33.61 Favored 'Isoleucine or valine' 0 C--N 1.351 0.663 0 C-N-CA 124.287 1.035 . . . . 0.0 109.693 176.078 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 93.24 -12.09 70.47 Favored Glycine 0 C--N 1.354 1.553 0 O-C-N 121.215 -0.928 . . . . 0.0 114.69 175.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 54.6 t30 . . . . . 0 C--O 1.259 1.564 0 O-C-N 121.082 -1.246 . . . . 0.0 111.574 -178.459 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 8.4 t80 . . . . . 0 N--CA 1.504 2.242 0 N-CA-C 116.528 2.048 . . . . 0.0 116.528 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -115.93 148.19 40.31 Favored 'General case' 0 C--N 1.354 0.789 0 C-N-CA 124.953 1.301 . . . . 0.0 107.721 161.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.7 p -123.09 133.26 69.6 Favored 'Isoleucine or valine' 0 C--N 1.351 0.648 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 171.071 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 24.0 m -133.39 154.12 38.44 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.683 0 C-N-CA 124.422 1.089 . . . . 0.0 108.235 178.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 96.2 p -79.67 155.72 27.91 Favored 'General case' 0 C--N 1.352 0.676 0 CA-C-O 121.856 0.836 . . . . 0.0 113.03 178.084 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 12.2 t -114.22 11.72 17.55 Favored 'General case' 0 C--N 1.351 0.648 0 C-N-CA 123.818 0.847 . . . . 0.0 110.519 -177.194 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 32.6 m120 59.24 28.9 18.35 Favored 'General case' 0 C--N 1.357 0.919 0 C-N-CA 128.108 2.563 . . . . 0.0 115.41 173.02 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 26.5 mmmt -134.74 160.07 39.33 Favored 'General case' 0 CA--C 1.513 -0.478 0 C-N-CA 127.057 2.143 . . . . 0.0 106.545 178.218 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -136.06 165.6 25.31 Favored 'General case' 0 C--N 1.351 0.664 0 O-C-N 121.088 -1.007 . . . . 0.0 109.493 173.237 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 30.7 m -120.9 147.87 44.83 Favored 'General case' 0 C--N 1.352 0.688 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 173.212 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 24.6 p -93.5 164.84 13.03 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 122.008 0.909 . . . . 0.0 110.365 153.34 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 46.9 t -61.32 130.84 48.13 Favored 'General case' 0 C--N 1.35 0.623 0 CA-C-O 122.125 0.964 . . . . 0.0 112.593 -178.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.35 -19.3 44.34 Favored Glycine 0 C--N 1.353 1.491 0 C-N-CA 124.94 1.257 . . . . 0.0 113.636 -178.034 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 21.8 mm100 -80.23 -47.94 13.86 Favored 'General case' 0 C--N 1.353 0.719 0 N-CA-C 114.775 1.398 . . . . 0.0 114.775 179.317 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 31.6 m120 50.08 41.19 23.15 Favored 'General case' 0 C--N 1.355 0.836 0 C-N-CA 126.17 1.788 . . . . 0.0 115.055 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -98.42 109.43 22.19 Favored 'General case' 0 C--N 1.355 0.839 0 O-C-N 121.033 -1.042 . . . . 0.0 111.38 -172.303 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 76.1 m -137.05 157.7 74.09 Favored Pre-proline 0 C--N 1.35 0.598 0 N-CA-C 105.728 -1.953 . . . . 0.0 105.728 167.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -69.41 159.71 52.6 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.756 2.304 . . . . 0.0 111.349 169.081 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -62.79 131.28 48.31 Favored 'General case' 0 C--N 1.354 0.765 0 C-N-CA 123.675 0.79 . . . . 0.0 112.229 -172.375 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 100.36 -13.7 59.82 Favored Glycine 0 C--N 1.356 1.643 0 C-N-CA 123.822 0.725 . . . . 0.0 112.575 -174.366 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 72.1 m -114.08 154.21 28.13 Favored 'General case' 0 C--N 1.349 0.574 0 C-N-CA 124.088 0.955 . . . . 0.0 109.949 177.176 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -136.3 156.67 48.32 Favored 'General case' 0 C--N 1.35 0.611 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 178.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 8.1 p -106.16 143.87 33.68 Favored 'General case' 0 CA--C 1.501 -0.905 0 CA-C-O 122.413 1.102 . . . . 0.0 111.157 171.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -84.09 74.93 2.44 Favored Glycine 0 C--N 1.352 1.432 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 178.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -92.22 121.53 33.83 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 -173.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -91.46 101.06 13.73 Favored 'General case' 0 C--N 1.352 0.678 0 O-C-N 120.674 -1.266 . . . . 0.0 108.969 -163.448 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 60.07 32.02 74.54 Favored Glycine 0 C--N 1.357 1.708 0 N-CA-C 115.629 1.012 . . . . 0.0 115.629 165.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 46.19 43.11 10.83 Favored 'General case' 0 C--N 1.354 0.8 0 C-N-CA 127.895 2.478 . . . . 0.0 116.148 -168.351 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 -89.6 -98.7 0.1 Allowed 'General case' 0 C--N 1.359 0.999 0 O-C-N 121.247 -0.908 . . . . 0.0 111.649 173.196 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -96.89 -89.16 0.28 Allowed 'General case' 0 C--N 1.355 0.809 0 O-C-N 120.646 -1.284 . . . . 0.0 113.636 -169.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -151.98 162.12 41.57 Favored 'General case' 0 N--CA 1.445 -0.707 0 O-C-N 121.142 -0.973 . . . . 0.0 108.956 -168.074 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -157.5 154.03 25.18 Favored Glycine 0 C--N 1.352 1.424 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 63.1 t60 -97.3 148.13 23.44 Favored 'General case' 0 C--N 1.349 0.569 0 O-C-N 121.601 -0.94 . . . . 0.0 109.166 -173.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 71.5 m -80.84 134.51 35.78 Favored 'General case' 0 C--N 1.359 1.02 0 O-C-N 120.956 -1.09 . . . . 0.0 111.516 -178.536 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -130.81 167.13 19.41 Favored 'General case' 0 C--N 1.351 0.633 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 -177.096 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 33.7 pttt -124.28 148.92 47.06 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 121.56 0.695 . . . . 0.0 110.553 156.456 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 82.3 mt -104.78 124.25 59.29 Favored 'Isoleucine or valine' 0 C--N 1.358 0.944 0 C-N-CA 125.811 1.645 . . . . 0.0 107.805 174.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.42 142.13 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 C-N-CA 124.989 1.316 . . . . 0.0 108.938 178.529 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 144.97 -148.27 19.93 Favored Glycine 0 C--N 1.351 1.393 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -175.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 15.5 p-10 . . . . . 0 C--O 1.259 1.565 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 179.631 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 28.3 t80 . . . . . 0 N--CA 1.504 2.249 0 N-CA-C 116.988 2.218 . . . . 0.0 116.988 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -144.65 158.21 43.87 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 105.11 -2.181 . . . . 0.0 105.11 167.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.7 p -130.82 133.05 63.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 175.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.5 m -133.27 161.6 41.18 Favored 'Isoleucine or valine' 0 C--N 1.351 0.634 0 C-N-CA 124.326 1.05 . . . . 0.0 108.313 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 87.3 p -75.82 149.81 37.81 Favored 'General case' 0 C--N 1.352 0.679 0 O-C-N 120.745 -1.222 . . . . 0.0 113.249 176.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 34.5 t -114.11 -0.12 14.1 Favored 'General case' 0 C--N 1.356 0.885 0 O-C-N 121.236 -0.915 . . . . 0.0 111.337 -172.217 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 53.3 t30 58.51 45.67 16.07 Favored 'General case' 0 C--N 1.356 0.864 0 C-N-CA 127.146 2.179 . . . . 0.0 114.827 175.294 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 15.5 tppt? -141.7 144.43 34.06 Favored 'General case' 0 C--N 1.349 0.565 0 N-CA-C 105.27 -2.122 . . . . 0.0 105.27 173.182 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 30.0 t30 -114.07 136.26 53.11 Favored 'General case' 0 C--N 1.353 0.76 0 O-C-N 121.2 -0.937 . . . . 0.0 110.387 -176.235 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 85.9 m -102.31 151.72 21.91 Favored 'General case' 0 C--N 1.356 0.855 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 170.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 40.0 m -128.16 160.18 32.84 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 101.774 -3.417 . . . . 0.0 101.774 176.096 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.2 t -51.15 -40.23 58.1 Favored 'General case' 0 C--N 1.345 0.393 0 C-N-CA 126.138 1.775 . . . . 0.0 115.461 -169.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -78.95 -1.5 85.01 Favored Glycine 0 C--N 1.351 1.374 0 N-CA-C 116.226 1.25 . . . . 0.0 116.226 178.535 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -145.9 135.45 23.17 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-N 120.34 2.07 . . . . 0.0 112.628 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 34.7 m120 -98.55 101.09 12.42 Favored 'General case' 0 C--N 1.353 0.744 0 O-C-N 119.833 -1.792 . . . . 0.0 106.491 172.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -130.42 95.02 3.78 Favored 'General case' 0 N--CA 1.446 -0.649 0 O-C-N 121.811 -0.556 . . . . 0.0 109.905 -164.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 73.1 m -136.05 156.54 76.94 Favored Pre-proline 0 C--N 1.351 0.633 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 170.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.85 160.44 49.67 Favored 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 122.478 2.119 . . . . 0.0 110.611 162.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 64.6 mm-40 -64.76 137.98 58.11 Favored 'General case' 0 C--N 1.351 0.673 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -174.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.37 -10.67 67.24 Favored Glycine 0 C--N 1.356 1.643 0 C-N-CA 123.83 0.728 . . . . 0.0 112.879 -174.327 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 71.3 m -115.61 153.74 30.71 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.219 1.008 . . . . 0.0 110.18 179.149 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -132.65 157.82 43.84 Favored 'General case' 0 C--N 1.355 0.836 0 N-CA-C 105.216 -2.142 . . . . 0.0 105.216 175.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 12.7 p -110.21 144.31 39.06 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-N 119.545 1.066 . . . . 0.0 110.666 169.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -85.16 71.63 2.91 Favored Glycine 0 C--N 1.352 1.418 0 N-CA-C 110.031 -1.228 . . . . 0.0 110.031 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -93.18 121.31 34.41 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 -172.199 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -88.71 82.65 6.79 Favored 'General case' 0 C--N 1.351 0.644 0 O-C-N 120.753 -1.217 . . . . 0.0 110.011 -162.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 64.21 37.29 94.34 Favored Glycine 0 C--N 1.354 1.578 0 O-C-N 121.029 -1.045 . . . . 0.0 115.197 167.511 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 47.49 44.64 16.96 Favored 'General case' 0 C--N 1.352 0.717 0 C-N-CA 128.811 2.844 . . . . 0.0 115.847 -173.119 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 64.0 m-80 -90.66 -61.43 1.68 Allowed 'General case' 0 C--N 1.357 0.892 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 171.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -127.36 -103.77 0.33 Allowed 'General case' 0 C--N 1.356 0.887 0 O-C-N 120.964 -1.085 . . . . 0.0 112.851 -169.123 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -152.37 159.98 43.36 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -169.241 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -164.68 151.5 20.6 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 111.174 -0.771 . . . . 0.0 111.174 -176.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 79.1 t60 -96.96 143.64 27.63 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 121.812 -0.816 . . . . 0.0 109.763 -171.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 74.4 m -76.94 139.38 40.15 Favored 'General case' 0 C--N 1.356 0.853 0 O-C-N 121.008 -1.057 . . . . 0.0 112.139 -178.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -123.96 151.01 44.11 Favored 'General case' 0 C--N 1.351 0.642 0 N-CA-C 106.962 -1.495 . . . . 0.0 106.962 -179.309 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -100.3 134.11 43.72 Favored 'General case' 0 C--N 1.346 0.453 0 C-N-CA 124.224 1.009 . . . . 0.0 108.317 173.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 96.6 mt -101.41 124.78 55.36 Favored 'Isoleucine or valine' 0 C--N 1.356 0.885 0 CA-C-O 122.08 0.943 . . . . 0.0 109.323 171.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -128.04 148.53 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 C-N-CA 125.827 1.651 . . . . 0.0 108.592 175.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 172.53 -167.3 40.18 Favored Glycine 0 CA--C 1.492 -1.346 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 47.4 p30 . . . . . 0 C--O 1.258 1.537 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 178.416 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 5.4 t80 . . . . . 0 N--CA 1.503 2.178 0 N-CA-C 115.828 1.788 . . . . 0.0 115.828 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -118.38 148.31 42.65 Favored 'General case' 0 C--N 1.356 0.863 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 162.378 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.0 p -120.74 134.99 62.39 Favored 'Isoleucine or valine' 0 C--N 1.35 0.626 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 174.057 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.7 m -131.76 160.01 42.69 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.603 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 177.135 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 94.5 p -77.26 153.71 33.7 Favored 'General case' 0 C--N 1.352 0.685 0 O-C-N 120.95 -1.094 . . . . 0.0 111.614 171.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 11.2 t -94.76 -8.68 36.89 Favored 'General case' 0 C--N 1.352 0.682 0 O-C-N 121.099 -1.001 . . . . 0.0 109.721 178.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 62.1 t30 58.44 45.23 16.95 Favored 'General case' 0 C--N 1.355 0.83 0 C-N-CA 128.4 2.68 . . . . 0.0 112.666 -173.274 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 53.5 tptt -133.12 135.89 45.48 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 177.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -91.14 136.26 33.21 Favored 'General case' 0 C--N 1.352 0.712 0 C-N-CA 125.429 1.492 . . . . 0.0 108.788 -178.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 25.2 p -129.16 150.09 50.69 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-O 122.093 0.949 . . . . 0.0 110.771 176.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 90.5 m -125.3 148.27 48.77 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 104.551 -2.388 . . . . 0.0 104.551 -174.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 80.9 p -57.92 -42.52 84.95 Favored 'General case' 0 C--N 1.353 0.734 0 N-CA-C 117.529 2.418 . . . . 0.0 117.529 -159.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -78.71 -48.96 6.83 Favored Glycine 0 C--N 1.353 1.492 0 CA-C-N 119.408 1.004 . . . . 0.0 113.475 176.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.6 mp0 -67.27 -43.97 80.49 Favored 'General case' 0 C--N 1.35 0.589 0 C-N-CA 125.143 1.377 . . . . 0.0 113.458 -174.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 54.09 45.1 28.21 Favored 'General case' 0 C--N 1.355 0.826 0 C-N-CA 129.004 2.922 . . . . 0.0 115.136 169.051 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 53.7 mp0 -75.97 123.54 25.9 Favored 'General case' 0 C--N 1.36 1.057 0 O-C-N 119.68 -1.887 . . . . 0.0 113.518 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 73.3 m -135.94 154.99 78.08 Favored Pre-proline 0 C--N 1.35 0.593 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 159.078 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.65 161.34 45.58 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.727 2.285 . . . . 0.0 110.998 167.196 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -62.92 130.76 46.19 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 121.483 0.659 . . . . 0.0 112.469 -175.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 100.63 -14.23 59.21 Favored Glycine 0 C--N 1.355 1.608 0 C-N-CA 123.675 0.655 . . . . 0.0 112.62 -173.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 73.9 m -113.3 153.71 28.01 Favored 'General case' 0 C--N 1.349 0.579 0 C-N-CA 123.92 0.888 . . . . 0.0 109.892 176.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -134.85 155.56 50.45 Favored 'General case' 0 C--N 1.352 0.705 0 O-C-N 121.235 -0.915 . . . . 0.0 110.3 -177.23 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 47.3 t -91.67 125.59 36.46 Favored 'General case' 0 C--N 1.351 0.652 0 C-N-CA 124.619 1.168 . . . . 0.0 111.788 -169.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -84.77 60.37 4.82 Favored Glycine 0 C--N 1.352 1.459 0 O-C-N 121.375 -0.828 . . . . 0.0 113.435 174.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -117.87 122.14 42.57 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 174.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -119.8 144.94 47.04 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 -173.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 76.39 10.43 85.59 Favored Glycine 0 C--N 1.355 1.636 0 O-C-N 121.547 -0.721 . . . . 0.0 114.806 166.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 55.7 46.29 22.86 Favored 'General case' 0 C--N 1.35 0.612 0 C-N-CA 126.655 1.982 . . . . 0.0 114.375 -175.105 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 -87.98 -109.09 0.07 Allowed 'General case' 0 C--N 1.356 0.869 0 O-C-N 121.469 -0.769 . . . . 0.0 112.558 -179.357 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -105.4 -107.29 0.3 Allowed 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.498 -1.376 . . . . 0.0 114.568 -169.375 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -114.37 154.23 28.43 Favored 'General case' 0 N--CA 1.439 -0.978 0 C-N-CA 126.882 2.073 . . . . 0.0 108.095 179.051 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -133.37 178.66 18.06 Favored Glycine 0 CA--C 1.493 -1.295 0 N-CA-C 107.233 -2.347 . . . . 0.0 107.233 173.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 40.9 t60 -128.2 147.6 50.58 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 105.052 -2.203 . . . . 0.0 105.052 177.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 79.9 m -83.26 140.86 32.26 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.036 -1.04 . . . . 0.0 112.408 -173.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -121.59 161.92 21.56 Favored 'General case' 0 C--N 1.356 0.885 0 O-C-N 121.42 -0.8 . . . . 0.0 108.871 -178.124 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -120.18 135.14 55.07 Favored 'General case' 0 C--N 1.35 0.588 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 167.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 78.5 mt -101.25 126.46 55.04 Favored 'Isoleucine or valine' 0 C--N 1.357 0.934 0 C-N-CA 125.134 1.374 . . . . 0.0 108.41 171.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.76 156.85 42.75 Favored 'Isoleucine or valine' 0 C--N 1.35 0.614 0 C-N-CA 124.947 1.299 . . . . 0.0 109.423 177.007 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 89.58 8.02 68.39 Favored Glycine 0 C--N 1.355 1.638 0 O-C-N 121.023 -1.048 . . . . 0.0 113.115 -176.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 17.2 p-10 . . . . . 0 C--O 1.259 1.566 0 N-CA-C 114.73 1.381 . . . . 0.0 114.73 179.203 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 6.4 t80 . . . . . 0 N--CA 1.505 2.306 0 N-CA-C 116.097 1.888 . . . . 0.0 116.097 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 52.5 m-20 -116.58 152.36 34.32 Favored 'General case' 0 C--N 1.355 0.835 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 164.602 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.1 p -123.22 134.47 66.15 Favored 'Isoleucine or valine' 0 C--N 1.348 0.522 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 174.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.7 m -131.24 157.99 43.27 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.802 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.3 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 80.4 p -83.65 151.08 25.48 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 122.151 0.977 . . . . 0.0 113.471 176.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 83.2 m -96.01 -2.76 46.24 Favored 'General case' 0 C--N 1.356 0.859 0 C-N-CA 123.927 0.891 . . . . 0.0 110.472 173.478 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 59.5 t30 57.19 45.23 20.91 Favored 'General case' 0 C--N 1.35 0.592 0 C-N-CA 129.093 2.957 . . . . 0.0 114.241 178.141 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.6 mmmt -130.07 147.57 51.83 Favored 'General case' 0 CA--C 1.506 -0.719 0 C-N-CA 126.877 2.071 . . . . 0.0 105.972 170.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -85.47 174.76 9.27 Favored 'General case' 0 C--N 1.354 0.8 0 CA-C-N 118.751 0.705 . . . . 0.0 110.228 173.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 17.0 p -126.89 -178.9 4.57 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 105.416 -2.068 . . . . 0.0 105.416 162.021 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 31.1 m -134.03 142.31 47.55 Favored 'General case' 0 CA--C 1.504 -0.824 1 N-CA-C 99.917 -4.105 . . . . 0.0 99.917 165.398 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 35.2 t -59.05 -44.58 91.81 Favored 'General case' 0 C--N 1.351 0.667 0 CA-C-N 120.508 1.504 . . . . 0.0 115.031 -163.702 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.9 -45.09 65.2 Favored Glycine 0 C--N 1.354 1.559 0 O-C-N 121.231 -0.918 . . . . 0.0 115.294 176.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -70.07 -43.51 71.03 Favored 'General case' 0 C--N 1.351 0.666 0 C-N-CA 125.113 1.365 . . . . 0.0 112.838 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 55.22 46.59 23.45 Favored 'General case' 0 C--N 1.353 0.72 0 C-N-CA 130.507 3.523 . . . . 0.0 112.694 -178.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -62.9 124.45 21.1 Favored 'General case' 0 C--N 1.359 1.012 0 C-N-CA 125.574 1.55 . . . . 0.0 113.455 177.143 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 86.0 m -143.3 159.66 54.55 Favored Pre-proline 0 C--N 1.351 0.665 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 159.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -68.7 156.61 64.91 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 122.746 2.298 . . . . 0.0 110.783 162.244 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -63.65 131.63 48.59 Favored 'General case' 0 C--N 1.352 0.707 0 CA-C-O 121.607 0.718 . . . . 0.0 112.804 -173.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.19 -12.31 61.98 Favored Glycine 0 C--N 1.356 1.676 0 O-C-N 121.605 -0.684 . . . . 0.0 112.896 -175.498 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 79.2 m -111.93 156.46 22.06 Favored 'General case' 0 C--N 1.349 0.56 0 C-N-CA 124.039 0.936 . . . . 0.0 108.914 177.191 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -138.13 159.96 40.66 Favored 'General case' 0 C--N 1.35 0.599 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 -177.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 41.9 t -117.33 121.14 40.32 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -88.91 93.44 1.9 Allowed Glycine 0 C--N 1.352 1.446 0 N-CA-C 107.943 -2.063 . . . . 0.0 107.943 177.061 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.418 HD21 ' O ' ' A' ' 46' ' ' LYS . 2.2 tm? -102.39 120.52 40.64 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 -167.176 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.483 HD22 ' H ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -89.65 115.11 26.79 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-O 123.18 1.466 . . . . 0.0 113.588 -177.84 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 69.64 14.19 69.5 Favored Glycine 0 C--N 1.356 1.685 0 N-CA-C 116.929 1.532 . . . . 0.0 116.929 159.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 60.22 27.73 17.26 Favored 'General case' 0 C--N 1.353 0.731 0 C-N-CA 126.672 1.989 . . . . 0.0 113.877 -176.04 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 65.4 m-80 -82.55 -46.79 12.91 Favored 'General case' 0 C--N 1.353 0.735 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 -172.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.418 ' O ' HD21 ' A' ' 41' ' ' LEU . 56.4 mtmt -139.24 -177.92 5.13 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-O 122.298 1.047 . . . . 0.0 108.261 -161.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.8 ptpp? -64.02 -37.71 88.42 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 126.9 2.08 . . . . 0.0 116.299 170.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.17 -162.38 53.0 Favored Glycine 0 C--N 1.355 1.591 0 O-C-N 119.494 -2.004 . . . . 0.0 112.678 -173.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 19.1 t60 -157.29 152.78 26.47 Favored 'General case' 0 C--N 1.356 0.876 0 N-CA-C 105.755 -1.942 . . . . 0.0 105.755 174.094 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 71.4 m -85.47 139.41 31.52 Favored 'General case' 0 C--N 1.357 0.896 0 O-C-N 120.581 -1.324 . . . . 0.0 113.469 -176.37 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -126.19 163.12 23.85 Favored 'General case' 0 C--N 1.357 0.926 0 C-N-CA 123.813 0.845 . . . . 0.0 109.447 -172.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 40.8 ttpt -121.23 136.97 54.88 Favored 'General case' 0 C--N 1.352 0.697 0 C-N-CA 125.336 1.454 . . . . 0.0 109.695 167.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 82.2 mt -94.03 124.4 46.48 Favored 'Isoleucine or valine' 0 C--N 1.361 1.078 0 C-N-CA 125.337 1.455 . . . . 0.0 109.687 172.416 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.72 140.02 49.14 Favored 'Isoleucine or valine' 0 C--N 1.351 0.643 0 C-N-CA 124.786 1.234 . . . . 0.0 109.977 173.194 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 166.06 177.77 38.41 Favored Glycine 0 CA--C 1.491 -1.422 0 N-CA-C 108.713 -1.755 . . . . 0.0 108.713 178.479 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 . . . . . 0 C--O 1.26 1.657 0 CA-C-O 117.488 -1.244 . . . . 0.0 111.503 178.56 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 9.4 t80 . . . . . 0 N--CA 1.503 2.186 0 N-CA-C 116.635 2.087 . . . . 0.0 116.635 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -123.12 148.36 45.77 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 161.59 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.1 p -119.53 132.0 70.55 Favored 'Isoleucine or valine' 0 C--N 1.351 0.662 0 N-CA-C 106.757 -1.572 . . . . 0.0 106.757 168.679 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.8 m -134.95 155.34 38.04 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.568 0 C-N-CA 124.795 1.238 . . . . 0.0 108.482 -177.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 89.6 p -79.73 157.48 27.14 Favored 'General case' 0 C--N 1.349 0.577 0 CA-C-O 122.25 1.024 . . . . 0.0 113.469 177.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 96.2 m -105.42 10.31 33.38 Favored 'General case' 0 C--N 1.352 0.703 0 C-N-CA 123.978 0.911 . . . . 0.0 111.971 177.023 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 53.7 t30 56.39 44.16 24.94 Favored 'General case' 0 C--N 1.355 0.825 0 C-N-CA 127.029 2.132 . . . . 0.0 113.166 -178.662 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 52.3 tptt -139.98 134.83 32.05 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.752 -1.217 . . . . 0.0 109.224 -177.087 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 60.8 t-20 -87.09 121.18 29.19 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.184 1.793 . . . . 0.0 109.564 179.028 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 27.8 p -116.94 167.25 11.3 Favored 'General case' 0 C--N 1.35 0.618 0 C-N-CA 123.917 0.887 . . . . 0.0 108.741 173.525 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 73.7 m -129.51 146.11 51.38 Favored 'General case' 0 C--N 1.349 0.561 0 N-CA-C 104.063 -2.569 . . . . 0.0 104.063 170.208 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.502 ' HB2' HD12 ' A' ' 41' ' ' LEU . 33.4 t -57.75 -38.43 75.35 Favored 'General case' 0 C--N 1.355 0.807 0 C-N-CA 126.418 1.887 . . . . 0.0 113.727 -170.192 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -90.86 9.41 77.83 Favored Glycine 0 C--N 1.35 1.308 0 O-C-N 121.193 -0.942 . . . . 0.0 113.59 177.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 22.1 mm-40 -118.2 -43.33 2.74 Favored 'General case' 0 C--N 1.351 0.637 0 O-C-N 121.479 -1.012 . . . . 0.0 111.088 176.653 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 22.1 m120 56.17 38.04 29.45 Favored 'General case' 0 C--N 1.358 0.957 0 C-N-CA 127.38 2.272 . . . . 0.0 115.23 176.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -86.32 108.67 18.53 Favored 'General case' 0 C--N 1.351 0.654 0 O-C-N 120.683 -1.261 . . . . 0.0 110.785 -178.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 91.5 m -134.64 157.73 76.63 Favored Pre-proline 0 C--N 1.351 0.636 0 C-N-CA 125.033 1.333 . . . . 0.0 108.476 175.253 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -69.98 161.27 46.6 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.877 2.385 . . . . 0.0 111.206 168.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -64.28 134.83 55.47 Favored 'General case' 0 C--N 1.353 0.743 0 CA-C-O 121.646 0.736 . . . . 0.0 112.591 -174.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.53 -10.89 68.94 Favored Glycine 0 C--N 1.354 1.561 0 C-N-CA 123.473 0.558 . . . . 0.0 113.027 -174.427 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 85.6 m -114.8 154.6 28.28 Favored 'General case' 0 C--N 1.351 0.634 0 CA-C-N 118.034 0.917 . . . . 0.0 109.33 -179.548 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -131.35 160.4 35.14 Favored 'General case' 0 C--N 1.351 0.65 0 O-C-N 121.211 -0.93 . . . . 0.0 108.533 -179.307 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 43.2 t -89.45 119.76 30.18 Favored 'General case' 0 C--N 1.353 0.728 0 O-C-N 121.533 -0.73 . . . . 0.0 109.688 -175.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -90.21 63.8 3.04 Favored Glycine 0 C--N 1.353 1.494 0 O-C-N 121.168 -0.957 . . . . 0.0 114.003 -175.584 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.502 HD12 ' HB2' ' A' ' 28' ' ' SER . 2.4 tm? -132.87 132.84 42.55 Favored 'General case' 0 C--N 1.352 0.712 0 CA-C-N 118.761 1.281 . . . . 0.0 108.414 177.371 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.43 ' N ' HD13 ' A' ' 41' ' ' LEU . 1.8 mm? -115.8 133.4 56.07 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 -175.103 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.79 5.85 86.72 Favored Glycine 0 C--N 1.356 1.677 0 N-CA-C 115.92 1.128 . . . . 0.0 115.92 166.393 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 56.42 40.5 29.64 Favored 'General case' 0 C--N 1.349 0.557 0 C-N-CA 127.224 2.209 . . . . 0.0 113.731 -173.262 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 62.0 m-80 -67.78 -46.56 71.65 Favored 'General case' 0 C--N 1.355 0.824 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 172.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -139.4 -133.46 0.12 Allowed 'General case' 0 C--N 1.351 0.668 0 CA-C-O 121.718 0.771 . . . . 0.0 109.236 -177.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.5 pttm -103.46 -56.71 2.16 Favored 'General case' 0 C--N 1.351 0.648 0 C-N-CA 125.522 1.529 . . . . 0.0 113.444 -178.721 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 94.4 175.98 38.84 Favored Glycine 0 C--N 1.352 1.441 0 CA-C-O 122.843 1.246 . . . . 0.0 111.444 -171.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 51.6 t60 -149.0 152.95 37.19 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 102.692 -3.077 . . . . 0.0 102.692 177.451 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 79.1 m -81.85 135.19 35.45 Favored 'General case' 0 C--N 1.351 0.672 0 O-C-N 121.054 -1.029 . . . . 0.0 112.244 -174.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 13.1 m-30 -123.9 160.68 26.95 Favored 'General case' 0 C--N 1.357 0.896 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -178.001 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 20.2 pttm -121.36 150.98 40.66 Favored 'General case' 0 C--N 1.35 0.606 0 CA-C-O 121.689 0.757 . . . . 0.0 109.653 160.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 83.7 mt -114.36 130.54 68.48 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.788 0 C-N-CA 124.861 1.264 . . . . 0.0 109.976 176.327 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.61 140.41 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 C-N-CA 126.679 1.991 . . . . 0.0 109.053 178.379 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 140.56 -140.48 10.56 Favored Glycine 0 C--N 1.35 1.35 0 N-CA-C 107.426 -2.269 . . . . 0.0 107.426 -172.029 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 . . . . . 0 C--O 1.26 1.633 0 CA-C-O 117.871 -1.062 . . . . 0.0 113.786 -179.546 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 11.8 t80 . . . . . 0 N--CA 1.504 2.259 0 N-CA-C 115.996 1.85 . . . . 0.0 115.996 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -116.87 154.12 31.33 Favored 'General case' 0 C--N 1.356 0.855 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 164.425 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.5 p -126.69 134.6 65.9 Favored 'Isoleucine or valine' 0 C--N 1.35 0.619 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 178.07 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 33.1 m -132.69 162.75 39.38 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 C-N-CA 124.585 1.154 . . . . 0.0 108.209 -179.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 78.5 p -72.9 145.06 47.11 Favored 'General case' 0 C--N 1.351 0.668 0 O-C-N 120.606 -1.309 . . . . 0.0 113.866 174.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 34.1 t -95.34 -10.12 31.0 Favored 'General case' 0 C--N 1.356 0.886 0 O-C-N 121.219 -0.926 . . . . 0.0 111.314 -179.506 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 54.0 t30 59.87 41.8 17.37 Favored 'General case' 0 C--N 1.355 0.835 0 C-N-CA 127.406 2.283 . . . . 0.0 112.874 -175.23 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 24.7 mmmt -130.83 144.21 51.29 Favored 'General case' 0 C--N 1.353 0.747 0 C-N-CA 124.571 1.148 . . . . 0.0 111.483 175.198 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 20.1 t30 -93.65 123.39 36.95 Favored 'General case' 0 C--N 1.354 0.796 0 CA-C-O 122.214 1.007 . . . . 0.0 110.231 -173.445 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 14.4 t -105.69 152.9 22.57 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 128.483 2.713 . . . . 0.0 107.638 176.298 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 42.1 m -131.09 160.07 35.74 Favored 'General case' 0 C--N 1.355 0.844 0 N-CA-C 104.729 -2.323 . . . . 0.0 104.729 172.24 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.5 t -62.35 -43.25 99.26 Favored 'General case' 0 C--N 1.353 0.737 0 O-C-N 120.083 -1.635 . . . . 0.0 112.966 174.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -63.76 -41.5 98.88 Favored Glycine 0 C--N 1.357 1.738 0 C-N-CA 124.397 0.998 . . . . 0.0 115.127 176.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 27.1 pt20 -132.53 117.01 17.45 Favored 'General case' 0 C--N 1.35 0.621 0 CA-C-O 122.698 1.237 . . . . 0.0 110.053 175.147 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 24.2 m120 -91.89 79.56 5.28 Favored 'General case' 0 C--N 1.353 0.742 0 O-C-N 120.514 -1.366 . . . . 0.0 108.644 -174.653 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -97.72 109.7 22.41 Favored 'General case' 0 C--N 1.35 0.612 0 O-C-N 120.906 -1.121 . . . . 0.0 110.885 -170.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 80.9 m -134.27 153.09 79.23 Favored Pre-proline 0 C--N 1.351 0.631 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 172.028 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -72.17 162.23 42.3 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 123.145 2.563 . . . . 0.0 111.036 168.718 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -64.92 135.15 55.36 Favored 'General case' 0 C--N 1.353 0.725 0 CA-C-O 121.647 0.736 . . . . 0.0 112.19 -178.521 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.76 -14.31 63.08 Favored Glycine 0 C--N 1.354 1.583 0 C-N-CA 123.779 0.704 . . . . 0.0 112.375 -171.589 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 76.7 m -113.76 155.24 25.99 Favored 'General case' 0 C--N 1.349 0.582 0 C-N-CA 124.236 1.014 . . . . 0.0 109.894 175.517 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -139.74 161.07 38.42 Favored 'General case' 0 C--N 1.352 0.714 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 -176.351 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 41.2 t -122.13 124.09 43.09 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 173.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -100.99 106.51 3.1 Favored Glycine 0 C--N 1.352 1.47 0 N-CA-C 107.092 -2.403 . . . . 0.0 107.092 170.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -101.13 120.1 39.72 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 -168.533 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -87.55 89.34 7.96 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-O 122.662 1.22 . . . . 0.0 113.122 -174.284 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 64.05 32.52 84.44 Favored Glycine 0 C--N 1.358 1.762 0 N-CA-C 117.226 1.65 . . . . 0.0 117.226 160.129 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.8 pm0 46.99 36.42 4.06 Favored 'General case' 0 C--N 1.354 0.79 0 C-N-CA 128.511 2.725 . . . . 0.0 115.172 -174.518 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 59.1 m-80 -77.92 -44.71 26.17 Favored 'General case' 0 CA--C 1.505 -0.78 0 C-N-CA 124.785 1.234 . . . . 0.0 112.372 174.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.5 pttm -155.61 174.54 15.12 Favored 'General case' 0 N--CA 1.425 -1.706 0 N-CA-C 106.009 -1.849 . . . . 0.0 106.009 -174.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -62.08 -36.5 81.86 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 129.747 3.219 . . . . 0.0 115.312 -173.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 83.47 -167.5 44.91 Favored Glycine 0 C--N 1.355 1.63 0 O-C-N 120.627 -1.296 . . . . 0.0 112.145 -175.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 69.1 t60 -156.9 151.3 25.33 Favored 'General case' 0 C--N 1.35 0.627 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 177.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 70.9 m -81.24 140.84 34.66 Favored 'General case' 0 C--N 1.356 0.86 0 CA-C-N 119.786 1.176 . . . . 0.0 112.723 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 8.6 m-30 -121.27 157.14 30.98 Favored 'General case' 0 C--N 1.353 0.74 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 -177.429 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 40.6 ttpt -110.42 137.43 48.14 Favored 'General case' 0 C--N 1.349 0.546 0 C-N-CA 124.17 0.988 . . . . 0.0 109.903 173.277 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 97.3 mt -97.12 123.55 49.52 Favored 'Isoleucine or valine' 0 C--N 1.361 1.066 0 C-N-CA 124.546 1.138 . . . . 0.0 109.874 176.657 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.78 138.23 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 C-N-CA 124.431 1.092 . . . . 0.0 108.798 173.285 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 148.95 -159.43 28.03 Favored Glycine 0 C--N 1.35 1.332 0 N-CA-C 108.854 -1.698 . . . . 0.0 108.854 -175.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 17.4 p-10 . . . . . 0 C--O 1.258 1.551 0 N-CA-C 114.823 1.416 . . . . 0.0 114.823 177.928 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 10.7 t80 . . . . . 0 N--CA 1.504 2.237 0 N-CA-C 115.856 1.798 . . . . 0.0 115.856 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -117.37 153.88 32.27 Favored 'General case' 0 C--N 1.355 0.83 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 162.226 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.9 p -128.06 133.39 67.26 Favored 'Isoleucine or valine' 0 C--N 1.349 0.585 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 177.175 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.9 m -134.22 161.55 40.55 Favored 'Isoleucine or valine' 0 C--N 1.352 0.691 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 78.5 p -72.88 144.48 47.39 Favored 'General case' 0 C--N 1.351 0.648 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 177.153 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 29.1 t -99.05 -6.4 28.56 Favored 'General case' 0 C--N 1.356 0.884 0 C-N-CA 123.938 0.895 . . . . 0.0 111.749 -177.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 60.28 46.69 9.91 Favored 'General case' 0 C--N 1.355 0.83 0 C-N-CA 127.016 2.126 . . . . 0.0 112.549 -178.792 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -137.19 140.26 41.64 Favored 'General case' 0 C--N 1.352 0.676 0 O-C-N 120.55 -1.344 . . . . 0.0 107.748 175.079 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.9 t30 -87.29 126.01 34.57 Favored 'General case' 0 C--N 1.356 0.89 0 C-N-CA 124.423 1.089 . . . . 0.0 110.856 -174.676 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 16.9 t -106.15 144.37 32.95 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 126.973 2.109 . . . . 0.0 109.842 175.481 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 16.3 m -134.51 153.06 52.13 Favored 'General case' 0 C--N 1.352 0.68 0 N-CA-C 102.209 -3.256 . . . . 0.0 102.209 170.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 38.7 t -58.87 -44.67 91.13 Favored 'General case' 0 C--N 1.356 0.872 0 CA-C-N 120.685 1.584 . . . . 0.0 114.496 -171.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -81.3 -3.95 90.55 Favored Glycine 0 C--N 1.353 1.478 0 O-C-N 121.299 -0.876 . . . . 0.0 113.989 -177.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -113.98 -48.19 2.92 Favored 'General case' 0 C--N 1.35 0.607 0 CA-C-N 117.693 0.746 . . . . 0.0 110.331 -177.495 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 49.93 48.97 21.09 Favored 'General case' 0 C--N 1.358 0.958 0 C-N-CA 130.492 3.517 . . . . 0.0 112.261 176.497 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 52.3 mm-40 -96.5 115.39 27.35 Favored 'General case' 0 C--N 1.353 0.731 0 O-C-N 120.745 -1.222 . . . . 0.0 111.714 -167.45 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 81.7 m -134.28 154.27 79.86 Favored Pre-proline 0 C--N 1.35 0.612 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 174.007 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -71.27 161.04 47.05 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.68 2.254 . . . . 0.0 111.044 168.711 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -63.23 130.82 46.18 Favored 'General case' 0 C--N 1.352 0.714 0 C-N-CA 123.33 0.652 . . . . 0.0 111.598 -176.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 100.63 -13.92 59.32 Favored Glycine 0 C--N 1.354 1.58 0 C-N-CA 123.754 0.692 . . . . 0.0 112.469 -173.041 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 82.2 m -112.71 154.51 26.02 Favored 'General case' 0 C--N 1.349 0.573 0 C-N-CA 124.022 0.929 . . . . 0.0 110.134 175.414 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -137.28 159.89 40.63 Favored 'General case' 0 C--N 1.354 0.783 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 -175.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 40.6 t -111.6 119.05 37.4 Favored 'General case' 0 C--N 1.35 0.624 0 CA-C-O 121.81 0.814 . . . . 0.0 109.843 174.704 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -92.63 69.23 1.73 Allowed Glycine 0 C--N 1.35 1.339 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 173.072 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 60.1 tp -105.8 123.31 47.74 Favored 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 172.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -113.62 130.45 56.39 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 -173.416 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.2 5.04 70.26 Favored Glycine 0 C--N 1.355 1.627 0 N-CA-C 115.946 1.138 . . . . 0.0 115.946 162.395 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 55.9 47.13 20.71 Favored 'General case' 0 C--N 1.351 0.635 0 C-N-CA 126.357 1.863 . . . . 0.0 113.696 -170.372 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 -64.98 -49.29 70.86 Favored 'General case' 0 C--N 1.356 0.849 0 N-CA-C 115.098 1.518 . . . . 0.0 115.098 173.056 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -144.32 -120.81 0.08 Allowed 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 175.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 15.7 ptpt -115.27 -35.14 4.75 Favored 'General case' 0 N--CA 1.439 -1.013 0 C-N-CA 127.171 2.188 . . . . 0.0 114.238 -176.559 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 75.51 -162.48 53.3 Favored Glycine 0 C--N 1.355 1.638 0 O-C-N 119.993 -1.692 . . . . 0.0 110.464 -171.074 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 67.8 t60 -157.95 159.95 37.05 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 103.454 -2.795 . . . . 0.0 103.454 170.193 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 77.1 m -79.23 139.09 38.02 Favored 'General case' 0 C--N 1.352 0.717 0 CA-C-N 120.226 1.375 . . . . 0.0 112.44 175.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -124.42 155.92 38.03 Favored 'General case' 0 C--N 1.353 0.731 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 -175.125 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -108.23 137.39 46.29 Favored 'General case' 0 C--N 1.348 0.512 0 C-N-CA 124.645 1.178 . . . . 0.0 109.153 173.408 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 95.8 mt -97.14 122.73 48.98 Favored 'Isoleucine or valine' 0 C--N 1.361 1.076 0 C-N-CA 124.185 0.994 . . . . 0.0 109.288 173.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.25 158.21 43.24 Favored 'Isoleucine or valine' 0 C--N 1.35 0.611 0 C-N-CA 124.495 1.118 . . . . 0.0 109.512 177.774 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 97.03 -12.66 65.5 Favored Glycine 0 C--N 1.355 1.622 0 O-C-N 121.218 -0.926 . . . . 0.0 113.667 -179.602 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 . . . . . 0 CA--C 1.569 1.69 0 O-C-N 121.101 -1.234 . . . . 0.0 111.918 176.128 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 6.9 t80 . . . . . 0 N--CA 1.504 2.275 0 N-CA-C 116.23 1.937 . . . . 0.0 116.23 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -120.15 151.64 38.8 Favored 'General case' 0 C--N 1.354 0.79 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 161.07 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.6 p -123.5 136.29 60.52 Favored 'Isoleucine or valine' 0 C--N 1.35 0.589 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 178.094 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 28.9 m -130.5 156.46 42.5 Favored 'Isoleucine or valine' 0 C--N 1.35 0.594 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 175.248 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 87.2 p -79.62 150.38 31.03 Favored 'General case' 0 C--N 1.351 0.646 0 O-C-N 121.093 -1.004 . . . . 0.0 112.375 174.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 14.4 t -98.7 -10.7 22.82 Favored 'General case' 0 C--N 1.352 0.712 0 O-C-N 121.269 -0.894 . . . . 0.0 109.748 178.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 59.73 42.83 16.25 Favored 'General case' 0 C--N 1.355 0.836 0 C-N-CA 128.208 2.603 . . . . 0.0 114.459 178.642 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 55.9 tptt -122.16 135.71 54.82 Favored 'General case' 0 C--N 1.35 0.623 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 172.07 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -88.31 127.63 35.48 Favored 'General case' 0 C--N 1.355 0.811 0 C-N-CA 125.096 1.358 . . . . 0.0 109.765 -178.725 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 6.7 t -119.39 133.57 55.65 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 124.973 1.309 . . . . 0.0 111.249 -177.502 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 88.9 m -117.98 146.22 44.17 Favored 'General case' 0 C--N 1.351 0.666 0 N-CA-C 103.987 -2.597 . . . . 0.0 103.987 -178.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 84.8 p -59.22 -41.74 89.34 Favored 'General case' 0 C--N 1.35 0.618 0 N-CA-C 116.665 2.098 . . . . 0.0 116.665 -165.071 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.14 -36.81 93.72 Favored Glycine 0 C--N 1.351 1.362 0 C-N-CA 124.517 1.056 . . . . 0.0 114.268 172.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 23.9 mm100 -77.57 -47.69 18.82 Favored 'General case' 0 C--N 1.351 0.654 0 C-N-CA 123.804 0.842 . . . . 0.0 111.565 -177.084 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 52.23 39.95 28.0 Favored 'General case' 0 C--N 1.354 0.795 0 C-N-CA 128.628 2.771 . . . . 0.0 112.69 179.201 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -100.97 135.84 41.77 Favored 'General case' 0 C--N 1.356 0.879 0 O-C-N 120.571 -1.331 . . . . 0.0 113.353 -168.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 72.5 m -136.88 159.93 68.24 Favored Pre-proline 0 C--N 1.352 0.681 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 161.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -69.44 160.97 47.75 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.585 2.19 . . . . 0.0 110.556 162.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -64.59 136.95 57.54 Favored 'General case' 0 C--N 1.351 0.649 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -171.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.86 -12.3 65.87 Favored Glycine 0 C--N 1.355 1.621 0 C-N-CA 123.918 0.77 . . . . 0.0 112.832 -175.086 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 72.7 m -115.19 154.71 28.51 Favored 'General case' 0 C--N 1.348 0.507 0 C-N-CA 124.494 1.117 . . . . 0.0 109.533 179.182 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -133.36 154.79 50.43 Favored 'General case' 0 C--N 1.354 0.777 0 O-C-N 121.184 -0.948 . . . . 0.0 110.483 -177.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 43.8 t -104.85 119.26 38.59 Favored 'General case' 0 C--N 1.355 0.821 0 C-N-CA 124.479 1.112 . . . . 0.0 109.029 -177.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -90.48 69.99 2.22 Favored Glycine 0 C--N 1.351 1.417 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 175.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -107.79 123.73 48.99 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 178.3 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -117.17 138.06 51.92 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 -166.147 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.7 14.63 72.83 Favored Glycine 0 C--N 1.358 1.773 0 N-CA-C 115.99 1.156 . . . . 0.0 115.99 164.086 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 55.96 43.79 26.71 Favored 'General case' 0 C--N 1.349 0.556 0 C-N-CA 127.629 2.371 . . . . 0.0 113.213 -169.007 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 59.8 m-80 -70.13 168.16 16.22 Favored 'General case' 0 C--N 1.356 0.881 0 O-C-N 120.777 -1.202 . . . . 0.0 110.924 163.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -68.42 -48.27 65.07 Favored 'General case' 0 C--N 1.349 0.554 0 N-CA-C 116.005 1.854 . . . . 0.0 116.005 -163.529 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 79.9 mttt -136.36 150.1 48.67 Favored 'General case' 0 C--N 1.352 0.689 0 C-N-CA 123.492 0.717 . . . . 0.0 111.324 -176.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -136.66 168.58 24.15 Favored Glycine 0 C--N 1.348 1.195 0 N-CA-C 106.683 -2.567 . . . . 0.0 106.683 171.429 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 70.1 t60 -125.6 144.59 50.51 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 -176.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 74.7 m -80.43 137.63 36.52 Favored 'General case' 0 C--N 1.351 0.669 0 O-C-N 121.18 -0.95 . . . . 0.0 112.885 -176.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -126.22 162.65 24.94 Favored 'General case' 0 C--N 1.357 0.928 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -174.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -123.18 136.84 54.93 Favored 'General case' 0 C--N 1.35 0.626 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 166.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 81.1 mt -100.66 127.41 53.79 Favored 'Isoleucine or valine' 0 C--N 1.358 0.945 0 C-N-CA 125.741 1.616 . . . . 0.0 109.232 175.366 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.37 157.24 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 C-N-CA 124.967 1.307 . . . . 0.0 109.774 177.081 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 98.71 -110.31 3.98 Favored Glycine 0 C--N 1.353 1.503 0 N-CA-C 108.922 -1.671 . . . . 0.0 108.922 -170.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 64.4 t30 . . . . . 0 CA--C 1.569 1.696 0 CA-C-O 117.057 -1.449 . . . . 0.0 114.678 174.759 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 49.4 t80 . . . . . 0 N--CA 1.503 2.222 0 N-CA-C 117.675 2.472 . . . . 0.0 117.675 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -120.12 154.33 34.87 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 106.374 -1.713 . . . . 0.0 106.374 156.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.7 p -125.69 135.42 63.99 Favored 'Isoleucine or valine' 0 C--N 1.35 0.605 0 N-CA-C 106.271 -1.752 . . . . 0.0 106.271 170.189 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.687 HG22 HD11 ' A' ' 54' ' ' ILE . 27.0 m -134.0 161.46 40.85 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.912 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -179.777 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 89.5 p -77.15 151.99 35.07 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 121.835 0.826 . . . . 0.0 112.105 170.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 18.1 t -110.37 16.99 21.3 Favored 'General case' 0 C--N 1.352 0.706 0 C-N-CA 124.155 0.982 . . . . 0.0 110.261 -177.472 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 30.4 m120 57.98 36.5 26.2 Favored 'General case' 0 C--N 1.353 0.734 0 C-N-CA 127.34 2.256 . . . . 0.0 114.504 170.344 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 58.0 tptt -138.38 136.53 36.4 Favored 'General case' 0 C--N 1.354 0.79 0 O-C-N 121.27 -0.894 . . . . 0.0 110.32 -174.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -79.74 128.21 33.15 Favored 'General case' 0 C--N 1.356 0.884 0 C-N-CA 126.7 2.0 . . . . 0.0 112.337 178.177 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 12.0 t -118.01 131.6 56.46 Favored 'General case' 0 C--N 1.351 0.661 0 C-N-CA 126.584 1.954 . . . . 0.0 110.862 -179.512 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 12.6 m -119.89 151.93 38.14 Favored 'General case' 0 C--N 1.353 0.726 0 N-CA-C 105.279 -2.119 . . . . 0.0 105.279 -178.31 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 95.1 p -59.94 -37.02 78.34 Favored 'General case' 0 C--N 1.352 0.688 0 N-CA-C 115.513 1.672 . . . . 0.0 115.513 -168.192 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -93.02 0.12 68.91 Favored Glycine 0 C--N 1.353 1.493 0 O-C-N 121.846 -0.534 . . . . 0.0 113.811 177.168 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -110.97 -46.22 3.36 Favored 'General case' 0 C--N 1.35 0.629 0 CA-C-N 118.294 1.047 . . . . 0.0 111.1 179.262 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 31.2 m120 51.76 45.07 28.76 Favored 'General case' 0 C--N 1.359 0.979 0 C-N-CA 126.597 1.959 . . . . 0.0 114.142 -174.09 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -84.31 115.51 22.52 Favored 'General case' 0 C--N 1.353 0.727 0 O-C-N 121.338 -0.851 . . . . 0.0 112.503 -164.042 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 74.1 m -134.64 157.33 77.5 Favored Pre-proline 0 C--N 1.355 0.829 0 CA-C-O 118.478 -0.772 . . . . 0.0 109.065 172.626 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -70.43 159.35 53.22 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.63 2.22 . . . . 0.0 110.503 161.63 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -65.17 136.59 56.85 Favored 'General case' 0 C--N 1.352 0.694 0 CA-C-O 121.646 0.736 . . . . 0.0 112.63 -177.197 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.64 -13.57 63.92 Favored Glycine 0 C--N 1.354 1.543 0 C-N-CA 123.855 0.74 . . . . 0.0 113.112 -174.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 90.6 m -114.51 157.22 23.27 Favored 'General case' 0 C--N 1.349 0.55 0 C-N-CA 124.525 1.13 . . . . 0.0 109.947 176.707 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 24.8 p90 -137.57 161.17 37.15 Favored 'General case' 0 C--N 1.351 0.65 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 -172.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 43.3 t -118.35 127.36 53.62 Favored 'General case' 0 CA--C 1.507 -0.684 0 O-C-N 121.32 -0.863 . . . . 0.0 110.881 -179.507 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -97.19 78.63 0.67 Allowed Glycine 0 C--N 1.352 1.438 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 167.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -113.63 122.61 47.7 Favored 'General case' 0 C--N 1.352 0.679 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 168.579 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -119.76 146.67 45.45 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 -163.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.84 12.7 78.69 Favored Glycine 0 C--N 1.357 1.713 0 O-C-N 121.73 -0.606 . . . . 0.0 114.435 165.681 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 8.7 mp0 54.91 46.57 24.13 Favored 'General case' 0 C--N 1.351 0.638 0 C-N-CA 126.685 1.994 . . . . 0.0 113.539 -171.083 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -76.16 175.13 9.26 Favored 'General case' 0 C--N 1.357 0.892 0 C-N-CA 124.463 1.105 . . . . 0.0 110.409 166.771 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -64.74 -48.94 72.76 Favored 'General case' 0 C--N 1.348 0.519 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 -154.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 19.4 pttp -163.74 159.05 20.96 Favored 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 178.39 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -137.05 -165.06 10.31 Favored Glycine 0 C--N 1.344 0.996 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 176.694 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 37.3 t60 -143.79 149.18 36.67 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 105.76 -1.941 . . . . 0.0 105.76 -174.27 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 75.0 m -81.86 143.77 31.48 Favored 'General case' 0 C--N 1.352 0.697 0 O-C-N 121.021 -1.049 . . . . 0.0 113.096 -176.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -124.46 158.56 32.54 Favored 'General case' 0 C--N 1.356 0.877 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 -174.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -117.93 136.46 53.47 Favored 'General case' 0 C--N 1.35 0.596 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 166.749 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 80.5 mt -96.72 127.38 48.93 Favored 'Isoleucine or valine' 0 C--N 1.356 0.857 0 C-N-CA 125.307 1.443 . . . . 0.0 108.214 167.126 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.687 HD11 HG22 ' A' ' 20' ' ' VAL . 4.4 mp -116.05 124.32 72.24 Favored 'Isoleucine or valine' 0 C--N 1.354 0.793 0 N-CA-C 103.718 -2.697 . . . . 0.0 103.718 -177.316 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -179.69 -173.35 44.69 Favored Glycine 0 CA--C 1.494 -1.25 0 O-C-N 120.756 -1.215 . . . . 0.0 110.487 -178.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 23.5 p30 . . . . . 0 C--O 1.261 1.699 0 CA-C-O 116.726 -1.607 . . . . 0.0 114.774 -179.001 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 22.7 t80 . . . . . 0 N--CA 1.502 2.14 0 N-CA-C 116.966 2.21 . . . . 0.0 116.966 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -124.67 148.28 48.06 Favored 'General case' 0 C--N 1.353 0.747 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 159.442 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.9 p -124.12 134.05 67.64 Favored 'Isoleucine or valine' 0 C--N 1.349 0.557 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 173.008 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 28.0 m -131.25 154.05 39.99 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.744 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 175.578 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 80.4 p -79.26 151.83 30.92 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 177.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 19.9 t -123.97 33.18 5.36 Favored 'General case' 0 C--N 1.355 0.804 0 CA-C-O 121.761 0.791 . . . . 0.0 109.919 -172.379 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 44.75 37.88 2.51 Favored 'General case' 0 C--N 1.357 0.899 0 C-N-CA 129.016 2.926 . . . . 0.0 118.267 169.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -148.81 143.17 26.16 Favored 'General case' 0 C--N 1.348 0.536 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -175.449 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 33.8 t30 -115.45 135.87 53.66 Favored 'General case' 0 C--N 1.353 0.727 0 C-N-CA 124.27 1.028 . . . . 0.0 110.568 -175.206 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 83.6 m -101.5 152.1 21.17 Favored 'General case' 0 C--N 1.355 0.846 0 C-N-CA 124.151 0.98 . . . . 0.0 108.54 171.252 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 55.5 m -128.17 156.25 43.19 Favored 'General case' 0 CA--C 1.507 -0.682 0 N-CA-C 102.046 -3.316 . . . . 0.0 102.046 174.585 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 46.8 t -52.53 -39.24 61.15 Favored 'General case' 0 C--N 1.349 0.57 0 N-CA-C 115.68 1.733 . . . . 0.0 115.68 -162.19 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -77.28 -0.96 73.25 Favored Glycine 0 C--N 1.351 1.373 0 N-CA-C 116.475 1.35 . . . . 0.0 116.475 178.012 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -143.58 140.78 30.36 Favored 'General case' 0 C--N 1.356 0.858 0 CA-C-N 120.347 2.073 . . . . 0.0 112.009 179.02 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 34.5 m120 -102.15 103.52 14.06 Favored 'General case' 0 C--N 1.352 0.715 0 O-C-N 119.973 -1.705 . . . . 0.0 106.523 170.188 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -126.93 94.32 4.0 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 -168.105 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 72.9 m -136.77 156.88 75.82 Favored Pre-proline 0 C--N 1.351 0.662 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 172.272 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -70.51 160.42 49.55 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.52 2.147 . . . . 0.0 110.64 164.252 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -62.77 134.38 56.19 Favored 'General case' 0 C--N 1.354 0.779 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -174.732 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.25 -11.89 65.34 Favored Glycine 0 C--N 1.355 1.61 0 C-N-CA 124.194 0.902 . . . . 0.0 113.409 -175.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 73.8 m -114.15 153.77 28.96 Favored 'General case' 0 C--N 1.348 0.518 0 C-N-CA 124.145 0.978 . . . . 0.0 110.116 179.019 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 31.5 p90 -132.5 158.22 42.65 Favored 'General case' 0 C--N 1.352 0.684 0 N-CA-C 105.699 -1.963 . . . . 0.0 105.699 178.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 9.8 p -109.69 146.66 34.48 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-O 122.531 1.157 . . . . 0.0 112.923 173.525 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -82.74 69.29 3.39 Favored Glycine 0 C--N 1.353 1.498 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 176.31 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -91.81 122.46 34.37 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 -175.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -86.02 77.34 9.66 Favored 'General case' 0 C--N 1.352 0.701 0 O-C-N 120.709 -1.244 . . . . 0.0 110.829 -161.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 62.61 45.39 95.92 Favored Glycine 0 C--N 1.355 1.594 0 N-CA-C 115.448 0.939 . . . . 0.0 115.448 166.714 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 48.31 43.75 19.4 Favored 'General case' 0 C--N 1.354 0.779 0 C-N-CA 128.474 2.71 . . . . 0.0 115.984 -172.614 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 66.0 m-80 -97.48 -74.08 0.59 Allowed 'General case' 0 C--N 1.356 0.867 0 O-C-N 121.135 -0.978 . . . . 0.0 112.509 170.594 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -119.66 -101.55 0.42 Allowed 'General case' 0 C--N 1.357 0.932 0 O-C-N 120.917 -1.115 . . . . 0.0 113.649 -163.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.4 pptp? -145.76 161.01 40.9 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 -175.7 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -162.39 151.28 21.15 Favored Glycine 0 C--N 1.349 1.297 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 -179.096 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 72.4 t60 -99.19 146.82 25.76 Favored 'General case' 0 C--N 1.347 0.473 0 O-C-N 121.51 -0.994 . . . . 0.0 109.883 -170.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 76.4 m -76.85 136.55 38.9 Favored 'General case' 0 C--N 1.358 0.946 0 O-C-N 121.197 -0.939 . . . . 0.0 112.015 -179.227 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -130.63 161.5 31.44 Favored 'General case' 0 C--N 1.351 0.649 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 -177.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -114.28 132.81 56.03 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 164.32 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 96.3 mt -106.06 127.37 61.25 Favored 'Isoleucine or valine' 0 C--N 1.358 0.973 0 CA-C-O 122.632 1.206 . . . . 0.0 110.243 169.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.75 160.51 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 C-N-CA 126.879 2.071 . . . . 0.0 110.725 -176.733 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 95.19 -73.17 0.95 Allowed Glycine 0 C--N 1.354 1.532 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 -169.112 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 . . . . . 0 C--O 1.26 1.64 0 N-CA-C 115.426 1.639 . . . . 0.0 115.426 176.309 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 42.2 t80 . . . . . 0 N--CA 1.505 2.318 0 N-CA-C 116.815 2.154 . . . . 0.0 116.815 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -121.65 154.57 36.63 Favored 'General case' 0 C--N 1.354 0.796 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 159.052 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.9 p -128.71 132.91 67.29 Favored 'Isoleucine or valine' 0 C--N 1.349 0.582 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 174.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 33.0 m -134.55 161.56 40.28 Favored 'Isoleucine or valine' 0 C--N 1.349 0.564 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 -177.409 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 96.8 p -76.84 155.42 32.99 Favored 'General case' 0 C--N 1.354 0.771 0 O-C-N 120.665 -1.272 . . . . 0.0 112.986 178.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 33.9 t -120.38 28.6 7.92 Favored 'General case' 0 C--N 1.355 0.812 0 C-N-CA 123.881 0.873 . . . . 0.0 109.44 -177.238 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 45.83 36.55 2.9 Favored 'General case' 0 C--N 1.357 0.897 0 C-N-CA 128.58 2.752 . . . . 0.0 117.452 173.02 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 50.4 tptt -140.79 138.32 34.01 Favored 'General case' 0 C--N 1.352 0.687 0 O-C-N 120.664 -1.272 . . . . 0.0 109.208 -169.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -90.99 123.02 34.14 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.311 1.845 . . . . 0.0 108.559 -175.528 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 17.5 p -112.95 172.17 7.09 Favored 'General case' 0 C--N 1.357 0.918 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 175.49 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 27.5 m -130.43 146.18 51.95 Favored 'General case' 0 C--N 1.35 0.593 0 N-CA-C 102.279 -3.23 . . . . 0.0 102.279 167.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.565 ' HB3' HD12 ' A' ' 41' ' ' LEU . 90.6 p -59.97 -30.72 69.3 Favored 'General case' 0 C--N 1.35 0.592 0 N-CA-C 115.966 1.839 . . . . 0.0 115.966 -172.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -93.77 -1.21 65.87 Favored Glycine 0 C--N 1.354 1.53 0 CA-C-N 118.582 0.628 . . . . 0.0 114.138 175.43 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -108.62 -41.46 4.8 Favored 'General case' 0 C--N 1.352 0.685 0 CA-C-N 118.266 1.033 . . . . 0.0 111.145 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 25.3 m120 57.06 35.74 26.76 Favored 'General case' 0 C--N 1.358 0.939 0 C-N-CA 126.93 2.092 . . . . 0.0 115.028 174.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 60.9 mm-40 -87.09 114.95 24.14 Favored 'General case' 0 C--N 1.351 0.657 0 O-C-N 120.575 -1.328 . . . . 0.0 111.386 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 73.4 m -135.93 156.9 76.87 Favored Pre-proline 0 N--CA 1.447 -0.604 0 N-CA-C 105.601 -2.0 . . . . 0.0 105.601 168.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.55 161.84 44.59 Favored 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.783 2.322 . . . . 0.0 111.497 171.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -62.42 132.88 54.02 Favored 'General case' 0 C--N 1.354 0.778 0 CA-C-O 121.783 0.802 . . . . 0.0 113.006 -174.387 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.37 -11.66 68.64 Favored Glycine 0 C--N 1.355 1.606 0 C-N-CA 124.06 0.838 . . . . 0.0 112.91 -172.144 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 71.8 m -116.56 156.13 27.5 Favored 'General case' 0 C--N 1.349 0.565 0 C-N-CA 124.178 0.991 . . . . 0.0 110.394 179.09 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -145.21 165.87 27.09 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 104.999 -2.223 . . . . 0.0 104.999 -174.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 31.5 p -128.22 153.55 46.81 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-N 120.262 1.392 . . . . 0.0 108.724 165.356 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -121.79 76.92 0.34 Allowed Glycine 0 CA--C 1.492 -1.38 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 -174.208 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.565 HD12 ' HB3' ' A' ' 28' ' ' SER . 3.4 tm? -106.18 124.79 50.14 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 105.944 -1.873 . . . . 0.0 105.944 177.729 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -113.92 140.57 48.27 Favored 'General case' 0 C--N 1.352 0.696 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 -175.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 76.78 8.7 86.53 Favored Glycine 0 C--N 1.355 1.634 0 N-CA-C 116.056 1.183 . . . . 0.0 116.056 164.072 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 57.83 35.89 25.88 Favored 'General case' 0 C--N 1.352 0.697 0 C-N-CA 126.865 2.066 . . . . 0.0 113.838 -175.603 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 60.8 m-80 -70.03 -43.77 70.61 Favored 'General case' 0 C--N 1.355 0.807 0 N-CA-C 114.228 1.195 . . . . 0.0 114.228 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm -144.13 -176.38 4.99 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.275 1.83 . . . . 0.0 106.465 -172.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -67.53 -45.59 75.29 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 115.878 1.806 . . . . 0.0 115.878 173.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.77 155.35 31.7 Favored Glycine 0 C--N 1.356 1.691 0 O-C-N 121.135 -0.978 . . . . 0.0 112.159 -168.297 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -137.81 143.81 41.2 Favored 'General case' 0 C--N 1.347 0.496 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 178.2 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 77.9 m -77.56 142.32 39.07 Favored 'General case' 0 C--N 1.353 0.747 0 CA-C-O 121.96 0.886 . . . . 0.0 113.126 -173.719 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -124.46 156.95 36.36 Favored 'General case' 0 C--N 1.35 0.606 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 -176.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 40.5 ttpt -112.7 136.03 52.76 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.649 1.18 . . . . 0.0 108.776 172.241 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 97.4 mt -98.49 125.32 51.87 Favored 'Isoleucine or valine' 0 C--N 1.359 0.994 0 C-N-CA 124.385 1.074 . . . . 0.0 108.987 175.685 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.92 156.26 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 C-N-CA 124.826 1.25 . . . . 0.0 109.536 178.116 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 102.25 -112.64 4.37 Favored Glycine 0 C--N 1.353 1.501 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 -172.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 . . . . . 0 C--O 1.258 1.543 0 O-C-N 121.373 -1.075 . . . . 0.0 113.523 -179.279 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 11.3 t80 . . . . . 0 N--CA 1.504 2.242 0 N-CA-C 116.3 1.963 . . . . 0.0 116.3 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -122.0 152.5 39.67 Favored 'General case' 0 C--N 1.355 0.821 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 162.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.3 p -127.1 135.94 62.14 Favored 'Isoleucine or valine' 0 C--N 1.349 0.585 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 176.601 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.4 m -131.21 158.0 43.27 Favored 'Isoleucine or valine' 0 C--N 1.351 0.647 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 177.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 87.7 p -81.88 157.37 24.39 Favored 'General case' 0 C--N 1.352 0.709 0 O-C-N 121.288 -0.882 . . . . 0.0 112.649 173.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 71.8 m -110.39 19.82 18.4 Favored 'General case' 0 C--N 1.355 0.847 0 O-C-N 121.413 -0.804 . . . . 0.0 111.791 177.429 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 47.34 39.56 9.14 Favored 'General case' 0 C--N 1.355 0.836 0 C-N-CA 127.432 2.293 . . . . 0.0 116.796 177.422 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 56.6 tptt -132.83 136.12 46.07 Favored 'General case' 0 C--N 1.352 0.677 0 O-C-N 121.127 -0.983 . . . . 0.0 109.006 -177.127 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -84.19 128.26 34.45 Favored 'General case' 0 C--N 1.354 0.786 0 C-N-CA 124.539 1.136 . . . . 0.0 110.742 -176.324 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 18.2 t -106.61 148.57 28.15 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 127.589 2.355 . . . . 0.0 108.93 178.319 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 23.3 m -133.0 154.73 50.24 Favored 'General case' 0 C--N 1.352 0.699 0 N-CA-C 102.488 -3.153 . . . . 0.0 102.488 168.256 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 79.4 p -58.93 -45.25 90.83 Favored 'General case' 0 C--N 1.349 0.549 0 N-CA-C 117.15 2.278 . . . . 0.0 117.15 -164.584 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -96.51 4.67 64.29 Favored Glycine 0 C--N 1.352 1.454 0 C-N-CA 123.605 0.622 . . . . 0.0 113.563 -176.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 11.1 mm-40 -115.96 -42.41 3.08 Favored 'General case' 0 C--N 1.346 0.433 0 O-C-N 121.82 -0.812 . . . . 0.0 109.803 178.459 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 56.3 45.95 22.02 Favored 'General case' 0 C--N 1.356 0.89 0 C-N-CA 128.575 2.75 . . . . 0.0 112.936 167.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -83.91 115.64 22.39 Favored 'General case' 0 C--N 1.352 0.701 0 O-C-N 121.043 -1.036 . . . . 0.0 112.742 -168.505 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 71.6 m -134.63 157.67 76.77 Favored Pre-proline 0 C--N 1.353 0.747 0 C-N-CA 124.785 1.234 . . . . 0.0 108.126 173.676 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.85 159.04 54.78 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.472 2.115 . . . . 0.0 110.618 164.372 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -65.09 135.17 55.23 Favored 'General case' 0 C--N 1.352 0.709 0 CA-C-O 121.599 0.714 . . . . 0.0 112.21 -176.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.59 -12.53 64.62 Favored Glycine 0 C--N 1.354 1.575 0 C-N-CA 123.593 0.616 . . . . 0.0 113.051 -173.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 72.2 m -113.13 155.45 24.94 Favored 'General case' 0 C--N 1.35 0.588 0 C-N-CA 124.242 1.017 . . . . 0.0 109.393 177.331 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -136.5 157.39 46.89 Favored 'General case' 0 C--N 1.351 0.634 0 O-C-N 121.278 -0.889 . . . . 0.0 108.729 -176.375 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 42.1 t -105.37 126.47 52.15 Favored 'General case' 0 CA--C 1.51 -0.57 0 O-C-N 121.205 -0.934 . . . . 0.0 111.027 -179.426 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.87 60.55 3.49 Favored Glycine 0 C--N 1.352 1.425 0 O-C-N 121.684 -0.635 . . . . 0.0 112.212 176.111 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -106.98 120.86 43.22 Favored 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 175.072 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -119.98 140.7 50.53 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 -176.009 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.18 5.42 76.4 Favored Glycine 0 C--N 1.355 1.603 0 N-CA-C 115.656 1.022 . . . . 0.0 115.656 161.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 56.75 42.9 26.07 Favored 'General case' 0 C--N 1.35 0.617 0 C-N-CA 126.639 1.976 . . . . 0.0 113.336 -171.669 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 54.0 m-80 -73.54 -49.37 26.84 Favored 'General case' 0 C--N 1.354 0.766 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 -178.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -140.65 -125.63 0.11 Allowed 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 177.676 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 16.6 pttp -107.79 -47.02 3.67 Favored 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 126.902 2.081 . . . . 0.0 114.146 -175.66 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 86.23 178.54 49.74 Favored Glycine 0 C--N 1.356 1.678 0 O-C-N 120.708 -1.245 . . . . 0.0 112.421 -173.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 72.7 t60 -154.12 155.24 35.04 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 105.877 -1.897 . . . . 0.0 105.877 178.272 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 76.4 m -86.86 135.57 33.28 Favored 'General case' 0 C--N 1.355 0.843 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -174.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -126.52 161.32 28.24 Favored 'General case' 0 C--N 1.358 0.946 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 -174.232 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -122.61 135.66 54.67 Favored 'General case' 0 C--N 1.352 0.69 0 C-N-CA 124.172 0.989 . . . . 0.0 110.098 165.674 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 83.3 mt -88.05 127.04 41.43 Favored 'Isoleucine or valine' 0 C--N 1.359 1.017 0 C-N-CA 125.963 1.705 . . . . 0.0 109.732 169.468 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.98 155.86 41.97 Favored 'Isoleucine or valine' 0 C--N 1.352 0.702 0 C-N-CA 123.949 0.899 . . . . 0.0 110.325 171.303 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 107.65 -149.64 16.75 Favored Glycine 0 C--N 1.354 1.538 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -175.75 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 . . . . . 0 C--O 1.26 1.629 0 N-CA-C 114.807 1.41 . . . . 0.0 114.807 177.943 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 10.9 t80 . . . . . 0 N--CA 1.505 2.287 0 N-CA-C 116.349 1.981 . . . . 0.0 116.349 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -122.75 148.7 45.03 Favored 'General case' 0 C--N 1.357 0.895 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 163.104 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.1 p -123.7 133.14 70.06 Favored 'Isoleucine or valine' 0 C--N 1.35 0.595 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 173.641 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.2 m -133.22 153.78 38.08 Favored 'Isoleucine or valine' 0 C--N 1.354 0.786 0 O-C-N 121.35 -0.844 . . . . 0.0 108.975 177.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 88.2 p -80.48 150.61 29.62 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 -179.151 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 71.7 m -102.1 -4.5 25.82 Favored 'General case' 0 C--N 1.354 0.783 0 O-C-N 121.399 -0.813 . . . . 0.0 111.11 178.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 56.29 43.46 26.39 Favored 'General case' 0 C--N 1.357 0.918 0 C-N-CA 127.423 2.289 . . . . 0.0 115.734 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 23.4 mmmt -131.2 149.89 52.38 Favored 'General case' 0 N--CA 1.442 -0.825 0 C-N-CA 127.061 2.144 . . . . 0.0 106.08 165.252 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -92.52 174.52 7.23 Favored 'General case' 0 C--N 1.351 0.657 0 O-C-N 121.698 -0.626 . . . . 0.0 109.6 171.28 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 15.2 p -121.21 172.36 8.05 Favored 'General case' 0 C--N 1.353 0.745 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 159.409 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 63.1 m -135.5 144.75 46.53 Favored 'General case' 0 CA--C 1.504 -0.808 0 N-CA-C 100.975 -3.713 . . . . 0.0 100.975 168.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 37.0 t -57.76 -43.93 85.81 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-N 120.459 1.481 . . . . 0.0 114.315 -164.649 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.15 -44.84 58.91 Favored Glycine 0 C--N 1.355 1.592 0 O-C-N 121.023 -1.048 . . . . 0.0 115.0 175.806 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -69.04 -43.22 75.13 Favored 'General case' 0 C--N 1.349 0.558 0 C-N-CA 126.114 1.766 . . . . 0.0 113.579 -176.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 55.42 38.01 29.68 Favored 'General case' 0 C--N 1.354 0.804 0 C-N-CA 129.008 2.923 . . . . 0.0 113.82 176.529 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -68.42 127.43 32.94 Favored 'General case' 0 C--N 1.352 0.681 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 175.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 94.9 m -143.34 159.23 55.95 Favored Pre-proline 0 C--N 1.354 0.786 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 152.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -70.08 159.09 54.4 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.83 2.353 . . . . 0.0 110.551 162.437 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -65.61 136.74 56.73 Favored 'General case' 0 C--N 1.352 0.681 0 CA-C-O 121.58 0.705 . . . . 0.0 112.7 -175.6 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.1 -9.65 70.03 Favored Glycine 0 C--N 1.356 1.668 0 O-C-N 121.689 -0.632 . . . . 0.0 113.19 -175.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 84.2 m -114.92 155.94 25.94 Favored 'General case' 0 C--N 1.348 0.508 0 C-N-CA 124.502 1.121 . . . . 0.0 108.381 178.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -136.3 163.1 31.2 Favored 'General case' 0 C--N 1.352 0.699 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 178.515 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 45.2 t -119.43 124.05 45.58 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 105.931 -1.877 . . . . 0.0 105.931 178.219 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -83.29 78.77 1.98 Allowed Glycine 0 C--N 1.352 1.443 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 177.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -98.46 113.39 25.38 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 104.387 -2.449 . . . . 0.0 104.387 -176.213 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.45 HD22 ' H ' ' A' ' 42' ' ' LEU . 2.1 mm? -77.03 -49.04 16.26 Favored 'General case' 0 C--N 1.357 0.929 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -148.216 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.94 76.97 0.16 Allowed Glycine 0 C--N 1.349 1.287 0 N-CA-C 108.69 -1.764 . . . . 0.0 108.69 175.001 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.8 pm0 45.59 59.38 3.65 Favored 'General case' 0 C--N 1.354 0.8 0 C-N-CA 128.519 2.727 . . . . 0.0 116.509 -178.106 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 34.7 m120 -103.33 -119.59 0.2 Allowed 'General case' 0 C--N 1.352 0.698 0 C-N-CA 123.953 0.901 . . . . 0.0 109.845 -171.292 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.72 -101.16 0.21 Allowed 'General case' 0 C--N 1.355 0.816 0 C-N-CA 124.159 0.984 . . . . 0.0 110.874 -172.734 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.0 pttm -130.33 -32.39 1.77 Allowed 'General case' 0 C--N 1.355 0.831 0 N-CA-C 116.306 1.965 . . . . 0.0 116.306 -163.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 62.05 -144.79 49.21 Favored Glycine 0 C--N 1.357 1.722 0 O-C-N 119.664 -1.897 . . . . 0.0 113.338 -174.474 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 43.4 t60 -160.51 160.41 31.91 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 101.808 -3.404 . . . . 0.0 101.808 163.548 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 72.5 m -89.36 134.16 34.19 Favored 'General case' 0 C--N 1.354 0.804 0 CA-C-N 120.89 1.677 . . . . 0.0 112.091 175.543 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -149.77 164.58 34.9 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.186 1.395 . . . . 0.0 112.099 -178.131 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -133.98 156.08 48.82 Favored 'General case' 0 C--N 1.354 0.784 0 CA-C-O 121.499 0.666 . . . . 0.0 111.516 -173.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 91.5 mt -108.77 124.98 65.74 Favored 'Isoleucine or valine' 0 C--N 1.355 0.843 0 C-N-CA 125.522 1.529 . . . . 0.0 108.84 -175.522 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.71 157.25 42.97 Favored 'Isoleucine or valine' 0 C--N 1.35 0.601 0 C-N-CA 124.224 1.01 . . . . 0.0 108.508 173.55 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 137.93 -147.28 19.13 Favored Glycine 0 C--N 1.352 1.464 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 -178.689 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 64.3 t30 . . . . . 0 CA--C 1.566 1.591 0 C-N-CA 124.192 0.997 . . . . 0.0 113.411 179.858 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 5.9 t80 . . . . . 0 N--CA 1.504 2.265 0 N-CA-C 115.929 1.826 . . . . 0.0 115.929 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -120.04 152.46 37.49 Favored 'General case' 0 C--N 1.356 0.848 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 163.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.6 p -124.63 135.99 62.11 Favored 'Isoleucine or valine' 0 C--N 1.348 0.54 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 176.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.3 m -129.96 157.29 42.54 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.681 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 177.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 85.3 p -79.7 152.67 29.78 Favored 'General case' 0 N--CA 1.447 -0.585 0 O-C-N 121.246 -0.909 . . . . 0.0 112.57 173.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 16.6 t -110.22 9.6 23.81 Favored 'General case' 0 C--N 1.352 0.701 0 O-C-N 121.274 -0.891 . . . . 0.0 110.892 -174.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 56.51 42.95 26.64 Favored 'General case' 0 C--N 1.355 0.842 0 C-N-CA 126.762 2.025 . . . . 0.0 114.736 175.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 54.2 tptt -140.87 137.64 33.37 Favored 'General case' 0 C--N 1.351 0.657 0 O-C-N 120.668 -1.27 . . . . 0.0 107.801 177.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -91.03 130.11 36.97 Favored 'General case' 0 C--N 1.351 0.632 0 C-N-CA 125.642 1.577 . . . . 0.0 109.946 -177.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 10.6 p -111.43 156.13 22.11 Favored 'General case' 0 C--N 1.358 0.955 0 O-C-N 121.415 -0.803 . . . . 0.0 109.131 -178.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 21.4 p -127.04 152.72 46.88 Favored 'General case' 0 CA--C 1.496 -1.098 0 O-C-N 121.069 -1.019 . . . . 0.0 112.745 177.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 40.7 t -63.91 126.16 26.76 Favored 'General case' 0 C--N 1.359 0.995 0 CA-C-O 122.437 1.113 . . . . 0.0 110.249 177.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 92.63 -9.19 76.19 Favored Glycine 0 C--N 1.344 1.026 0 CA-C-N 114.975 -1.011 . . . . 0.0 113.05 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 15.1 mm-40 -121.54 -46.75 2.25 Favored 'General case' 0 C--N 1.352 0.677 0 CA-C-N 118.374 1.087 . . . . 0.0 111.902 179.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 51.41 47.51 24.68 Favored 'General case' 0 C--N 1.36 1.039 0 N-CA-C 116.343 1.979 . . . . 0.0 116.343 -177.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -67.5 118.03 10.26 Favored 'General case' 0 C--N 1.355 0.841 0 O-C-N 120.791 -1.193 . . . . 0.0 113.216 178.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 73.5 m -137.76 158.07 72.3 Favored Pre-proline 0 C--N 1.352 0.69 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 169.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.07 159.03 54.61 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.473 2.116 . . . . 0.0 110.428 164.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 58.6 mp0 -64.04 134.06 54.26 Favored 'General case' 0 C--N 1.352 0.717 0 CA-C-O 121.812 0.815 . . . . 0.0 112.467 -173.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 98.35 -15.06 61.75 Favored Glycine 0 C--N 1.355 1.601 0 C-N-CA 123.799 0.714 . . . . 0.0 112.934 -174.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 93.1 m -110.21 157.7 19.15 Favored 'General case' 0 C--N 1.349 0.549 0 C-N-CA 124.23 1.012 . . . . 0.0 110.248 176.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 28.4 p90 -142.14 164.31 30.51 Favored 'General case' 0 C--N 1.348 0.541 0 N-CA-C 105.674 -1.973 . . . . 0.0 105.674 -175.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 36.3 t -117.45 128.48 55.04 Favored 'General case' 0 CA--C 1.51 -0.578 0 O-C-N 121.039 -1.038 . . . . 0.0 108.915 -177.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -85.75 61.81 4.49 Favored Glycine 0 C--N 1.353 1.516 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 176.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.6 HD23 ' H ' ' A' ' 42' ' ' LEU . 1.1 tt -69.81 139.55 53.2 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 125.159 1.384 . . . . 0.0 110.502 -175.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.6 ' H ' HD23 ' A' ' 41' ' ' LEU . 1.5 mm? -80.89 72.37 7.88 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 125.423 1.489 . . . . 0.0 108.997 -163.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.75 14.71 81.19 Favored Glycine 0 C--N 1.352 1.456 0 O-C-N 120.689 -1.257 . . . . 0.0 113.292 178.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.497 ' HA ' HD22 ' A' ' 41' ' ' LEU . 34.6 mt-30 56.35 41.24 29.29 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 127.35 2.26 . . . . 0.0 114.664 -170.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -68.47 -45.15 73.21 Favored 'General case' 0 C--N 1.356 0.887 0 N-CA-C 115.726 1.75 . . . . 0.0 115.726 174.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 17.5 pttp -155.15 -64.65 0.12 Allowed 'General case' 0 C--N 1.348 0.539 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -176.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.8 ptmt -157.21 161.2 39.26 Favored 'General case' 0 N--CA 1.439 -1.022 0 O-C-N 121.111 -0.993 . . . . 0.0 108.638 -172.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -159.28 -171.78 25.54 Favored Glycine 0 C--N 1.345 1.045 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 175.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 77.7 t60 -127.3 140.87 51.91 Favored 'General case' 0 C--N 1.35 0.603 0 O-C-N 121.301 -1.117 . . . . 0.0 108.309 -175.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 75.0 m -76.87 145.73 38.14 Favored 'General case' 0 C--N 1.356 0.879 0 O-C-N 120.83 -1.169 . . . . 0.0 113.626 -172.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -126.07 162.48 25.21 Favored 'General case' 0 C--N 1.358 0.976 0 C-N-CA 123.89 0.876 . . . . 0.0 108.815 -175.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -121.4 136.43 54.96 Favored 'General case' 0 C--N 1.351 0.632 0 C-N-CA 124.616 1.166 . . . . 0.0 108.514 166.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 84.8 mt -98.39 126.28 51.52 Favored 'Isoleucine or valine' 0 C--N 1.359 0.997 0 C-N-CA 124.851 1.261 . . . . 0.0 109.137 172.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.55 148.32 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 C-N-CA 125.321 1.448 . . . . 0.0 108.388 176.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.349 1.292 0 O-C-N 119.884 -1.76 . . . . 0.0 110.845 -176.804 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 14.0 t80 . . . . . 0 N--CA 1.504 2.249 0 N-CA-C 116.314 1.968 . . . . 0.0 116.314 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -123.05 155.62 36.52 Favored 'General case' 0 C--N 1.355 0.825 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 166.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.3 p -126.81 135.81 62.61 Favored 'Isoleucine or valine' 0 C--N 1.349 0.572 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 174.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 30.2 m -131.58 159.73 42.86 Favored 'Isoleucine or valine' 0 C--N 1.35 0.63 0 C-N-CA 124.709 1.204 . . . . 0.0 107.8 175.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 87.8 p -77.6 153.41 33.26 Favored 'General case' 0 C--N 1.351 0.646 0 CA-C-O 122.15 0.976 . . . . 0.0 112.58 174.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 8.8 t -104.73 3.59 31.53 Favored 'General case' 0 C--N 1.353 0.724 0 O-C-N 121.21 -0.931 . . . . 0.0 110.298 -176.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 72.4 m-80 58.26 41.38 23.49 Favored 'General case' 0 C--N 1.356 0.877 0 C-N-CA 127.456 2.303 . . . . 0.0 114.378 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 52.6 tptt -139.72 134.54 32.06 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 -177.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -89.01 133.61 34.27 Favored 'General case' 0 C--N 1.355 0.836 0 C-N-CA 125.002 1.321 . . . . 0.0 109.288 -179.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 26.1 p -131.99 152.58 51.04 Favored 'General case' 0 C--N 1.352 0.711 0 CA-C-O 122.049 0.928 . . . . 0.0 110.424 177.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.7 m -127.39 149.52 50.04 Favored 'General case' 0 C--N 1.349 0.569 0 N-CA-C 105.56 -2.015 . . . . 0.0 105.56 -167.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 36.6 t -62.71 133.43 54.8 Favored 'General case' 0 C--N 1.36 1.055 0 O-C-N 120.689 -1.257 . . . . 0.0 109.907 170.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 92.88 -15.08 63.58 Favored Glycine 0 C--N 1.349 1.286 0 C-N-CA 123.841 0.734 . . . . 0.0 112.443 -172.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -113.79 -53.56 2.67 Favored 'General case' 0 C--N 1.356 0.866 0 CA-C-N 118.652 1.226 . . . . 0.0 111.954 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 49.36 41.75 21.06 Favored 'General case' 0 C--N 1.364 1.204 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 -176.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 59.6 mm-40 -83.95 112.93 20.61 Favored 'General case' 0 C--N 1.353 0.752 0 O-C-N 120.436 -1.415 . . . . 0.0 111.581 -179.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 79.0 m -134.83 155.57 79.23 Favored Pre-proline 0 C--N 1.35 0.601 0 N-CA-C 106.169 -1.789 . . . . 0.0 106.169 171.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -70.54 160.1 50.59 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.589 2.192 . . . . 0.0 110.574 165.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -65.02 141.46 58.76 Favored 'General case' 0 C--N 1.353 0.757 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -175.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.8 -13.88 65.6 Favored Glycine 0 C--N 1.354 1.554 0 C-N-CA 123.774 0.702 . . . . 0.0 112.522 -172.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 71.2 m -115.32 154.94 28.23 Favored 'General case' 0 C--N 1.349 0.562 0 C-N-CA 124.487 1.115 . . . . 0.0 109.929 178.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -129.9 158.61 39.04 Favored 'General case' 0 C--N 1.352 0.686 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -178.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 52.2 t -88.66 126.53 35.35 Favored 'General case' 0 C--N 1.35 0.593 0 O-C-N 121.494 -0.754 . . . . 0.0 110.609 -174.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -82.55 67.88 3.64 Favored Glycine 0 C--N 1.356 1.665 0 O-C-N 121.107 -0.996 . . . . 0.0 113.79 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 56.7 mt -104.76 134.17 48.36 Favored 'General case' 0 CA--C 1.505 -0.759 0 C-N-CA 125.142 1.377 . . . . 0.0 110.429 170.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.526 HD22 ' H ' ' A' ' 42' ' ' LEU . 1.5 mm? -70.0 -44.86 68.52 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 125.479 1.512 . . . . 0.0 111.035 -166.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -160.93 49.65 0.36 Allowed Glycine 0 C--N 1.346 1.123 0 N-CA-C 107.279 -2.328 . . . . 0.0 107.279 170.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 17.4 mp0 52.73 51.21 16.45 Favored 'General case' 0 C--N 1.356 0.862 0 C-N-CA 127.011 2.124 . . . . 0.0 114.605 -177.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 23.2 m120 -92.33 -53.69 4.12 Favored 'General case' 0 C--N 1.357 0.9 0 O-C-N 120.494 -1.379 . . . . 0.0 112.628 -166.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -131.46 -98.69 0.31 Allowed 'General case' 0 C--N 1.355 0.811 0 CA-C-O 122.394 1.092 . . . . 0.0 109.774 -174.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 15.0 ptmm? -138.25 156.93 47.2 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 106.012 -1.847 . . . . 0.0 106.012 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -148.53 -171.03 16.95 Favored Glycine 0 CA--C 1.493 -1.284 0 N-CA-C 108.405 -1.878 . . . . 0.0 108.405 -178.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 51.6 t60 -132.42 147.42 52.38 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 104.712 -2.329 . . . . 0.0 104.712 -176.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 71.9 m -78.46 139.38 38.71 Favored 'General case' 0 C--N 1.351 0.636 0 O-C-N 120.984 -1.072 . . . . 0.0 112.079 -174.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -125.72 156.91 38.63 Favored 'General case' 0 C--N 1.351 0.671 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 -176.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -112.46 135.54 53.04 Favored 'General case' 0 C--N 1.35 0.625 0 C-N-CA 124.043 0.937 . . . . 0.0 109.669 175.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 43.0 mm -91.8 122.06 42.88 Favored 'Isoleucine or valine' 0 C--N 1.361 1.091 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 172.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.64 137.54 57.05 Favored 'Isoleucine or valine' 0 C--N 1.351 0.663 0 CA-C-O 122.363 1.078 . . . . 0.0 110.46 169.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.327 0 N-CA-C 106.014 -2.834 . . . . 0.0 106.014 -176.072 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 14.0 t80 . . . . . 0 N--CA 1.503 2.218 0 N-CA-C 116.702 2.112 . . . . 0.0 116.702 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -111.74 151.83 28.49 Favored 'General case' 0 C--N 1.353 0.73 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 159.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.2 p -126.33 136.02 62.06 Favored 'Isoleucine or valine' 0 C--N 1.351 0.65 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 173.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.585 HG22 HD11 ' A' ' 54' ' ' ILE . 35.9 m -133.72 159.39 42.59 Favored 'Isoleucine or valine' 0 C--N 1.353 0.727 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 176.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 87.4 p -80.42 154.32 27.73 Favored 'General case' 0 C--N 1.349 0.547 0 CA-C-O 121.684 0.754 . . . . 0.0 112.934 171.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 78.2 m -105.38 5.0 31.4 Favored 'General case' 0 C--N 1.356 0.866 0 O-C-N 121.114 -0.991 . . . . 0.0 111.539 173.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 58.16 40.73 24.71 Favored 'General case' 0 C--N 1.355 0.821 0 C-N-CA 126.928 2.091 . . . . 0.0 114.977 178.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 37.2 mmtm -132.7 142.83 49.24 Favored 'General case' 0 C--N 1.351 0.632 0 C-N-CA 124.593 1.157 . . . . 0.0 110.416 176.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.5 t30 -88.09 133.29 34.02 Favored 'General case' 0 C--N 1.351 0.668 0 C-N-CA 126.374 1.87 . . . . 0.0 109.135 176.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 13.8 p -109.31 153.51 23.8 Favored 'General case' 0 C--N 1.356 0.887 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 171.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 59.7 m -128.9 145.71 51.14 Favored 'General case' 0 C--N 1.346 0.435 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 -173.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 47.4 t -59.2 138.53 57.55 Favored 'General case' 0 C--N 1.358 0.937 0 C-N-CA 123.829 0.852 . . . . 0.0 112.941 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.94 -53.88 4.4 Favored Glycine 0 C--N 1.358 1.774 0 C-N-CA 124.666 1.127 . . . . 0.0 112.377 -175.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -64.39 -45.74 86.35 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 128.685 2.794 . . . . 0.0 115.465 -178.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.4 m120 54.99 43.01 30.55 Favored 'General case' 0 C--N 1.355 0.814 0 C-N-CA 127.084 2.154 . . . . 0.0 115.654 168.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 55.2 mm-40 -75.76 117.89 18.0 Favored 'General case' 0 C--N 1.354 0.784 0 O-C-N 120.124 -1.61 . . . . 0.0 113.929 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 77.1 m -138.06 155.99 74.22 Favored Pre-proline 0 C--N 1.354 0.793 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 159.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.21 160.08 50.07 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 123.109 2.539 . . . . 0.0 111.25 166.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -62.94 131.14 47.69 Favored 'General case' 0 C--N 1.353 0.718 0 C-N-CA 123.539 0.735 . . . . 0.0 112.534 -176.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 100.27 -14.07 59.79 Favored Glycine 0 C--N 1.356 1.649 0 C-N-CA 123.827 0.727 . . . . 0.0 112.679 -174.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 75.0 m -112.69 156.67 22.38 Favored 'General case' 0 C--N 1.349 0.549 0 C-N-CA 124.055 0.942 . . . . 0.0 109.145 177.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -141.47 163.03 34.03 Favored 'General case' 0 C--N 1.348 0.509 0 N-CA-C 105.346 -2.094 . . . . 0.0 105.346 -178.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 46.3 t -124.25 125.9 45.18 Favored 'General case' 0 CA--C 1.508 -0.665 0 O-C-N 120.85 -1.156 . . . . 0.0 109.59 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -85.9 63.94 4.16 Favored Glycine 0 C--N 1.354 1.544 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 177.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.612 HD23 ' H ' ' A' ' 42' ' ' LEU . 1.0 OUTLIER -69.46 141.16 54.07 Favored 'General case' 0 C--N 1.349 0.573 0 C-N-CA 125.27 1.428 . . . . 0.0 110.292 -178.94 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.612 ' H ' HD23 ' A' ' 41' ' ' LEU . 1.4 mm? -81.59 69.94 8.36 Favored 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 125.502 1.521 . . . . 0.0 109.288 -161.282 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.76 24.31 76.31 Favored Glycine 0 C--N 1.352 1.438 0 O-C-N 120.975 -1.078 . . . . 0.0 113.943 178.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 69.2 mm-40 58.32 34.29 23.91 Favored 'General case' 0 C--N 1.356 0.88 0 C-N-CA 126.2 1.8 . . . . 0.0 114.592 -175.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 57.4 m-80 -76.38 -46.92 25.17 Favored 'General case' 0 C--N 1.356 0.871 0 O-C-N 120.028 -1.67 . . . . 0.0 115.371 176.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 48.2 mmtm -137.7 -100.97 0.19 Allowed 'General case' 0 C--N 1.348 0.542 0 CA-C-O 122.103 0.954 . . . . 0.0 110.124 -173.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 10.3 ptpp? -143.58 161.65 37.94 Favored 'General case' 0 N--CA 1.436 -1.136 0 C-N-CA 125.311 1.444 . . . . 0.0 107.654 -173.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -154.91 -174.13 24.5 Favored Glycine 0 C--N 1.344 1.005 0 N-CA-C 108.748 -1.741 . . . . 0.0 108.748 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 52.6 t60 -126.7 142.97 51.38 Favored 'General case' 0 C--N 1.35 0.589 0 O-C-N 121.159 -1.201 . . . . 0.0 108.218 -173.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 75.9 m -80.15 139.98 36.57 Favored 'General case' 0 C--N 1.356 0.849 0 O-C-N 120.751 -1.218 . . . . 0.0 112.978 -173.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -128.0 162.15 27.48 Favored 'General case' 0 C--N 1.357 0.919 0 C-N-CA 124.0 0.92 . . . . 0.0 108.986 -173.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -116.35 137.91 51.77 Favored 'General case' 0 C--N 1.352 0.7 0 C-N-CA 124.596 1.158 . . . . 0.0 108.267 164.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 83.5 mt -95.56 126.42 48.08 Favored 'Isoleucine or valine' 0 C--N 1.358 0.972 0 C-N-CA 125.726 1.61 . . . . 0.0 107.54 167.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.585 HD11 HG22 ' A' ' 20' ' ' VAL . 4.7 mp -115.75 125.71 73.01 Favored 'Isoleucine or valine' 0 C--N 1.355 0.836 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 -177.178 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.353 1.503 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 173.434 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 13.3 t80 . . . . . 0 N--CA 1.503 2.205 0 N-CA-C 116.773 2.138 . . . . 0.0 116.773 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -120.53 150.6 40.6 Favored 'General case' 0 C--N 1.356 0.867 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 165.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.2 p -122.93 134.41 66.16 Favored 'Isoleucine or valine' 0 C--N 1.351 0.643 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 171.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 28.4 m -132.21 156.97 42.97 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.619 0 C-N-CA 124.983 1.313 . . . . 0.0 107.547 177.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 96.5 p -81.16 158.27 25.0 Favored 'General case' 0 C--N 1.353 0.735 0 CA-C-O 122.391 1.091 . . . . 0.0 112.342 175.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 79.0 m -98.77 10.53 41.01 Favored 'General case' 0 C--N 1.349 0.556 0 C-N-CA 125.007 1.323 . . . . 0.0 110.194 176.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 8.3 m120 62.69 21.55 12.8 Favored 'General case' 0 C--N 1.356 0.87 0 C-N-CA 128.788 2.835 . . . . 0.0 114.146 177.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt -118.8 143.12 47.12 Favored 'General case' 0 CA--C 1.511 -0.553 0 C-N-CA 125.038 1.335 . . . . 0.0 111.586 179.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -96.83 130.03 44.17 Favored 'General case' 0 C--N 1.351 0.666 0 C-N-CA 126.878 2.071 . . . . 0.0 109.992 178.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 14.2 p -103.17 155.69 18.24 Favored 'General case' 0 C--N 1.354 0.786 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 170.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 61.6 m -130.38 145.34 51.79 Favored 'General case' 0 C--N 1.353 0.749 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 -177.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 39.7 t -60.6 133.12 55.79 Favored 'General case' 0 C--N 1.356 0.855 0 O-C-N 119.531 -1.981 . . . . 0.0 112.003 177.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.71 -18.96 56.13 Favored Glycine 0 C--N 1.352 1.43 0 C-N-CA 125.024 1.297 . . . . 0.0 112.824 -172.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -148.8 102.21 3.26 Favored 'General case' 0 C--N 1.355 0.808 0 CA-C-O 123.847 1.784 . . . . 0.0 111.233 174.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 33.7 m120 -80.91 82.63 6.84 Favored 'General case' 0 C--N 1.353 0.747 0 O-C-N 120.058 -1.652 . . . . 0.0 110.833 -175.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -82.5 75.81 9.4 Favored 'General case' 0 C--N 1.353 0.734 0 C-N-CA 124.461 1.105 . . . . 0.0 112.581 -167.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 74.7 m -118.63 151.21 49.56 Favored Pre-proline 0 C--N 1.351 0.668 0 O-C-N 120.694 -1.254 . . . . 0.0 110.806 177.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -71.83 159.77 49.71 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.776 2.318 . . . . 0.0 110.603 163.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -63.77 134.82 55.99 Favored 'General case' 0 C--N 1.352 0.684 0 C-N-CA 123.503 0.721 . . . . 0.0 112.524 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 98.59 -10.51 62.84 Favored Glycine 0 C--N 1.356 1.639 0 C-N-CA 123.817 0.722 . . . . 0.0 113.542 -175.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 82.5 m -112.77 154.47 26.15 Favored 'General case' 0 C--N 1.348 0.52 0 CA-C-N 118.003 0.901 . . . . 0.0 108.891 178.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -129.03 160.36 32.99 Favored 'General case' 0 C--N 1.353 0.737 0 N-CA-C 104.691 -2.337 . . . . 0.0 104.691 177.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 41.9 t -114.21 128.59 56.44 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-N 120.586 1.539 . . . . 0.0 109.33 178.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -83.8 61.6 4.72 Favored Glycine 0 C--N 1.355 1.595 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.528 HD23 ' H ' ' A' ' 42' ' ' LEU . 0.8 OUTLIER -81.93 137.79 35.11 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 124.21 1.004 . . . . 0.0 109.142 -175.063 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.528 ' H ' HD23 ' A' ' 41' ' ' LEU . 1.3 mm? -81.21 72.24 8.23 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 125.637 1.575 . . . . 0.0 109.044 -163.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.67 20.25 79.78 Favored Glycine 0 C--N 1.354 1.554 0 O-C-N 120.742 -1.224 . . . . 0.0 113.692 178.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 56.37 39.67 30.0 Favored 'General case' 0 C--N 1.352 0.717 0 C-N-CA 127.376 2.271 . . . . 0.0 114.091 -172.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 61.2 m-80 -80.47 -45.14 18.06 Favored 'General case' 0 C--N 1.351 0.671 0 N-CA-C 115.073 1.509 . . . . 0.0 115.073 173.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -131.0 -105.34 0.27 Allowed 'General case' 0 C--N 1.354 0.78 0 O-C-N 121.109 -0.995 . . . . 0.0 111.756 -169.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.03 164.57 31.68 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 105.38 -2.082 . . . . 0.0 105.38 -178.021 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -166.16 179.64 40.14 Favored Glycine 0 CA--C 1.493 -1.299 0 N-CA-C 108.25 -1.94 . . . . 0.0 108.25 178.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 12.3 m80 -105.83 150.94 25.12 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 115.689 1.737 . . . . 0.0 115.689 176.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 81.0 m -81.68 134.35 35.46 Favored 'General case' 0 C--N 1.353 0.733 0 C-N-CA 125.347 1.459 . . . . 0.0 110.047 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -127.68 158.97 36.14 Favored 'General case' 0 C--N 1.351 0.654 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 -172.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 20.7 pttm -125.22 154.87 40.96 Favored 'General case' 0 C--N 1.352 0.717 0 CA-C-O 121.987 0.898 . . . . 0.0 111.55 168.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 46.4 mm -103.62 121.15 54.68 Favored 'Isoleucine or valine' 0 C--N 1.353 0.725 0 C-N-CA 125.397 1.479 . . . . 0.0 107.671 -175.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.24 146.9 33.51 Favored 'Isoleucine or valine' 0 C--N 1.353 0.739 0 CA-C-O 121.908 0.861 . . . . 0.0 110.443 175.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.355 1.598 0 O-C-N 121.21 -0.931 . . . . 0.0 113.889 -179.88 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 11.3 t80 . . . . . 0 N--CA 1.504 2.25 0 N-CA-C 116.254 1.946 . . . . 0.0 116.254 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -123.19 147.91 46.35 Favored 'General case' 0 C--N 1.357 0.892 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 158.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 5.3 p -126.89 135.38 63.83 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.62 0 C-N-CA 124.474 1.109 . . . . 0.0 108.418 174.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 30.4 m -129.97 158.97 42.43 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.638 0 C-N-CA 124.715 1.206 . . . . 0.0 108.265 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 78.9 p -76.43 143.05 40.82 Favored 'General case' 0 N--CA 1.446 -0.647 0 O-C-N 121.186 -0.946 . . . . 0.0 112.741 174.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 15.5 t -91.98 -1.8 57.07 Favored 'General case' 0 C--N 1.354 0.768 0 O-C-N 121.256 -0.903 . . . . 0.0 110.916 178.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 54.5 t30 59.95 46.45 11.05 Favored 'General case' 0 C--N 1.356 0.869 0 C-N-CA 127.591 2.357 . . . . 0.0 113.55 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 55.6 tptt -140.98 138.26 33.62 Favored 'General case' 0 C--N 1.352 0.679 0 O-C-N 121.086 -1.009 . . . . 0.0 108.429 178.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -84.4 133.56 34.5 Favored 'General case' 0 C--N 1.355 0.816 0 C-N-CA 125.7 1.6 . . . . 0.0 111.217 176.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 26.0 p -132.48 157.37 44.81 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 122.122 0.963 . . . . 0.0 110.434 173.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 37.3 p -128.87 165.44 21.02 Favored 'General case' 0 CA--C 1.5 -0.978 0 C-N-CA 124.794 1.238 . . . . 0.0 111.362 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 47.3 t -58.94 135.1 57.48 Favored 'General case' 0 C--N 1.355 0.839 0 C-N-CA 125.956 1.702 . . . . 0.0 111.465 177.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 82.66 -61.08 4.8 Favored Glycine 0 C--N 1.352 1.456 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 -170.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 24.4 mm100 -62.15 -48.48 79.89 Favored 'General case' 0 C--N 1.351 0.643 0 N-CA-C 117.047 2.24 . . . . 0.0 117.047 -174.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 48.52 36.93 8.12 Favored 'General case' 0 C--N 1.359 1.006 0 N-CA-C 115.917 1.821 . . . . 0.0 115.917 175.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -81.53 117.79 22.22 Favored 'General case' 0 C--N 1.356 0.866 0 O-C-N 120.464 -1.397 . . . . 0.0 112.382 -173.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 82.1 m -137.14 158.03 73.35 Favored Pre-proline 0 N--CA 1.448 -0.548 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 176.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -70.15 159.96 51.28 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.626 2.217 . . . . 0.0 110.609 164.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -64.73 140.81 58.91 Favored 'General case' 0 C--N 1.353 0.73 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -174.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.22 -13.45 66.84 Favored Glycine 0 C--N 1.355 1.585 0 O-C-N 121.562 -0.711 . . . . 0.0 112.806 -173.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 72.8 m -115.41 155.09 28.05 Favored 'General case' 0 C--N 1.349 0.577 0 C-N-CA 124.458 1.103 . . . . 0.0 110.247 178.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -127.18 161.34 28.75 Favored 'General case' 0 C--N 1.348 0.527 0 C-N-CA 124.763 1.225 . . . . 0.0 109.472 178.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 53.2 t -86.83 125.46 33.99 Favored 'General case' 0 C--N 1.35 0.603 0 C-N-CA 123.939 0.895 . . . . 0.0 110.9 -177.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -91.08 84.82 1.28 Allowed Glycine 0 C--N 1.355 1.603 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 172.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -103.75 139.9 38.35 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 -179.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -80.29 68.11 6.35 Favored 'General case' 0 C--N 1.351 0.632 0 C-N-CA 125.162 1.385 . . . . 0.0 109.111 -175.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.16 21.51 77.12 Favored Glycine 0 C--N 1.356 1.646 0 O-C-N 120.699 -1.251 . . . . 0.0 113.695 179.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 56.91 35.37 26.26 Favored 'General case' 0 C--N 1.348 0.543 0 C-N-CA 127.365 2.266 . . . . 0.0 116.401 -173.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 61.3 m-80 -67.68 -44.8 76.94 Favored 'General case' 0 C--N 1.357 0.896 0 N-CA-C 115.065 1.506 . . . . 0.0 115.065 168.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.516 ' HG3' ' H ' ' A' ' 47' ' ' LYS . 20.1 pttp -149.33 -106.2 0.07 Allowed 'General case' 0 C--N 1.354 0.764 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 -173.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.516 ' H ' ' HG3' ' A' ' 46' ' ' LYS . 25.8 pttm -119.27 159.07 24.79 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 125.388 1.475 . . . . 0.0 110.109 -177.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -154.79 -166.76 15.62 Favored Glycine 0 C--N 1.352 1.417 0 N-CA-C 110.504 -1.039 . . . . 0.0 110.504 178.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 50.5 t60 -136.49 146.35 46.17 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 -172.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 79.2 m -79.92 140.88 36.52 Favored 'General case' 0 C--N 1.349 0.561 0 O-C-N 120.752 -1.218 . . . . 0.0 111.637 -177.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 17.3 m-30 -126.03 162.41 25.35 Favored 'General case' 0 C--N 1.355 0.823 0 O-C-N 121.048 -1.032 . . . . 0.0 108.821 -178.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -123.68 137.44 54.71 Favored 'General case' 0 C--N 1.352 0.689 0 C-N-CA 124.422 1.089 . . . . 0.0 108.448 168.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 94.3 mt -107.16 130.05 59.91 Favored 'Isoleucine or valine' 0 C--N 1.361 1.085 0 C-N-CA 124.242 1.017 . . . . 0.0 108.782 177.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -131.57 149.97 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 C-N-CA 125.796 1.639 . . . . 0.0 110.153 -177.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.35 1.355 0 N-CA-C 107.945 -2.062 . . . . 0.0 107.945 -177.846 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 7.5 t80 . . . . . 0 N--CA 1.5 2.075 0 N-CA-C 116.222 1.934 . . . . 0.0 116.222 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 49.0 m-20 -120.35 149.64 42.02 Favored 'General case' 0 C--N 1.354 0.782 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 161.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.9 p -125.21 135.15 64.95 Favored 'Isoleucine or valine' 0 C--N 1.35 0.593 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 174.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 28.9 m -132.01 155.88 41.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.574 0 C-N-CA 123.481 0.712 . . . . 0.0 109.122 179.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 79.2 p -79.91 147.87 31.49 Favored 'General case' 0 C--N 1.349 0.549 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 175.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 10.9 t -102.5 -4.13 25.82 Favored 'General case' 0 C--N 1.353 0.754 0 C-N-CA 123.732 0.813 . . . . 0.0 112.062 -175.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 56.6 t30 58.95 44.48 16.38 Favored 'General case' 0 C--N 1.357 0.91 0 C-N-CA 127.176 2.19 . . . . 0.0 113.656 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.5 tppt? -144.06 146.44 32.83 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 102.473 -3.158 . . . . 0.0 102.473 173.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.4 p-10 -120.05 167.96 11.67 Favored 'General case' 0 C--N 1.355 0.845 0 CA-C-N 120.976 1.716 . . . . 0.0 110.402 171.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 57.1 m -116.42 160.87 19.93 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 173.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 32.3 m -111.23 159.33 18.0 Favored 'General case' 0 C--N 1.345 0.409 0 N-CA-C 102.231 -3.248 . . . . 0.0 102.231 166.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.2 t -58.6 144.1 44.07 Favored 'General case' 0 C--N 1.352 0.716 0 CA-C-O 122.353 1.073 . . . . 0.0 112.922 178.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.58 -58.62 4.85 Favored Glycine 0 C--N 1.353 1.523 0 C-N-CA 124.125 0.869 . . . . 0.0 111.359 -171.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -63.55 -45.77 89.01 Favored 'General case' 0 C--N 1.348 0.535 0 N-CA-C 115.503 1.668 . . . . 0.0 115.503 -167.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 50.54 44.53 27.17 Favored 'General case' 0 C--N 1.36 1.039 0 N-CA-C 116.557 2.058 . . . . 0.0 116.557 175.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -91.93 114.77 27.4 Favored 'General case' 0 C--N 1.35 0.609 0 C-N-CA 124.396 1.079 . . . . 0.0 111.683 -176.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 98.2 m -132.6 157.4 78.41 Favored Pre-proline 0 C--N 1.351 0.671 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 171.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -69.72 160.27 50.34 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 122.775 2.317 . . . . 0.0 110.021 166.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -63.72 135.65 56.85 Favored 'General case' 0 C--N 1.353 0.75 0 N-CA-C 113.269 0.841 . . . . 0.0 113.269 -171.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.9 -12.62 65.7 Favored Glycine 0 C--N 1.355 1.587 0 C-N-CA 123.921 0.772 . . . . 0.0 113.212 -175.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 73.3 m -115.45 153.71 30.61 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-N 118.023 0.912 . . . . 0.0 110.489 -178.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -139.24 154.65 48.03 Favored 'General case' 0 C--N 1.355 0.831 0 O-C-N 121.099 -1.001 . . . . 0.0 110.015 -178.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 53.0 m -94.7 136.3 35.17 Favored 'General case' 0 C--N 1.353 0.752 0 CA-C-O 121.879 0.847 . . . . 0.0 111.053 168.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -91.88 90.05 1.47 Allowed Glycine 0 C--N 1.351 1.386 0 N-CA-C 107.332 -2.307 . . . . 0.0 107.332 167.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -106.1 125.52 51.1 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 -168.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -90.17 79.44 6.43 Favored 'General case' 0 C--N 1.352 0.678 0 O-C-N 120.987 -1.071 . . . . 0.0 109.68 -156.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 67.16 42.12 91.67 Favored Glycine 0 C--N 1.354 1.557 0 O-C-N 120.95 -1.094 . . . . 0.0 115.09 172.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 47.64 45.14 17.87 Favored 'General case' 0 C--N 1.354 0.766 0 C-N-CA 128.403 2.681 . . . . 0.0 116.843 -175.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 -94.62 -72.83 0.6 Allowed 'General case' 0 C--N 1.355 0.821 0 N-CA-C 114.72 1.378 . . . . 0.0 114.72 175.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -116.01 -96.41 0.46 Allowed 'General case' 0 C--N 1.357 0.919 0 O-C-N 120.536 -1.352 . . . . 0.0 113.083 -161.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -154.18 161.2 42.01 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 104.719 -2.326 . . . . 0.0 104.719 -171.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -154.25 156.48 26.87 Favored Glycine 0 CA--C 1.493 -1.329 0 N-CA-C 108.709 -1.756 . . . . 0.0 108.709 -177.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 73.6 t60 -101.45 144.84 29.74 Favored 'General case' 0 C--N 1.345 0.391 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 -175.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 72.3 m -78.98 133.22 36.87 Favored 'General case' 0 C--N 1.358 0.957 0 O-C-N 120.737 -1.227 . . . . 0.0 111.165 -178.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -123.61 159.91 28.23 Favored 'General case' 0 C--N 1.354 0.766 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 -175.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -118.98 135.09 54.79 Favored 'General case' 0 C--N 1.349 0.55 0 C-N-CA 124.228 1.011 . . . . 0.0 108.365 168.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 78.5 mt -101.28 125.71 55.22 Favored 'Isoleucine or valine' 0 C--N 1.358 0.944 0 C-N-CA 125.344 1.458 . . . . 0.0 109.038 173.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.5 162.4 39.88 Favored 'Isoleucine or valine' 0 C--N 1.351 0.644 0 C-N-CA 124.986 1.314 . . . . 0.0 110.678 179.153 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.355 1.593 0 O-C-N 121.074 -1.016 . . . . 0.0 111.667 -175.982 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 6.6 t80 . . . . . 0 N--CA 1.5 2.036 0 N-CA-C 115.0 1.481 . . . . 0.0 115.0 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -117.42 154.27 31.66 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 106.407 -1.701 . . . . 0.0 106.407 161.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.4 p -125.71 134.24 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 178.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.3 m -132.18 157.61 43.12 Favored 'Isoleucine or valine' 0 C--N 1.352 0.684 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 177.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 80.4 p -79.91 153.38 29.03 Favored 'General case' 0 C--N 1.349 0.548 0 O-C-N 120.704 -1.248 . . . . 0.0 113.97 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 21.0 t -121.96 25.25 9.22 Favored 'General case' 0 C--N 1.358 0.95 0 O-C-N 121.219 -0.926 . . . . 0.0 111.381 -171.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 45.57 39.18 4.57 Favored 'General case' 0 C--N 1.358 0.967 0 C-N-CA 128.184 2.594 . . . . 0.0 117.722 173.204 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 45.1 tptt -149.51 141.88 24.24 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 -174.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.8 p-10 -107.29 159.62 16.23 Favored 'General case' 0 C--N 1.355 0.837 0 CA-C-N 120.661 1.573 . . . . 0.0 111.075 170.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 84.5 m -106.61 156.15 18.9 Favored 'General case' 0 CA--C 1.509 -0.63 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 164.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 67.5 m -117.7 141.75 48.04 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 102.705 -3.072 . . . . 0.0 102.705 169.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 45.1 t -60.26 130.62 47.56 Favored 'General case' 0 C--N 1.357 0.893 0 O-C-N 120.815 -1.178 . . . . 0.0 111.242 178.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 89.32 -3.75 84.07 Favored Glycine 0 C--N 1.356 1.66 0 O-C-N 121.568 -0.707 . . . . 0.0 112.382 -176.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 11.4 mm-40 -112.55 -46.04 3.19 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 121.561 -0.964 . . . . 0.0 110.05 168.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 17.4 m120 53.47 43.61 31.07 Favored 'General case' 0 C--N 1.362 1.113 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 171.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -100.77 116.42 32.61 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 124.79 1.236 . . . . 0.0 111.877 -166.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 71.9 m -134.27 157.2 78.06 Favored Pre-proline 0 C--N 1.351 0.65 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 166.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.06 160.2 50.45 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.435 2.09 . . . . 0.0 110.962 166.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -62.64 134.67 56.67 Favored 'General case' 0 C--N 1.353 0.728 0 C-N-CA 123.91 0.884 . . . . 0.0 113.124 -173.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 98.8 -12.82 62.62 Favored Glycine 0 C--N 1.356 1.667 0 C-N-CA 124.185 0.897 . . . . 0.0 113.259 -173.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 71.2 m -116.29 154.56 29.96 Favored 'General case' 0 C--N 1.35 0.591 0 CA-C-N 118.019 0.909 . . . . 0.0 110.52 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -134.06 161.11 35.74 Favored 'General case' 0 C--N 1.355 0.811 0 N-CA-C 104.866 -2.272 . . . . 0.0 104.866 178.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 15.1 p -115.05 144.87 42.95 Favored 'General case' 0 CA--C 1.503 -0.849 0 CA-C-N 119.986 1.266 . . . . 0.0 112.455 172.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -90.97 62.91 2.89 Favored Glycine 0 C--N 1.352 1.421 0 CA-C-N 115.435 -0.802 . . . . 0.0 112.889 -172.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 62.6 mt -75.86 130.93 39.32 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 122.244 1.021 . . . . 0.0 111.895 167.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.537 HD22 ' H ' ' A' ' 42' ' ' LEU . 1.8 mm? -66.92 -44.56 80.37 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 126.297 1.839 . . . . 0.0 111.62 -164.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -167.45 49.57 0.24 Allowed Glycine 0 CA--C 1.499 -0.934 0 N-CA-C 106.609 -2.597 . . . . 0.0 106.609 173.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 45.11 54.48 7.01 Favored 'General case' 0 C--N 1.359 0.986 0 C-N-CA 127.537 2.335 . . . . 0.0 115.774 -176.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -94.06 -50.55 5.25 Favored 'General case' 0 C--N 1.359 0.986 0 O-C-N 119.996 -1.69 . . . . 0.0 111.802 -174.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 63.4 mttm -131.15 -103.07 0.28 Allowed 'General case' 0 C--N 1.356 0.862 0 C-N-CA 123.803 0.841 . . . . 0.0 111.479 -171.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 57.5 pttt -142.7 152.09 42.02 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 126.246 1.818 . . . . 0.0 106.833 -176.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -157.1 158.33 28.78 Favored Glycine 0 C--N 1.351 1.365 0 N-CA-C 108.142 -1.983 . . . . 0.0 108.142 -178.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 67.8 t60 -95.67 147.24 23.81 Favored 'General case' 0 C--N 1.346 0.433 0 O-C-N 121.717 -0.873 . . . . 0.0 110.49 -169.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 72.0 m -79.81 137.83 37.07 Favored 'General case' 0 C--N 1.359 1.002 0 O-C-N 121.078 -1.014 . . . . 0.0 111.792 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -127.09 154.62 44.47 Favored 'General case' 0 C--N 1.349 0.587 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 -178.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -104.69 135.87 45.26 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 124.629 1.171 . . . . 0.0 108.077 172.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 91.1 mt -101.19 123.4 54.23 Favored 'Isoleucine or valine' 0 C--N 1.356 0.86 0 C-N-CA 123.725 0.81 . . . . 0.0 108.937 176.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.19 146.51 33.61 Favored 'Isoleucine or valine' 0 C--N 1.351 0.663 0 C-N-CA 124.287 1.035 . . . . 0.0 109.693 176.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.354 1.553 0 O-C-N 121.215 -0.928 . . . . 0.0 114.69 175.893 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 8.4 t80 . . . . . 0 N--CA 1.504 2.242 0 N-CA-C 116.528 2.048 . . . . 0.0 116.528 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -115.93 148.19 40.31 Favored 'General case' 0 C--N 1.354 0.789 0 C-N-CA 124.953 1.301 . . . . 0.0 107.721 161.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.7 p -123.09 133.26 69.6 Favored 'Isoleucine or valine' 0 C--N 1.351 0.648 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 171.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 24.0 m -133.39 154.12 38.44 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.683 0 C-N-CA 124.422 1.089 . . . . 0.0 108.235 178.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 96.2 p -79.67 155.72 27.91 Favored 'General case' 0 C--N 1.352 0.676 0 CA-C-O 121.856 0.836 . . . . 0.0 113.03 178.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 12.2 t -114.22 11.72 17.55 Favored 'General case' 0 C--N 1.351 0.648 0 C-N-CA 123.818 0.847 . . . . 0.0 110.519 -177.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 32.6 m120 59.24 28.9 18.35 Favored 'General case' 0 C--N 1.357 0.919 0 C-N-CA 128.108 2.563 . . . . 0.0 115.41 173.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 26.5 mmmt -134.74 160.07 39.33 Favored 'General case' 0 CA--C 1.513 -0.478 0 C-N-CA 127.057 2.143 . . . . 0.0 106.545 178.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -136.06 165.6 25.31 Favored 'General case' 0 C--N 1.351 0.664 0 O-C-N 121.088 -1.007 . . . . 0.0 109.493 173.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 30.7 m -120.9 147.87 44.83 Favored 'General case' 0 C--N 1.352 0.688 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 173.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 24.6 p -93.5 164.84 13.03 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 122.008 0.909 . . . . 0.0 110.365 153.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 46.9 t -61.32 130.84 48.13 Favored 'General case' 0 C--N 1.35 0.623 0 CA-C-O 122.125 0.964 . . . . 0.0 112.593 -178.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.35 -19.3 44.34 Favored Glycine 0 C--N 1.353 1.491 0 C-N-CA 124.94 1.257 . . . . 0.0 113.636 -178.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 21.8 mm100 -80.23 -47.94 13.86 Favored 'General case' 0 C--N 1.353 0.719 0 N-CA-C 114.775 1.398 . . . . 0.0 114.775 179.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 31.6 m120 50.08 41.19 23.15 Favored 'General case' 0 C--N 1.355 0.836 0 C-N-CA 126.17 1.788 . . . . 0.0 115.055 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -98.42 109.43 22.19 Favored 'General case' 0 C--N 1.355 0.839 0 O-C-N 121.033 -1.042 . . . . 0.0 111.38 -172.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 76.1 m -137.05 157.7 74.09 Favored Pre-proline 0 C--N 1.35 0.598 0 N-CA-C 105.728 -1.953 . . . . 0.0 105.728 167.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -69.41 159.71 52.6 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.756 2.304 . . . . 0.0 111.349 169.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -62.79 131.28 48.31 Favored 'General case' 0 C--N 1.354 0.765 0 C-N-CA 123.675 0.79 . . . . 0.0 112.229 -172.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 100.36 -13.7 59.82 Favored Glycine 0 C--N 1.356 1.643 0 C-N-CA 123.822 0.725 . . . . 0.0 112.575 -174.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 72.1 m -114.08 154.21 28.13 Favored 'General case' 0 C--N 1.349 0.574 0 C-N-CA 124.088 0.955 . . . . 0.0 109.949 177.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -136.3 156.67 48.32 Favored 'General case' 0 C--N 1.35 0.611 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 178.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 8.1 p -106.16 143.87 33.68 Favored 'General case' 0 CA--C 1.501 -0.905 0 CA-C-O 122.413 1.102 . . . . 0.0 111.157 171.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -84.09 74.93 2.44 Favored Glycine 0 C--N 1.352 1.432 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 178.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -92.22 121.53 33.83 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 -173.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -91.46 101.06 13.73 Favored 'General case' 0 C--N 1.352 0.678 0 O-C-N 120.674 -1.266 . . . . 0.0 108.969 -163.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 60.07 32.02 74.54 Favored Glycine 0 C--N 1.357 1.708 0 N-CA-C 115.629 1.012 . . . . 0.0 115.629 165.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 46.19 43.11 10.83 Favored 'General case' 0 C--N 1.354 0.8 0 C-N-CA 127.895 2.478 . . . . 0.0 116.148 -168.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 -89.6 -98.7 0.1 Allowed 'General case' 0 C--N 1.359 0.999 0 O-C-N 121.247 -0.908 . . . . 0.0 111.649 173.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -96.89 -89.16 0.28 Allowed 'General case' 0 C--N 1.355 0.809 0 O-C-N 120.646 -1.284 . . . . 0.0 113.636 -169.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -151.98 162.12 41.57 Favored 'General case' 0 N--CA 1.445 -0.707 0 O-C-N 121.142 -0.973 . . . . 0.0 108.956 -168.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -157.5 154.03 25.18 Favored Glycine 0 C--N 1.352 1.424 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 63.1 t60 -97.3 148.13 23.44 Favored 'General case' 0 C--N 1.349 0.569 0 O-C-N 121.601 -0.94 . . . . 0.0 109.166 -173.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 71.5 m -80.84 134.51 35.78 Favored 'General case' 0 C--N 1.359 1.02 0 O-C-N 120.956 -1.09 . . . . 0.0 111.516 -178.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -130.81 167.13 19.41 Favored 'General case' 0 C--N 1.351 0.633 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 -177.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 33.7 pttt -124.28 148.92 47.06 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 121.56 0.695 . . . . 0.0 110.553 156.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 82.3 mt -104.78 124.25 59.29 Favored 'Isoleucine or valine' 0 C--N 1.358 0.944 0 C-N-CA 125.811 1.645 . . . . 0.0 107.805 174.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.42 142.13 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 C-N-CA 124.989 1.316 . . . . 0.0 108.938 178.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.351 1.393 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -175.707 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 28.3 t80 . . . . . 0 N--CA 1.504 2.249 0 N-CA-C 116.988 2.218 . . . . 0.0 116.988 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -144.65 158.21 43.87 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 105.11 -2.181 . . . . 0.0 105.11 167.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.7 p -130.82 133.05 63.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 175.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.5 m -133.27 161.6 41.18 Favored 'Isoleucine or valine' 0 C--N 1.351 0.634 0 C-N-CA 124.326 1.05 . . . . 0.0 108.313 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 87.3 p -75.82 149.81 37.81 Favored 'General case' 0 C--N 1.352 0.679 0 O-C-N 120.745 -1.222 . . . . 0.0 113.249 176.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 34.5 t -114.11 -0.12 14.1 Favored 'General case' 0 C--N 1.356 0.885 0 O-C-N 121.236 -0.915 . . . . 0.0 111.337 -172.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 53.3 t30 58.51 45.67 16.07 Favored 'General case' 0 C--N 1.356 0.864 0 C-N-CA 127.146 2.179 . . . . 0.0 114.827 175.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 15.5 tppt? -141.7 144.43 34.06 Favored 'General case' 0 C--N 1.349 0.565 0 N-CA-C 105.27 -2.122 . . . . 0.0 105.27 173.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 30.0 t30 -114.07 136.26 53.11 Favored 'General case' 0 C--N 1.353 0.76 0 O-C-N 121.2 -0.937 . . . . 0.0 110.387 -176.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 85.9 m -102.31 151.72 21.91 Favored 'General case' 0 C--N 1.356 0.855 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 170.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 40.0 m -128.16 160.18 32.84 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 101.774 -3.417 . . . . 0.0 101.774 176.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.2 t -51.15 -40.23 58.1 Favored 'General case' 0 C--N 1.345 0.393 0 C-N-CA 126.138 1.775 . . . . 0.0 115.461 -169.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -78.95 -1.5 85.01 Favored Glycine 0 C--N 1.351 1.374 0 N-CA-C 116.226 1.25 . . . . 0.0 116.226 178.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -145.9 135.45 23.17 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-N 120.34 2.07 . . . . 0.0 112.628 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 34.7 m120 -98.55 101.09 12.42 Favored 'General case' 0 C--N 1.353 0.744 0 O-C-N 119.833 -1.792 . . . . 0.0 106.491 172.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -130.42 95.02 3.78 Favored 'General case' 0 N--CA 1.446 -0.649 0 O-C-N 121.811 -0.556 . . . . 0.0 109.905 -164.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 73.1 m -136.05 156.54 76.94 Favored Pre-proline 0 C--N 1.351 0.633 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 170.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.85 160.44 49.67 Favored 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 122.478 2.119 . . . . 0.0 110.611 162.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 64.6 mm-40 -64.76 137.98 58.11 Favored 'General case' 0 C--N 1.351 0.673 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -174.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.37 -10.67 67.24 Favored Glycine 0 C--N 1.356 1.643 0 C-N-CA 123.83 0.728 . . . . 0.0 112.879 -174.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 71.3 m -115.61 153.74 30.71 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.219 1.008 . . . . 0.0 110.18 179.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -132.65 157.82 43.84 Favored 'General case' 0 C--N 1.355 0.836 0 N-CA-C 105.216 -2.142 . . . . 0.0 105.216 175.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 12.7 p -110.21 144.31 39.06 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-N 119.545 1.066 . . . . 0.0 110.666 169.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -85.16 71.63 2.91 Favored Glycine 0 C--N 1.352 1.418 0 N-CA-C 110.031 -1.228 . . . . 0.0 110.031 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -93.18 121.31 34.41 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 -172.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -88.71 82.65 6.79 Favored 'General case' 0 C--N 1.351 0.644 0 O-C-N 120.753 -1.217 . . . . 0.0 110.011 -162.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 64.21 37.29 94.34 Favored Glycine 0 C--N 1.354 1.578 0 O-C-N 121.029 -1.045 . . . . 0.0 115.197 167.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 47.49 44.64 16.96 Favored 'General case' 0 C--N 1.352 0.717 0 C-N-CA 128.811 2.844 . . . . 0.0 115.847 -173.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 64.0 m-80 -90.66 -61.43 1.68 Allowed 'General case' 0 C--N 1.357 0.892 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 171.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -127.36 -103.77 0.33 Allowed 'General case' 0 C--N 1.356 0.887 0 O-C-N 120.964 -1.085 . . . . 0.0 112.851 -169.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -152.37 159.98 43.36 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -169.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -164.68 151.5 20.6 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 111.174 -0.771 . . . . 0.0 111.174 -176.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 79.1 t60 -96.96 143.64 27.63 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 121.812 -0.816 . . . . 0.0 109.763 -171.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 74.4 m -76.94 139.38 40.15 Favored 'General case' 0 C--N 1.356 0.853 0 O-C-N 121.008 -1.057 . . . . 0.0 112.139 -178.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -123.96 151.01 44.11 Favored 'General case' 0 C--N 1.351 0.642 0 N-CA-C 106.962 -1.495 . . . . 0.0 106.962 -179.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -100.3 134.11 43.72 Favored 'General case' 0 C--N 1.346 0.453 0 C-N-CA 124.224 1.009 . . . . 0.0 108.317 173.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 96.6 mt -101.41 124.78 55.36 Favored 'Isoleucine or valine' 0 C--N 1.356 0.885 0 CA-C-O 122.08 0.943 . . . . 0.0 109.323 171.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -128.04 148.53 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 C-N-CA 125.827 1.651 . . . . 0.0 108.592 175.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.492 -1.346 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 -179.619 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 5.4 t80 . . . . . 0 N--CA 1.503 2.178 0 N-CA-C 115.828 1.788 . . . . 0.0 115.828 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -118.38 148.31 42.65 Favored 'General case' 0 C--N 1.356 0.863 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 162.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.0 p -120.74 134.99 62.39 Favored 'Isoleucine or valine' 0 C--N 1.35 0.626 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 174.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.7 m -131.76 160.01 42.69 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.603 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 177.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 94.5 p -77.26 153.71 33.7 Favored 'General case' 0 C--N 1.352 0.685 0 O-C-N 120.95 -1.094 . . . . 0.0 111.614 171.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 11.2 t -94.76 -8.68 36.89 Favored 'General case' 0 C--N 1.352 0.682 0 O-C-N 121.099 -1.001 . . . . 0.0 109.721 178.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 62.1 t30 58.44 45.23 16.95 Favored 'General case' 0 C--N 1.355 0.83 0 C-N-CA 128.4 2.68 . . . . 0.0 112.666 -173.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 53.5 tptt -133.12 135.89 45.48 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 177.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -91.14 136.26 33.21 Favored 'General case' 0 C--N 1.352 0.712 0 C-N-CA 125.429 1.492 . . . . 0.0 108.788 -178.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 25.2 p -129.16 150.09 50.69 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-O 122.093 0.949 . . . . 0.0 110.771 176.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 90.5 m -125.3 148.27 48.77 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 104.551 -2.388 . . . . 0.0 104.551 -174.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 80.9 p -57.92 -42.52 84.95 Favored 'General case' 0 C--N 1.353 0.734 0 N-CA-C 117.529 2.418 . . . . 0.0 117.529 -159.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -78.71 -48.96 6.83 Favored Glycine 0 C--N 1.353 1.492 0 CA-C-N 119.408 1.004 . . . . 0.0 113.475 176.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.6 mp0 -67.27 -43.97 80.49 Favored 'General case' 0 C--N 1.35 0.589 0 C-N-CA 125.143 1.377 . . . . 0.0 113.458 -174.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 54.09 45.1 28.21 Favored 'General case' 0 C--N 1.355 0.826 0 C-N-CA 129.004 2.922 . . . . 0.0 115.136 169.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 53.7 mp0 -75.97 123.54 25.9 Favored 'General case' 0 C--N 1.36 1.057 0 O-C-N 119.68 -1.887 . . . . 0.0 113.518 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 73.3 m -135.94 154.99 78.08 Favored Pre-proline 0 C--N 1.35 0.593 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 159.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.65 161.34 45.58 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.727 2.285 . . . . 0.0 110.998 167.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -62.92 130.76 46.19 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 121.483 0.659 . . . . 0.0 112.469 -175.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 100.63 -14.23 59.21 Favored Glycine 0 C--N 1.355 1.608 0 C-N-CA 123.675 0.655 . . . . 0.0 112.62 -173.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 73.9 m -113.3 153.71 28.01 Favored 'General case' 0 C--N 1.349 0.579 0 C-N-CA 123.92 0.888 . . . . 0.0 109.892 176.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -134.85 155.56 50.45 Favored 'General case' 0 C--N 1.352 0.705 0 O-C-N 121.235 -0.915 . . . . 0.0 110.3 -177.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 47.3 t -91.67 125.59 36.46 Favored 'General case' 0 C--N 1.351 0.652 0 C-N-CA 124.619 1.168 . . . . 0.0 111.788 -169.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -84.77 60.37 4.82 Favored Glycine 0 C--N 1.352 1.459 0 O-C-N 121.375 -0.828 . . . . 0.0 113.435 174.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -117.87 122.14 42.57 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 174.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -119.8 144.94 47.04 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 -173.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 76.39 10.43 85.59 Favored Glycine 0 C--N 1.355 1.636 0 O-C-N 121.547 -0.721 . . . . 0.0 114.806 166.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 55.7 46.29 22.86 Favored 'General case' 0 C--N 1.35 0.612 0 C-N-CA 126.655 1.982 . . . . 0.0 114.375 -175.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 -87.98 -109.09 0.07 Allowed 'General case' 0 C--N 1.356 0.869 0 O-C-N 121.469 -0.769 . . . . 0.0 112.558 -179.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -105.4 -107.29 0.3 Allowed 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.498 -1.376 . . . . 0.0 114.568 -169.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -114.37 154.23 28.43 Favored 'General case' 0 N--CA 1.439 -0.978 0 C-N-CA 126.882 2.073 . . . . 0.0 108.095 179.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -133.37 178.66 18.06 Favored Glycine 0 CA--C 1.493 -1.295 0 N-CA-C 107.233 -2.347 . . . . 0.0 107.233 173.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 40.9 t60 -128.2 147.6 50.58 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 105.052 -2.203 . . . . 0.0 105.052 177.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 79.9 m -83.26 140.86 32.26 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.036 -1.04 . . . . 0.0 112.408 -173.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -121.59 161.92 21.56 Favored 'General case' 0 C--N 1.356 0.885 0 O-C-N 121.42 -0.8 . . . . 0.0 108.871 -178.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -120.18 135.14 55.07 Favored 'General case' 0 C--N 1.35 0.588 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 167.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 78.5 mt -101.25 126.46 55.04 Favored 'Isoleucine or valine' 0 C--N 1.357 0.934 0 C-N-CA 125.134 1.374 . . . . 0.0 108.41 171.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.76 156.85 42.75 Favored 'Isoleucine or valine' 0 C--N 1.35 0.614 0 C-N-CA 124.947 1.299 . . . . 0.0 109.423 177.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.355 1.638 0 O-C-N 121.023 -1.048 . . . . 0.0 113.115 -176.681 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 6.4 t80 . . . . . 0 N--CA 1.505 2.306 0 N-CA-C 116.097 1.888 . . . . 0.0 116.097 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 52.5 m-20 -116.58 152.36 34.32 Favored 'General case' 0 C--N 1.355 0.835 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 164.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.1 p -123.22 134.47 66.15 Favored 'Isoleucine or valine' 0 C--N 1.348 0.522 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 174.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.7 m -131.24 157.99 43.27 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.802 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 80.4 p -83.65 151.08 25.48 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 122.151 0.977 . . . . 0.0 113.471 176.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 83.2 m -96.01 -2.76 46.24 Favored 'General case' 0 C--N 1.356 0.859 0 C-N-CA 123.927 0.891 . . . . 0.0 110.472 173.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 59.5 t30 57.19 45.23 20.91 Favored 'General case' 0 C--N 1.35 0.592 0 C-N-CA 129.093 2.957 . . . . 0.0 114.241 178.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.6 mmmt -130.07 147.57 51.83 Favored 'General case' 0 CA--C 1.506 -0.719 0 C-N-CA 126.877 2.071 . . . . 0.0 105.972 170.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -85.47 174.76 9.27 Favored 'General case' 0 C--N 1.354 0.8 0 CA-C-N 118.751 0.705 . . . . 0.0 110.228 173.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 17.0 p -126.89 -178.9 4.57 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 105.416 -2.068 . . . . 0.0 105.416 162.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 31.1 m -134.03 142.31 47.55 Favored 'General case' 0 CA--C 1.504 -0.824 1 N-CA-C 99.917 -4.105 . . . . 0.0 99.917 165.398 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 35.2 t -59.05 -44.58 91.81 Favored 'General case' 0 C--N 1.351 0.667 0 CA-C-N 120.508 1.504 . . . . 0.0 115.031 -163.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.9 -45.09 65.2 Favored Glycine 0 C--N 1.354 1.559 0 O-C-N 121.231 -0.918 . . . . 0.0 115.294 176.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -70.07 -43.51 71.03 Favored 'General case' 0 C--N 1.351 0.666 0 C-N-CA 125.113 1.365 . . . . 0.0 112.838 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 55.22 46.59 23.45 Favored 'General case' 0 C--N 1.353 0.72 0 C-N-CA 130.507 3.523 . . . . 0.0 112.694 -178.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -62.9 124.45 21.1 Favored 'General case' 0 C--N 1.359 1.012 0 C-N-CA 125.574 1.55 . . . . 0.0 113.455 177.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 86.0 m -143.3 159.66 54.55 Favored Pre-proline 0 C--N 1.351 0.665 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 159.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -68.7 156.61 64.91 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 122.746 2.298 . . . . 0.0 110.783 162.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -63.65 131.63 48.59 Favored 'General case' 0 C--N 1.352 0.707 0 CA-C-O 121.607 0.718 . . . . 0.0 112.804 -173.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.19 -12.31 61.98 Favored Glycine 0 C--N 1.356 1.676 0 O-C-N 121.605 -0.684 . . . . 0.0 112.896 -175.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 79.2 m -111.93 156.46 22.06 Favored 'General case' 0 C--N 1.349 0.56 0 C-N-CA 124.039 0.936 . . . . 0.0 108.914 177.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -138.13 159.96 40.66 Favored 'General case' 0 C--N 1.35 0.599 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 -177.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 41.9 t -117.33 121.14 40.32 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -88.91 93.44 1.9 Allowed Glycine 0 C--N 1.352 1.446 0 N-CA-C 107.943 -2.063 . . . . 0.0 107.943 177.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.418 HD21 ' O ' ' A' ' 46' ' ' LYS . 2.2 tm? -102.39 120.52 40.64 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 -167.176 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.483 HD22 ' H ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -89.65 115.11 26.79 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-O 123.18 1.466 . . . . 0.0 113.588 -177.84 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 69.64 14.19 69.5 Favored Glycine 0 C--N 1.356 1.685 0 N-CA-C 116.929 1.532 . . . . 0.0 116.929 159.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 60.22 27.73 17.26 Favored 'General case' 0 C--N 1.353 0.731 0 C-N-CA 126.672 1.989 . . . . 0.0 113.877 -176.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 65.4 m-80 -82.55 -46.79 12.91 Favored 'General case' 0 C--N 1.353 0.735 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 -172.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.418 ' O ' HD21 ' A' ' 41' ' ' LEU . 56.4 mtmt -139.24 -177.92 5.13 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-O 122.298 1.047 . . . . 0.0 108.261 -161.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.8 ptpp? -64.02 -37.71 88.42 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 126.9 2.08 . . . . 0.0 116.299 170.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.17 -162.38 53.0 Favored Glycine 0 C--N 1.355 1.591 0 O-C-N 119.494 -2.004 . . . . 0.0 112.678 -173.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 19.1 t60 -157.29 152.78 26.47 Favored 'General case' 0 C--N 1.356 0.876 0 N-CA-C 105.755 -1.942 . . . . 0.0 105.755 174.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 71.4 m -85.47 139.41 31.52 Favored 'General case' 0 C--N 1.357 0.896 0 O-C-N 120.581 -1.324 . . . . 0.0 113.469 -176.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -126.19 163.12 23.85 Favored 'General case' 0 C--N 1.357 0.926 0 C-N-CA 123.813 0.845 . . . . 0.0 109.447 -172.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 40.8 ttpt -121.23 136.97 54.88 Favored 'General case' 0 C--N 1.352 0.697 0 C-N-CA 125.336 1.454 . . . . 0.0 109.695 167.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 82.2 mt -94.03 124.4 46.48 Favored 'Isoleucine or valine' 0 C--N 1.361 1.078 0 C-N-CA 125.337 1.455 . . . . 0.0 109.687 172.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.72 140.02 49.14 Favored 'Isoleucine or valine' 0 C--N 1.351 0.643 0 C-N-CA 124.786 1.234 . . . . 0.0 109.977 173.194 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.491 -1.422 0 N-CA-C 108.713 -1.755 . . . . 0.0 108.713 178.479 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 9.4 t80 . . . . . 0 N--CA 1.503 2.186 0 N-CA-C 116.635 2.087 . . . . 0.0 116.635 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -123.12 148.36 45.77 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 161.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.1 p -119.53 132.0 70.55 Favored 'Isoleucine or valine' 0 C--N 1.351 0.662 0 N-CA-C 106.757 -1.572 . . . . 0.0 106.757 168.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.8 m -134.95 155.34 38.04 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.568 0 C-N-CA 124.795 1.238 . . . . 0.0 108.482 -177.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 89.6 p -79.73 157.48 27.14 Favored 'General case' 0 C--N 1.349 0.577 0 CA-C-O 122.25 1.024 . . . . 0.0 113.469 177.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 96.2 m -105.42 10.31 33.38 Favored 'General case' 0 C--N 1.352 0.703 0 C-N-CA 123.978 0.911 . . . . 0.0 111.971 177.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 53.7 t30 56.39 44.16 24.94 Favored 'General case' 0 C--N 1.355 0.825 0 C-N-CA 127.029 2.132 . . . . 0.0 113.166 -178.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 52.3 tptt -139.98 134.83 32.05 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.752 -1.217 . . . . 0.0 109.224 -177.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -87.09 121.18 29.19 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.184 1.793 . . . . 0.0 109.564 179.028 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 27.8 p -116.94 167.25 11.3 Favored 'General case' 0 C--N 1.35 0.618 0 C-N-CA 123.917 0.887 . . . . 0.0 108.741 173.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 73.7 m -129.51 146.11 51.38 Favored 'General case' 0 C--N 1.349 0.561 0 N-CA-C 104.063 -2.569 . . . . 0.0 104.063 170.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.502 ' HB2' HD12 ' A' ' 41' ' ' LEU . 33.4 t -57.75 -38.43 75.35 Favored 'General case' 0 C--N 1.355 0.807 0 C-N-CA 126.418 1.887 . . . . 0.0 113.727 -170.192 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -90.86 9.41 77.83 Favored Glycine 0 C--N 1.35 1.308 0 O-C-N 121.193 -0.942 . . . . 0.0 113.59 177.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 22.1 mm-40 -118.2 -43.33 2.74 Favored 'General case' 0 C--N 1.351 0.637 0 O-C-N 121.479 -1.012 . . . . 0.0 111.088 176.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 22.1 m120 56.17 38.04 29.45 Favored 'General case' 0 C--N 1.358 0.957 0 C-N-CA 127.38 2.272 . . . . 0.0 115.23 176.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -86.32 108.67 18.53 Favored 'General case' 0 C--N 1.351 0.654 0 O-C-N 120.683 -1.261 . . . . 0.0 110.785 -178.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 91.5 m -134.64 157.73 76.63 Favored Pre-proline 0 C--N 1.351 0.636 0 C-N-CA 125.033 1.333 . . . . 0.0 108.476 175.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -69.98 161.27 46.6 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.877 2.385 . . . . 0.0 111.206 168.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -64.28 134.83 55.47 Favored 'General case' 0 C--N 1.353 0.743 0 CA-C-O 121.646 0.736 . . . . 0.0 112.591 -174.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.53 -10.89 68.94 Favored Glycine 0 C--N 1.354 1.561 0 C-N-CA 123.473 0.558 . . . . 0.0 113.027 -174.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 85.6 m -114.8 154.6 28.28 Favored 'General case' 0 C--N 1.351 0.634 0 CA-C-N 118.034 0.917 . . . . 0.0 109.33 -179.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -131.35 160.4 35.14 Favored 'General case' 0 C--N 1.351 0.65 0 O-C-N 121.211 -0.93 . . . . 0.0 108.533 -179.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 43.2 t -89.45 119.76 30.18 Favored 'General case' 0 C--N 1.353 0.728 0 O-C-N 121.533 -0.73 . . . . 0.0 109.688 -175.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -90.21 63.8 3.04 Favored Glycine 0 C--N 1.353 1.494 0 O-C-N 121.168 -0.957 . . . . 0.0 114.003 -175.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.502 HD12 ' HB2' ' A' ' 28' ' ' SER . 2.4 tm? -132.87 132.84 42.55 Favored 'General case' 0 C--N 1.352 0.712 0 CA-C-N 118.761 1.281 . . . . 0.0 108.414 177.371 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.43 ' N ' HD13 ' A' ' 41' ' ' LEU . 1.8 mm? -115.8 133.4 56.07 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 -175.103 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.79 5.85 86.72 Favored Glycine 0 C--N 1.356 1.677 0 N-CA-C 115.92 1.128 . . . . 0.0 115.92 166.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 56.42 40.5 29.64 Favored 'General case' 0 C--N 1.349 0.557 0 C-N-CA 127.224 2.209 . . . . 0.0 113.731 -173.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 62.0 m-80 -67.78 -46.56 71.65 Favored 'General case' 0 C--N 1.355 0.824 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 172.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -139.4 -133.46 0.12 Allowed 'General case' 0 C--N 1.351 0.668 0 CA-C-O 121.718 0.771 . . . . 0.0 109.236 -177.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.5 pttm -103.46 -56.71 2.16 Favored 'General case' 0 C--N 1.351 0.648 0 C-N-CA 125.522 1.529 . . . . 0.0 113.444 -178.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 94.4 175.98 38.84 Favored Glycine 0 C--N 1.352 1.441 0 CA-C-O 122.843 1.246 . . . . 0.0 111.444 -171.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 51.6 t60 -149.0 152.95 37.19 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 102.692 -3.077 . . . . 0.0 102.692 177.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 79.1 m -81.85 135.19 35.45 Favored 'General case' 0 C--N 1.351 0.672 0 O-C-N 121.054 -1.029 . . . . 0.0 112.244 -174.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 13.1 m-30 -123.9 160.68 26.95 Favored 'General case' 0 C--N 1.357 0.896 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -178.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 20.2 pttm -121.36 150.98 40.66 Favored 'General case' 0 C--N 1.35 0.606 0 CA-C-O 121.689 0.757 . . . . 0.0 109.653 160.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 83.7 mt -114.36 130.54 68.48 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.788 0 C-N-CA 124.861 1.264 . . . . 0.0 109.976 176.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.61 140.41 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 C-N-CA 126.679 1.991 . . . . 0.0 109.053 178.379 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.35 1.35 0 N-CA-C 107.426 -2.269 . . . . 0.0 107.426 -172.029 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 11.8 t80 . . . . . 0 N--CA 1.504 2.259 0 N-CA-C 115.996 1.85 . . . . 0.0 115.996 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -116.87 154.12 31.33 Favored 'General case' 0 C--N 1.356 0.855 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 164.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.5 p -126.69 134.6 65.9 Favored 'Isoleucine or valine' 0 C--N 1.35 0.619 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 178.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 33.1 m -132.69 162.75 39.38 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 C-N-CA 124.585 1.154 . . . . 0.0 108.209 -179.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 78.5 p -72.9 145.06 47.11 Favored 'General case' 0 C--N 1.351 0.668 0 O-C-N 120.606 -1.309 . . . . 0.0 113.866 174.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 34.1 t -95.34 -10.12 31.0 Favored 'General case' 0 C--N 1.356 0.886 0 O-C-N 121.219 -0.926 . . . . 0.0 111.314 -179.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 54.0 t30 59.87 41.8 17.37 Favored 'General case' 0 C--N 1.355 0.835 0 C-N-CA 127.406 2.283 . . . . 0.0 112.874 -175.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 24.7 mmmt -130.83 144.21 51.29 Favored 'General case' 0 C--N 1.353 0.747 0 C-N-CA 124.571 1.148 . . . . 0.0 111.483 175.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 20.1 t30 -93.65 123.39 36.95 Favored 'General case' 0 C--N 1.354 0.796 0 CA-C-O 122.214 1.007 . . . . 0.0 110.231 -173.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 14.4 t -105.69 152.9 22.57 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 128.483 2.713 . . . . 0.0 107.638 176.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 42.1 m -131.09 160.07 35.74 Favored 'General case' 0 C--N 1.355 0.844 0 N-CA-C 104.729 -2.323 . . . . 0.0 104.729 172.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.5 t -62.35 -43.25 99.26 Favored 'General case' 0 C--N 1.353 0.737 0 O-C-N 120.083 -1.635 . . . . 0.0 112.966 174.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -63.76 -41.5 98.88 Favored Glycine 0 C--N 1.357 1.738 0 C-N-CA 124.397 0.998 . . . . 0.0 115.127 176.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 27.1 pt20 -132.53 117.01 17.45 Favored 'General case' 0 C--N 1.35 0.621 0 CA-C-O 122.698 1.237 . . . . 0.0 110.053 175.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 24.2 m120 -91.89 79.56 5.28 Favored 'General case' 0 C--N 1.353 0.742 0 O-C-N 120.514 -1.366 . . . . 0.0 108.644 -174.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -97.72 109.7 22.41 Favored 'General case' 0 C--N 1.35 0.612 0 O-C-N 120.906 -1.121 . . . . 0.0 110.885 -170.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 80.9 m -134.27 153.09 79.23 Favored Pre-proline 0 C--N 1.351 0.631 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 172.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -72.17 162.23 42.3 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 123.145 2.563 . . . . 0.0 111.036 168.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -64.92 135.15 55.36 Favored 'General case' 0 C--N 1.353 0.725 0 CA-C-O 121.647 0.736 . . . . 0.0 112.19 -178.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.76 -14.31 63.08 Favored Glycine 0 C--N 1.354 1.583 0 C-N-CA 123.779 0.704 . . . . 0.0 112.375 -171.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 76.7 m -113.76 155.24 25.99 Favored 'General case' 0 C--N 1.349 0.582 0 C-N-CA 124.236 1.014 . . . . 0.0 109.894 175.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -139.74 161.07 38.42 Favored 'General case' 0 C--N 1.352 0.714 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 -176.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 41.2 t -122.13 124.09 43.09 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 173.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -100.99 106.51 3.1 Favored Glycine 0 C--N 1.352 1.47 0 N-CA-C 107.092 -2.403 . . . . 0.0 107.092 170.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -101.13 120.1 39.72 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 -168.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -87.55 89.34 7.96 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-O 122.662 1.22 . . . . 0.0 113.122 -174.284 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 64.05 32.52 84.44 Favored Glycine 0 C--N 1.358 1.762 0 N-CA-C 117.226 1.65 . . . . 0.0 117.226 160.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.8 pm0 46.99 36.42 4.06 Favored 'General case' 0 C--N 1.354 0.79 0 C-N-CA 128.511 2.725 . . . . 0.0 115.172 -174.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 59.1 m-80 -77.92 -44.71 26.17 Favored 'General case' 0 CA--C 1.505 -0.78 0 C-N-CA 124.785 1.234 . . . . 0.0 112.372 174.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.5 pttm -155.61 174.54 15.12 Favored 'General case' 0 N--CA 1.425 -1.706 0 N-CA-C 106.009 -1.849 . . . . 0.0 106.009 -174.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -62.08 -36.5 81.86 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 129.747 3.219 . . . . 0.0 115.312 -173.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 83.47 -167.5 44.91 Favored Glycine 0 C--N 1.355 1.63 0 O-C-N 120.627 -1.296 . . . . 0.0 112.145 -175.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 69.1 t60 -156.9 151.3 25.33 Favored 'General case' 0 C--N 1.35 0.627 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 177.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 70.9 m -81.24 140.84 34.66 Favored 'General case' 0 C--N 1.356 0.86 0 CA-C-N 119.786 1.176 . . . . 0.0 112.723 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 8.6 m-30 -121.27 157.14 30.98 Favored 'General case' 0 C--N 1.353 0.74 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 -177.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 40.6 ttpt -110.42 137.43 48.14 Favored 'General case' 0 C--N 1.349 0.546 0 C-N-CA 124.17 0.988 . . . . 0.0 109.903 173.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 97.3 mt -97.12 123.55 49.52 Favored 'Isoleucine or valine' 0 C--N 1.361 1.066 0 C-N-CA 124.546 1.138 . . . . 0.0 109.874 176.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.78 138.23 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 C-N-CA 124.431 1.092 . . . . 0.0 108.798 173.285 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.35 1.332 0 N-CA-C 108.854 -1.698 . . . . 0.0 108.854 -175.973 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 10.7 t80 . . . . . 0 N--CA 1.504 2.237 0 N-CA-C 115.856 1.798 . . . . 0.0 115.856 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -117.37 153.88 32.27 Favored 'General case' 0 C--N 1.355 0.83 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 162.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.9 p -128.06 133.39 67.26 Favored 'Isoleucine or valine' 0 C--N 1.349 0.585 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 177.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.9 m -134.22 161.55 40.55 Favored 'Isoleucine or valine' 0 C--N 1.352 0.691 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 78.5 p -72.88 144.48 47.39 Favored 'General case' 0 C--N 1.351 0.648 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 177.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 29.1 t -99.05 -6.4 28.56 Favored 'General case' 0 C--N 1.356 0.884 0 C-N-CA 123.938 0.895 . . . . 0.0 111.749 -177.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 60.28 46.69 9.91 Favored 'General case' 0 C--N 1.355 0.83 0 C-N-CA 127.016 2.126 . . . . 0.0 112.549 -178.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -137.19 140.26 41.64 Favored 'General case' 0 C--N 1.352 0.676 0 O-C-N 120.55 -1.344 . . . . 0.0 107.748 175.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.9 t30 -87.29 126.01 34.57 Favored 'General case' 0 C--N 1.356 0.89 0 C-N-CA 124.423 1.089 . . . . 0.0 110.856 -174.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 16.9 t -106.15 144.37 32.95 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 126.973 2.109 . . . . 0.0 109.842 175.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 16.3 m -134.51 153.06 52.13 Favored 'General case' 0 C--N 1.352 0.68 0 N-CA-C 102.209 -3.256 . . . . 0.0 102.209 170.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 38.7 t -58.87 -44.67 91.13 Favored 'General case' 0 C--N 1.356 0.872 0 CA-C-N 120.685 1.584 . . . . 0.0 114.496 -171.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -81.3 -3.95 90.55 Favored Glycine 0 C--N 1.353 1.478 0 O-C-N 121.299 -0.876 . . . . 0.0 113.989 -177.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -113.98 -48.19 2.92 Favored 'General case' 0 C--N 1.35 0.607 0 CA-C-N 117.693 0.746 . . . . 0.0 110.331 -177.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 49.93 48.97 21.09 Favored 'General case' 0 C--N 1.358 0.958 0 C-N-CA 130.492 3.517 . . . . 0.0 112.261 176.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 52.3 mm-40 -96.5 115.39 27.35 Favored 'General case' 0 C--N 1.353 0.731 0 O-C-N 120.745 -1.222 . . . . 0.0 111.714 -167.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 81.7 m -134.28 154.27 79.86 Favored Pre-proline 0 C--N 1.35 0.612 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 174.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -71.27 161.04 47.05 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.68 2.254 . . . . 0.0 111.044 168.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -63.23 130.82 46.18 Favored 'General case' 0 C--N 1.352 0.714 0 C-N-CA 123.33 0.652 . . . . 0.0 111.598 -176.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 100.63 -13.92 59.32 Favored Glycine 0 C--N 1.354 1.58 0 C-N-CA 123.754 0.692 . . . . 0.0 112.469 -173.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 82.2 m -112.71 154.51 26.02 Favored 'General case' 0 C--N 1.349 0.573 0 C-N-CA 124.022 0.929 . . . . 0.0 110.134 175.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -137.28 159.89 40.63 Favored 'General case' 0 C--N 1.354 0.783 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 -175.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 40.6 t -111.6 119.05 37.4 Favored 'General case' 0 C--N 1.35 0.624 0 CA-C-O 121.81 0.814 . . . . 0.0 109.843 174.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -92.63 69.23 1.73 Allowed Glycine 0 C--N 1.35 1.339 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 173.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 60.1 tp -105.8 123.31 47.74 Favored 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 172.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -113.62 130.45 56.39 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 -173.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.2 5.04 70.26 Favored Glycine 0 C--N 1.355 1.627 0 N-CA-C 115.946 1.138 . . . . 0.0 115.946 162.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 55.9 47.13 20.71 Favored 'General case' 0 C--N 1.351 0.635 0 C-N-CA 126.357 1.863 . . . . 0.0 113.696 -170.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 -64.98 -49.29 70.86 Favored 'General case' 0 C--N 1.356 0.849 0 N-CA-C 115.098 1.518 . . . . 0.0 115.098 173.056 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -144.32 -120.81 0.08 Allowed 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 175.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 15.7 ptpt -115.27 -35.14 4.75 Favored 'General case' 0 N--CA 1.439 -1.013 0 C-N-CA 127.171 2.188 . . . . 0.0 114.238 -176.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 75.51 -162.48 53.3 Favored Glycine 0 C--N 1.355 1.638 0 O-C-N 119.993 -1.692 . . . . 0.0 110.464 -171.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 67.8 t60 -157.95 159.95 37.05 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 103.454 -2.795 . . . . 0.0 103.454 170.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 77.1 m -79.23 139.09 38.02 Favored 'General case' 0 C--N 1.352 0.717 0 CA-C-N 120.226 1.375 . . . . 0.0 112.44 175.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -124.42 155.92 38.03 Favored 'General case' 0 C--N 1.353 0.731 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 -175.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -108.23 137.39 46.29 Favored 'General case' 0 C--N 1.348 0.512 0 C-N-CA 124.645 1.178 . . . . 0.0 109.153 173.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 95.8 mt -97.14 122.73 48.98 Favored 'Isoleucine or valine' 0 C--N 1.361 1.076 0 C-N-CA 124.185 0.994 . . . . 0.0 109.288 173.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.25 158.21 43.24 Favored 'Isoleucine or valine' 0 C--N 1.35 0.611 0 C-N-CA 124.495 1.118 . . . . 0.0 109.512 177.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.355 1.622 0 O-C-N 121.218 -0.926 . . . . 0.0 113.667 -179.602 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 6.9 t80 . . . . . 0 N--CA 1.504 2.275 0 N-CA-C 116.23 1.937 . . . . 0.0 116.23 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -120.15 151.64 38.8 Favored 'General case' 0 C--N 1.354 0.79 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 161.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.6 p -123.5 136.29 60.52 Favored 'Isoleucine or valine' 0 C--N 1.35 0.589 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 178.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 28.9 m -130.5 156.46 42.5 Favored 'Isoleucine or valine' 0 C--N 1.35 0.594 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 175.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 87.2 p -79.62 150.38 31.03 Favored 'General case' 0 C--N 1.351 0.646 0 O-C-N 121.093 -1.004 . . . . 0.0 112.375 174.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 14.4 t -98.7 -10.7 22.82 Favored 'General case' 0 C--N 1.352 0.712 0 O-C-N 121.269 -0.894 . . . . 0.0 109.748 178.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 59.73 42.83 16.25 Favored 'General case' 0 C--N 1.355 0.836 0 C-N-CA 128.208 2.603 . . . . 0.0 114.459 178.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 55.9 tptt -122.16 135.71 54.82 Favored 'General case' 0 C--N 1.35 0.623 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 172.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -88.31 127.63 35.48 Favored 'General case' 0 C--N 1.355 0.811 0 C-N-CA 125.096 1.358 . . . . 0.0 109.765 -178.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 6.7 t -119.39 133.57 55.65 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 124.973 1.309 . . . . 0.0 111.249 -177.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 88.9 m -117.98 146.22 44.17 Favored 'General case' 0 C--N 1.351 0.666 0 N-CA-C 103.987 -2.597 . . . . 0.0 103.987 -178.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 84.8 p -59.22 -41.74 89.34 Favored 'General case' 0 C--N 1.35 0.618 0 N-CA-C 116.665 2.098 . . . . 0.0 116.665 -165.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.14 -36.81 93.72 Favored Glycine 0 C--N 1.351 1.362 0 C-N-CA 124.517 1.056 . . . . 0.0 114.268 172.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 23.9 mm100 -77.57 -47.69 18.82 Favored 'General case' 0 C--N 1.351 0.654 0 C-N-CA 123.804 0.842 . . . . 0.0 111.565 -177.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 52.23 39.95 28.0 Favored 'General case' 0 C--N 1.354 0.795 0 C-N-CA 128.628 2.771 . . . . 0.0 112.69 179.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -100.97 135.84 41.77 Favored 'General case' 0 C--N 1.356 0.879 0 O-C-N 120.571 -1.331 . . . . 0.0 113.353 -168.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 72.5 m -136.88 159.93 68.24 Favored Pre-proline 0 C--N 1.352 0.681 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 161.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -69.44 160.97 47.75 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.585 2.19 . . . . 0.0 110.556 162.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -64.59 136.95 57.54 Favored 'General case' 0 C--N 1.351 0.649 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -171.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.86 -12.3 65.87 Favored Glycine 0 C--N 1.355 1.621 0 C-N-CA 123.918 0.77 . . . . 0.0 112.832 -175.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 72.7 m -115.19 154.71 28.51 Favored 'General case' 0 C--N 1.348 0.507 0 C-N-CA 124.494 1.117 . . . . 0.0 109.533 179.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -133.36 154.79 50.43 Favored 'General case' 0 C--N 1.354 0.777 0 O-C-N 121.184 -0.948 . . . . 0.0 110.483 -177.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 43.8 t -104.85 119.26 38.59 Favored 'General case' 0 C--N 1.355 0.821 0 C-N-CA 124.479 1.112 . . . . 0.0 109.029 -177.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -90.48 69.99 2.22 Favored Glycine 0 C--N 1.351 1.417 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 175.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -107.79 123.73 48.99 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 178.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -117.17 138.06 51.92 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 -166.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.7 14.63 72.83 Favored Glycine 0 C--N 1.358 1.773 0 N-CA-C 115.99 1.156 . . . . 0.0 115.99 164.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 55.96 43.79 26.71 Favored 'General case' 0 C--N 1.349 0.556 0 C-N-CA 127.629 2.371 . . . . 0.0 113.213 -169.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 59.8 m-80 -70.13 168.16 16.22 Favored 'General case' 0 C--N 1.356 0.881 0 O-C-N 120.777 -1.202 . . . . 0.0 110.924 163.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -68.42 -48.27 65.07 Favored 'General case' 0 C--N 1.349 0.554 0 N-CA-C 116.005 1.854 . . . . 0.0 116.005 -163.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 79.9 mttt -136.36 150.1 48.67 Favored 'General case' 0 C--N 1.352 0.689 0 C-N-CA 123.492 0.717 . . . . 0.0 111.324 -176.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -136.66 168.58 24.15 Favored Glycine 0 C--N 1.348 1.195 0 N-CA-C 106.683 -2.567 . . . . 0.0 106.683 171.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 70.1 t60 -125.6 144.59 50.51 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 -176.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 74.7 m -80.43 137.63 36.52 Favored 'General case' 0 C--N 1.351 0.669 0 O-C-N 121.18 -0.95 . . . . 0.0 112.885 -176.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -126.22 162.65 24.94 Favored 'General case' 0 C--N 1.357 0.928 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -174.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -123.18 136.84 54.93 Favored 'General case' 0 C--N 1.35 0.626 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 166.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 81.1 mt -100.66 127.41 53.79 Favored 'Isoleucine or valine' 0 C--N 1.358 0.945 0 C-N-CA 125.741 1.616 . . . . 0.0 109.232 175.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.37 157.24 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 C-N-CA 124.967 1.307 . . . . 0.0 109.774 177.081 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.353 1.503 0 N-CA-C 108.922 -1.671 . . . . 0.0 108.922 -170.63 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 49.4 t80 . . . . . 0 N--CA 1.503 2.222 0 N-CA-C 117.675 2.472 . . . . 0.0 117.675 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -120.12 154.33 34.87 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 106.374 -1.713 . . . . 0.0 106.374 156.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.7 p -125.69 135.42 63.99 Favored 'Isoleucine or valine' 0 C--N 1.35 0.605 0 N-CA-C 106.271 -1.752 . . . . 0.0 106.271 170.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.687 HG22 HD11 ' A' ' 54' ' ' ILE . 27.0 m -134.0 161.46 40.85 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.912 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -179.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 89.5 p -77.15 151.99 35.07 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 121.835 0.826 . . . . 0.0 112.105 170.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 18.1 t -110.37 16.99 21.3 Favored 'General case' 0 C--N 1.352 0.706 0 C-N-CA 124.155 0.982 . . . . 0.0 110.261 -177.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 30.4 m120 57.98 36.5 26.2 Favored 'General case' 0 C--N 1.353 0.734 0 C-N-CA 127.34 2.256 . . . . 0.0 114.504 170.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 58.0 tptt -138.38 136.53 36.4 Favored 'General case' 0 C--N 1.354 0.79 0 O-C-N 121.27 -0.894 . . . . 0.0 110.32 -174.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -79.74 128.21 33.15 Favored 'General case' 0 C--N 1.356 0.884 0 C-N-CA 126.7 2.0 . . . . 0.0 112.337 178.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 12.0 t -118.01 131.6 56.46 Favored 'General case' 0 C--N 1.351 0.661 0 C-N-CA 126.584 1.954 . . . . 0.0 110.862 -179.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 12.6 m -119.89 151.93 38.14 Favored 'General case' 0 C--N 1.353 0.726 0 N-CA-C 105.279 -2.119 . . . . 0.0 105.279 -178.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 95.1 p -59.94 -37.02 78.34 Favored 'General case' 0 C--N 1.352 0.688 0 N-CA-C 115.513 1.672 . . . . 0.0 115.513 -168.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -93.02 0.12 68.91 Favored Glycine 0 C--N 1.353 1.493 0 O-C-N 121.846 -0.534 . . . . 0.0 113.811 177.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -110.97 -46.22 3.36 Favored 'General case' 0 C--N 1.35 0.629 0 CA-C-N 118.294 1.047 . . . . 0.0 111.1 179.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 31.2 m120 51.76 45.07 28.76 Favored 'General case' 0 C--N 1.359 0.979 0 C-N-CA 126.597 1.959 . . . . 0.0 114.142 -174.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -84.31 115.51 22.52 Favored 'General case' 0 C--N 1.353 0.727 0 O-C-N 121.338 -0.851 . . . . 0.0 112.503 -164.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 74.1 m -134.64 157.33 77.5 Favored Pre-proline 0 C--N 1.355 0.829 0 CA-C-O 118.478 -0.772 . . . . 0.0 109.065 172.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -70.43 159.35 53.22 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.63 2.22 . . . . 0.0 110.503 161.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -65.17 136.59 56.85 Favored 'General case' 0 C--N 1.352 0.694 0 CA-C-O 121.646 0.736 . . . . 0.0 112.63 -177.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.64 -13.57 63.92 Favored Glycine 0 C--N 1.354 1.543 0 C-N-CA 123.855 0.74 . . . . 0.0 113.112 -174.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 90.6 m -114.51 157.22 23.27 Favored 'General case' 0 C--N 1.349 0.55 0 C-N-CA 124.525 1.13 . . . . 0.0 109.947 176.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 24.8 p90 -137.57 161.17 37.15 Favored 'General case' 0 C--N 1.351 0.65 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 -172.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 43.3 t -118.35 127.36 53.62 Favored 'General case' 0 CA--C 1.507 -0.684 0 O-C-N 121.32 -0.863 . . . . 0.0 110.881 -179.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -97.19 78.63 0.67 Allowed Glycine 0 C--N 1.352 1.438 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 167.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -113.63 122.61 47.7 Favored 'General case' 0 C--N 1.352 0.679 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 168.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -119.76 146.67 45.45 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 -163.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.84 12.7 78.69 Favored Glycine 0 C--N 1.357 1.713 0 O-C-N 121.73 -0.606 . . . . 0.0 114.435 165.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 8.7 mp0 54.91 46.57 24.13 Favored 'General case' 0 C--N 1.351 0.638 0 C-N-CA 126.685 1.994 . . . . 0.0 113.539 -171.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -76.16 175.13 9.26 Favored 'General case' 0 C--N 1.357 0.892 0 C-N-CA 124.463 1.105 . . . . 0.0 110.409 166.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -64.74 -48.94 72.76 Favored 'General case' 0 C--N 1.348 0.519 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 -154.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 19.4 pttp -163.74 159.05 20.96 Favored 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 178.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -137.05 -165.06 10.31 Favored Glycine 0 C--N 1.344 0.996 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 176.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 37.3 t60 -143.79 149.18 36.67 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 105.76 -1.941 . . . . 0.0 105.76 -174.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 75.0 m -81.86 143.77 31.48 Favored 'General case' 0 C--N 1.352 0.697 0 O-C-N 121.021 -1.049 . . . . 0.0 113.096 -176.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -124.46 158.56 32.54 Favored 'General case' 0 C--N 1.356 0.877 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 -174.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -117.93 136.46 53.47 Favored 'General case' 0 C--N 1.35 0.596 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 166.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 80.5 mt -96.72 127.38 48.93 Favored 'Isoleucine or valine' 0 C--N 1.356 0.857 0 C-N-CA 125.307 1.443 . . . . 0.0 108.214 167.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.687 HD11 HG22 ' A' ' 20' ' ' VAL . 4.4 mp -116.05 124.32 72.24 Favored 'Isoleucine or valine' 0 C--N 1.354 0.793 0 N-CA-C 103.718 -2.697 . . . . 0.0 103.718 -177.316 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.25 0 O-C-N 120.756 -1.215 . . . . 0.0 110.487 -178.961 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 22.7 t80 . . . . . 0 N--CA 1.502 2.14 0 N-CA-C 116.966 2.21 . . . . 0.0 116.966 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -124.67 148.28 48.06 Favored 'General case' 0 C--N 1.353 0.747 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 159.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.9 p -124.12 134.05 67.64 Favored 'Isoleucine or valine' 0 C--N 1.349 0.557 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 173.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 28.0 m -131.25 154.05 39.99 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.744 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 175.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 80.4 p -79.26 151.83 30.92 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 177.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 19.9 t -123.97 33.18 5.36 Favored 'General case' 0 C--N 1.355 0.804 0 CA-C-O 121.761 0.791 . . . . 0.0 109.919 -172.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 44.75 37.88 2.51 Favored 'General case' 0 C--N 1.357 0.899 0 C-N-CA 129.016 2.926 . . . . 0.0 118.267 169.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -148.81 143.17 26.16 Favored 'General case' 0 C--N 1.348 0.536 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -175.449 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 33.8 t30 -115.45 135.87 53.66 Favored 'General case' 0 C--N 1.353 0.727 0 C-N-CA 124.27 1.028 . . . . 0.0 110.568 -175.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 83.6 m -101.5 152.1 21.17 Favored 'General case' 0 C--N 1.355 0.846 0 C-N-CA 124.151 0.98 . . . . 0.0 108.54 171.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 55.5 m -128.17 156.25 43.19 Favored 'General case' 0 CA--C 1.507 -0.682 0 N-CA-C 102.046 -3.316 . . . . 0.0 102.046 174.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 46.8 t -52.53 -39.24 61.15 Favored 'General case' 0 C--N 1.349 0.57 0 N-CA-C 115.68 1.733 . . . . 0.0 115.68 -162.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -77.28 -0.96 73.25 Favored Glycine 0 C--N 1.351 1.373 0 N-CA-C 116.475 1.35 . . . . 0.0 116.475 178.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -143.58 140.78 30.36 Favored 'General case' 0 C--N 1.356 0.858 0 CA-C-N 120.347 2.073 . . . . 0.0 112.009 179.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 34.5 m120 -102.15 103.52 14.06 Favored 'General case' 0 C--N 1.352 0.715 0 O-C-N 119.973 -1.705 . . . . 0.0 106.523 170.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -126.93 94.32 4.0 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 -168.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 72.9 m -136.77 156.88 75.82 Favored Pre-proline 0 C--N 1.351 0.662 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 172.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -70.51 160.42 49.55 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.52 2.147 . . . . 0.0 110.64 164.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -62.77 134.38 56.19 Favored 'General case' 0 C--N 1.354 0.779 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -174.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.25 -11.89 65.34 Favored Glycine 0 C--N 1.355 1.61 0 C-N-CA 124.194 0.902 . . . . 0.0 113.409 -175.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 73.8 m -114.15 153.77 28.96 Favored 'General case' 0 C--N 1.348 0.518 0 C-N-CA 124.145 0.978 . . . . 0.0 110.116 179.019 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 31.5 p90 -132.5 158.22 42.65 Favored 'General case' 0 C--N 1.352 0.684 0 N-CA-C 105.699 -1.963 . . . . 0.0 105.699 178.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 9.8 p -109.69 146.66 34.48 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-O 122.531 1.157 . . . . 0.0 112.923 173.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -82.74 69.29 3.39 Favored Glycine 0 C--N 1.353 1.498 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 176.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -91.81 122.46 34.37 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 -175.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -86.02 77.34 9.66 Favored 'General case' 0 C--N 1.352 0.701 0 O-C-N 120.709 -1.244 . . . . 0.0 110.829 -161.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 62.61 45.39 95.92 Favored Glycine 0 C--N 1.355 1.594 0 N-CA-C 115.448 0.939 . . . . 0.0 115.448 166.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 48.31 43.75 19.4 Favored 'General case' 0 C--N 1.354 0.779 0 C-N-CA 128.474 2.71 . . . . 0.0 115.984 -172.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 66.0 m-80 -97.48 -74.08 0.59 Allowed 'General case' 0 C--N 1.356 0.867 0 O-C-N 121.135 -0.978 . . . . 0.0 112.509 170.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -119.66 -101.55 0.42 Allowed 'General case' 0 C--N 1.357 0.932 0 O-C-N 120.917 -1.115 . . . . 0.0 113.649 -163.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.4 pptp? -145.76 161.01 40.9 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 -175.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -162.39 151.28 21.15 Favored Glycine 0 C--N 1.349 1.297 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 -179.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 72.4 t60 -99.19 146.82 25.76 Favored 'General case' 0 C--N 1.347 0.473 0 O-C-N 121.51 -0.994 . . . . 0.0 109.883 -170.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 76.4 m -76.85 136.55 38.9 Favored 'General case' 0 C--N 1.358 0.946 0 O-C-N 121.197 -0.939 . . . . 0.0 112.015 -179.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -130.63 161.5 31.44 Favored 'General case' 0 C--N 1.351 0.649 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 -177.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -114.28 132.81 56.03 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 164.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 96.3 mt -106.06 127.37 61.25 Favored 'Isoleucine or valine' 0 C--N 1.358 0.973 0 CA-C-O 122.632 1.206 . . . . 0.0 110.243 169.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.75 160.51 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 C-N-CA 126.879 2.071 . . . . 0.0 110.725 -176.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.354 1.532 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 -169.112 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 42.2 t80 . . . . . 0 N--CA 1.505 2.318 0 N-CA-C 116.815 2.154 . . . . 0.0 116.815 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -121.65 154.57 36.63 Favored 'General case' 0 C--N 1.354 0.796 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 159.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.9 p -128.71 132.91 67.29 Favored 'Isoleucine or valine' 0 C--N 1.349 0.582 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 174.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 33.0 m -134.55 161.56 40.28 Favored 'Isoleucine or valine' 0 C--N 1.349 0.564 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 -177.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 96.8 p -76.84 155.42 32.99 Favored 'General case' 0 C--N 1.354 0.771 0 O-C-N 120.665 -1.272 . . . . 0.0 112.986 178.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 33.9 t -120.38 28.6 7.92 Favored 'General case' 0 C--N 1.355 0.812 0 C-N-CA 123.881 0.873 . . . . 0.0 109.44 -177.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 45.83 36.55 2.9 Favored 'General case' 0 C--N 1.357 0.897 0 C-N-CA 128.58 2.752 . . . . 0.0 117.452 173.02 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 50.4 tptt -140.79 138.32 34.01 Favored 'General case' 0 C--N 1.352 0.687 0 O-C-N 120.664 -1.272 . . . . 0.0 109.208 -169.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -90.99 123.02 34.14 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.311 1.845 . . . . 0.0 108.559 -175.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 17.5 p -112.95 172.17 7.09 Favored 'General case' 0 C--N 1.357 0.918 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 175.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 27.5 m -130.43 146.18 51.95 Favored 'General case' 0 C--N 1.35 0.593 0 N-CA-C 102.279 -3.23 . . . . 0.0 102.279 167.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.565 ' HB3' HD12 ' A' ' 41' ' ' LEU . 90.6 p -59.97 -30.72 69.3 Favored 'General case' 0 C--N 1.35 0.592 0 N-CA-C 115.966 1.839 . . . . 0.0 115.966 -172.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -93.77 -1.21 65.87 Favored Glycine 0 C--N 1.354 1.53 0 CA-C-N 118.582 0.628 . . . . 0.0 114.138 175.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -108.62 -41.46 4.8 Favored 'General case' 0 C--N 1.352 0.685 0 CA-C-N 118.266 1.033 . . . . 0.0 111.145 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 25.3 m120 57.06 35.74 26.76 Favored 'General case' 0 C--N 1.358 0.939 0 C-N-CA 126.93 2.092 . . . . 0.0 115.028 174.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 60.9 mm-40 -87.09 114.95 24.14 Favored 'General case' 0 C--N 1.351 0.657 0 O-C-N 120.575 -1.328 . . . . 0.0 111.386 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 73.4 m -135.93 156.9 76.87 Favored Pre-proline 0 N--CA 1.447 -0.604 0 N-CA-C 105.601 -2.0 . . . . 0.0 105.601 168.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.55 161.84 44.59 Favored 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.783 2.322 . . . . 0.0 111.497 171.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -62.42 132.88 54.02 Favored 'General case' 0 C--N 1.354 0.778 0 CA-C-O 121.783 0.802 . . . . 0.0 113.006 -174.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.37 -11.66 68.64 Favored Glycine 0 C--N 1.355 1.606 0 C-N-CA 124.06 0.838 . . . . 0.0 112.91 -172.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 71.8 m -116.56 156.13 27.5 Favored 'General case' 0 C--N 1.349 0.565 0 C-N-CA 124.178 0.991 . . . . 0.0 110.394 179.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -145.21 165.87 27.09 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 104.999 -2.223 . . . . 0.0 104.999 -174.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 31.5 p -128.22 153.55 46.81 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-N 120.262 1.392 . . . . 0.0 108.724 165.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -121.79 76.92 0.34 Allowed Glycine 0 CA--C 1.492 -1.38 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 -174.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.565 HD12 ' HB3' ' A' ' 28' ' ' SER . 3.4 tm? -106.18 124.79 50.14 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 105.944 -1.873 . . . . 0.0 105.944 177.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -113.92 140.57 48.27 Favored 'General case' 0 C--N 1.352 0.696 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 -175.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 76.78 8.7 86.53 Favored Glycine 0 C--N 1.355 1.634 0 N-CA-C 116.056 1.183 . . . . 0.0 116.056 164.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 57.83 35.89 25.88 Favored 'General case' 0 C--N 1.352 0.697 0 C-N-CA 126.865 2.066 . . . . 0.0 113.838 -175.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 60.8 m-80 -70.03 -43.77 70.61 Favored 'General case' 0 C--N 1.355 0.807 0 N-CA-C 114.228 1.195 . . . . 0.0 114.228 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm -144.13 -176.38 4.99 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.275 1.83 . . . . 0.0 106.465 -172.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -67.53 -45.59 75.29 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 115.878 1.806 . . . . 0.0 115.878 173.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.77 155.35 31.7 Favored Glycine 0 C--N 1.356 1.691 0 O-C-N 121.135 -0.978 . . . . 0.0 112.159 -168.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -137.81 143.81 41.2 Favored 'General case' 0 C--N 1.347 0.496 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 178.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 77.9 m -77.56 142.32 39.07 Favored 'General case' 0 C--N 1.353 0.747 0 CA-C-O 121.96 0.886 . . . . 0.0 113.126 -173.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -124.46 156.95 36.36 Favored 'General case' 0 C--N 1.35 0.606 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 -176.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 40.5 ttpt -112.7 136.03 52.76 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.649 1.18 . . . . 0.0 108.776 172.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 97.4 mt -98.49 125.32 51.87 Favored 'Isoleucine or valine' 0 C--N 1.359 0.994 0 C-N-CA 124.385 1.074 . . . . 0.0 108.987 175.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.92 156.26 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 C-N-CA 124.826 1.25 . . . . 0.0 109.536 178.116 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.353 1.501 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 -172.804 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 11.3 t80 . . . . . 0 N--CA 1.504 2.242 0 N-CA-C 116.3 1.963 . . . . 0.0 116.3 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -122.0 152.5 39.67 Favored 'General case' 0 C--N 1.355 0.821 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 162.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.3 p -127.1 135.94 62.14 Favored 'Isoleucine or valine' 0 C--N 1.349 0.585 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 176.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.4 m -131.21 158.0 43.27 Favored 'Isoleucine or valine' 0 C--N 1.351 0.647 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 177.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 87.7 p -81.88 157.37 24.39 Favored 'General case' 0 C--N 1.352 0.709 0 O-C-N 121.288 -0.882 . . . . 0.0 112.649 173.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 71.8 m -110.39 19.82 18.4 Favored 'General case' 0 C--N 1.355 0.847 0 O-C-N 121.413 -0.804 . . . . 0.0 111.791 177.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 47.34 39.56 9.14 Favored 'General case' 0 C--N 1.355 0.836 0 C-N-CA 127.432 2.293 . . . . 0.0 116.796 177.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 56.6 tptt -132.83 136.12 46.07 Favored 'General case' 0 C--N 1.352 0.677 0 O-C-N 121.127 -0.983 . . . . 0.0 109.006 -177.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -84.19 128.26 34.45 Favored 'General case' 0 C--N 1.354 0.786 0 C-N-CA 124.539 1.136 . . . . 0.0 110.742 -176.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 18.2 t -106.61 148.57 28.15 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 127.589 2.355 . . . . 0.0 108.93 178.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 23.3 m -133.0 154.73 50.24 Favored 'General case' 0 C--N 1.352 0.699 0 N-CA-C 102.488 -3.153 . . . . 0.0 102.488 168.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 79.4 p -58.93 -45.25 90.83 Favored 'General case' 0 C--N 1.349 0.549 0 N-CA-C 117.15 2.278 . . . . 0.0 117.15 -164.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -96.51 4.67 64.29 Favored Glycine 0 C--N 1.352 1.454 0 C-N-CA 123.605 0.622 . . . . 0.0 113.563 -176.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 11.1 mm-40 -115.96 -42.41 3.08 Favored 'General case' 0 C--N 1.346 0.433 0 O-C-N 121.82 -0.812 . . . . 0.0 109.803 178.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 56.3 45.95 22.02 Favored 'General case' 0 C--N 1.356 0.89 0 C-N-CA 128.575 2.75 . . . . 0.0 112.936 167.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -83.91 115.64 22.39 Favored 'General case' 0 C--N 1.352 0.701 0 O-C-N 121.043 -1.036 . . . . 0.0 112.742 -168.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 71.6 m -134.63 157.67 76.77 Favored Pre-proline 0 C--N 1.353 0.747 0 C-N-CA 124.785 1.234 . . . . 0.0 108.126 173.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.85 159.04 54.78 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.472 2.115 . . . . 0.0 110.618 164.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -65.09 135.17 55.23 Favored 'General case' 0 C--N 1.352 0.709 0 CA-C-O 121.599 0.714 . . . . 0.0 112.21 -176.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.59 -12.53 64.62 Favored Glycine 0 C--N 1.354 1.575 0 C-N-CA 123.593 0.616 . . . . 0.0 113.051 -173.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 72.2 m -113.13 155.45 24.94 Favored 'General case' 0 C--N 1.35 0.588 0 C-N-CA 124.242 1.017 . . . . 0.0 109.393 177.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -136.5 157.39 46.89 Favored 'General case' 0 C--N 1.351 0.634 0 O-C-N 121.278 -0.889 . . . . 0.0 108.729 -176.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 42.1 t -105.37 126.47 52.15 Favored 'General case' 0 CA--C 1.51 -0.57 0 O-C-N 121.205 -0.934 . . . . 0.0 111.027 -179.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.87 60.55 3.49 Favored Glycine 0 C--N 1.352 1.425 0 O-C-N 121.684 -0.635 . . . . 0.0 112.212 176.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -106.98 120.86 43.22 Favored 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 175.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -119.98 140.7 50.53 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 -176.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.18 5.42 76.4 Favored Glycine 0 C--N 1.355 1.603 0 N-CA-C 115.656 1.022 . . . . 0.0 115.656 161.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 56.75 42.9 26.07 Favored 'General case' 0 C--N 1.35 0.617 0 C-N-CA 126.639 1.976 . . . . 0.0 113.336 -171.669 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 54.0 m-80 -73.54 -49.37 26.84 Favored 'General case' 0 C--N 1.354 0.766 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 -178.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -140.65 -125.63 0.11 Allowed 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 177.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 16.6 pttp -107.79 -47.02 3.67 Favored 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 126.902 2.081 . . . . 0.0 114.146 -175.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 86.23 178.54 49.74 Favored Glycine 0 C--N 1.356 1.678 0 O-C-N 120.708 -1.245 . . . . 0.0 112.421 -173.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 72.7 t60 -154.12 155.24 35.04 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 105.877 -1.897 . . . . 0.0 105.877 178.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 76.4 m -86.86 135.57 33.28 Favored 'General case' 0 C--N 1.355 0.843 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -174.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -126.52 161.32 28.24 Favored 'General case' 0 C--N 1.358 0.946 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 -174.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -122.61 135.66 54.67 Favored 'General case' 0 C--N 1.352 0.69 0 C-N-CA 124.172 0.989 . . . . 0.0 110.098 165.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 83.3 mt -88.05 127.04 41.43 Favored 'Isoleucine or valine' 0 C--N 1.359 1.017 0 C-N-CA 125.963 1.705 . . . . 0.0 109.732 169.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.98 155.86 41.97 Favored 'Isoleucine or valine' 0 C--N 1.352 0.702 0 C-N-CA 123.949 0.899 . . . . 0.0 110.325 171.303 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.354 1.538 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -175.75 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 10.9 t80 . . . . . 0 N--CA 1.505 2.287 0 N-CA-C 116.349 1.981 . . . . 0.0 116.349 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -122.75 148.7 45.03 Favored 'General case' 0 C--N 1.357 0.895 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 163.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.1 p -123.7 133.14 70.06 Favored 'Isoleucine or valine' 0 C--N 1.35 0.595 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 173.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.2 m -133.22 153.78 38.08 Favored 'Isoleucine or valine' 0 C--N 1.354 0.786 0 O-C-N 121.35 -0.844 . . . . 0.0 108.975 177.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 88.2 p -80.48 150.61 29.62 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 -179.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 71.7 m -102.1 -4.5 25.82 Favored 'General case' 0 C--N 1.354 0.783 0 O-C-N 121.399 -0.813 . . . . 0.0 111.11 178.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 56.29 43.46 26.39 Favored 'General case' 0 C--N 1.357 0.918 0 C-N-CA 127.423 2.289 . . . . 0.0 115.734 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 23.4 mmmt -131.2 149.89 52.38 Favored 'General case' 0 N--CA 1.442 -0.825 0 C-N-CA 127.061 2.144 . . . . 0.0 106.08 165.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -92.52 174.52 7.23 Favored 'General case' 0 C--N 1.351 0.657 0 O-C-N 121.698 -0.626 . . . . 0.0 109.6 171.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 15.2 p -121.21 172.36 8.05 Favored 'General case' 0 C--N 1.353 0.745 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 159.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 63.1 m -135.5 144.75 46.53 Favored 'General case' 0 CA--C 1.504 -0.808 0 N-CA-C 100.975 -3.713 . . . . 0.0 100.975 168.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 37.0 t -57.76 -43.93 85.81 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-N 120.459 1.481 . . . . 0.0 114.315 -164.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.15 -44.84 58.91 Favored Glycine 0 C--N 1.355 1.592 0 O-C-N 121.023 -1.048 . . . . 0.0 115.0 175.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -69.04 -43.22 75.13 Favored 'General case' 0 C--N 1.349 0.558 0 C-N-CA 126.114 1.766 . . . . 0.0 113.579 -176.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 55.42 38.01 29.68 Favored 'General case' 0 C--N 1.354 0.804 0 C-N-CA 129.008 2.923 . . . . 0.0 113.82 176.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -68.42 127.43 32.94 Favored 'General case' 0 C--N 1.352 0.681 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 175.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 94.9 m -143.34 159.23 55.95 Favored Pre-proline 0 C--N 1.354 0.786 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 152.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -70.08 159.09 54.4 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.83 2.353 . . . . 0.0 110.551 162.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -65.61 136.74 56.73 Favored 'General case' 0 C--N 1.352 0.681 0 CA-C-O 121.58 0.705 . . . . 0.0 112.7 -175.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.1 -9.65 70.03 Favored Glycine 0 C--N 1.356 1.668 0 O-C-N 121.689 -0.632 . . . . 0.0 113.19 -175.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 84.2 m -114.92 155.94 25.94 Favored 'General case' 0 C--N 1.348 0.508 0 C-N-CA 124.502 1.121 . . . . 0.0 108.381 178.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -136.3 163.1 31.2 Favored 'General case' 0 C--N 1.352 0.699 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 178.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 45.2 t -119.43 124.05 45.58 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 105.931 -1.877 . . . . 0.0 105.931 178.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -83.29 78.77 1.98 Allowed Glycine 0 C--N 1.352 1.443 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 177.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -98.46 113.39 25.38 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 104.387 -2.449 . . . . 0.0 104.387 -176.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.45 HD22 ' H ' ' A' ' 42' ' ' LEU . 2.1 mm? -77.03 -49.04 16.26 Favored 'General case' 0 C--N 1.357 0.929 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -148.216 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.94 76.97 0.16 Allowed Glycine 0 C--N 1.349 1.287 0 N-CA-C 108.69 -1.764 . . . . 0.0 108.69 175.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.8 pm0 45.59 59.38 3.65 Favored 'General case' 0 C--N 1.354 0.8 0 C-N-CA 128.519 2.727 . . . . 0.0 116.509 -178.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 34.7 m120 -103.33 -119.59 0.2 Allowed 'General case' 0 C--N 1.352 0.698 0 C-N-CA 123.953 0.901 . . . . 0.0 109.845 -171.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.72 -101.16 0.21 Allowed 'General case' 0 C--N 1.355 0.816 0 C-N-CA 124.159 0.984 . . . . 0.0 110.874 -172.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.0 pttm -130.33 -32.39 1.77 Allowed 'General case' 0 C--N 1.355 0.831 0 N-CA-C 116.306 1.965 . . . . 0.0 116.306 -163.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 62.05 -144.79 49.21 Favored Glycine 0 C--N 1.357 1.722 0 O-C-N 119.664 -1.897 . . . . 0.0 113.338 -174.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 43.4 t60 -160.51 160.41 31.91 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 101.808 -3.404 . . . . 0.0 101.808 163.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 72.5 m -89.36 134.16 34.19 Favored 'General case' 0 C--N 1.354 0.804 0 CA-C-N 120.89 1.677 . . . . 0.0 112.091 175.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -149.77 164.58 34.9 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.186 1.395 . . . . 0.0 112.099 -178.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -133.98 156.08 48.82 Favored 'General case' 0 C--N 1.354 0.784 0 CA-C-O 121.499 0.666 . . . . 0.0 111.516 -173.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 91.5 mt -108.77 124.98 65.74 Favored 'Isoleucine or valine' 0 C--N 1.355 0.843 0 C-N-CA 125.522 1.529 . . . . 0.0 108.84 -175.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.71 157.25 42.97 Favored 'Isoleucine or valine' 0 C--N 1.35 0.601 0 C-N-CA 124.224 1.01 . . . . 0.0 108.508 173.55 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.352 1.464 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 -178.689 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 5.9 t80 . . . . . 0 N--CA 1.504 2.265 0 N-CA-C 115.929 1.826 . . . . 0.0 115.929 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -120.04 152.46 37.49 Favored 'General case' 0 C--N 1.356 0.848 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 163.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.6 p -124.63 135.99 62.11 Favored 'Isoleucine or valine' 0 C--N 1.348 0.54 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 176.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.3 m -129.96 157.29 42.54 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.681 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 177.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 85.3 p -79.7 152.67 29.78 Favored 'General case' 0 N--CA 1.447 -0.585 0 O-C-N 121.246 -0.909 . . . . 0.0 112.57 173.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 16.6 t -110.22 9.6 23.81 Favored 'General case' 0 C--N 1.352 0.701 0 O-C-N 121.274 -0.891 . . . . 0.0 110.892 -174.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 56.51 42.95 26.64 Favored 'General case' 0 C--N 1.355 0.842 0 C-N-CA 126.762 2.025 . . . . 0.0 114.736 175.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 54.2 tptt -140.87 137.64 33.37 Favored 'General case' 0 C--N 1.351 0.657 0 O-C-N 120.668 -1.27 . . . . 0.0 107.801 177.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -91.03 130.11 36.97 Favored 'General case' 0 C--N 1.351 0.632 0 C-N-CA 125.642 1.577 . . . . 0.0 109.946 -177.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 10.6 p -111.43 156.13 22.11 Favored 'General case' 0 C--N 1.358 0.955 0 O-C-N 121.415 -0.803 . . . . 0.0 109.131 -178.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 21.4 p -127.04 152.72 46.88 Favored 'General case' 0 CA--C 1.496 -1.098 0 O-C-N 121.069 -1.019 . . . . 0.0 112.745 177.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 40.7 t -63.91 126.16 26.76 Favored 'General case' 0 C--N 1.359 0.995 0 CA-C-O 122.437 1.113 . . . . 0.0 110.249 177.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 92.63 -9.19 76.19 Favored Glycine 0 C--N 1.344 1.026 0 CA-C-N 114.975 -1.011 . . . . 0.0 113.05 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 15.1 mm-40 -121.54 -46.75 2.25 Favored 'General case' 0 C--N 1.352 0.677 0 CA-C-N 118.374 1.087 . . . . 0.0 111.902 179.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 51.41 47.51 24.68 Favored 'General case' 0 C--N 1.36 1.039 0 N-CA-C 116.343 1.979 . . . . 0.0 116.343 -177.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -67.5 118.03 10.26 Favored 'General case' 0 C--N 1.355 0.841 0 O-C-N 120.791 -1.193 . . . . 0.0 113.216 178.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 73.5 m -137.76 158.07 72.3 Favored Pre-proline 0 C--N 1.352 0.69 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 169.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.07 159.03 54.61 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.473 2.116 . . . . 0.0 110.428 164.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 58.6 mp0 -64.04 134.06 54.26 Favored 'General case' 0 C--N 1.352 0.717 0 CA-C-O 121.812 0.815 . . . . 0.0 112.467 -173.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 98.35 -15.06 61.75 Favored Glycine 0 C--N 1.355 1.601 0 C-N-CA 123.799 0.714 . . . . 0.0 112.934 -174.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 93.1 m -110.21 157.7 19.15 Favored 'General case' 0 C--N 1.349 0.549 0 C-N-CA 124.23 1.012 . . . . 0.0 110.248 176.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 28.4 p90 -142.14 164.31 30.51 Favored 'General case' 0 C--N 1.348 0.541 0 N-CA-C 105.674 -1.973 . . . . 0.0 105.674 -175.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 36.3 t -117.45 128.48 55.04 Favored 'General case' 0 CA--C 1.51 -0.578 0 O-C-N 121.039 -1.038 . . . . 0.0 108.915 -177.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -85.75 61.81 4.49 Favored Glycine 0 C--N 1.353 1.516 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 176.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.6 HD23 ' H ' ' A' ' 42' ' ' LEU . 1.1 tt -69.81 139.55 53.2 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 125.159 1.384 . . . . 0.0 110.502 -175.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.6 ' H ' HD23 ' A' ' 41' ' ' LEU . 1.5 mm? -80.89 72.37 7.88 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 125.423 1.489 . . . . 0.0 108.997 -163.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.75 14.71 81.19 Favored Glycine 0 C--N 1.352 1.456 0 O-C-N 120.689 -1.257 . . . . 0.0 113.292 178.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.497 ' HA ' HD22 ' A' ' 41' ' ' LEU . 34.6 mt-30 56.35 41.24 29.29 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 127.35 2.26 . . . . 0.0 114.664 -170.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -68.47 -45.15 73.21 Favored 'General case' 0 C--N 1.356 0.887 0 N-CA-C 115.726 1.75 . . . . 0.0 115.726 174.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 17.5 pttp -155.15 -64.65 0.12 Allowed 'General case' 0 C--N 1.348 0.539 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -176.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.8 ptmt -157.21 161.2 39.26 Favored 'General case' 0 N--CA 1.439 -1.022 0 O-C-N 121.111 -0.993 . . . . 0.0 108.638 -172.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -159.28 -171.78 25.54 Favored Glycine 0 C--N 1.345 1.045 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 175.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 77.7 t60 -127.3 140.87 51.91 Favored 'General case' 0 C--N 1.35 0.603 0 O-C-N 121.301 -1.117 . . . . 0.0 108.309 -175.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 75.0 m -76.87 145.73 38.14 Favored 'General case' 0 C--N 1.356 0.879 0 O-C-N 120.83 -1.169 . . . . 0.0 113.626 -172.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -126.07 162.48 25.21 Favored 'General case' 0 C--N 1.358 0.976 0 C-N-CA 123.89 0.876 . . . . 0.0 108.815 -175.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -121.4 136.43 54.96 Favored 'General case' 0 C--N 1.351 0.632 0 C-N-CA 124.616 1.166 . . . . 0.0 108.514 166.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 84.8 mt -98.39 126.28 51.52 Favored 'Isoleucine or valine' 0 C--N 1.359 0.997 0 C-N-CA 124.851 1.261 . . . . 0.0 109.137 172.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.55 148.32 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 C-N-CA 125.321 1.448 . . . . 0.0 108.388 176.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 160.52 -154.02 24.99 Favored Glycine 0 C--N 1.349 1.292 0 O-C-N 119.884 -1.76 . . . . 0.0 110.845 -176.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 . . . . . 0 C--O 1.261 1.671 0 C-N-CA 124.499 1.12 . . . . 0.0 113.859 -175.431 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 14.0 t80 . . . . . 0 N--CA 1.504 2.249 0 N-CA-C 116.314 1.968 . . . . 0.0 116.314 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -123.05 155.62 36.52 Favored 'General case' 0 C--N 1.355 0.825 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 166.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.3 p -126.81 135.81 62.61 Favored 'Isoleucine or valine' 0 C--N 1.349 0.572 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 174.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 30.2 m -131.58 159.73 42.86 Favored 'Isoleucine or valine' 0 C--N 1.35 0.63 0 C-N-CA 124.709 1.204 . . . . 0.0 107.8 175.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 87.8 p -77.6 153.41 33.26 Favored 'General case' 0 C--N 1.351 0.646 0 CA-C-O 122.15 0.976 . . . . 0.0 112.58 174.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 8.8 t -104.73 3.59 31.53 Favored 'General case' 0 C--N 1.353 0.724 0 O-C-N 121.21 -0.931 . . . . 0.0 110.298 -176.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 72.4 m-80 58.26 41.38 23.49 Favored 'General case' 0 C--N 1.356 0.877 0 C-N-CA 127.456 2.303 . . . . 0.0 114.378 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 52.6 tptt -139.72 134.54 32.06 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 -177.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -89.01 133.61 34.27 Favored 'General case' 0 C--N 1.355 0.836 0 C-N-CA 125.002 1.321 . . . . 0.0 109.288 -179.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 26.1 p -131.99 152.58 51.04 Favored 'General case' 0 C--N 1.352 0.711 0 CA-C-O 122.049 0.928 . . . . 0.0 110.424 177.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.7 m -127.39 149.52 50.04 Favored 'General case' 0 C--N 1.349 0.569 0 N-CA-C 105.56 -2.015 . . . . 0.0 105.56 -167.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 36.6 t -62.71 133.43 54.8 Favored 'General case' 0 C--N 1.36 1.055 0 O-C-N 120.689 -1.257 . . . . 0.0 109.907 170.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 92.88 -15.08 63.58 Favored Glycine 0 C--N 1.349 1.286 0 C-N-CA 123.841 0.734 . . . . 0.0 112.443 -172.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -113.79 -53.56 2.67 Favored 'General case' 0 C--N 1.356 0.866 0 CA-C-N 118.652 1.226 . . . . 0.0 111.954 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 49.36 41.75 21.06 Favored 'General case' 0 C--N 1.364 1.204 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 -176.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 59.6 mm-40 -83.95 112.93 20.61 Favored 'General case' 0 C--N 1.353 0.752 0 O-C-N 120.436 -1.415 . . . . 0.0 111.581 -179.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 79.0 m -134.83 155.57 79.23 Favored Pre-proline 0 C--N 1.35 0.601 0 N-CA-C 106.169 -1.789 . . . . 0.0 106.169 171.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -70.54 160.1 50.59 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.589 2.192 . . . . 0.0 110.574 165.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -65.02 141.46 58.76 Favored 'General case' 0 C--N 1.353 0.757 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -175.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.8 -13.88 65.6 Favored Glycine 0 C--N 1.354 1.554 0 C-N-CA 123.774 0.702 . . . . 0.0 112.522 -172.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 71.2 m -115.32 154.94 28.23 Favored 'General case' 0 C--N 1.349 0.562 0 C-N-CA 124.487 1.115 . . . . 0.0 109.929 178.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -129.9 158.61 39.04 Favored 'General case' 0 C--N 1.352 0.686 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -178.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 52.2 t -88.66 126.53 35.35 Favored 'General case' 0 C--N 1.35 0.593 0 O-C-N 121.494 -0.754 . . . . 0.0 110.609 -174.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -82.55 67.88 3.64 Favored Glycine 0 C--N 1.356 1.665 0 O-C-N 121.107 -0.996 . . . . 0.0 113.79 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 56.7 mt -104.76 134.17 48.36 Favored 'General case' 0 CA--C 1.505 -0.759 0 C-N-CA 125.142 1.377 . . . . 0.0 110.429 170.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.526 HD22 ' H ' ' A' ' 42' ' ' LEU . 1.5 mm? -70.0 -44.86 68.52 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 125.479 1.512 . . . . 0.0 111.035 -166.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -160.93 49.65 0.36 Allowed Glycine 0 C--N 1.346 1.123 0 N-CA-C 107.279 -2.328 . . . . 0.0 107.279 170.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 17.4 mp0 52.73 51.21 16.45 Favored 'General case' 0 C--N 1.356 0.862 0 C-N-CA 127.011 2.124 . . . . 0.0 114.605 -177.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 23.2 m120 -92.33 -53.69 4.12 Favored 'General case' 0 C--N 1.357 0.9 0 O-C-N 120.494 -1.379 . . . . 0.0 112.628 -166.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -131.46 -98.69 0.31 Allowed 'General case' 0 C--N 1.355 0.811 0 CA-C-O 122.394 1.092 . . . . 0.0 109.774 -174.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 15.0 ptmm? -138.25 156.93 47.2 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 106.012 -1.847 . . . . 0.0 106.012 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -148.53 -171.03 16.95 Favored Glycine 0 CA--C 1.493 -1.284 0 N-CA-C 108.405 -1.878 . . . . 0.0 108.405 -178.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 51.6 t60 -132.42 147.42 52.38 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 104.712 -2.329 . . . . 0.0 104.712 -176.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 71.9 m -78.46 139.38 38.71 Favored 'General case' 0 C--N 1.351 0.636 0 O-C-N 120.984 -1.072 . . . . 0.0 112.079 -174.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 19.0 m-85 -125.72 156.91 38.63 Favored 'General case' 0 C--N 1.351 0.671 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 -176.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -112.46 135.54 53.04 Favored 'General case' 0 C--N 1.35 0.625 0 C-N-CA 124.043 0.937 . . . . 0.0 109.669 175.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 43.0 mm -91.8 122.06 42.88 Favored 'Isoleucine or valine' 0 C--N 1.361 1.091 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 172.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.64 137.54 57.05 Favored 'Isoleucine or valine' 0 C--N 1.351 0.663 0 CA-C-O 122.363 1.078 . . . . 0.0 110.46 169.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 166.45 -174.36 41.92 Favored Glycine 0 CA--C 1.493 -1.327 0 N-CA-C 106.014 -2.834 . . . . 0.0 106.014 -176.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 53.4 p30 . . . . . 0 C--O 1.259 1.584 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 178.932 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 14.0 t80 . . . . . 0 N--CA 1.503 2.218 0 N-CA-C 116.702 2.112 . . . . 0.0 116.702 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -111.74 151.83 28.49 Favored 'General case' 0 C--N 1.353 0.73 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 159.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.2 p -126.33 136.02 62.06 Favored 'Isoleucine or valine' 0 C--N 1.351 0.65 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 173.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.585 HG22 HD11 ' A' ' 54' ' ' ILE . 35.9 m -133.72 159.39 42.59 Favored 'Isoleucine or valine' 0 C--N 1.353 0.727 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 176.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 87.4 p -80.42 154.32 27.73 Favored 'General case' 0 C--N 1.349 0.547 0 CA-C-O 121.684 0.754 . . . . 0.0 112.934 171.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 78.2 m -105.38 5.0 31.4 Favored 'General case' 0 C--N 1.356 0.866 0 O-C-N 121.114 -0.991 . . . . 0.0 111.539 173.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 80.5 m-20 58.16 40.73 24.71 Favored 'General case' 0 C--N 1.355 0.821 0 C-N-CA 126.928 2.091 . . . . 0.0 114.977 178.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 37.2 mmtm -132.7 142.83 49.24 Favored 'General case' 0 C--N 1.351 0.632 0 C-N-CA 124.593 1.157 . . . . 0.0 110.416 176.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.5 t30 -88.09 133.29 34.02 Favored 'General case' 0 C--N 1.351 0.668 0 C-N-CA 126.374 1.87 . . . . 0.0 109.135 176.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 13.8 p -109.31 153.51 23.8 Favored 'General case' 0 C--N 1.356 0.887 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 171.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 59.7 m -128.9 145.71 51.14 Favored 'General case' 0 C--N 1.346 0.435 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 -173.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 47.4 t -59.2 138.53 57.55 Favored 'General case' 0 C--N 1.358 0.937 0 C-N-CA 123.829 0.852 . . . . 0.0 112.941 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 79.94 -53.88 4.4 Favored Glycine 0 C--N 1.358 1.774 0 C-N-CA 124.666 1.127 . . . . 0.0 112.377 -175.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -64.39 -45.74 86.35 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 128.685 2.794 . . . . 0.0 115.465 -178.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.4 m120 54.99 43.01 30.55 Favored 'General case' 0 C--N 1.355 0.814 0 C-N-CA 127.084 2.154 . . . . 0.0 115.654 168.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 55.2 mm-40 -75.76 117.89 18.0 Favored 'General case' 0 C--N 1.354 0.784 0 O-C-N 120.124 -1.61 . . . . 0.0 113.929 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 77.1 m -138.06 155.99 74.22 Favored Pre-proline 0 C--N 1.354 0.793 0 N-CA-C 106.703 -1.591 . . . . 0.0 106.703 159.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.21 160.08 50.07 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 123.109 2.539 . . . . 0.0 111.25 166.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -62.94 131.14 47.69 Favored 'General case' 0 C--N 1.353 0.718 0 C-N-CA 123.539 0.735 . . . . 0.0 112.534 -176.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 100.27 -14.07 59.79 Favored Glycine 0 C--N 1.356 1.649 0 C-N-CA 123.827 0.727 . . . . 0.0 112.679 -174.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 75.0 m -112.69 156.67 22.38 Favored 'General case' 0 C--N 1.349 0.549 0 C-N-CA 124.055 0.942 . . . . 0.0 109.145 177.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 34.6 p90 -141.47 163.03 34.03 Favored 'General case' 0 C--N 1.348 0.509 0 N-CA-C 105.346 -2.094 . . . . 0.0 105.346 -178.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 46.3 t -124.25 125.9 45.18 Favored 'General case' 0 CA--C 1.508 -0.665 0 O-C-N 120.85 -1.156 . . . . 0.0 109.59 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -85.9 63.94 4.16 Favored Glycine 0 C--N 1.354 1.544 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 177.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.612 HD23 ' H ' ' A' ' 42' ' ' LEU . 1.0 OUTLIER -69.46 141.16 54.07 Favored 'General case' 0 C--N 1.349 0.573 0 C-N-CA 125.27 1.428 . . . . 0.0 110.292 -178.94 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.612 ' H ' HD23 ' A' ' 41' ' ' LEU . 1.4 mm? -81.59 69.94 8.36 Favored 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 125.502 1.521 . . . . 0.0 109.288 -161.282 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.76 24.31 76.31 Favored Glycine 0 C--N 1.352 1.438 0 O-C-N 120.975 -1.078 . . . . 0.0 113.943 178.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 69.2 mm-40 58.32 34.29 23.91 Favored 'General case' 0 C--N 1.356 0.88 0 C-N-CA 126.2 1.8 . . . . 0.0 114.592 -175.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 57.4 m-80 -76.38 -46.92 25.17 Favored 'General case' 0 C--N 1.356 0.871 0 O-C-N 120.028 -1.67 . . . . 0.0 115.371 176.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 48.2 mmtm -137.7 -100.97 0.19 Allowed 'General case' 0 C--N 1.348 0.542 0 CA-C-O 122.103 0.954 . . . . 0.0 110.124 -173.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 10.3 ptpp? -143.58 161.65 37.94 Favored 'General case' 0 N--CA 1.436 -1.136 0 C-N-CA 125.311 1.444 . . . . 0.0 107.654 -173.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -154.91 -174.13 24.5 Favored Glycine 0 C--N 1.344 1.005 0 N-CA-C 108.748 -1.741 . . . . 0.0 108.748 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 52.6 t60 -126.7 142.97 51.38 Favored 'General case' 0 C--N 1.35 0.589 0 O-C-N 121.159 -1.201 . . . . 0.0 108.218 -173.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 75.9 m -80.15 139.98 36.57 Favored 'General case' 0 C--N 1.356 0.849 0 O-C-N 120.751 -1.218 . . . . 0.0 112.978 -173.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -128.0 162.15 27.48 Favored 'General case' 0 C--N 1.357 0.919 0 C-N-CA 124.0 0.92 . . . . 0.0 108.986 -173.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -116.35 137.91 51.77 Favored 'General case' 0 C--N 1.352 0.7 0 C-N-CA 124.596 1.158 . . . . 0.0 108.267 164.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 83.5 mt -95.56 126.42 48.08 Favored 'Isoleucine or valine' 0 C--N 1.358 0.972 0 C-N-CA 125.726 1.61 . . . . 0.0 107.54 167.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.585 HD11 HG22 ' A' ' 20' ' ' VAL . 4.7 mp -115.75 125.71 73.01 Favored 'Isoleucine or valine' 0 C--N 1.355 0.836 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 -177.178 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 142.16 -61.12 0.53 Allowed Glycine 0 C--N 1.353 1.503 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 173.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 24.9 p30 . . . . . 0 C--O 1.261 1.694 0 CA-C-O 117.014 -1.47 . . . . 0.0 114.225 177.729 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 13.3 t80 . . . . . 0 N--CA 1.503 2.205 0 N-CA-C 116.773 2.138 . . . . 0.0 116.773 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -120.53 150.6 40.6 Favored 'General case' 0 C--N 1.356 0.867 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 165.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.2 p -122.93 134.41 66.16 Favored 'Isoleucine or valine' 0 C--N 1.351 0.643 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 171.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 28.4 m -132.21 156.97 42.97 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.619 0 C-N-CA 124.983 1.313 . . . . 0.0 107.547 177.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 96.5 p -81.16 158.27 25.0 Favored 'General case' 0 C--N 1.353 0.735 0 CA-C-O 122.391 1.091 . . . . 0.0 112.342 175.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 79.0 m -98.77 10.53 41.01 Favored 'General case' 0 C--N 1.349 0.556 0 C-N-CA 125.007 1.323 . . . . 0.0 110.194 176.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 8.3 m120 62.69 21.55 12.8 Favored 'General case' 0 C--N 1.356 0.87 0 C-N-CA 128.788 2.835 . . . . 0.0 114.146 177.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt -118.8 143.12 47.12 Favored 'General case' 0 CA--C 1.511 -0.553 0 C-N-CA 125.038 1.335 . . . . 0.0 111.586 179.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -96.83 130.03 44.17 Favored 'General case' 0 C--N 1.351 0.666 0 C-N-CA 126.878 2.071 . . . . 0.0 109.992 178.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 14.2 p -103.17 155.69 18.24 Favored 'General case' 0 C--N 1.354 0.786 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 170.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 61.6 m -130.38 145.34 51.79 Favored 'General case' 0 C--N 1.353 0.749 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 -177.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 39.7 t -60.6 133.12 55.79 Favored 'General case' 0 C--N 1.356 0.855 0 O-C-N 119.531 -1.981 . . . . 0.0 112.003 177.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.71 -18.96 56.13 Favored Glycine 0 C--N 1.352 1.43 0 C-N-CA 125.024 1.297 . . . . 0.0 112.824 -172.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -148.8 102.21 3.26 Favored 'General case' 0 C--N 1.355 0.808 0 CA-C-O 123.847 1.784 . . . . 0.0 111.233 174.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 33.7 m120 -80.91 82.63 6.84 Favored 'General case' 0 C--N 1.353 0.747 0 O-C-N 120.058 -1.652 . . . . 0.0 110.833 -175.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -82.5 75.81 9.4 Favored 'General case' 0 C--N 1.353 0.734 0 C-N-CA 124.461 1.105 . . . . 0.0 112.581 -167.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 74.7 m -118.63 151.21 49.56 Favored Pre-proline 0 C--N 1.351 0.668 0 O-C-N 120.694 -1.254 . . . . 0.0 110.806 177.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -71.83 159.77 49.71 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.776 2.318 . . . . 0.0 110.603 163.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -63.77 134.82 55.99 Favored 'General case' 0 C--N 1.352 0.684 0 C-N-CA 123.503 0.721 . . . . 0.0 112.524 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 98.59 -10.51 62.84 Favored Glycine 0 C--N 1.356 1.639 0 C-N-CA 123.817 0.722 . . . . 0.0 113.542 -175.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 82.5 m -112.77 154.47 26.15 Favored 'General case' 0 C--N 1.348 0.52 0 CA-C-N 118.003 0.901 . . . . 0.0 108.891 178.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -129.03 160.36 32.99 Favored 'General case' 0 C--N 1.353 0.737 0 N-CA-C 104.691 -2.337 . . . . 0.0 104.691 177.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 41.9 t -114.21 128.59 56.44 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-N 120.586 1.539 . . . . 0.0 109.33 178.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -83.8 61.6 4.72 Favored Glycine 0 C--N 1.355 1.595 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.528 HD23 ' H ' ' A' ' 42' ' ' LEU . 0.8 OUTLIER -81.93 137.79 35.11 Favored 'General case' 0 N--CA 1.445 -0.686 0 C-N-CA 124.21 1.004 . . . . 0.0 109.142 -175.063 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.528 ' H ' HD23 ' A' ' 41' ' ' LEU . 1.3 mm? -81.21 72.24 8.23 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 125.637 1.575 . . . . 0.0 109.044 -163.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 73.67 20.25 79.78 Favored Glycine 0 C--N 1.354 1.554 0 O-C-N 120.742 -1.224 . . . . 0.0 113.692 178.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 56.37 39.67 30.0 Favored 'General case' 0 C--N 1.352 0.717 0 C-N-CA 127.376 2.271 . . . . 0.0 114.091 -172.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 61.2 m-80 -80.47 -45.14 18.06 Favored 'General case' 0 C--N 1.351 0.671 0 N-CA-C 115.073 1.509 . . . . 0.0 115.073 173.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -131.0 -105.34 0.27 Allowed 'General case' 0 C--N 1.354 0.78 0 O-C-N 121.109 -0.995 . . . . 0.0 111.756 -169.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.03 164.57 31.68 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 105.38 -2.082 . . . . 0.0 105.38 -178.021 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -166.16 179.64 40.14 Favored Glycine 0 CA--C 1.493 -1.299 0 N-CA-C 108.25 -1.94 . . . . 0.0 108.25 178.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 12.3 m80 -105.83 150.94 25.12 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 115.689 1.737 . . . . 0.0 115.689 176.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 81.0 m -81.68 134.35 35.46 Favored 'General case' 0 C--N 1.353 0.733 0 C-N-CA 125.347 1.459 . . . . 0.0 110.047 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -127.68 158.97 36.14 Favored 'General case' 0 C--N 1.351 0.654 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 -172.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 20.7 pttm -125.22 154.87 40.96 Favored 'General case' 0 C--N 1.352 0.717 0 CA-C-O 121.987 0.898 . . . . 0.0 111.55 168.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 46.4 mm -103.62 121.15 54.68 Favored 'Isoleucine or valine' 0 C--N 1.353 0.725 0 C-N-CA 125.397 1.479 . . . . 0.0 107.671 -175.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.24 146.9 33.51 Favored 'Isoleucine or valine' 0 C--N 1.353 0.739 0 CA-C-O 121.908 0.861 . . . . 0.0 110.443 175.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 94.66 -7.57 71.02 Favored Glycine 0 C--N 1.355 1.598 0 O-C-N 121.21 -0.931 . . . . 0.0 113.889 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 . . . . . 0 CA--C 1.567 1.613 0 O-C-N 121.127 -1.22 . . . . 0.0 111.18 177.718 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 11.3 t80 . . . . . 0 N--CA 1.504 2.25 0 N-CA-C 116.254 1.946 . . . . 0.0 116.254 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -123.19 147.91 46.35 Favored 'General case' 0 C--N 1.357 0.892 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 158.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 5.3 p -126.89 135.38 63.83 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.62 0 C-N-CA 124.474 1.109 . . . . 0.0 108.418 174.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 30.4 m -129.97 158.97 42.43 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.638 0 C-N-CA 124.715 1.206 . . . . 0.0 108.265 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 78.9 p -76.43 143.05 40.82 Favored 'General case' 0 N--CA 1.446 -0.647 0 O-C-N 121.186 -0.946 . . . . 0.0 112.741 174.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 15.5 t -91.98 -1.8 57.07 Favored 'General case' 0 C--N 1.354 0.768 0 O-C-N 121.256 -0.903 . . . . 0.0 110.916 178.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 54.5 t30 59.95 46.45 11.05 Favored 'General case' 0 C--N 1.356 0.869 0 C-N-CA 127.591 2.357 . . . . 0.0 113.55 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 55.6 tptt -140.98 138.26 33.62 Favored 'General case' 0 C--N 1.352 0.679 0 O-C-N 121.086 -1.009 . . . . 0.0 108.429 178.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -84.4 133.56 34.5 Favored 'General case' 0 C--N 1.355 0.816 0 C-N-CA 125.7 1.6 . . . . 0.0 111.217 176.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 26.0 p -132.48 157.37 44.81 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 122.122 0.963 . . . . 0.0 110.434 173.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 37.3 p -128.87 165.44 21.02 Favored 'General case' 0 CA--C 1.5 -0.978 0 C-N-CA 124.794 1.238 . . . . 0.0 111.362 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 47.3 t -58.94 135.1 57.48 Favored 'General case' 0 C--N 1.355 0.839 0 C-N-CA 125.956 1.702 . . . . 0.0 111.465 177.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 82.66 -61.08 4.8 Favored Glycine 0 C--N 1.352 1.456 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 -170.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 24.4 mm100 -62.15 -48.48 79.89 Favored 'General case' 0 C--N 1.351 0.643 0 N-CA-C 117.047 2.24 . . . . 0.0 117.047 -174.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 48.52 36.93 8.12 Favored 'General case' 0 C--N 1.359 1.006 0 N-CA-C 115.917 1.821 . . . . 0.0 115.917 175.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -81.53 117.79 22.22 Favored 'General case' 0 C--N 1.356 0.866 0 O-C-N 120.464 -1.397 . . . . 0.0 112.382 -173.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 82.1 m -137.14 158.03 73.35 Favored Pre-proline 0 N--CA 1.448 -0.548 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 176.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -70.15 159.96 51.28 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.626 2.217 . . . . 0.0 110.609 164.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -64.73 140.81 58.91 Favored 'General case' 0 C--N 1.353 0.73 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -174.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.22 -13.45 66.84 Favored Glycine 0 C--N 1.355 1.585 0 O-C-N 121.562 -0.711 . . . . 0.0 112.806 -173.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 72.8 m -115.41 155.09 28.05 Favored 'General case' 0 C--N 1.349 0.577 0 C-N-CA 124.458 1.103 . . . . 0.0 110.247 178.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -127.18 161.34 28.75 Favored 'General case' 0 C--N 1.348 0.527 0 C-N-CA 124.763 1.225 . . . . 0.0 109.472 178.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 53.2 t -86.83 125.46 33.99 Favored 'General case' 0 C--N 1.35 0.603 0 C-N-CA 123.939 0.895 . . . . 0.0 110.9 -177.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -91.08 84.82 1.28 Allowed Glycine 0 C--N 1.355 1.603 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 172.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -103.75 139.9 38.35 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 -179.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -80.29 68.11 6.35 Favored 'General case' 0 C--N 1.351 0.632 0 C-N-CA 125.162 1.385 . . . . 0.0 109.111 -175.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.16 21.51 77.12 Favored Glycine 0 C--N 1.356 1.646 0 O-C-N 120.699 -1.251 . . . . 0.0 113.695 179.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 56.91 35.37 26.26 Favored 'General case' 0 C--N 1.348 0.543 0 C-N-CA 127.365 2.266 . . . . 0.0 116.401 -173.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 61.3 m-80 -67.68 -44.8 76.94 Favored 'General case' 0 C--N 1.357 0.896 0 N-CA-C 115.065 1.506 . . . . 0.0 115.065 168.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.516 ' HG3' ' H ' ' A' ' 47' ' ' LYS . 20.1 pttp -149.33 -106.2 0.07 Allowed 'General case' 0 C--N 1.354 0.764 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 -173.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.516 ' H ' ' HG3' ' A' ' 46' ' ' LYS . 25.8 pttm -119.27 159.07 24.79 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 125.388 1.475 . . . . 0.0 110.109 -177.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -154.79 -166.76 15.62 Favored Glycine 0 C--N 1.352 1.417 0 N-CA-C 110.504 -1.039 . . . . 0.0 110.504 178.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 50.5 t60 -136.49 146.35 46.17 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 -172.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 79.2 m -79.92 140.88 36.52 Favored 'General case' 0 C--N 1.349 0.561 0 O-C-N 120.752 -1.218 . . . . 0.0 111.637 -177.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 17.3 m-30 -126.03 162.41 25.35 Favored 'General case' 0 C--N 1.355 0.823 0 O-C-N 121.048 -1.032 . . . . 0.0 108.821 -178.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -123.68 137.44 54.71 Favored 'General case' 0 C--N 1.352 0.689 0 C-N-CA 124.422 1.089 . . . . 0.0 108.448 168.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 94.3 mt -107.16 130.05 59.91 Favored 'Isoleucine or valine' 0 C--N 1.361 1.085 0 C-N-CA 124.242 1.017 . . . . 0.0 108.782 177.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -131.57 149.97 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 C-N-CA 125.796 1.639 . . . . 0.0 110.153 -177.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 134.55 -155.4 21.91 Favored Glycine 0 C--N 1.35 1.355 0 N-CA-C 107.945 -2.062 . . . . 0.0 107.945 -177.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 59.5 t30 . . . . . 0 CA--C 1.569 1.711 0 CA-C-O 117.001 -1.476 . . . . 0.0 114.776 173.713 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 7.5 t80 . . . . . 0 N--CA 1.5 2.075 0 N-CA-C 116.222 1.934 . . . . 0.0 116.222 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 49.0 m-20 -120.35 149.64 42.02 Favored 'General case' 0 C--N 1.354 0.782 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 161.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.9 p -125.21 135.15 64.95 Favored 'Isoleucine or valine' 0 C--N 1.35 0.593 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 174.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 28.9 m -132.01 155.88 41.98 Favored 'Isoleucine or valine' 0 C--N 1.349 0.574 0 C-N-CA 123.481 0.712 . . . . 0.0 109.122 179.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 79.2 p -79.91 147.87 31.49 Favored 'General case' 0 C--N 1.349 0.549 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 175.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 10.9 t -102.5 -4.13 25.82 Favored 'General case' 0 C--N 1.353 0.754 0 C-N-CA 123.732 0.813 . . . . 0.0 112.062 -175.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 56.6 t30 58.95 44.48 16.38 Favored 'General case' 0 C--N 1.357 0.91 0 C-N-CA 127.176 2.19 . . . . 0.0 113.656 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.5 tppt? -144.06 146.44 32.83 Favored 'General case' 0 N--CA 1.445 -0.708 0 N-CA-C 102.473 -3.158 . . . . 0.0 102.473 173.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.4 p-10 -120.05 167.96 11.67 Favored 'General case' 0 C--N 1.355 0.845 0 CA-C-N 120.976 1.716 . . . . 0.0 110.402 171.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 57.1 m -116.42 160.87 19.93 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 173.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 32.3 m -111.23 159.33 18.0 Favored 'General case' 0 C--N 1.345 0.409 0 N-CA-C 102.231 -3.248 . . . . 0.0 102.231 166.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.2 t -58.6 144.1 44.07 Favored 'General case' 0 C--N 1.352 0.716 0 CA-C-O 122.353 1.073 . . . . 0.0 112.922 178.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.58 -58.62 4.85 Favored Glycine 0 C--N 1.353 1.523 0 C-N-CA 124.125 0.869 . . . . 0.0 111.359 -171.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 30.1 mm100 -63.55 -45.77 89.01 Favored 'General case' 0 C--N 1.348 0.535 0 N-CA-C 115.503 1.668 . . . . 0.0 115.503 -167.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 50.54 44.53 27.17 Favored 'General case' 0 C--N 1.36 1.039 0 N-CA-C 116.557 2.058 . . . . 0.0 116.557 175.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -91.93 114.77 27.4 Favored 'General case' 0 C--N 1.35 0.609 0 C-N-CA 124.396 1.079 . . . . 0.0 111.683 -176.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 98.2 m -132.6 157.4 78.41 Favored Pre-proline 0 C--N 1.351 0.671 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 171.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -69.72 160.27 50.34 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 122.775 2.317 . . . . 0.0 110.021 166.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -63.72 135.65 56.85 Favored 'General case' 0 C--N 1.353 0.75 0 N-CA-C 113.269 0.841 . . . . 0.0 113.269 -171.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.9 -12.62 65.7 Favored Glycine 0 C--N 1.355 1.587 0 C-N-CA 123.921 0.772 . . . . 0.0 113.212 -175.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 73.3 m -115.45 153.71 30.61 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-N 118.023 0.912 . . . . 0.0 110.489 -178.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -139.24 154.65 48.03 Favored 'General case' 0 C--N 1.355 0.831 0 O-C-N 121.099 -1.001 . . . . 0.0 110.015 -178.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 53.0 m -94.7 136.3 35.17 Favored 'General case' 0 C--N 1.353 0.752 0 CA-C-O 121.879 0.847 . . . . 0.0 111.053 168.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -91.88 90.05 1.47 Allowed Glycine 0 C--N 1.351 1.386 0 N-CA-C 107.332 -2.307 . . . . 0.0 107.332 167.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -106.1 125.52 51.1 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 -168.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -90.17 79.44 6.43 Favored 'General case' 0 C--N 1.352 0.678 0 O-C-N 120.987 -1.071 . . . . 0.0 109.68 -156.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 67.16 42.12 91.67 Favored Glycine 0 C--N 1.354 1.557 0 O-C-N 120.95 -1.094 . . . . 0.0 115.09 172.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 47.64 45.14 17.87 Favored 'General case' 0 C--N 1.354 0.766 0 C-N-CA 128.403 2.681 . . . . 0.0 116.843 -175.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 -94.62 -72.83 0.6 Allowed 'General case' 0 C--N 1.355 0.821 0 N-CA-C 114.72 1.378 . . . . 0.0 114.72 175.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -116.01 -96.41 0.46 Allowed 'General case' 0 C--N 1.357 0.919 0 O-C-N 120.536 -1.352 . . . . 0.0 113.083 -161.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -154.18 161.2 42.01 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 104.719 -2.326 . . . . 0.0 104.719 -171.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -154.25 156.48 26.87 Favored Glycine 0 CA--C 1.493 -1.329 0 N-CA-C 108.709 -1.756 . . . . 0.0 108.709 -177.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 73.6 t60 -101.45 144.84 29.74 Favored 'General case' 0 C--N 1.345 0.391 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 -175.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 72.3 m -78.98 133.22 36.87 Favored 'General case' 0 C--N 1.358 0.957 0 O-C-N 120.737 -1.227 . . . . 0.0 111.165 -178.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -123.61 159.91 28.23 Favored 'General case' 0 C--N 1.354 0.766 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 -175.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -118.98 135.09 54.79 Favored 'General case' 0 C--N 1.349 0.55 0 C-N-CA 124.228 1.011 . . . . 0.0 108.365 168.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 78.5 mt -101.28 125.71 55.22 Favored 'Isoleucine or valine' 0 C--N 1.358 0.944 0 C-N-CA 125.344 1.458 . . . . 0.0 109.038 173.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.5 162.4 39.88 Favored 'Isoleucine or valine' 0 C--N 1.351 0.644 0 C-N-CA 124.986 1.314 . . . . 0.0 110.678 179.153 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 95.77 -59.47 1.5 Allowed Glycine 0 C--N 1.355 1.593 0 O-C-N 121.074 -1.016 . . . . 0.0 111.667 -175.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 . . . . . 0 C--O 1.259 1.573 0 O-C-N 121.331 -1.099 . . . . 0.0 113.21 178.797 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 6.6 t80 . . . . . 0 N--CA 1.5 2.036 0 N-CA-C 115.0 1.481 . . . . 0.0 115.0 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -117.42 154.27 31.66 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 106.407 -1.701 . . . . 0.0 106.407 161.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.4 p -125.71 134.24 67.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 178.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.3 m -132.18 157.61 43.12 Favored 'Isoleucine or valine' 0 C--N 1.352 0.684 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 177.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 80.4 p -79.91 153.38 29.03 Favored 'General case' 0 C--N 1.349 0.548 0 O-C-N 120.704 -1.248 . . . . 0.0 113.97 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 21.0 t -121.96 25.25 9.22 Favored 'General case' 0 C--N 1.358 0.95 0 O-C-N 121.219 -0.926 . . . . 0.0 111.381 -171.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 45.57 39.18 4.57 Favored 'General case' 0 C--N 1.358 0.967 0 C-N-CA 128.184 2.594 . . . . 0.0 117.722 173.204 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 45.1 tptt -149.51 141.88 24.24 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 -174.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.8 p-10 -107.29 159.62 16.23 Favored 'General case' 0 C--N 1.355 0.837 0 CA-C-N 120.661 1.573 . . . . 0.0 111.075 170.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 84.5 m -106.61 156.15 18.9 Favored 'General case' 0 CA--C 1.509 -0.63 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 164.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 67.5 m -117.7 141.75 48.04 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 102.705 -3.072 . . . . 0.0 102.705 169.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 45.1 t -60.26 130.62 47.56 Favored 'General case' 0 C--N 1.357 0.893 0 O-C-N 120.815 -1.178 . . . . 0.0 111.242 178.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 89.32 -3.75 84.07 Favored Glycine 0 C--N 1.356 1.66 0 O-C-N 121.568 -0.707 . . . . 0.0 112.382 -176.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 11.4 mm-40 -112.55 -46.04 3.19 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 121.561 -0.964 . . . . 0.0 110.05 168.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 17.4 m120 53.47 43.61 31.07 Favored 'General case' 0 C--N 1.362 1.113 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 171.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -100.77 116.42 32.61 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 124.79 1.236 . . . . 0.0 111.877 -166.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 71.9 m -134.27 157.2 78.06 Favored Pre-proline 0 C--N 1.351 0.65 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 166.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.06 160.2 50.45 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.435 2.09 . . . . 0.0 110.962 166.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -62.64 134.67 56.67 Favored 'General case' 0 C--N 1.353 0.728 0 C-N-CA 123.91 0.884 . . . . 0.0 113.124 -173.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 98.8 -12.82 62.62 Favored Glycine 0 C--N 1.356 1.667 0 C-N-CA 124.185 0.897 . . . . 0.0 113.259 -173.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 71.2 m -116.29 154.56 29.96 Favored 'General case' 0 C--N 1.35 0.591 0 CA-C-N 118.019 0.909 . . . . 0.0 110.52 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 14.6 p90 -134.06 161.11 35.74 Favored 'General case' 0 C--N 1.355 0.811 0 N-CA-C 104.866 -2.272 . . . . 0.0 104.866 178.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 15.1 p -115.05 144.87 42.95 Favored 'General case' 0 CA--C 1.503 -0.849 0 CA-C-N 119.986 1.266 . . . . 0.0 112.455 172.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -90.97 62.91 2.89 Favored Glycine 0 C--N 1.352 1.421 0 CA-C-N 115.435 -0.802 . . . . 0.0 112.889 -172.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 62.6 mt -75.86 130.93 39.32 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 122.244 1.021 . . . . 0.0 111.895 167.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.537 HD22 ' H ' ' A' ' 42' ' ' LEU . 1.8 mm? -66.92 -44.56 80.37 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 126.297 1.839 . . . . 0.0 111.62 -164.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -167.45 49.57 0.24 Allowed Glycine 0 CA--C 1.499 -0.934 0 N-CA-C 106.609 -2.597 . . . . 0.0 106.609 173.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 45.11 54.48 7.01 Favored 'General case' 0 C--N 1.359 0.986 0 C-N-CA 127.537 2.335 . . . . 0.0 115.774 -176.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -94.06 -50.55 5.25 Favored 'General case' 0 C--N 1.359 0.986 0 O-C-N 119.996 -1.69 . . . . 0.0 111.802 -174.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 63.4 mttm -131.15 -103.07 0.28 Allowed 'General case' 0 C--N 1.356 0.862 0 C-N-CA 123.803 0.841 . . . . 0.0 111.479 -171.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 57.5 pttt -142.7 152.09 42.02 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 126.246 1.818 . . . . 0.0 106.833 -176.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -157.1 158.33 28.78 Favored Glycine 0 C--N 1.351 1.365 0 N-CA-C 108.142 -1.983 . . . . 0.0 108.142 -178.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 67.8 t60 -95.67 147.24 23.81 Favored 'General case' 0 C--N 1.346 0.433 0 O-C-N 121.717 -0.873 . . . . 0.0 110.49 -169.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 72.0 m -79.81 137.83 37.07 Favored 'General case' 0 C--N 1.359 1.002 0 O-C-N 121.078 -1.014 . . . . 0.0 111.792 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -127.09 154.62 44.47 Favored 'General case' 0 C--N 1.349 0.587 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 -178.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -104.69 135.87 45.26 Favored 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 124.629 1.171 . . . . 0.0 108.077 172.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 91.1 mt -101.19 123.4 54.23 Favored 'Isoleucine or valine' 0 C--N 1.356 0.86 0 C-N-CA 123.725 0.81 . . . . 0.0 108.937 176.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -128.19 146.51 33.61 Favored 'Isoleucine or valine' 0 C--N 1.351 0.663 0 C-N-CA 124.287 1.035 . . . . 0.0 109.693 176.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 93.24 -12.09 70.47 Favored Glycine 0 C--N 1.354 1.553 0 O-C-N 121.215 -0.928 . . . . 0.0 114.69 175.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 54.6 t30 . . . . . 0 C--O 1.259 1.564 0 O-C-N 121.082 -1.246 . . . . 0.0 111.574 -178.459 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 8.4 t80 . . . . . 0 N--CA 1.504 2.242 0 N-CA-C 116.528 2.048 . . . . 0.0 116.528 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -115.93 148.19 40.31 Favored 'General case' 0 C--N 1.354 0.789 0 C-N-CA 124.953 1.301 . . . . 0.0 107.721 161.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.7 p -123.09 133.26 69.6 Favored 'Isoleucine or valine' 0 C--N 1.351 0.648 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 171.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 24.0 m -133.39 154.12 38.44 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.683 0 C-N-CA 124.422 1.089 . . . . 0.0 108.235 178.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 96.2 p -79.67 155.72 27.91 Favored 'General case' 0 C--N 1.352 0.676 0 CA-C-O 121.856 0.836 . . . . 0.0 113.03 178.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 12.2 t -114.22 11.72 17.55 Favored 'General case' 0 C--N 1.351 0.648 0 C-N-CA 123.818 0.847 . . . . 0.0 110.519 -177.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 32.6 m120 59.24 28.9 18.35 Favored 'General case' 0 C--N 1.357 0.919 0 C-N-CA 128.108 2.563 . . . . 0.0 115.41 173.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 26.5 mmmt -134.74 160.07 39.33 Favored 'General case' 0 CA--C 1.513 -0.478 0 C-N-CA 127.057 2.143 . . . . 0.0 106.545 178.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -136.06 165.6 25.31 Favored 'General case' 0 C--N 1.351 0.664 0 O-C-N 121.088 -1.007 . . . . 0.0 109.493 173.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 30.7 m -120.9 147.87 44.83 Favored 'General case' 0 C--N 1.352 0.688 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 173.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 24.6 p -93.5 164.84 13.03 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 122.008 0.909 . . . . 0.0 110.365 153.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 46.9 t -61.32 130.84 48.13 Favored 'General case' 0 C--N 1.35 0.623 0 CA-C-O 122.125 0.964 . . . . 0.0 112.593 -178.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.35 -19.3 44.34 Favored Glycine 0 C--N 1.353 1.491 0 C-N-CA 124.94 1.257 . . . . 0.0 113.636 -178.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 21.8 mm100 -80.23 -47.94 13.86 Favored 'General case' 0 C--N 1.353 0.719 0 N-CA-C 114.775 1.398 . . . . 0.0 114.775 179.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 31.6 m120 50.08 41.19 23.15 Favored 'General case' 0 C--N 1.355 0.836 0 C-N-CA 126.17 1.788 . . . . 0.0 115.055 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -98.42 109.43 22.19 Favored 'General case' 0 C--N 1.355 0.839 0 O-C-N 121.033 -1.042 . . . . 0.0 111.38 -172.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 76.1 m -137.05 157.7 74.09 Favored Pre-proline 0 C--N 1.35 0.598 0 N-CA-C 105.728 -1.953 . . . . 0.0 105.728 167.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -69.41 159.71 52.6 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.756 2.304 . . . . 0.0 111.349 169.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -62.79 131.28 48.31 Favored 'General case' 0 C--N 1.354 0.765 0 C-N-CA 123.675 0.79 . . . . 0.0 112.229 -172.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 100.36 -13.7 59.82 Favored Glycine 0 C--N 1.356 1.643 0 C-N-CA 123.822 0.725 . . . . 0.0 112.575 -174.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 72.1 m -114.08 154.21 28.13 Favored 'General case' 0 C--N 1.349 0.574 0 C-N-CA 124.088 0.955 . . . . 0.0 109.949 177.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -136.3 156.67 48.32 Favored 'General case' 0 C--N 1.35 0.611 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 178.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 8.1 p -106.16 143.87 33.68 Favored 'General case' 0 CA--C 1.501 -0.905 0 CA-C-O 122.413 1.102 . . . . 0.0 111.157 171.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -84.09 74.93 2.44 Favored Glycine 0 C--N 1.352 1.432 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 178.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -92.22 121.53 33.83 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 -173.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -91.46 101.06 13.73 Favored 'General case' 0 C--N 1.352 0.678 0 O-C-N 120.674 -1.266 . . . . 0.0 108.969 -163.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 60.07 32.02 74.54 Favored Glycine 0 C--N 1.357 1.708 0 N-CA-C 115.629 1.012 . . . . 0.0 115.629 165.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 46.19 43.11 10.83 Favored 'General case' 0 C--N 1.354 0.8 0 C-N-CA 127.895 2.478 . . . . 0.0 116.148 -168.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 67.2 m-80 -89.6 -98.7 0.1 Allowed 'General case' 0 C--N 1.359 0.999 0 O-C-N 121.247 -0.908 . . . . 0.0 111.649 173.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 35.3 mmtp -96.89 -89.16 0.28 Allowed 'General case' 0 C--N 1.355 0.809 0 O-C-N 120.646 -1.284 . . . . 0.0 113.636 -169.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 63.6 pttt -151.98 162.12 41.57 Favored 'General case' 0 N--CA 1.445 -0.707 0 O-C-N 121.142 -0.973 . . . . 0.0 108.956 -168.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -157.5 154.03 25.18 Favored Glycine 0 C--N 1.352 1.424 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 63.1 t60 -97.3 148.13 23.44 Favored 'General case' 0 C--N 1.349 0.569 0 O-C-N 121.601 -0.94 . . . . 0.0 109.166 -173.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 71.5 m -80.84 134.51 35.78 Favored 'General case' 0 C--N 1.359 1.02 0 O-C-N 120.956 -1.09 . . . . 0.0 111.516 -178.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -130.81 167.13 19.41 Favored 'General case' 0 C--N 1.351 0.633 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 -177.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 33.7 pttt -124.28 148.92 47.06 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 121.56 0.695 . . . . 0.0 110.553 156.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 82.3 mt -104.78 124.25 59.29 Favored 'Isoleucine or valine' 0 C--N 1.358 0.944 0 C-N-CA 125.811 1.645 . . . . 0.0 107.805 174.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.42 142.13 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 C-N-CA 124.989 1.316 . . . . 0.0 108.938 178.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 144.97 -148.27 19.93 Favored Glycine 0 C--N 1.351 1.393 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -175.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 15.5 p-10 . . . . . 0 C--O 1.259 1.565 0 N-CA-C 114.581 1.326 . . . . 0.0 114.581 179.631 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 28.3 t80 . . . . . 0 N--CA 1.504 2.249 0 N-CA-C 116.988 2.218 . . . . 0.0 116.988 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 41.9 t0 -144.65 158.21 43.87 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 105.11 -2.181 . . . . 0.0 105.11 167.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.7 p -130.82 133.05 63.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 175.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.5 m -133.27 161.6 41.18 Favored 'Isoleucine or valine' 0 C--N 1.351 0.634 0 C-N-CA 124.326 1.05 . . . . 0.0 108.313 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 87.3 p -75.82 149.81 37.81 Favored 'General case' 0 C--N 1.352 0.679 0 O-C-N 120.745 -1.222 . . . . 0.0 113.249 176.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 34.5 t -114.11 -0.12 14.1 Favored 'General case' 0 C--N 1.356 0.885 0 O-C-N 121.236 -0.915 . . . . 0.0 111.337 -172.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 53.3 t30 58.51 45.67 16.07 Favored 'General case' 0 C--N 1.356 0.864 0 C-N-CA 127.146 2.179 . . . . 0.0 114.827 175.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 15.5 tppt? -141.7 144.43 34.06 Favored 'General case' 0 C--N 1.349 0.565 0 N-CA-C 105.27 -2.122 . . . . 0.0 105.27 173.182 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 30.0 t30 -114.07 136.26 53.11 Favored 'General case' 0 C--N 1.353 0.76 0 O-C-N 121.2 -0.937 . . . . 0.0 110.387 -176.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 85.9 m -102.31 151.72 21.91 Favored 'General case' 0 C--N 1.356 0.855 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 170.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 40.0 m -128.16 160.18 32.84 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 101.774 -3.417 . . . . 0.0 101.774 176.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.2 t -51.15 -40.23 58.1 Favored 'General case' 0 C--N 1.345 0.393 0 C-N-CA 126.138 1.775 . . . . 0.0 115.461 -169.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -78.95 -1.5 85.01 Favored Glycine 0 C--N 1.351 1.374 0 N-CA-C 116.226 1.25 . . . . 0.0 116.226 178.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -145.9 135.45 23.17 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-N 120.34 2.07 . . . . 0.0 112.628 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 34.7 m120 -98.55 101.09 12.42 Favored 'General case' 0 C--N 1.353 0.744 0 O-C-N 119.833 -1.792 . . . . 0.0 106.491 172.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -130.42 95.02 3.78 Favored 'General case' 0 N--CA 1.446 -0.649 0 O-C-N 121.811 -0.556 . . . . 0.0 109.905 -164.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 73.1 m -136.05 156.54 76.94 Favored Pre-proline 0 C--N 1.351 0.633 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 170.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.85 160.44 49.67 Favored 'Trans proline' 0 N--CA 1.46 -0.5 0 C-N-CA 122.478 2.119 . . . . 0.0 110.611 162.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 64.6 mm-40 -64.76 137.98 58.11 Favored 'General case' 0 C--N 1.351 0.673 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -174.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.37 -10.67 67.24 Favored Glycine 0 C--N 1.356 1.643 0 C-N-CA 123.83 0.728 . . . . 0.0 112.879 -174.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 71.3 m -115.61 153.74 30.71 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.219 1.008 . . . . 0.0 110.18 179.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -132.65 157.82 43.84 Favored 'General case' 0 C--N 1.355 0.836 0 N-CA-C 105.216 -2.142 . . . . 0.0 105.216 175.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 12.7 p -110.21 144.31 39.06 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-N 119.545 1.066 . . . . 0.0 110.666 169.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -85.16 71.63 2.91 Favored Glycine 0 C--N 1.352 1.418 0 N-CA-C 110.031 -1.228 . . . . 0.0 110.031 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -93.18 121.31 34.41 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 -172.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -88.71 82.65 6.79 Favored 'General case' 0 C--N 1.351 0.644 0 O-C-N 120.753 -1.217 . . . . 0.0 110.011 -162.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 64.21 37.29 94.34 Favored Glycine 0 C--N 1.354 1.578 0 O-C-N 121.029 -1.045 . . . . 0.0 115.197 167.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 47.49 44.64 16.96 Favored 'General case' 0 C--N 1.352 0.717 0 C-N-CA 128.811 2.844 . . . . 0.0 115.847 -173.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 64.0 m-80 -90.66 -61.43 1.68 Allowed 'General case' 0 C--N 1.357 0.892 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 171.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -127.36 -103.77 0.33 Allowed 'General case' 0 C--N 1.356 0.887 0 O-C-N 120.964 -1.085 . . . . 0.0 112.851 -169.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -152.37 159.98 43.36 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -169.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -164.68 151.5 20.6 Favored Glycine 0 C--N 1.35 1.358 0 N-CA-C 111.174 -0.771 . . . . 0.0 111.174 -176.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 79.1 t60 -96.96 143.64 27.63 Favored 'General case' 0 N--CA 1.449 -0.479 0 O-C-N 121.812 -0.816 . . . . 0.0 109.763 -171.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 74.4 m -76.94 139.38 40.15 Favored 'General case' 0 C--N 1.356 0.853 0 O-C-N 121.008 -1.057 . . . . 0.0 112.139 -178.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -123.96 151.01 44.11 Favored 'General case' 0 C--N 1.351 0.642 0 N-CA-C 106.962 -1.495 . . . . 0.0 106.962 -179.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -100.3 134.11 43.72 Favored 'General case' 0 C--N 1.346 0.453 0 C-N-CA 124.224 1.009 . . . . 0.0 108.317 173.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 96.6 mt -101.41 124.78 55.36 Favored 'Isoleucine or valine' 0 C--N 1.356 0.885 0 CA-C-O 122.08 0.943 . . . . 0.0 109.323 171.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -128.04 148.53 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 C-N-CA 125.827 1.651 . . . . 0.0 108.592 175.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 172.53 -167.3 40.18 Favored Glycine 0 CA--C 1.492 -1.346 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 47.4 p30 . . . . . 0 C--O 1.258 1.537 0 N-CA-C 114.691 1.367 . . . . 0.0 114.691 178.416 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 5.4 t80 . . . . . 0 N--CA 1.503 2.178 0 N-CA-C 115.828 1.788 . . . . 0.0 115.828 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -118.38 148.31 42.65 Favored 'General case' 0 C--N 1.356 0.863 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 162.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.0 p -120.74 134.99 62.39 Favored 'Isoleucine or valine' 0 C--N 1.35 0.626 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 174.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.7 m -131.76 160.01 42.69 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.603 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 177.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 94.5 p -77.26 153.71 33.7 Favored 'General case' 0 C--N 1.352 0.685 0 O-C-N 120.95 -1.094 . . . . 0.0 111.614 171.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 11.2 t -94.76 -8.68 36.89 Favored 'General case' 0 C--N 1.352 0.682 0 O-C-N 121.099 -1.001 . . . . 0.0 109.721 178.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 62.1 t30 58.44 45.23 16.95 Favored 'General case' 0 C--N 1.355 0.83 0 C-N-CA 128.4 2.68 . . . . 0.0 112.666 -173.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 53.5 tptt -133.12 135.89 45.48 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 177.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -91.14 136.26 33.21 Favored 'General case' 0 C--N 1.352 0.712 0 C-N-CA 125.429 1.492 . . . . 0.0 108.788 -178.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 25.2 p -129.16 150.09 50.69 Favored 'General case' 0 C--N 1.353 0.756 0 CA-C-O 122.093 0.949 . . . . 0.0 110.771 176.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 90.5 m -125.3 148.27 48.77 Favored 'General case' 0 CA--C 1.507 -0.691 0 N-CA-C 104.551 -2.388 . . . . 0.0 104.551 -174.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 80.9 p -57.92 -42.52 84.95 Favored 'General case' 0 C--N 1.353 0.734 0 N-CA-C 117.529 2.418 . . . . 0.0 117.529 -159.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -78.71 -48.96 6.83 Favored Glycine 0 C--N 1.353 1.492 0 CA-C-N 119.408 1.004 . . . . 0.0 113.475 176.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.6 mp0 -67.27 -43.97 80.49 Favored 'General case' 0 C--N 1.35 0.589 0 C-N-CA 125.143 1.377 . . . . 0.0 113.458 -174.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 54.09 45.1 28.21 Favored 'General case' 0 C--N 1.355 0.826 0 C-N-CA 129.004 2.922 . . . . 0.0 115.136 169.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 53.7 mp0 -75.97 123.54 25.9 Favored 'General case' 0 C--N 1.36 1.057 0 O-C-N 119.68 -1.887 . . . . 0.0 113.518 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 73.3 m -135.94 154.99 78.08 Favored Pre-proline 0 C--N 1.35 0.593 0 N-CA-C 105.576 -2.009 . . . . 0.0 105.576 159.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -71.65 161.34 45.58 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.727 2.285 . . . . 0.0 110.998 167.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -62.92 130.76 46.19 Favored 'General case' 0 C--N 1.353 0.733 0 CA-C-O 121.483 0.659 . . . . 0.0 112.469 -175.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 100.63 -14.23 59.21 Favored Glycine 0 C--N 1.355 1.608 0 C-N-CA 123.675 0.655 . . . . 0.0 112.62 -173.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 73.9 m -113.3 153.71 28.01 Favored 'General case' 0 C--N 1.349 0.579 0 C-N-CA 123.92 0.888 . . . . 0.0 109.892 176.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -134.85 155.56 50.45 Favored 'General case' 0 C--N 1.352 0.705 0 O-C-N 121.235 -0.915 . . . . 0.0 110.3 -177.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 47.3 t -91.67 125.59 36.46 Favored 'General case' 0 C--N 1.351 0.652 0 C-N-CA 124.619 1.168 . . . . 0.0 111.788 -169.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -84.77 60.37 4.82 Favored Glycine 0 C--N 1.352 1.459 0 O-C-N 121.375 -0.828 . . . . 0.0 113.435 174.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -117.87 122.14 42.57 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 174.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -119.8 144.94 47.04 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 -173.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 76.39 10.43 85.59 Favored Glycine 0 C--N 1.355 1.636 0 O-C-N 121.547 -0.721 . . . . 0.0 114.806 166.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 55.7 46.29 22.86 Favored 'General case' 0 C--N 1.35 0.612 0 C-N-CA 126.655 1.982 . . . . 0.0 114.375 -175.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 -87.98 -109.09 0.07 Allowed 'General case' 0 C--N 1.356 0.869 0 O-C-N 121.469 -0.769 . . . . 0.0 112.558 -179.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -105.4 -107.29 0.3 Allowed 'General case' 0 C--N 1.352 0.71 0 O-C-N 120.498 -1.376 . . . . 0.0 114.568 -169.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -114.37 154.23 28.43 Favored 'General case' 0 N--CA 1.439 -0.978 0 C-N-CA 126.882 2.073 . . . . 0.0 108.095 179.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -133.37 178.66 18.06 Favored Glycine 0 CA--C 1.493 -1.295 0 N-CA-C 107.233 -2.347 . . . . 0.0 107.233 173.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 40.9 t60 -128.2 147.6 50.58 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 105.052 -2.203 . . . . 0.0 105.052 177.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 79.9 m -83.26 140.86 32.26 Favored 'General case' 0 C--N 1.351 0.673 0 O-C-N 121.036 -1.04 . . . . 0.0 112.408 -173.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -121.59 161.92 21.56 Favored 'General case' 0 C--N 1.356 0.885 0 O-C-N 121.42 -0.8 . . . . 0.0 108.871 -178.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -120.18 135.14 55.07 Favored 'General case' 0 C--N 1.35 0.588 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 167.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 78.5 mt -101.25 126.46 55.04 Favored 'Isoleucine or valine' 0 C--N 1.357 0.934 0 C-N-CA 125.134 1.374 . . . . 0.0 108.41 171.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.76 156.85 42.75 Favored 'Isoleucine or valine' 0 C--N 1.35 0.614 0 C-N-CA 124.947 1.299 . . . . 0.0 109.423 177.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 89.58 8.02 68.39 Favored Glycine 0 C--N 1.355 1.638 0 O-C-N 121.023 -1.048 . . . . 0.0 113.115 -176.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 17.2 p-10 . . . . . 0 C--O 1.259 1.566 0 N-CA-C 114.73 1.381 . . . . 0.0 114.73 179.203 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 6.4 t80 . . . . . 0 N--CA 1.505 2.306 0 N-CA-C 116.097 1.888 . . . . 0.0 116.097 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 52.5 m-20 -116.58 152.36 34.32 Favored 'General case' 0 C--N 1.355 0.835 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 164.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.1 p -123.22 134.47 66.15 Favored 'Isoleucine or valine' 0 C--N 1.348 0.522 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 174.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.7 m -131.24 157.99 43.27 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.802 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 80.4 p -83.65 151.08 25.48 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 122.151 0.977 . . . . 0.0 113.471 176.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 83.2 m -96.01 -2.76 46.24 Favored 'General case' 0 C--N 1.356 0.859 0 C-N-CA 123.927 0.891 . . . . 0.0 110.472 173.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 59.5 t30 57.19 45.23 20.91 Favored 'General case' 0 C--N 1.35 0.592 0 C-N-CA 129.093 2.957 . . . . 0.0 114.241 178.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.6 mmmt -130.07 147.57 51.83 Favored 'General case' 0 CA--C 1.506 -0.719 0 C-N-CA 126.877 2.071 . . . . 0.0 105.972 170.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -85.47 174.76 9.27 Favored 'General case' 0 C--N 1.354 0.8 0 CA-C-N 118.751 0.705 . . . . 0.0 110.228 173.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 17.0 p -126.89 -178.9 4.57 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 105.416 -2.068 . . . . 0.0 105.416 162.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 31.1 m -134.03 142.31 47.55 Favored 'General case' 0 CA--C 1.504 -0.824 1 N-CA-C 99.917 -4.105 . . . . 0.0 99.917 165.398 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 35.2 t -59.05 -44.58 91.81 Favored 'General case' 0 C--N 1.351 0.667 0 CA-C-N 120.508 1.504 . . . . 0.0 115.031 -163.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -68.9 -45.09 65.2 Favored Glycine 0 C--N 1.354 1.559 0 O-C-N 121.231 -0.918 . . . . 0.0 115.294 176.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -70.07 -43.51 71.03 Favored 'General case' 0 C--N 1.351 0.666 0 C-N-CA 125.113 1.365 . . . . 0.0 112.838 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 55.22 46.59 23.45 Favored 'General case' 0 C--N 1.353 0.72 0 C-N-CA 130.507 3.523 . . . . 0.0 112.694 -178.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -62.9 124.45 21.1 Favored 'General case' 0 C--N 1.359 1.012 0 C-N-CA 125.574 1.55 . . . . 0.0 113.455 177.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 86.0 m -143.3 159.66 54.55 Favored Pre-proline 0 C--N 1.351 0.665 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 159.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -68.7 156.61 64.91 Favored 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 122.746 2.298 . . . . 0.0 110.783 162.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -63.65 131.63 48.59 Favored 'General case' 0 C--N 1.352 0.707 0 CA-C-O 121.607 0.718 . . . . 0.0 112.804 -173.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 99.19 -12.31 61.98 Favored Glycine 0 C--N 1.356 1.676 0 O-C-N 121.605 -0.684 . . . . 0.0 112.896 -175.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 79.2 m -111.93 156.46 22.06 Favored 'General case' 0 C--N 1.349 0.56 0 C-N-CA 124.039 0.936 . . . . 0.0 108.914 177.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -138.13 159.96 40.66 Favored 'General case' 0 C--N 1.35 0.599 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 -177.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 41.9 t -117.33 121.14 40.32 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -88.91 93.44 1.9 Allowed Glycine 0 C--N 1.352 1.446 0 N-CA-C 107.943 -2.063 . . . . 0.0 107.943 177.061 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.418 HD21 ' O ' ' A' ' 46' ' ' LYS . 2.2 tm? -102.39 120.52 40.64 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 -167.176 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.483 HD22 ' H ' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -89.65 115.11 26.79 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-O 123.18 1.466 . . . . 0.0 113.588 -177.84 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 69.64 14.19 69.5 Favored Glycine 0 C--N 1.356 1.685 0 N-CA-C 116.929 1.532 . . . . 0.0 116.929 159.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 60.22 27.73 17.26 Favored 'General case' 0 C--N 1.353 0.731 0 C-N-CA 126.672 1.989 . . . . 0.0 113.877 -176.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 65.4 m-80 -82.55 -46.79 12.91 Favored 'General case' 0 C--N 1.353 0.735 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 -172.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.418 ' O ' HD21 ' A' ' 41' ' ' LEU . 56.4 mtmt -139.24 -177.92 5.13 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-O 122.298 1.047 . . . . 0.0 108.261 -161.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.8 ptpp? -64.02 -37.71 88.42 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 126.9 2.08 . . . . 0.0 116.299 170.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 70.17 -162.38 53.0 Favored Glycine 0 C--N 1.355 1.591 0 O-C-N 119.494 -2.004 . . . . 0.0 112.678 -173.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 19.1 t60 -157.29 152.78 26.47 Favored 'General case' 0 C--N 1.356 0.876 0 N-CA-C 105.755 -1.942 . . . . 0.0 105.755 174.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 71.4 m -85.47 139.41 31.52 Favored 'General case' 0 C--N 1.357 0.896 0 O-C-N 120.581 -1.324 . . . . 0.0 113.469 -176.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -126.19 163.12 23.85 Favored 'General case' 0 C--N 1.357 0.926 0 C-N-CA 123.813 0.845 . . . . 0.0 109.447 -172.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 40.8 ttpt -121.23 136.97 54.88 Favored 'General case' 0 C--N 1.352 0.697 0 C-N-CA 125.336 1.454 . . . . 0.0 109.695 167.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 82.2 mt -94.03 124.4 46.48 Favored 'Isoleucine or valine' 0 C--N 1.361 1.078 0 C-N-CA 125.337 1.455 . . . . 0.0 109.687 172.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.72 140.02 49.14 Favored 'Isoleucine or valine' 0 C--N 1.351 0.643 0 C-N-CA 124.786 1.234 . . . . 0.0 109.977 173.194 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 166.06 177.77 38.41 Favored Glycine 0 CA--C 1.491 -1.422 0 N-CA-C 108.713 -1.755 . . . . 0.0 108.713 178.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 . . . . . 0 C--O 1.26 1.657 0 CA-C-O 117.488 -1.244 . . . . 0.0 111.503 178.56 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 9.4 t80 . . . . . 0 N--CA 1.503 2.186 0 N-CA-C 116.635 2.087 . . . . 0.0 116.635 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -123.12 148.36 45.77 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 161.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.1 p -119.53 132.0 70.55 Favored 'Isoleucine or valine' 0 C--N 1.351 0.662 0 N-CA-C 106.757 -1.572 . . . . 0.0 106.757 168.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 18.8 m -134.95 155.34 38.04 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.568 0 C-N-CA 124.795 1.238 . . . . 0.0 108.482 -177.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 89.6 p -79.73 157.48 27.14 Favored 'General case' 0 C--N 1.349 0.577 0 CA-C-O 122.25 1.024 . . . . 0.0 113.469 177.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 96.2 m -105.42 10.31 33.38 Favored 'General case' 0 C--N 1.352 0.703 0 C-N-CA 123.978 0.911 . . . . 0.0 111.971 177.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 53.7 t30 56.39 44.16 24.94 Favored 'General case' 0 C--N 1.355 0.825 0 C-N-CA 127.029 2.132 . . . . 0.0 113.166 -178.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 52.3 tptt -139.98 134.83 32.05 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 120.752 -1.217 . . . . 0.0 109.224 -177.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -87.09 121.18 29.19 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.184 1.793 . . . . 0.0 109.564 179.028 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 27.8 p -116.94 167.25 11.3 Favored 'General case' 0 C--N 1.35 0.618 0 C-N-CA 123.917 0.887 . . . . 0.0 108.741 173.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 73.7 m -129.51 146.11 51.38 Favored 'General case' 0 C--N 1.349 0.561 0 N-CA-C 104.063 -2.569 . . . . 0.0 104.063 170.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.502 ' HB2' HD12 ' A' ' 41' ' ' LEU . 33.4 t -57.75 -38.43 75.35 Favored 'General case' 0 C--N 1.355 0.807 0 C-N-CA 126.418 1.887 . . . . 0.0 113.727 -170.192 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -90.86 9.41 77.83 Favored Glycine 0 C--N 1.35 1.308 0 O-C-N 121.193 -0.942 . . . . 0.0 113.59 177.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 22.1 mm-40 -118.2 -43.33 2.74 Favored 'General case' 0 C--N 1.351 0.637 0 O-C-N 121.479 -1.012 . . . . 0.0 111.088 176.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 22.1 m120 56.17 38.04 29.45 Favored 'General case' 0 C--N 1.358 0.957 0 C-N-CA 127.38 2.272 . . . . 0.0 115.23 176.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -86.32 108.67 18.53 Favored 'General case' 0 C--N 1.351 0.654 0 O-C-N 120.683 -1.261 . . . . 0.0 110.785 -178.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 91.5 m -134.64 157.73 76.63 Favored Pre-proline 0 C--N 1.351 0.636 0 C-N-CA 125.033 1.333 . . . . 0.0 108.476 175.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -69.98 161.27 46.6 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.877 2.385 . . . . 0.0 111.206 168.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -64.28 134.83 55.47 Favored 'General case' 0 C--N 1.353 0.743 0 CA-C-O 121.646 0.736 . . . . 0.0 112.591 -174.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.53 -10.89 68.94 Favored Glycine 0 C--N 1.354 1.561 0 C-N-CA 123.473 0.558 . . . . 0.0 113.027 -174.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 85.6 m -114.8 154.6 28.28 Favored 'General case' 0 C--N 1.351 0.634 0 CA-C-N 118.034 0.917 . . . . 0.0 109.33 -179.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -131.35 160.4 35.14 Favored 'General case' 0 C--N 1.351 0.65 0 O-C-N 121.211 -0.93 . . . . 0.0 108.533 -179.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 43.2 t -89.45 119.76 30.18 Favored 'General case' 0 C--N 1.353 0.728 0 O-C-N 121.533 -0.73 . . . . 0.0 109.688 -175.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -90.21 63.8 3.04 Favored Glycine 0 C--N 1.353 1.494 0 O-C-N 121.168 -0.957 . . . . 0.0 114.003 -175.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.502 HD12 ' HB2' ' A' ' 28' ' ' SER . 2.4 tm? -132.87 132.84 42.55 Favored 'General case' 0 C--N 1.352 0.712 0 CA-C-N 118.761 1.281 . . . . 0.0 108.414 177.371 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.43 ' N ' HD13 ' A' ' 41' ' ' LEU . 1.8 mm? -115.8 133.4 56.07 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 -175.103 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 77.79 5.85 86.72 Favored Glycine 0 C--N 1.356 1.677 0 N-CA-C 115.92 1.128 . . . . 0.0 115.92 166.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 56.42 40.5 29.64 Favored 'General case' 0 C--N 1.349 0.557 0 C-N-CA 127.224 2.209 . . . . 0.0 113.731 -173.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 62.0 m-80 -67.78 -46.56 71.65 Favored 'General case' 0 C--N 1.355 0.824 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 172.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -139.4 -133.46 0.12 Allowed 'General case' 0 C--N 1.351 0.668 0 CA-C-O 121.718 0.771 . . . . 0.0 109.236 -177.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.5 pttm -103.46 -56.71 2.16 Favored 'General case' 0 C--N 1.351 0.648 0 C-N-CA 125.522 1.529 . . . . 0.0 113.444 -178.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 94.4 175.98 38.84 Favored Glycine 0 C--N 1.352 1.441 0 CA-C-O 122.843 1.246 . . . . 0.0 111.444 -171.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 51.6 t60 -149.0 152.95 37.19 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 102.692 -3.077 . . . . 0.0 102.692 177.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 79.1 m -81.85 135.19 35.45 Favored 'General case' 0 C--N 1.351 0.672 0 O-C-N 121.054 -1.029 . . . . 0.0 112.244 -174.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 13.1 m-30 -123.9 160.68 26.95 Favored 'General case' 0 C--N 1.357 0.896 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -178.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 20.2 pttm -121.36 150.98 40.66 Favored 'General case' 0 C--N 1.35 0.606 0 CA-C-O 121.689 0.757 . . . . 0.0 109.653 160.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 83.7 mt -114.36 130.54 68.48 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.788 0 C-N-CA 124.861 1.264 . . . . 0.0 109.976 176.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.61 140.41 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 C-N-CA 126.679 1.991 . . . . 0.0 109.053 178.379 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 140.56 -140.48 10.56 Favored Glycine 0 C--N 1.35 1.35 0 N-CA-C 107.426 -2.269 . . . . 0.0 107.426 -172.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 . . . . . 0 C--O 1.26 1.633 0 CA-C-O 117.871 -1.062 . . . . 0.0 113.786 -179.546 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 11.8 t80 . . . . . 0 N--CA 1.504 2.259 0 N-CA-C 115.996 1.85 . . . . 0.0 115.996 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -116.87 154.12 31.33 Favored 'General case' 0 C--N 1.356 0.855 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 164.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.5 p -126.69 134.6 65.9 Favored 'Isoleucine or valine' 0 C--N 1.35 0.619 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 178.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 33.1 m -132.69 162.75 39.38 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 C-N-CA 124.585 1.154 . . . . 0.0 108.209 -179.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 78.5 p -72.9 145.06 47.11 Favored 'General case' 0 C--N 1.351 0.668 0 O-C-N 120.606 -1.309 . . . . 0.0 113.866 174.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 34.1 t -95.34 -10.12 31.0 Favored 'General case' 0 C--N 1.356 0.886 0 O-C-N 121.219 -0.926 . . . . 0.0 111.314 -179.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 54.0 t30 59.87 41.8 17.37 Favored 'General case' 0 C--N 1.355 0.835 0 C-N-CA 127.406 2.283 . . . . 0.0 112.874 -175.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 24.7 mmmt -130.83 144.21 51.29 Favored 'General case' 0 C--N 1.353 0.747 0 C-N-CA 124.571 1.148 . . . . 0.0 111.483 175.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 20.1 t30 -93.65 123.39 36.95 Favored 'General case' 0 C--N 1.354 0.796 0 CA-C-O 122.214 1.007 . . . . 0.0 110.231 -173.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 14.4 t -105.69 152.9 22.57 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 128.483 2.713 . . . . 0.0 107.638 176.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 42.1 m -131.09 160.07 35.74 Favored 'General case' 0 C--N 1.355 0.844 0 N-CA-C 104.729 -2.323 . . . . 0.0 104.729 172.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.5 t -62.35 -43.25 99.26 Favored 'General case' 0 C--N 1.353 0.737 0 O-C-N 120.083 -1.635 . . . . 0.0 112.966 174.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -63.76 -41.5 98.88 Favored Glycine 0 C--N 1.357 1.738 0 C-N-CA 124.397 0.998 . . . . 0.0 115.127 176.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 27.1 pt20 -132.53 117.01 17.45 Favored 'General case' 0 C--N 1.35 0.621 0 CA-C-O 122.698 1.237 . . . . 0.0 110.053 175.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 24.2 m120 -91.89 79.56 5.28 Favored 'General case' 0 C--N 1.353 0.742 0 O-C-N 120.514 -1.366 . . . . 0.0 108.644 -174.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -97.72 109.7 22.41 Favored 'General case' 0 C--N 1.35 0.612 0 O-C-N 120.906 -1.121 . . . . 0.0 110.885 -170.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 80.9 m -134.27 153.09 79.23 Favored Pre-proline 0 C--N 1.351 0.631 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 172.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -72.17 162.23 42.3 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 123.145 2.563 . . . . 0.0 111.036 168.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -64.92 135.15 55.36 Favored 'General case' 0 C--N 1.353 0.725 0 CA-C-O 121.647 0.736 . . . . 0.0 112.19 -178.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.76 -14.31 63.08 Favored Glycine 0 C--N 1.354 1.583 0 C-N-CA 123.779 0.704 . . . . 0.0 112.375 -171.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 76.7 m -113.76 155.24 25.99 Favored 'General case' 0 C--N 1.349 0.582 0 C-N-CA 124.236 1.014 . . . . 0.0 109.894 175.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -139.74 161.07 38.42 Favored 'General case' 0 C--N 1.352 0.714 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 -176.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 41.2 t -122.13 124.09 43.09 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 173.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -100.99 106.51 3.1 Favored Glycine 0 C--N 1.352 1.47 0 N-CA-C 107.092 -2.403 . . . . 0.0 107.092 170.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -101.13 120.1 39.72 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 -168.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -87.55 89.34 7.96 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-O 122.662 1.22 . . . . 0.0 113.122 -174.284 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 64.05 32.52 84.44 Favored Glycine 0 C--N 1.358 1.762 0 N-CA-C 117.226 1.65 . . . . 0.0 117.226 160.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.8 pm0 46.99 36.42 4.06 Favored 'General case' 0 C--N 1.354 0.79 0 C-N-CA 128.511 2.725 . . . . 0.0 115.172 -174.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 59.1 m-80 -77.92 -44.71 26.17 Favored 'General case' 0 CA--C 1.505 -0.78 0 C-N-CA 124.785 1.234 . . . . 0.0 112.372 174.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.5 pttm -155.61 174.54 15.12 Favored 'General case' 0 N--CA 1.425 -1.706 0 N-CA-C 106.009 -1.849 . . . . 0.0 106.009 -174.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -62.08 -36.5 81.86 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 129.747 3.219 . . . . 0.0 115.312 -173.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 83.47 -167.5 44.91 Favored Glycine 0 C--N 1.355 1.63 0 O-C-N 120.627 -1.296 . . . . 0.0 112.145 -175.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 69.1 t60 -156.9 151.3 25.33 Favored 'General case' 0 C--N 1.35 0.627 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 177.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 70.9 m -81.24 140.84 34.66 Favored 'General case' 0 C--N 1.356 0.86 0 CA-C-N 119.786 1.176 . . . . 0.0 112.723 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 8.6 m-30 -121.27 157.14 30.98 Favored 'General case' 0 C--N 1.353 0.74 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 -177.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 40.6 ttpt -110.42 137.43 48.14 Favored 'General case' 0 C--N 1.349 0.546 0 C-N-CA 124.17 0.988 . . . . 0.0 109.903 173.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 97.3 mt -97.12 123.55 49.52 Favored 'Isoleucine or valine' 0 C--N 1.361 1.066 0 C-N-CA 124.546 1.138 . . . . 0.0 109.874 176.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.78 138.23 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 C-N-CA 124.431 1.092 . . . . 0.0 108.798 173.285 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 148.95 -159.43 28.03 Favored Glycine 0 C--N 1.35 1.332 0 N-CA-C 108.854 -1.698 . . . . 0.0 108.854 -175.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 17.4 p-10 . . . . . 0 C--O 1.258 1.551 0 N-CA-C 114.823 1.416 . . . . 0.0 114.823 177.928 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 10.7 t80 . . . . . 0 N--CA 1.504 2.237 0 N-CA-C 115.856 1.798 . . . . 0.0 115.856 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -117.37 153.88 32.27 Favored 'General case' 0 C--N 1.355 0.83 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 162.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.9 p -128.06 133.39 67.26 Favored 'Isoleucine or valine' 0 C--N 1.349 0.585 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 177.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.9 m -134.22 161.55 40.55 Favored 'Isoleucine or valine' 0 C--N 1.352 0.691 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 78.5 p -72.88 144.48 47.39 Favored 'General case' 0 C--N 1.351 0.648 0 N-CA-C 114.089 1.144 . . . . 0.0 114.089 177.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 29.1 t -99.05 -6.4 28.56 Favored 'General case' 0 C--N 1.356 0.884 0 C-N-CA 123.938 0.895 . . . . 0.0 111.749 -177.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 60.28 46.69 9.91 Favored 'General case' 0 C--N 1.355 0.83 0 C-N-CA 127.016 2.126 . . . . 0.0 112.549 -178.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -137.19 140.26 41.64 Favored 'General case' 0 C--N 1.352 0.676 0 O-C-N 120.55 -1.344 . . . . 0.0 107.748 175.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.9 t30 -87.29 126.01 34.57 Favored 'General case' 0 C--N 1.356 0.89 0 C-N-CA 124.423 1.089 . . . . 0.0 110.856 -174.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 16.9 t -106.15 144.37 32.95 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 126.973 2.109 . . . . 0.0 109.842 175.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 16.3 m -134.51 153.06 52.13 Favored 'General case' 0 C--N 1.352 0.68 0 N-CA-C 102.209 -3.256 . . . . 0.0 102.209 170.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 38.7 t -58.87 -44.67 91.13 Favored 'General case' 0 C--N 1.356 0.872 0 CA-C-N 120.685 1.584 . . . . 0.0 114.496 -171.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -81.3 -3.95 90.55 Favored Glycine 0 C--N 1.353 1.478 0 O-C-N 121.299 -0.876 . . . . 0.0 113.989 -177.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -113.98 -48.19 2.92 Favored 'General case' 0 C--N 1.35 0.607 0 CA-C-N 117.693 0.746 . . . . 0.0 110.331 -177.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 49.93 48.97 21.09 Favored 'General case' 0 C--N 1.358 0.958 0 C-N-CA 130.492 3.517 . . . . 0.0 112.261 176.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 52.3 mm-40 -96.5 115.39 27.35 Favored 'General case' 0 C--N 1.353 0.731 0 O-C-N 120.745 -1.222 . . . . 0.0 111.714 -167.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 81.7 m -134.28 154.27 79.86 Favored Pre-proline 0 C--N 1.35 0.612 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 174.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -71.27 161.04 47.05 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.68 2.254 . . . . 0.0 111.044 168.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -63.23 130.82 46.18 Favored 'General case' 0 C--N 1.352 0.714 0 C-N-CA 123.33 0.652 . . . . 0.0 111.598 -176.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 100.63 -13.92 59.32 Favored Glycine 0 C--N 1.354 1.58 0 C-N-CA 123.754 0.692 . . . . 0.0 112.469 -173.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 82.2 m -112.71 154.51 26.02 Favored 'General case' 0 C--N 1.349 0.573 0 C-N-CA 124.022 0.929 . . . . 0.0 110.134 175.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -137.28 159.89 40.63 Favored 'General case' 0 C--N 1.354 0.783 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 -175.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 40.6 t -111.6 119.05 37.4 Favored 'General case' 0 C--N 1.35 0.624 0 CA-C-O 121.81 0.814 . . . . 0.0 109.843 174.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -92.63 69.23 1.73 Allowed Glycine 0 C--N 1.35 1.339 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 173.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 60.1 tp -105.8 123.31 47.74 Favored 'General case' 0 CA--C 1.509 -0.622 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 172.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -113.62 130.45 56.39 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 106.746 -1.576 . . . . 0.0 106.746 -173.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.2 5.04 70.26 Favored Glycine 0 C--N 1.355 1.627 0 N-CA-C 115.946 1.138 . . . . 0.0 115.946 162.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 55.9 47.13 20.71 Favored 'General case' 0 C--N 1.351 0.635 0 C-N-CA 126.357 1.863 . . . . 0.0 113.696 -170.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 -64.98 -49.29 70.86 Favored 'General case' 0 C--N 1.356 0.849 0 N-CA-C 115.098 1.518 . . . . 0.0 115.098 173.056 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -144.32 -120.81 0.08 Allowed 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 175.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 15.7 ptpt -115.27 -35.14 4.75 Favored 'General case' 0 N--CA 1.439 -1.013 0 C-N-CA 127.171 2.188 . . . . 0.0 114.238 -176.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 75.51 -162.48 53.3 Favored Glycine 0 C--N 1.355 1.638 0 O-C-N 119.993 -1.692 . . . . 0.0 110.464 -171.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 67.8 t60 -157.95 159.95 37.05 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 103.454 -2.795 . . . . 0.0 103.454 170.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 77.1 m -79.23 139.09 38.02 Favored 'General case' 0 C--N 1.352 0.717 0 CA-C-N 120.226 1.375 . . . . 0.0 112.44 175.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -124.42 155.92 38.03 Favored 'General case' 0 C--N 1.353 0.731 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 -175.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -108.23 137.39 46.29 Favored 'General case' 0 C--N 1.348 0.512 0 C-N-CA 124.645 1.178 . . . . 0.0 109.153 173.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 95.8 mt -97.14 122.73 48.98 Favored 'Isoleucine or valine' 0 C--N 1.361 1.076 0 C-N-CA 124.185 0.994 . . . . 0.0 109.288 173.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.25 158.21 43.24 Favored 'Isoleucine or valine' 0 C--N 1.35 0.611 0 C-N-CA 124.495 1.118 . . . . 0.0 109.512 177.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 97.03 -12.66 65.5 Favored Glycine 0 C--N 1.355 1.622 0 O-C-N 121.218 -0.926 . . . . 0.0 113.667 -179.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 . . . . . 0 CA--C 1.569 1.69 0 O-C-N 121.101 -1.234 . . . . 0.0 111.918 176.128 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 6.9 t80 . . . . . 0 N--CA 1.504 2.275 0 N-CA-C 116.23 1.937 . . . . 0.0 116.23 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 -120.15 151.64 38.8 Favored 'General case' 0 C--N 1.354 0.79 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 161.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.6 p -123.5 136.29 60.52 Favored 'Isoleucine or valine' 0 C--N 1.35 0.589 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 178.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 28.9 m -130.5 156.46 42.5 Favored 'Isoleucine or valine' 0 C--N 1.35 0.594 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 175.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 87.2 p -79.62 150.38 31.03 Favored 'General case' 0 C--N 1.351 0.646 0 O-C-N 121.093 -1.004 . . . . 0.0 112.375 174.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 14.4 t -98.7 -10.7 22.82 Favored 'General case' 0 C--N 1.352 0.712 0 O-C-N 121.269 -0.894 . . . . 0.0 109.748 178.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 59.73 42.83 16.25 Favored 'General case' 0 C--N 1.355 0.836 0 C-N-CA 128.208 2.603 . . . . 0.0 114.459 178.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 55.9 tptt -122.16 135.71 54.82 Favored 'General case' 0 C--N 1.35 0.623 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 172.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -88.31 127.63 35.48 Favored 'General case' 0 C--N 1.355 0.811 0 C-N-CA 125.096 1.358 . . . . 0.0 109.765 -178.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 6.7 t -119.39 133.57 55.65 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 124.973 1.309 . . . . 0.0 111.249 -177.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 88.9 m -117.98 146.22 44.17 Favored 'General case' 0 C--N 1.351 0.666 0 N-CA-C 103.987 -2.597 . . . . 0.0 103.987 -178.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 84.8 p -59.22 -41.74 89.34 Favored 'General case' 0 C--N 1.35 0.618 0 N-CA-C 116.665 2.098 . . . . 0.0 116.665 -165.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.14 -36.81 93.72 Favored Glycine 0 C--N 1.351 1.362 0 C-N-CA 124.517 1.056 . . . . 0.0 114.268 172.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 23.9 mm100 -77.57 -47.69 18.82 Favored 'General case' 0 C--N 1.351 0.654 0 C-N-CA 123.804 0.842 . . . . 0.0 111.565 -177.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 52.23 39.95 28.0 Favored 'General case' 0 C--N 1.354 0.795 0 C-N-CA 128.628 2.771 . . . . 0.0 112.69 179.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -100.97 135.84 41.77 Favored 'General case' 0 C--N 1.356 0.879 0 O-C-N 120.571 -1.331 . . . . 0.0 113.353 -168.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 72.5 m -136.88 159.93 68.24 Favored Pre-proline 0 C--N 1.352 0.681 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 161.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -69.44 160.97 47.75 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.585 2.19 . . . . 0.0 110.556 162.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -64.59 136.95 57.54 Favored 'General case' 0 C--N 1.351 0.649 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -171.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 96.86 -12.3 65.87 Favored Glycine 0 C--N 1.355 1.621 0 C-N-CA 123.918 0.77 . . . . 0.0 112.832 -175.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 72.7 m -115.19 154.71 28.51 Favored 'General case' 0 C--N 1.348 0.507 0 C-N-CA 124.494 1.117 . . . . 0.0 109.533 179.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -133.36 154.79 50.43 Favored 'General case' 0 C--N 1.354 0.777 0 O-C-N 121.184 -0.948 . . . . 0.0 110.483 -177.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 43.8 t -104.85 119.26 38.59 Favored 'General case' 0 C--N 1.355 0.821 0 C-N-CA 124.479 1.112 . . . . 0.0 109.029 -177.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -90.48 69.99 2.22 Favored Glycine 0 C--N 1.351 1.417 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 175.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -107.79 123.73 48.99 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 178.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -117.17 138.06 51.92 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 -166.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 70.7 14.63 72.83 Favored Glycine 0 C--N 1.358 1.773 0 N-CA-C 115.99 1.156 . . . . 0.0 115.99 164.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 55.96 43.79 26.71 Favored 'General case' 0 C--N 1.349 0.556 0 C-N-CA 127.629 2.371 . . . . 0.0 113.213 -169.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 59.8 m-80 -70.13 168.16 16.22 Favored 'General case' 0 C--N 1.356 0.881 0 O-C-N 120.777 -1.202 . . . . 0.0 110.924 163.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -68.42 -48.27 65.07 Favored 'General case' 0 C--N 1.349 0.554 0 N-CA-C 116.005 1.854 . . . . 0.0 116.005 -163.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 79.9 mttt -136.36 150.1 48.67 Favored 'General case' 0 C--N 1.352 0.689 0 C-N-CA 123.492 0.717 . . . . 0.0 111.324 -176.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -136.66 168.58 24.15 Favored Glycine 0 C--N 1.348 1.195 0 N-CA-C 106.683 -2.567 . . . . 0.0 106.683 171.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 70.1 t60 -125.6 144.59 50.51 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 -176.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 74.7 m -80.43 137.63 36.52 Favored 'General case' 0 C--N 1.351 0.669 0 O-C-N 121.18 -0.95 . . . . 0.0 112.885 -176.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -126.22 162.65 24.94 Favored 'General case' 0 C--N 1.357 0.928 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -174.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -123.18 136.84 54.93 Favored 'General case' 0 C--N 1.35 0.626 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 166.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 81.1 mt -100.66 127.41 53.79 Favored 'Isoleucine or valine' 0 C--N 1.358 0.945 0 C-N-CA 125.741 1.616 . . . . 0.0 109.232 175.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.37 157.24 43.17 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 C-N-CA 124.967 1.307 . . . . 0.0 109.774 177.081 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 98.71 -110.31 3.98 Favored Glycine 0 C--N 1.353 1.503 0 N-CA-C 108.922 -1.671 . . . . 0.0 108.922 -170.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 64.4 t30 . . . . . 0 CA--C 1.569 1.696 0 CA-C-O 117.057 -1.449 . . . . 0.0 114.678 174.759 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 49.4 t80 . . . . . 0 N--CA 1.503 2.222 0 N-CA-C 117.675 2.472 . . . . 0.0 117.675 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 -120.12 154.33 34.87 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 106.374 -1.713 . . . . 0.0 106.374 156.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.7 p -125.69 135.42 63.99 Favored 'Isoleucine or valine' 0 C--N 1.35 0.605 0 N-CA-C 106.271 -1.752 . . . . 0.0 106.271 170.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.687 HG22 HD11 ' A' ' 54' ' ' ILE . 27.0 m -134.0 161.46 40.85 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.912 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -179.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 89.5 p -77.15 151.99 35.07 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 121.835 0.826 . . . . 0.0 112.105 170.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 18.1 t -110.37 16.99 21.3 Favored 'General case' 0 C--N 1.352 0.706 0 C-N-CA 124.155 0.982 . . . . 0.0 110.261 -177.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 30.4 m120 57.98 36.5 26.2 Favored 'General case' 0 C--N 1.353 0.734 0 C-N-CA 127.34 2.256 . . . . 0.0 114.504 170.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 58.0 tptt -138.38 136.53 36.4 Favored 'General case' 0 C--N 1.354 0.79 0 O-C-N 121.27 -0.894 . . . . 0.0 110.32 -174.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -79.74 128.21 33.15 Favored 'General case' 0 C--N 1.356 0.884 0 C-N-CA 126.7 2.0 . . . . 0.0 112.337 178.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 12.0 t -118.01 131.6 56.46 Favored 'General case' 0 C--N 1.351 0.661 0 C-N-CA 126.584 1.954 . . . . 0.0 110.862 -179.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 12.6 m -119.89 151.93 38.14 Favored 'General case' 0 C--N 1.353 0.726 0 N-CA-C 105.279 -2.119 . . . . 0.0 105.279 -178.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 95.1 p -59.94 -37.02 78.34 Favored 'General case' 0 C--N 1.352 0.688 0 N-CA-C 115.513 1.672 . . . . 0.0 115.513 -168.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -93.02 0.12 68.91 Favored Glycine 0 C--N 1.353 1.493 0 O-C-N 121.846 -0.534 . . . . 0.0 113.811 177.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -110.97 -46.22 3.36 Favored 'General case' 0 C--N 1.35 0.629 0 CA-C-N 118.294 1.047 . . . . 0.0 111.1 179.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 31.2 m120 51.76 45.07 28.76 Favored 'General case' 0 C--N 1.359 0.979 0 C-N-CA 126.597 1.959 . . . . 0.0 114.142 -174.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -84.31 115.51 22.52 Favored 'General case' 0 C--N 1.353 0.727 0 O-C-N 121.338 -0.851 . . . . 0.0 112.503 -164.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 74.1 m -134.64 157.33 77.5 Favored Pre-proline 0 C--N 1.355 0.829 0 CA-C-O 118.478 -0.772 . . . . 0.0 109.065 172.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -70.43 159.35 53.22 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.63 2.22 . . . . 0.0 110.503 161.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -65.17 136.59 56.85 Favored 'General case' 0 C--N 1.352 0.694 0 CA-C-O 121.646 0.736 . . . . 0.0 112.63 -177.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.64 -13.57 63.92 Favored Glycine 0 C--N 1.354 1.543 0 C-N-CA 123.855 0.74 . . . . 0.0 113.112 -174.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 90.6 m -114.51 157.22 23.27 Favored 'General case' 0 C--N 1.349 0.55 0 C-N-CA 124.525 1.13 . . . . 0.0 109.947 176.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 24.8 p90 -137.57 161.17 37.15 Favored 'General case' 0 C--N 1.351 0.65 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 -172.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 43.3 t -118.35 127.36 53.62 Favored 'General case' 0 CA--C 1.507 -0.684 0 O-C-N 121.32 -0.863 . . . . 0.0 110.881 -179.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -97.19 78.63 0.67 Allowed Glycine 0 C--N 1.352 1.438 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 167.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -113.63 122.61 47.7 Favored 'General case' 0 C--N 1.352 0.679 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 168.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -119.76 146.67 45.45 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 -163.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 72.84 12.7 78.69 Favored Glycine 0 C--N 1.357 1.713 0 O-C-N 121.73 -0.606 . . . . 0.0 114.435 165.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 8.7 mp0 54.91 46.57 24.13 Favored 'General case' 0 C--N 1.351 0.638 0 C-N-CA 126.685 1.994 . . . . 0.0 113.539 -171.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -76.16 175.13 9.26 Favored 'General case' 0 C--N 1.357 0.892 0 C-N-CA 124.463 1.105 . . . . 0.0 110.409 166.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 31.0 mmtp -64.74 -48.94 72.76 Favored 'General case' 0 C--N 1.348 0.519 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 -154.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 19.4 pttp -163.74 159.05 20.96 Favored 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 178.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -137.05 -165.06 10.31 Favored Glycine 0 C--N 1.344 0.996 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 176.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 37.3 t60 -143.79 149.18 36.67 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 105.76 -1.941 . . . . 0.0 105.76 -174.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 75.0 m -81.86 143.77 31.48 Favored 'General case' 0 C--N 1.352 0.697 0 O-C-N 121.021 -1.049 . . . . 0.0 113.096 -176.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -124.46 158.56 32.54 Favored 'General case' 0 C--N 1.356 0.877 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 -174.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -117.93 136.46 53.47 Favored 'General case' 0 C--N 1.35 0.596 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 166.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 80.5 mt -96.72 127.38 48.93 Favored 'Isoleucine or valine' 0 C--N 1.356 0.857 0 C-N-CA 125.307 1.443 . . . . 0.0 108.214 167.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.687 HD11 HG22 ' A' ' 20' ' ' VAL . 4.4 mp -116.05 124.32 72.24 Favored 'Isoleucine or valine' 0 C--N 1.354 0.793 0 N-CA-C 103.718 -2.697 . . . . 0.0 103.718 -177.316 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -179.69 -173.35 44.69 Favored Glycine 0 CA--C 1.494 -1.25 0 O-C-N 120.756 -1.215 . . . . 0.0 110.487 -178.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 23.5 p30 . . . . . 0 C--O 1.261 1.699 0 CA-C-O 116.726 -1.607 . . . . 0.0 114.774 -179.001 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 22.7 t80 . . . . . 0 N--CA 1.502 2.14 0 N-CA-C 116.966 2.21 . . . . 0.0 116.966 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -124.67 148.28 48.06 Favored 'General case' 0 C--N 1.353 0.747 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 159.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.9 p -124.12 134.05 67.64 Favored 'Isoleucine or valine' 0 C--N 1.349 0.557 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 173.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 28.0 m -131.25 154.05 39.99 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.744 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 175.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 80.4 p -79.26 151.83 30.92 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 177.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 19.9 t -123.97 33.18 5.36 Favored 'General case' 0 C--N 1.355 0.804 0 CA-C-O 121.761 0.791 . . . . 0.0 109.919 -172.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 44.75 37.88 2.51 Favored 'General case' 0 C--N 1.357 0.899 0 C-N-CA 129.016 2.926 . . . . 0.0 118.267 169.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -148.81 143.17 26.16 Favored 'General case' 0 C--N 1.348 0.536 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -175.449 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 33.8 t30 -115.45 135.87 53.66 Favored 'General case' 0 C--N 1.353 0.727 0 C-N-CA 124.27 1.028 . . . . 0.0 110.568 -175.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 83.6 m -101.5 152.1 21.17 Favored 'General case' 0 C--N 1.355 0.846 0 C-N-CA 124.151 0.98 . . . . 0.0 108.54 171.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 55.5 m -128.17 156.25 43.19 Favored 'General case' 0 CA--C 1.507 -0.682 0 N-CA-C 102.046 -3.316 . . . . 0.0 102.046 174.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 46.8 t -52.53 -39.24 61.15 Favored 'General case' 0 C--N 1.349 0.57 0 N-CA-C 115.68 1.733 . . . . 0.0 115.68 -162.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -77.28 -0.96 73.25 Favored Glycine 0 C--N 1.351 1.373 0 N-CA-C 116.475 1.35 . . . . 0.0 116.475 178.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -143.58 140.78 30.36 Favored 'General case' 0 C--N 1.356 0.858 0 CA-C-N 120.347 2.073 . . . . 0.0 112.009 179.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 34.5 m120 -102.15 103.52 14.06 Favored 'General case' 0 C--N 1.352 0.715 0 O-C-N 119.973 -1.705 . . . . 0.0 106.523 170.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -126.93 94.32 4.0 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 -168.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 72.9 m -136.77 156.88 75.82 Favored Pre-proline 0 C--N 1.351 0.662 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 172.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -70.51 160.42 49.55 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.52 2.147 . . . . 0.0 110.64 164.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -62.77 134.38 56.19 Favored 'General case' 0 C--N 1.354 0.779 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -174.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.25 -11.89 65.34 Favored Glycine 0 C--N 1.355 1.61 0 C-N-CA 124.194 0.902 . . . . 0.0 113.409 -175.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 73.8 m -114.15 153.77 28.96 Favored 'General case' 0 C--N 1.348 0.518 0 C-N-CA 124.145 0.978 . . . . 0.0 110.116 179.019 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 31.5 p90 -132.5 158.22 42.65 Favored 'General case' 0 C--N 1.352 0.684 0 N-CA-C 105.699 -1.963 . . . . 0.0 105.699 178.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 9.8 p -109.69 146.66 34.48 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-O 122.531 1.157 . . . . 0.0 112.923 173.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -82.74 69.29 3.39 Favored Glycine 0 C--N 1.353 1.498 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 176.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -91.81 122.46 34.37 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 -175.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -86.02 77.34 9.66 Favored 'General case' 0 C--N 1.352 0.701 0 O-C-N 120.709 -1.244 . . . . 0.0 110.829 -161.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 62.61 45.39 95.92 Favored Glycine 0 C--N 1.355 1.594 0 N-CA-C 115.448 0.939 . . . . 0.0 115.448 166.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 48.31 43.75 19.4 Favored 'General case' 0 C--N 1.354 0.779 0 C-N-CA 128.474 2.71 . . . . 0.0 115.984 -172.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 66.0 m-80 -97.48 -74.08 0.59 Allowed 'General case' 0 C--N 1.356 0.867 0 O-C-N 121.135 -0.978 . . . . 0.0 112.509 170.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -119.66 -101.55 0.42 Allowed 'General case' 0 C--N 1.357 0.932 0 O-C-N 120.917 -1.115 . . . . 0.0 113.649 -163.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.4 pptp? -145.76 161.01 40.9 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 -175.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -162.39 151.28 21.15 Favored Glycine 0 C--N 1.349 1.297 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 -179.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 72.4 t60 -99.19 146.82 25.76 Favored 'General case' 0 C--N 1.347 0.473 0 O-C-N 121.51 -0.994 . . . . 0.0 109.883 -170.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 76.4 m -76.85 136.55 38.9 Favored 'General case' 0 C--N 1.358 0.946 0 O-C-N 121.197 -0.939 . . . . 0.0 112.015 -179.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -130.63 161.5 31.44 Favored 'General case' 0 C--N 1.351 0.649 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 -177.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 37.1 ttmt -114.28 132.81 56.03 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 164.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 96.3 mt -106.06 127.37 61.25 Favored 'Isoleucine or valine' 0 C--N 1.358 0.973 0 CA-C-O 122.632 1.206 . . . . 0.0 110.243 169.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.75 160.51 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 C-N-CA 126.879 2.071 . . . . 0.0 110.725 -176.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 95.19 -73.17 0.95 Allowed Glycine 0 C--N 1.354 1.532 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 -169.112 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 . . . . . 0 C--O 1.26 1.64 0 N-CA-C 115.426 1.639 . . . . 0.0 115.426 176.309 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 42.2 t80 . . . . . 0 N--CA 1.505 2.318 0 N-CA-C 116.815 2.154 . . . . 0.0 116.815 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 48.3 m-20 -121.65 154.57 36.63 Favored 'General case' 0 C--N 1.354 0.796 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 159.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.9 p -128.71 132.91 67.29 Favored 'Isoleucine or valine' 0 C--N 1.349 0.582 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 174.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 33.0 m -134.55 161.56 40.28 Favored 'Isoleucine or valine' 0 C--N 1.349 0.564 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 -177.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 96.8 p -76.84 155.42 32.99 Favored 'General case' 0 C--N 1.354 0.771 0 O-C-N 120.665 -1.272 . . . . 0.0 112.986 178.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 33.9 t -120.38 28.6 7.92 Favored 'General case' 0 C--N 1.355 0.812 0 C-N-CA 123.881 0.873 . . . . 0.0 109.44 -177.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 45.83 36.55 2.9 Favored 'General case' 0 C--N 1.357 0.897 0 C-N-CA 128.58 2.752 . . . . 0.0 117.452 173.02 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 50.4 tptt -140.79 138.32 34.01 Favored 'General case' 0 C--N 1.352 0.687 0 O-C-N 120.664 -1.272 . . . . 0.0 109.208 -169.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -90.99 123.02 34.14 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 126.311 1.845 . . . . 0.0 108.559 -175.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 17.5 p -112.95 172.17 7.09 Favored 'General case' 0 C--N 1.357 0.918 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 175.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 27.5 m -130.43 146.18 51.95 Favored 'General case' 0 C--N 1.35 0.593 0 N-CA-C 102.279 -3.23 . . . . 0.0 102.279 167.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.565 ' HB3' HD12 ' A' ' 41' ' ' LEU . 90.6 p -59.97 -30.72 69.3 Favored 'General case' 0 C--N 1.35 0.592 0 N-CA-C 115.966 1.839 . . . . 0.0 115.966 -172.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -93.77 -1.21 65.87 Favored Glycine 0 C--N 1.354 1.53 0 CA-C-N 118.582 0.628 . . . . 0.0 114.138 175.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -108.62 -41.46 4.8 Favored 'General case' 0 C--N 1.352 0.685 0 CA-C-N 118.266 1.033 . . . . 0.0 111.145 179.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 25.3 m120 57.06 35.74 26.76 Favored 'General case' 0 C--N 1.358 0.939 0 C-N-CA 126.93 2.092 . . . . 0.0 115.028 174.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 60.9 mm-40 -87.09 114.95 24.14 Favored 'General case' 0 C--N 1.351 0.657 0 O-C-N 120.575 -1.328 . . . . 0.0 111.386 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 73.4 m -135.93 156.9 76.87 Favored Pre-proline 0 N--CA 1.447 -0.604 0 N-CA-C 105.601 -2.0 . . . . 0.0 105.601 168.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.55 161.84 44.59 Favored 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.783 2.322 . . . . 0.0 111.497 171.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -62.42 132.88 54.02 Favored 'General case' 0 C--N 1.354 0.778 0 CA-C-O 121.783 0.802 . . . . 0.0 113.006 -174.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.37 -11.66 68.64 Favored Glycine 0 C--N 1.355 1.606 0 C-N-CA 124.06 0.838 . . . . 0.0 112.91 -172.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 71.8 m -116.56 156.13 27.5 Favored 'General case' 0 C--N 1.349 0.565 0 C-N-CA 124.178 0.991 . . . . 0.0 110.394 179.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -145.21 165.87 27.09 Favored 'General case' 0 C--N 1.349 0.553 0 N-CA-C 104.999 -2.223 . . . . 0.0 104.999 -174.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 31.5 p -128.22 153.55 46.81 Favored 'General case' 0 CA--C 1.508 -0.667 0 CA-C-N 120.262 1.392 . . . . 0.0 108.724 165.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -121.79 76.92 0.34 Allowed Glycine 0 CA--C 1.492 -1.38 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 -174.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.565 HD12 ' HB3' ' A' ' 28' ' ' SER . 3.4 tm? -106.18 124.79 50.14 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 105.944 -1.873 . . . . 0.0 105.944 177.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -113.92 140.57 48.27 Favored 'General case' 0 C--N 1.352 0.696 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 -175.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 76.78 8.7 86.53 Favored Glycine 0 C--N 1.355 1.634 0 N-CA-C 116.056 1.183 . . . . 0.0 116.056 164.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 57.83 35.89 25.88 Favored 'General case' 0 C--N 1.352 0.697 0 C-N-CA 126.865 2.066 . . . . 0.0 113.838 -175.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 60.8 m-80 -70.03 -43.77 70.61 Favored 'General case' 0 C--N 1.355 0.807 0 N-CA-C 114.228 1.195 . . . . 0.0 114.228 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 42.9 mmtm -144.13 -176.38 4.99 Favored 'General case' 0 N--CA 1.445 -0.717 0 C-N-CA 126.275 1.83 . . . . 0.0 106.465 -172.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -67.53 -45.59 75.29 Favored 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 115.878 1.806 . . . . 0.0 115.878 173.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 91.77 155.35 31.7 Favored Glycine 0 C--N 1.356 1.691 0 O-C-N 121.135 -0.978 . . . . 0.0 112.159 -168.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 81.5 t60 -137.81 143.81 41.2 Favored 'General case' 0 C--N 1.347 0.496 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 178.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 77.9 m -77.56 142.32 39.07 Favored 'General case' 0 C--N 1.353 0.747 0 CA-C-O 121.96 0.886 . . . . 0.0 113.126 -173.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -124.46 156.95 36.36 Favored 'General case' 0 C--N 1.35 0.606 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 -176.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 40.5 ttpt -112.7 136.03 52.76 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.649 1.18 . . . . 0.0 108.776 172.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 97.4 mt -98.49 125.32 51.87 Favored 'Isoleucine or valine' 0 C--N 1.359 0.994 0 C-N-CA 124.385 1.074 . . . . 0.0 108.987 175.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.92 156.26 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 C-N-CA 124.826 1.25 . . . . 0.0 109.536 178.116 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 102.25 -112.64 4.37 Favored Glycine 0 C--N 1.353 1.501 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 -172.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 . . . . . 0 C--O 1.258 1.543 0 O-C-N 121.373 -1.075 . . . . 0.0 113.523 -179.279 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 11.3 t80 . . . . . 0 N--CA 1.504 2.242 0 N-CA-C 116.3 1.963 . . . . 0.0 116.3 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -122.0 152.5 39.67 Favored 'General case' 0 C--N 1.355 0.821 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 162.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.3 p -127.1 135.94 62.14 Favored 'Isoleucine or valine' 0 C--N 1.349 0.585 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 176.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.4 m -131.21 158.0 43.27 Favored 'Isoleucine or valine' 0 C--N 1.351 0.647 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 177.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 87.7 p -81.88 157.37 24.39 Favored 'General case' 0 C--N 1.352 0.709 0 O-C-N 121.288 -0.882 . . . . 0.0 112.649 173.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 71.8 m -110.39 19.82 18.4 Favored 'General case' 0 C--N 1.355 0.847 0 O-C-N 121.413 -0.804 . . . . 0.0 111.791 177.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 47.34 39.56 9.14 Favored 'General case' 0 C--N 1.355 0.836 0 C-N-CA 127.432 2.293 . . . . 0.0 116.796 177.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 56.6 tptt -132.83 136.12 46.07 Favored 'General case' 0 C--N 1.352 0.677 0 O-C-N 121.127 -0.983 . . . . 0.0 109.006 -177.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -84.19 128.26 34.45 Favored 'General case' 0 C--N 1.354 0.786 0 C-N-CA 124.539 1.136 . . . . 0.0 110.742 -176.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 18.2 t -106.61 148.57 28.15 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 127.589 2.355 . . . . 0.0 108.93 178.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 23.3 m -133.0 154.73 50.24 Favored 'General case' 0 C--N 1.352 0.699 0 N-CA-C 102.488 -3.153 . . . . 0.0 102.488 168.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 79.4 p -58.93 -45.25 90.83 Favored 'General case' 0 C--N 1.349 0.549 0 N-CA-C 117.15 2.278 . . . . 0.0 117.15 -164.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -96.51 4.67 64.29 Favored Glycine 0 C--N 1.352 1.454 0 C-N-CA 123.605 0.622 . . . . 0.0 113.563 -176.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 11.1 mm-40 -115.96 -42.41 3.08 Favored 'General case' 0 C--N 1.346 0.433 0 O-C-N 121.82 -0.812 . . . . 0.0 109.803 178.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 56.3 45.95 22.02 Favored 'General case' 0 C--N 1.356 0.89 0 C-N-CA 128.575 2.75 . . . . 0.0 112.936 167.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -83.91 115.64 22.39 Favored 'General case' 0 C--N 1.352 0.701 0 O-C-N 121.043 -1.036 . . . . 0.0 112.742 -168.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 71.6 m -134.63 157.67 76.77 Favored Pre-proline 0 C--N 1.353 0.747 0 C-N-CA 124.785 1.234 . . . . 0.0 108.126 173.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.85 159.04 54.78 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.472 2.115 . . . . 0.0 110.618 164.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -65.09 135.17 55.23 Favored 'General case' 0 C--N 1.352 0.709 0 CA-C-O 121.599 0.714 . . . . 0.0 112.21 -176.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 97.59 -12.53 64.62 Favored Glycine 0 C--N 1.354 1.575 0 C-N-CA 123.593 0.616 . . . . 0.0 113.051 -173.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 72.2 m -113.13 155.45 24.94 Favored 'General case' 0 C--N 1.35 0.588 0 C-N-CA 124.242 1.017 . . . . 0.0 109.393 177.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -136.5 157.39 46.89 Favored 'General case' 0 C--N 1.351 0.634 0 O-C-N 121.278 -0.889 . . . . 0.0 108.729 -176.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 42.1 t -105.37 126.47 52.15 Favored 'General case' 0 CA--C 1.51 -0.57 0 O-C-N 121.205 -0.934 . . . . 0.0 111.027 -179.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.87 60.55 3.49 Favored Glycine 0 C--N 1.352 1.425 0 O-C-N 121.684 -0.635 . . . . 0.0 112.212 176.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -106.98 120.86 43.22 Favored 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 175.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -119.98 140.7 50.53 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 -176.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 75.18 5.42 76.4 Favored Glycine 0 C--N 1.355 1.603 0 N-CA-C 115.656 1.022 . . . . 0.0 115.656 161.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 56.75 42.9 26.07 Favored 'General case' 0 C--N 1.35 0.617 0 C-N-CA 126.639 1.976 . . . . 0.0 113.336 -171.669 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 54.0 m-80 -73.54 -49.37 26.84 Favored 'General case' 0 C--N 1.354 0.766 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 -178.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -140.65 -125.63 0.11 Allowed 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 177.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 16.6 pttp -107.79 -47.02 3.67 Favored 'General case' 0 N--CA 1.439 -1.009 0 C-N-CA 126.902 2.081 . . . . 0.0 114.146 -175.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 86.23 178.54 49.74 Favored Glycine 0 C--N 1.356 1.678 0 O-C-N 120.708 -1.245 . . . . 0.0 112.421 -173.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 72.7 t60 -154.12 155.24 35.04 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 105.877 -1.897 . . . . 0.0 105.877 178.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 76.4 m -86.86 135.57 33.28 Favored 'General case' 0 C--N 1.355 0.843 0 N-CA-C 113.581 0.956 . . . . 0.0 113.581 -174.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -126.52 161.32 28.24 Favored 'General case' 0 C--N 1.358 0.946 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 -174.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -122.61 135.66 54.67 Favored 'General case' 0 C--N 1.352 0.69 0 C-N-CA 124.172 0.989 . . . . 0.0 110.098 165.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 83.3 mt -88.05 127.04 41.43 Favored 'Isoleucine or valine' 0 C--N 1.359 1.017 0 C-N-CA 125.963 1.705 . . . . 0.0 109.732 169.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.98 155.86 41.97 Favored 'Isoleucine or valine' 0 C--N 1.352 0.702 0 C-N-CA 123.949 0.899 . . . . 0.0 110.325 171.303 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 107.65 -149.64 16.75 Favored Glycine 0 C--N 1.354 1.538 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -175.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 . . . . . 0 C--O 1.26 1.629 0 N-CA-C 114.807 1.41 . . . . 0.0 114.807 177.943 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 10.9 t80 . . . . . 0 N--CA 1.505 2.287 0 N-CA-C 116.349 1.981 . . . . 0.0 116.349 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -122.75 148.7 45.03 Favored 'General case' 0 C--N 1.357 0.895 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 163.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.1 p -123.7 133.14 70.06 Favored 'Isoleucine or valine' 0 C--N 1.35 0.595 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 173.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.2 m -133.22 153.78 38.08 Favored 'Isoleucine or valine' 0 C--N 1.354 0.786 0 O-C-N 121.35 -0.844 . . . . 0.0 108.975 177.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 88.2 p -80.48 150.61 29.62 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 -179.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 71.7 m -102.1 -4.5 25.82 Favored 'General case' 0 C--N 1.354 0.783 0 O-C-N 121.399 -0.813 . . . . 0.0 111.11 178.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 56.29 43.46 26.39 Favored 'General case' 0 C--N 1.357 0.918 0 C-N-CA 127.423 2.289 . . . . 0.0 115.734 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 23.4 mmmt -131.2 149.89 52.38 Favored 'General case' 0 N--CA 1.442 -0.825 0 C-N-CA 127.061 2.144 . . . . 0.0 106.08 165.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -92.52 174.52 7.23 Favored 'General case' 0 C--N 1.351 0.657 0 O-C-N 121.698 -0.626 . . . . 0.0 109.6 171.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 15.2 p -121.21 172.36 8.05 Favored 'General case' 0 C--N 1.353 0.745 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 159.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 63.1 m -135.5 144.75 46.53 Favored 'General case' 0 CA--C 1.504 -0.808 0 N-CA-C 100.975 -3.713 . . . . 0.0 100.975 168.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 37.0 t -57.76 -43.93 85.81 Favored 'General case' 0 C--N 1.356 0.88 0 CA-C-N 120.459 1.481 . . . . 0.0 114.315 -164.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.15 -44.84 58.91 Favored Glycine 0 C--N 1.355 1.592 0 O-C-N 121.023 -1.048 . . . . 0.0 115.0 175.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -69.04 -43.22 75.13 Favored 'General case' 0 C--N 1.349 0.558 0 C-N-CA 126.114 1.766 . . . . 0.0 113.579 -176.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 55.42 38.01 29.68 Favored 'General case' 0 C--N 1.354 0.804 0 C-N-CA 129.008 2.923 . . . . 0.0 113.82 176.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -68.42 127.43 32.94 Favored 'General case' 0 C--N 1.352 0.681 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 175.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 94.9 m -143.34 159.23 55.95 Favored Pre-proline 0 C--N 1.354 0.786 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 152.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -70.08 159.09 54.4 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.83 2.353 . . . . 0.0 110.551 162.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -65.61 136.74 56.73 Favored 'General case' 0 C--N 1.352 0.681 0 CA-C-O 121.58 0.705 . . . . 0.0 112.7 -175.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 95.1 -9.65 70.03 Favored Glycine 0 C--N 1.356 1.668 0 O-C-N 121.689 -0.632 . . . . 0.0 113.19 -175.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 84.2 m -114.92 155.94 25.94 Favored 'General case' 0 C--N 1.348 0.508 0 C-N-CA 124.502 1.121 . . . . 0.0 108.381 178.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -136.3 163.1 31.2 Favored 'General case' 0 C--N 1.352 0.699 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 178.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 45.2 t -119.43 124.05 45.58 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 105.931 -1.877 . . . . 0.0 105.931 178.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -83.29 78.77 1.98 Allowed Glycine 0 C--N 1.352 1.443 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 177.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -98.46 113.39 25.38 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 104.387 -2.449 . . . . 0.0 104.387 -176.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.45 HD22 ' H ' ' A' ' 42' ' ' LEU . 2.1 mm? -77.03 -49.04 16.26 Favored 'General case' 0 C--N 1.357 0.929 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -148.216 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -162.94 76.97 0.16 Allowed Glycine 0 C--N 1.349 1.287 0 N-CA-C 108.69 -1.764 . . . . 0.0 108.69 175.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.8 pm0 45.59 59.38 3.65 Favored 'General case' 0 C--N 1.354 0.8 0 C-N-CA 128.519 2.727 . . . . 0.0 116.509 -178.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 34.7 m120 -103.33 -119.59 0.2 Allowed 'General case' 0 C--N 1.352 0.698 0 C-N-CA 123.953 0.901 . . . . 0.0 109.845 -171.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.72 -101.16 0.21 Allowed 'General case' 0 C--N 1.355 0.816 0 C-N-CA 124.159 0.984 . . . . 0.0 110.874 -172.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.0 pttm -130.33 -32.39 1.77 Allowed 'General case' 0 C--N 1.355 0.831 0 N-CA-C 116.306 1.965 . . . . 0.0 116.306 -163.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 62.05 -144.79 49.21 Favored Glycine 0 C--N 1.357 1.722 0 O-C-N 119.664 -1.897 . . . . 0.0 113.338 -174.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 43.4 t60 -160.51 160.41 31.91 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 101.808 -3.404 . . . . 0.0 101.808 163.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 72.5 m -89.36 134.16 34.19 Favored 'General case' 0 C--N 1.354 0.804 0 CA-C-N 120.89 1.677 . . . . 0.0 112.091 175.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -149.77 164.58 34.9 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.186 1.395 . . . . 0.0 112.099 -178.131 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 64.0 pttt -133.98 156.08 48.82 Favored 'General case' 0 C--N 1.354 0.784 0 CA-C-O 121.499 0.666 . . . . 0.0 111.516 -173.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 91.5 mt -108.77 124.98 65.74 Favored 'Isoleucine or valine' 0 C--N 1.355 0.843 0 C-N-CA 125.522 1.529 . . . . 0.0 108.84 -175.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -132.71 157.25 42.97 Favored 'Isoleucine or valine' 0 C--N 1.35 0.601 0 C-N-CA 124.224 1.01 . . . . 0.0 108.508 173.55 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 137.93 -147.28 19.13 Favored Glycine 0 C--N 1.352 1.464 0 N-CA-C 109.029 -1.628 . . . . 0.0 109.029 -178.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 64.3 t30 . . . . . 0 CA--C 1.566 1.591 0 C-N-CA 124.192 0.997 . . . . 0.0 113.411 179.858 . . . . . . . . 0 0 . 1 stop_ save_